1.txt	NCT01778946	Condition	Huntington's disease	EXC	
1.txt	NCT01778946	Condition	multi-infarct dementia	EXC	
1.txt	NCT01778946	Condition	brain tumor	EXC	
1.txt	NCT01778946	Condition	normal pressure hydrocephalus	EXC	
1.txt	NCT01522404	Measurement	Visual & auditory acuity	INC	modified_by:adequate;
1.txt	NCT01778946	Condition	seizure disorder	EXC	
1.txt	NCT01778946	Condition	progressive supranuclear palsy	EXC	
1.txt	NCT01522404	Demographic	aged	INC	has_value:50 - 90 ( inclusive );
1.txt	NCT01778946	Condition	multiple sclerosis	EXC	
1.txt	NCT01778946	Condition	subdural hematoma	EXC	
1.txt	NCT01659398	Procedure	surgical repair	EXC	
1.txt	NCT01522404	Measurement	Modified Rosen Hachinski	INC	has_value:<=  4;
1.txt	NCT01522404	Observation	general health	INC	modified_by:Good;
1.txt	NCT01778946	Condition	head trauma	EXC	modified_by:significant;
1.txt	NCT01778946	Condition	neurologic deficits	EXC	modified_by:persistent;
1.txt	NCT01778946	Condition	structural brain abnormalities	EXC	
1.txt	NCT01522404	Drug	memantine	INC	modified_by:stable;has_TempMea:x12 wks;
1.txt	NCT01778946	Condition	DSM IV criteria	EXC	
1.txt	NCT01778946	Condition	Major depression	EXC	modified_by:Active;
1.txt	NCT01522404	Drug	Cholinesterase inhibitors	INC	modified_by:stable;has_TempMea:x12 wks;
1.txt	NCT01778946	Condition	psychiatric disorder	EXC	modified_by:another;modified_by:major;
1.txt	NCT01522404	Measurement	Geriatric Depression Scale	INC	has_value:<=  6;
1.txt	NCT01522404	Drug	psychoactive medication	INC	has_TempMea:x4 wks;
1.txt	NCT01522404	Drug	medications	INC	has_TempMea:x4 wks;modified_by:Stability;
1.txt	NCT01778946	Drug	alcohol or substance abuse or dependence	EXC	has_TempMea:within the past 2 years;
1.txt	NCT01522404	Condition	memory concern	INC	modified_by:Subjective;
1.txt	NCT01778946	Condition	systemic illness	EXC	modified_by:significant;
1.txt	NCT01778946	Condition	medical condition	EXC	modified_by:unstable;
1.txt	NCT01778946	Condition	Cognitive complaints	INC	
1.txt	NCT01778946	Condition	memory difficulties	INC	
1.txt	NCT01778946	Measurement	Cognitive Global Rating	INC	
1.txt	NCT01778946	Condition	impairment	INC	modified_by:mild;
1.txt	NCT01778946	Condition	deterioration	INC	modified_by:mild;
1.txt	NCT01778946	Condition	cerebrovascular disease	INC	modified_by:significant;is_negated:No;
1.txt	NCT01778946	Condition	myocardial infarction	EXC	has_TempMea:in the past year;
1.txt	NCT01778946	Condition	cardiovascular disease	EXC	modified_by:unstable;modified_by:severe;Specified_by:congestive heart failure ( CHF );Specified_by:angina;
1.txt	NCT01778946	Condition	congestive heart failure ( CHF )	EXC	
1.txt	NCT01778946	Condition	angina	EXC	
1.txt	NCT01778946	Condition	General cognition	INC	
1.txt	NCT00937846	Condition	healthy	INC	modified_by:Generally;
1.txt	NCT00937846	Demographic	age	INC	has_value:between 35 and 55 years;
1.txt	NCT01330160	Condition	contra-indication	EXC	
1.txt	NCT01330160	Procedure	MRI	EXC	
1.txt	NCT01330160	Condition	traumatic intracranial hemorrhage	EXC	
1.txt	NCT01330160	Condition	subarachnoidal hemorrhage	EXC	
1.txt	NCT00937846	Procedure	PET	EXC	has_TempMea:for 1 - 2 hours;
1.txt	NCT00937846	Measurement	Weight	INC	has_value:more than 50 kg;
1.txt	NCT01522404	Measurement	lacunes	INC	modified_by:multiple;
1.txt	NCT00937846	Condition	Asthma	EXC	
1.txt	NCT01522404	Measurement	lacunes	INC	
1.txt	NCT01522404	Condition	large vessel infarction	INC	
1.txt	NCT01522404	Condition	focal structural lesion	INC	modified_by:other;
1.txt	NCT00937846	Condition	Psychiatric disorder	EXC	
1.txt	NCT01522404	Procedure	MRI scan	INC	
1.txt	NCT01778946	Condition	Alzheimer's disease/dementia	INC	is_negated:cannot;
1.txt	NCT01522404	Condition	infection	INC	
1.txt	NCT00937846	Condition	ECG abnormality	EXC	
1.txt	NCT01522404	Condition	neurologic disease	INC	Specified_by:MCI;modified_by:Significant;
1.txt	NCT00937846	Drug	tobacco- or nicotine-containing products	EXC	
1.txt	NCT01522404	Condition	MCI	INC	is_negated:other than;
1.txt	NCT01522404	Condition	Contraindication	INC	Specified_by:pacemakers;Specified_by:foreign objects;Specified_by:ear implants;Specified_by:metal fragments;Specified_by:aneurysm clips;Specified_by:artificial heart valves;
1.txt	NCT00937846	Condition	Medical illness	EXC	
1.txt	NCT01522404	Procedure	MRI	INC	
1.txt	NCT00937846	Condition	claustrophobia	EXC	
1.txt	NCT00937846	Condition	asthma	EXC	
1.txt	NCT00937846	Observation	Smoker	EXC	
1.txt	NCT00937846	Condition	Abuse of drugs or alcohol	EXC	
1.txt	NCT00937846	Procedure	MRI	EXC	has_TempMea:for 1 - 2 hours;
1.txt	NCT00937846	Condition	blood supply	INC	modified_by:Adequate;
1.txt	NCT00937846	Measurement	BMI	INC	has_value:within the range 19 - 29 kg/m2;
1.txt	NCT00596284	Condition	psychosis	EXC	has_TempMea:Current;
1.txt	NCT01778946	Condition	gastrointestinal bleeding	EXC	has_TempMea:within two years;modified_by:active or occult;
1.txt	NCT01522404	Condition	schizophrenia	INC	has_TempMea:within last 3 mos;
1.txt	NCT01778946	Condition	ulcer disease	EXC	
1.txt	NCT01522404	Condition	bipolar disorder	INC	has_TempMea:within past yr;
1.txt	NCT00596284	Condition	Suicidal intent	EXC	
1.txt	NCT00596284	Measurement	Neuropsychiatric Inventory ( NPI )	INC	has_value:4;
1.txt	NCT01778946	Condition	gastrointestinal disorder	EXC	modified_by:Clinically significant;modified_by:unstable;Specified_by:ulcer disease;
1.txt	NCT01522404	Condition	Major depression	INC	has_TempMea:within past yr;
1.txt	NCT01778946	Condition	laboratory test abnormalities	EXC	modified_by:Clinically significant;
1.txt	NCT01522404	Measurement	Wechsler Memory Scale-Revised	INC	
1.txt	NCT01778946	Measurement	hematology	EXC	
1.txt	NCT01522404	Condition	agitation	INC	has_TempMea:within last 3 mos;
1.txt	NCT00596284	Condition	substance abuse	EXC	has_TempMea:within 1 month;
1.txt	NCT01522404	Condition	behavioral problems	INC	has_TempMea:within last 3 mos;
1.txt	NCT00596284	Condition	bipolar disorder	EXC	has_TempMea:Current;
1.txt	NCT01522404	Condition	Psychotic features	INC	has_TempMea:within last 3 mos;
1.txt	NCT01522404	Procedure	metal fragments	INC	
1.txt	NCT00596284	Condition	Alzheimer's disease	INC	modified_by:mild or moderate;
1.txt	NCT01522404	Procedure	foreign objects	INC	
1.txt	NCT01522404	Procedure	artificial heart valves	INC	
1.txt	NCT00937846	Procedure	ferromagnetic metal foreign bodies	EXC	modified_by:other;
1.txt	NCT01522404	Procedure	ear implants	INC	
1.txt	NCT00937846	Condition	Neurological disorder	EXC	
1.txt	NCT01522404	Procedure	pacemakers	INC	
1.txt	NCT00937846	Procedure	cardiac pacemaker	EXC	
1.txt	NCT01522404	Procedure	aneurysm clips	INC	
1.txt	NCT00937846	Procedure	electrical device	EXC	modified_by:other;
1.txt	NCT01778946	Condition	asthma	EXC	modified_by:Clinically significant;
1.txt	NCT01522404	Condition	suicide risk	INC	modified_by:Clinically significant;
1.txt	NCT00596284	Measurement	Clinical Dementia Rating ( CDR ) Scale	INC	has_value:0.5 to 2.0;
1.txt	NCT01522404	Condition	Suicide attempt	INC	has_TempMea:within past yr;
1.txt	NCT00596284	Condition	anxiety	INC	modified_by:Significant;
1.txt	NCT01522404	Measurement	weight	INC	modified_by:excessive;
1.txt	NCT01778946	Condition	obstructive pulmonary disease	EXC	modified_by:Clinically significant;
1.txt	NCT01659398	Demographic	age	INC	has_value:between 18 and 85 years;
1.txt	NCT01522404	Condition	hypertension	INC	modified_by:untreated;
1.txt	NCT01659398	Measurement	Hachinski Ischemic Index	EXC	
1.txt	NCT01522404	Condition	hepatic insufficiency	INC	
1.txt	NCT01778946	Drug	investigational drugs	EXC	has_TempMea:within 30 days or 5 half-lives;
1.txt	NCT01659398	Condition	postmenopausal	INC	has_TempMea:at least 1 year;
1.txt	NCT01522404	Condition	pheochromocytoma	INC	
1.txt	NCT01522404	Condition	narrow angle glaucoma	INC	
1.txt	NCT01659398	Measurement	CDR ( Clinical Dementia Rating ) Score	INC	has_value:0.5;
1.txt	NCT01522404	Condition	cardiac problems	INC	modified_by:serious;
1.txt	NCT01522404	Condition	cardiovascular or cerebrovascular disease	INC	modified_by:untreated;
1.txt	NCT01522404	Condition	Allergic	INC	
1.txt	NCT01778946	Condition	diabetes mellitus	EXC	modified_by:uncontrolled;
1.txt	NCT01778946	Procedure	ECG	EXC	
1.txt	NCT01522404	Measurement	methylmalonic acid	INC	modified_by:clinical significance;
1.txt	NCT01778946	Condition	diabetes	EXC	modified_by:Insulin-requiring;
1.txt	NCT01778946	Measurement	chemistry	EXC	
1.txt	NCT01522404	Condition	alcohol or substance abuse/dependence	INC	has_TempMea:within past 2 yrs;
1.txt	NCT01778946	Measurement	urinalysis	EXC	
1.txt	NCT01522404	Condition	memory deficits	INC	
1.txt	NCT01522404	Measurement	homocysteine	INC	modified_by:clinical significance;
1.txt	NCT01778946	Measurement	Modified Hachinski score	INC	has_value:less than or equal to 4;
1.txt	NCT01778946	Demographic	Age	INC	has_value:25+;
1.txt	NCT01522404	Drug	atomoxetine	INC	
1.txt	NCT01778946	Drug	medications	INC	modified_by:Stable;has_TempMea:at least 1 month;
1.txt	NCT01778946	Measurement	diastolic BP	EXC	has_value:> 100;
1.txt	NCT01522404	Condition	medical condition	INC	
1.txt	NCT01778946	Condition	hypertension	EXC	modified_by:Uncontrolled;
1.txt	NCT01522404	Condition	medical condition	INC	modified_by:Uncontrolled;
1.txt	NCT01778946	Condition	DSM-IV	EXC	
1.txt	NCT01778946	Measurement	systolic BP	EXC	has_value:> 170;
1.txt	NCT01522404	Condition	contraindication	INC	Specified_by:cardiovascular or cerebrovascular disease;Specified_by:hepatic insufficiency;Specified_by:hypertension;
1.txt	NCT01522404	Drug	atomoxetine	INC	
1.txt	NCT01778946	Drug	Central nervous system ( CNS ) medications	INC	modified_by:stable;has_TempMea:for 3 months;
1.txt	NCT01659398	Condition	bleeding diathesis	EXC	
1.txt	NCT01522404	Condition	lactating	INC	
1.txt	NCT01659398	Condition	arrhythmias	EXC	
1.txt	NCT01522404	Drug	neuroleptics	INC	has_TempMea:current;
1.txt	NCT01522404	Drug	chronic anxiolytics	INC	has_TempMea:current;
1.txt	NCT01778946	Condition	major depression	INC	is_negated:No;
1.txt	NCT01778946	Measurement	visual and auditory acuity	INC	modified_by:Adequate;
1.txt	NCT01659398	Condition	pregnant	EXC	
1.txt	NCT01778946	Procedure	neuropsychological testing	INC	
1.txt	NCT01659398	Measurement	blood pressure	EXC	has_value:higher than 180 - 110 mmHg;
1.txt	NCT01522404	Drug	anti-psychotics	INC	has_TempMea:Current;
1.txt	NCT01659398	Condition	lower extremity vaso-occlusive disease	EXC	modified_by:severe;
1.txt	NCT01522404	Drug	monoamine oxidase inhibitor	INC	has_TempMea:within 60 days;
1.txt	NCT01778946	Observation	general health	INC	modified_by:Good;
1.txt	NCT01659398	Condition	aortic aneurysm	EXC	
1.txt	NCT01522404	Drug	potent CYP2D6 inhibitor	INC	has_TempMea:within 60 days;
1.txt	NCT01522404	Drug	warfarin	INC	has_TempMea:Current;
1.txt	NCT01659398	Condition	thrombophlebitis	EXC	modified_by:active;
1.txt	NCT01522404	Drug	sedative hypnotics	INC	has_TempMea:current;
1.txt	NCT01659398	Condition	glaucoma	EXC	
1.txt	NCT01659398	Condition	surgically sterile	INC	
1.txt	NCT01522404	Condition	abnormal findings	INC	modified_by:Clinically significant;
1.txt	NCT01778946	Condition	additional diseases	INC	is_negated:no;
1.txt	NCT01778946	Measurement	B12	INC	modified_by:Normal;
1.txt	NCT01778946	Measurement	rapid plasma reagin ( RPR )	INC	modified_by:Normal;
1.txt	NCT01778946	Measurement	Thyroid Function Tests	INC	modified_by:Normal;
1.txt	NCT01778946	Condition	abnormalities	INC	is_negated:without;modified_by:clinically significant;
1.txt	NCT01659398	Drug	dabigatran	EXC	Specified_by:Pradaxa;has_TempMea:Currently;
1.txt	NCT01659398	Drug	Pradaxa	EXC	
1.txt	NCT01522404	Condition	pregnant	INC	
1.txt	NCT01659398	Drug	tropicamide	EXC	
1.txt	NCT01522404	Measurement	Vitamin B12 level	INC	modified_by:Low;
1.txt	NCT01778946	Procedure	ECG	INC	
1.txt	NCT01659398	Drug	warfarin	EXC	has_TempMea:Currently;
1.txt	NCT01659398	Drug	ophthalmic dilating agents	EXC	Specified_by:phenylephrine;Specified_by:tropicamide;
1.txt	NCT01522404	Measurement	LFTs	INC	modified_by:Abnormalities;
1.txt	NCT01659398	Drug	phenylephrine	EXC	
1.txt	NCT01522404	Measurement	Vitamin B12 level	INC	modified_by:Abnormalities;
1.txt	NCT01659398	Condition	adverse effects	EXC	
1.txt	NCT01522404	Measurement	TFTs	INC	modified_by:Abnormalities;
1.txt	NCT01522404	Condition	amnestic MCI	INC	modified_by:single;modified_by:multi-domain;
1.txt	NCT01778946	Condition	abnormalities	INC	modified_by:clinically significant;is_negated:without;
1.txt	NCT01330160	Condition	hemispheric stroke	INC	
1.txt	NCT01330160	Condition	stroke	INC	has_TempMea:from less 72h;
1.txt	NCT01778946	Condition	lactating	INC	is_negated:not;
1.txt	NCT01778946	Condition	pregnant	INC	is_negated:not;
1.txt	NCT01778946	Drug	drugs with cholinergic properties	INC	Specified_by:donepezil;is_negated:no;
1.txt	NCT01522404	Measurement	Memory Box score	INC	has_value:>=  0.5;
1.txt	NCT01778946	Drug	donepezil	INC	
1.txt	NCT01522404	Measurement	Clinical Dementia Rating	INC	has_value:0.5;
1.txt	NCT01330160	Condition	malformative intracranial hemorrhage	EXC	
1.txt	NCT01522404	Measurement	MMSE score	INC	has_value:24 - 30 inclusive;
1.txt	NCT01330160	Condition	non hemispheric stroke	EXC	
1.txt	NCT01522404	Condition	memory	INC	modified_by:Abnormal;
1.txt	NCT01330160	Measurement	IQ-code	INC	has_value:< 64;
1.txt	NCT01522404	Drug	anti-depressant medications	INC	Specified_by:venlafaxine;has_TempMea:Current;Specified_by:duloxetine;Specified_by:amitryptiline;Specified_by:desvenlafaxine;Specified_by:imipramine;
1.txt	NCT01659398	Measurement	heart rate	EXC	has_value:more than 120 bpm;
1.txt	NCT01778946	Drug	supplements	INC	modified_by:other;is_negated:not;Specified_by:multivitamins;
1.txt	NCT01522404	Drug	duloxetine	INC	
1.txt	NCT01778946	Drug	vitamin	INC	modified_by:other;is_negated:not;
1.txt	NCT01522404	Drug	venlafaxine	INC	
1.txt	NCT01778946	Drug	multivitamins	INC	is_negated:other than;
1.txt	NCT01778946	Measurement	urine pregnancy test	INC	modified_by:Negative;
1.txt	NCT01778946	Condition	Alzheimer's disease	EXC	
1.txt	NCT01778946	Condition	neurologic disease	EXC	Specified_by:Alzheimer's disease;modified_by:significant;Specified_by:multi-infarct dementia;Specified_by:Parkinson's disease;Specified_by:normal pressure hydrocephalus;Specified_by:Huntington's disease;Specified_by:progressive supranuclear palsy;Specified_by:brain tumor;Specified_by:seizure disorder;Specified_by:multiple sclerosis;Specified_by:subdural hematoma;
1.txt	NCT01659398	Procedure	pacemakers	EXC	
1.txt	NCT01522404	Measurement	Cerebrospinal fluid profile	INC	
1.txt	NCT01778946	Condition	Parkinson's disease	EXC	
1.txt	NCT01659398	Procedure	metallic implantable devices	EXC	modified_by:other;
1.txt	NCT01522404	Condition	AD	INC	
1.txt	NCT01522404	Drug	total radiation dose exposure	INC	has_value:> limits of annual & total dose;
1.txt	NCT01659398	Condition	vascular disease	EXC	modified_by:severe;
1.txt	NCT01522404	Drug	amitryptiline	INC	
1.txt	NCT01659398	Condition	valvular disease	EXC	modified_by:clinically significant;
1.txt	NCT01522404	Drug	radioactive agents	INC	has_TempMea:Current/recent;
1.txt	NCT01522404	Drug	desvenlafaxine	INC	
1.txt	NCT01522404	Drug	imipramine	INC	
10.txt	NCT01079819	Condition	Hypertension	EXC	
10.txt	NCT00966017	Condition	Psychiatric diagnosis	EXC	has_TempMea:within 3 months;
10.txt	NCT00966017	Condition	depressed	INC	is_negated:not;has_TempMea:currently;
10.txt	NCT00966017	Condition	drug dependence	EXC	has_TempMea:Current;
10.txt	NCT01203384	Observation	health	INC	modified_by:good;
10.txt	NCT01023425	Condition	AD	INC	modified_by:probable;
10.txt	NCT01023425	Measurement	Korean version Mini-Mental State Examination scores	INC	has_value:between 10 and 26;
10.txt	NCT00966017	Drug	thyroid replacement therapy	INC	
10.txt	NCT00966017	Drug	antihypertensives	INC	
10.txt	NCT00966017	Drug	estrogen replacement therapy	INC	
10.txt	NCT00966017	Condition	major depression	INC	is_negated:no;has_TempMea:2 years;
10.txt	NCT00966017	Procedure	treatment	EXC	has_TempMea:within 3 months;
10.txt	NCT01023425	Condition	cognitive decline	INC	has_value:at least 6 months;modified_by:progressive;modified_by:gradual in onset;
10.txt	NCT00966017	Condition	abnormalities	INC	is_negated:without;modified_by:significant;
10.txt	NCT01023425	Condition	AD	EXC	is_negated:other than;
10.txt	NCT01023425	Condition	neurodegenerative diseases	EXC	Specified_by:Parkinson's disease;Specified_by:Huntington's disease;Specified_by:AD;
10.txt	NCT01023425	Condition	Huntington's disease	EXC	
10.txt	NCT01023425	Condition	Parkinson's disease	EXC	
10.txt	NCT01023425	Condition	Psychiatric disorder	EXC	
10.txt	NCT00966017	Drug	antidepressants	INC	modified_by:stable;has_TempMea:> 1 month;
10.txt	NCT00966017	Measurement	MMSE score	INC	has_value:between 24 and 30;
10.txt	NCT00966017	Measurement	Screening laboratory tests	INC	
10.txt	NCT00966017	Procedure	ECG	INC	
10.txt	NCT01023425	Condition	behavioral disturbances	EXC	modified_by:severe;
10.txt	NCT01023425	Condition	Cerebral injuries	EXC	
10.txt	NCT01023425	Drug	psychotropic medications	EXC	
10.txt	NCT01023425	Condition	hypoxia	EXC	
10.txt	NCT01023425	Condition	trauma	EXC	
10.txt	NCT01023425	Condition	ischemia	EXC	
10.txt	NCT01023425	Condition	cerebrovascular disease	EXC	modified_by:Clinically active;
10.txt	NCT01227252	Condition	Healthy	INC	
10.txt	NCT01227252	Condition	non-childbearing potential	INC	
10.txt	NCT01227252	Measurement	Body mass index	INC	has_value:between 18.0 - 32.0 kg/m2;
10.txt	NCT01227252	Drug	over-the-counter	EXC	
10.txt	NCT01227252	Drug	vitamins	EXC	is_negated:exception;
10.txt	NCT01227252	Drug	minerals	EXC	is_negated:exception;
10.txt	NCT01227252	Observation	Smoke	EXC	has_value:more than 10 cigarettes per day;
10.txt	NCT01023425	Condition	seizure disorder	EXC	
10.txt	NCT00966017	Condition	euthyroid	INC	
10.txt	NCT01023425	Condition	physical conditions	EXC	modified_by:Other;
10.txt	NCT00987220	Demographic	ages	INC	has_value:18 and 55 years, inclusive;
10.txt	NCT00987220	Condition	Healthy	INC	
10.txt	NCT00987220	Condition	Healthy	INC	
10.txt	NCT00987220	Condition	abnormalities	INC	
10.txt	NCT00966017	Condition	lacunes	EXC	
10.txt	NCT00966017	Condition	Parkinson's Disease	EXC	
10.txt	NCT00966017	Condition	TIAs	EXC	
10.txt	NCT00966017	Condition	carotid bruits	EXC	
10.txt	NCT00966017	Condition	cognitive deterioration	EXC	
10.txt	NCT00966017	Condition	Karyotype DX of trisomy	INC	
10.txt	NCT00966017	Condition	neurological or other physical illness	EXC	
10.txt	NCT00966017	Condition	myocardial infarction	EXC	has_TempMea:within the previous year;
10.txt	NCT00966017	Condition	Down syndrome	INC	
10.txt	NCT00966017	Condition	translocation DS Mosaic form	INC	
10.txt	NCT00987220	Measurement	clinical laboratory tests	INC	
10.txt	NCT00987220	Measurement	Body Mass Index ( BMI )	INC	has_value:18 to 33 kg/m2;
10.txt	NCT00966017	Condition	psychiatric disorders	EXC	Specified_by:schizophrenia;modified_by:Major;Specified_by:bipolar disorder;
10.txt	NCT00987220	Measurement	pulse rate measurement	INC	
10.txt	NCT00966017	Condition	diabetes	EXC	modified_by:clinically significant;
10.txt	NCT00987220	Procedure	12 -lead ECG	INC	
10.txt	NCT00966017	Condition	cancer	EXC	modified_by:clinically significant;
10.txt	NCT00987220	Measurement	full physical examination	INC	Specified_by:blood pressure;Specified_by:pulse rate measurement;Specified_by:clinical laboratory tests;Specified_by:12 -lead ECG;
10.txt	NCT00987220	Measurement	blood pressure	INC	
10.txt	NCT00966017	Condition	pulmonary disease	EXC	modified_by:clinically significant;
10.txt	NCT00966017	Measurement	psychometric test results	EXC	
10.txt	NCT00966017	Condition	schizophrenia	EXC	
10.txt	NCT00987220	Measurement	total body weight	INC	has_value:> 50 kg ( 110 lbs );
10.txt	NCT00966017	Drug	Medicines	EXC	
10.txt	NCT00966017	Condition	bipolar disorder	EXC	
10.txt	NCT00966017	Measurement	diastolic BP	EXC	has_value:> 100;
10.txt	NCT00966017	Measurement	systolic BP	EXC	has_value:> 170;
10.txt	NCT00966017	Condition	hypertension	EXC	modified_by:Uncontrolled;
10.txt	NCT00966017	Condition	cardiac disease	EXC	modified_by:unstable;
10.txt	NCT00987220	Observation	medical history	INC	
10.txt	NCT00966017	Condition	liver disease	EXC	modified_by:significant;
10.txt	NCT00987220	Measurement	urine drug screen	EXC	modified_by:positive;
10.txt	NCT01227252	Drug	prescription medication	EXC	
10.txt	NCT00987220	Drug	alcohol	EXC	modified_by:regular;has_value:exceeding 14 drinks/week;has_TempMea:within 6 months;
10.txt	NCT00966017	Condition	alcoholism	EXC	has_TempMea:Current;
10.txt	NCT00987220	Drug	dietary supplements	EXC	has_TempMea:within 7 days or 5 half-lives;
10.txt	NCT00966017	Drug	investigational drugs	EXC	has_TempMea:within the previous month or longer;
10.txt	NCT00987220	Drug	prescription or nonprescription drugs	EXC	has_TempMea:within 7 days or 5 half-lives;
10.txt	NCT00966017	Condition	depression	EXC	modified_by:untreated;
10.txt	NCT00987220	Drug	vitamins	EXC	has_TempMea:within 7 days or 5 half-lives;
10.txt	NCT00966017	Condition	anxiety	EXC	modified_by:untreated;
10.txt	NCT00987220	Drug	tobacco- or nicotine-containing products	EXC	has_value:excess of the equivalent of 5 cigarettes per day;
10.txt	NCT01079819	Condition	be venipunctured	EXC	is_negated:Inability;
10.txt	NCT00966017	Drug	benzodiazepines	EXC	
10.txt	NCT00987220	Condition	drug allergies	EXC	
10.txt	NCT00966017	Drug	clonidine	EXC	
10.txt	NCT00966017	Drug	anti-Parkinsonian medications	EXC	
10.txt	NCT00966017	Drug	centrally active beta-blockers	EXC	
10.txt	NCT00987220	Condition	hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurological or allergic disease	EXC	modified_by:clinically significant;Specified_by:seasonal allergies;Specified_by:drug allergies;
10.txt	NCT00966017	Drug	narcotics	EXC	
10.txt	NCT01227252	Drug	caffeine containing beverages	EXC	Specified_by:coffee;Specified_by:tea;has_value:more than 5 cups;has_value:per day;
10.txt	NCT01227252	Drug	tea	EXC	
10.txt	NCT01227252	Drug	coffee	EXC	
10.txt	NCT01203384	Observation	medical history	INC	
10.txt	NCT00966017	Drug	anti-convulsants	EXC	
10.txt	NCT00966017	Drug	warfarin	EXC	
10.txt	NCT01203384	Measurement	complete physical examination	INC	Specified_by:12 -lead electrocardiogram ( ECG );Specified_by:vital signs;
10.txt	NCT01079819	Drug	oral medication	EXC	is_negated:Inability;
10.txt	NCT00987220	Condition	febrile illness	EXC	has_TempMea:within 5 days;
10.txt	NCT00966017	Drug	systemic corticosteroids	EXC	
10.txt	NCT01203384	Measurement	vital signs	INC	Specified_by:standard laboratory tests;
10.txt	NCT00987220	Condition	seasonal allergies	EXC	modified_by:asymptomatic;modified_by:untreated;is_negated:excluding;
10.txt	NCT00966017	Drug	medications with significant cholinergic or anticholinergic effects	EXC	
10.txt	NCT00987220	Condition	childbearing potential	EXC	
10.txt	NCT00966017	Condition	Lewy body	EXC	
10.txt	NCT00966017	Condition	frontotemporal	EXC	
10.txt	NCT00966017	Condition	Down syndrome	EXC	
10.txt	NCT01203384	Procedure	12 -lead electrocardiogram ( ECG )	INC	
10.txt	NCT01203384	Measurement	standard laboratory tests	INC	
10.txt	NCT01203384	Measurement	liver function tests	EXC	modified_by:Abnormal;
10.txt	NCT01203384	Condition	cardiovascular, hepatic or renal disease	EXC	modified_by:major;has_TempMea:within the last 10 years;
10.txt	NCT01023425	Measurement	NINCDS-ADRDA	INC	
10.txt	NCT01203384	Measurement	renal function tests	EXC	modified_by:Abnormal;
10.txt	NCT00987220	Condition	papilledema	EXC	
10.txt	NCT00966017	Condition	neurological disorder or disease	EXC	modified_by:clinically significant;
10.txt	NCT00987220	Measurement	laboratory values	EXC	modified_by:clinically significant;modified_by:outside the normal ranges;
10.txt	NCT00987220	Procedure	Blood donation	EXC	has_TempMea:within 56 days;has_value:approximately 1 pint ( 500 mL );
10.txt	NCT00987220	Procedure	non-pharmacological methods	EXC	is_negated:exception;
10.txt	NCT00966017	Condition	claustrophobia	EXC	
10.txt	NCT01079819	Condition	venous access	EXC	is_negated:Inability;
10.txt	NCT00987220	Drug	analgesics	EXC	is_negated:exception;
10.txt	NCT00966017	Condition	Contraindication	EXC	Specified_by:claustrophobia;Specified_by:metal;
10.txt	NCT00987220	Drug	caffeine	EXC	is_negated:exception;
10.txt	NCT00966017	Procedure	MRI scan	EXC	
10.txt	NCT01203384	Measurement	thyroid tests	EXC	modified_by:Abnormal;
10.txt	NCT01203384	Condition	allergic conditions	EXC	modified_by:Significant;
10.txt	NCT01203384	Drug	psychoactive, recreational or prescription drug	EXC	has_TempMea:within the 4 weeks;
10.txt	NCT01203384	Drug	sulindac sulfide	EXC	has_TempMea:within 2 weeks;
10.txt	NCT01203384	Drug	ibuprofen	EXC	has_TempMea:within 2 weeks;
10.txt	NCT01203384	Drug	flurbiprofen	EXC	has_TempMea:within 2 weeks;
10.txt	NCT00987220	Condition	Pregnant	EXC	
10.txt	NCT00966017	Condition	MCI	EXC	
10.txt	NCT01203384	Drug	indomethacin	EXC	has_TempMea:within 2 weeks;
10.txt	NCT00987220	Condition	nursing	EXC	
10.txt	NCT00966017	Condition	vascular	EXC	
10.txt	NCT00987220	Drug	investigational drug	EXC	has_TempMea:within 30 days;
10.txt	NCT00966017	Condition	dementia	EXC	modified_by:other;Specified_by:vascular;Specified_by:Lewy body;Specified_by:frontotemporal;
10.txt	NCT00987220	Drug	aspirin containing products	EXC	
10.txt	NCT00987220	Drug	non-steroidal anti-inflammatory agents	EXC	
10.txt	NCT00966017	Condition	AD	EXC	modified_by:possible or probable;
10.txt	NCT00966017	Procedure	metal	EXC	
10.txt	NCT00987220	Drug	Aspirin	EXC	
10.txt	NCT00987220	Condition	medical or psychiatric condition/status	EXC	modified_by:acute or chronic;
10.txt	NCT01079819	Condition	Healthy	INC	
10.txt	NCT00987220	Condition	laboratory abnormality	EXC	
10.txt	NCT01023425	Procedure	treatment	EXC	modified_by:acute;
10.txt	NCT01079819	Condition	postmenopausal	INC	
10.txt	NCT01079819	Condition	childbearing potential	EXC	
10.txt	NCT00966017	Condition	Mosaic form of Down syndrome	EXC	
10.txt	NCT01079819	Condition	Bleeding disorders	EXC	
10.txt	NCT01079819	Condition	Gastrointestinal disorders	EXC	
10.txt	NCT00966017	Measurement	visual and auditory acuity	INC	modified_by:Adequate;
10.txt	NCT00966017	Condition	cerebrovascular disease	INC	modified_by:significant;is_negated:No;
10.txt	NCT00966017	Measurement	modified Ischemic Score	INC	has_value:< 4;
10.txt	NCT00966017	Demographic	Age	INC	has_value:45 years or older;
10.txt	NCT00987220	Measurement	Coagulation indices	EXC	Specified_by:PT/aPTT;Specified_by:platelet count;
10.txt	NCT00987220	Measurement	PT/aPTT	EXC	
10.txt	NCT01079819	Condition	Peptic ulcer disease	EXC	
10.txt	NCT01079819	Procedure	ECG	EXC	modified_by:Abnormal;
10.txt	NCT00987220	Measurement	platelet count	EXC	
10.txt	NCT00966017	Condition	Down syndrome	INC	
10.txt	NCT01079819	Measurement	Clinical laboratory tests	EXC	modified_by:Abnormal;
10.txt	NCT01079819	Measurement	Thyroid	EXC	modified_by:Abnormal;
10.txt	NCT01079819	Procedure	Cholecystectomy	EXC	
10.txt	NCT01079819	Condition	Congestive heart failure	EXC	
10.txt	NCT01079819	Condition	Asthma	EXC	
10.txt	NCT00966017	Condition	anticholinergic effects	INC	is_negated:without;
10.txt	NCT00987220	Condition	abnormalities	EXC	modified_by:other;
10.txt	NCT00987220	Procedure	lumbar puncture ( LP )	EXC	is_negated:exclude;
10.txt	NCT00987220	Condition	local infection	EXC	
10.txt	NCT00966017	Procedure	MRI scan	EXC	
10.txt	NCT00987220	Condition	lower spinal malformations	EXC	
11.txt	NCT02420756	Procedure	therapy	EXC	
11.txt	NCT02420756	Condition	medical co-morbidities	EXC	
11.txt	NCT02363504	Measurement	Mini-Mental State Examination ( MMSE )	INC	has_value:>= 23;
11.txt	NCT02363504	Measurement	Clinical Dementia Rating score	INC	has_value:0.5;
11.txt	NCT02363504	Condition	mentally competent	INC	
11.txt	NCT01421056	Drug	memantine	EXC	has_value:> 20 mg/day;has_TempMea:Concomitant;
11.txt	NCT02363504	Condition	alcohol/drug abuse	EXC	
11.txt	NCT01421056	Drug	rivastigmine	EXC	
11.txt	NCT01421056	Drug	galantamine	EXC	
11.txt	NCT02363504	Condition	Cognitive impairment	EXC	
11.txt	NCT02363504	Condition	Abuse of alcohol and drugs	EXC	
11.txt	NCT01421056	Drug	cholinesterase inhibitors	EXC	Specified_by:galantamine;modified_by:other;Specified_by:rivastigmine;
11.txt	NCT01421056	Drug	donepezil	EXC	has_value:> 5 mg/day;has_TempMea:Concomitant;
11.txt	NCT02363504	Drug	Psychoactive medication	EXC	
11.txt	NCT02363504	Condition	Reduced vision	EXC	
11.txt	NCT01421056	Drug	psychoactive drugs	EXC	has_TempMea:Concomitant;Specified_by:sedatives;Specified_by:hypnotics;
11.txt	NCT01421056	Drug	sedatives	EXC	
11.txt	NCT02363504	Measurement	neuropsychological test results	INC	modified_by:Average;
11.txt	NCT02363504	Measurement	MMSE	INC	has_value:>= 18;
11.txt	NCT02363504	Demographic	Age	INC	has_value:between 60 and 85 years old;
11.txt	NCT02363504	Condition	substantial memory complaints	INC	is_negated:No;
11.txt	NCT02363504	Demographic	Age	INC	has_value:between 60 and 85 years old;
11.txt	NCT01421056	Condition	inflammatory bowel disease	EXC	modified_by:chronic;
11.txt	NCT00825084	Procedure	active peptic ulcer	EXC	has_TempMea:within last 3 months;
11.txt	NCT00825084	Observation	drug absorption	EXC	
11.txt	NCT02120664	Condition	AD	INC	modified_by:probable;
11.txt	NCT00825084	Procedure	gastrectomy	EXC	
11.txt	NCT02120664	Measurement	MMSE	INC	has_value:>= 16 and <= 26;
11.txt	NCT02363504	Condition	vascular disorders	EXC	Specified_by:stroke;modified_by:Major;
11.txt	NCT00825084	Measurement	total body weight	INC	has_value:within the range of 50 to 100 kg;
11.txt	NCT02120664	Condition	dementia	INC	
11.txt	NCT02363504	Condition	Menire's disease	EXC	
11.txt	NCT02363504	Condition	brain infections	EXC	
11.txt	NCT02363504	Procedure	electroshock therapy	EXC	
11.txt	NCT00884533	Condition	child bearing potential	INC	
11.txt	NCT02120664	Demographic	age	INC	has_value:>= 50 years;
11.txt	NCT02363504	Procedure	kidney dialysis	EXC	
11.txt	NCT02363504	Condition	Contraindications	EXC	Specified_by:body tattoos;Specified_by:metal implants;Specified_by:claustrophobia;Specified_by:brain surgery;Specified_by:cardiac pacemaker;
11.txt	NCT02420756	Procedure	CT	INC	has_TempMea:within 24 months;
11.txt	NCT02120664	Demographic	age	INC	has_value:>= 50 years;
11.txt	NCT02363504	Procedure	scanning	EXC	
11.txt	NCT02363504	Condition	Heart diseases	EXC	
11.txt	NCT02120664	Condition	AD	INC	modified_by:Possible;
11.txt	NCT02363504	Procedure	pacemakers	EXC	
11.txt	NCT00857415	Procedure	PET scan	INC	has_value:10 minute;
11.txt	NCT02363504	Condition	stroke	EXC	
11.txt	NCT02120664	Measurement	Mini-mental state examination ( MMSE )	INC	has_value:>= 29;
11.txt	NCT02363504	Condition	stroke	EXC	
11.txt	NCT02363504	Condition	psychotic disorder	EXC	
11.txt	NCT02363504	Condition	epilepsy	EXC	
11.txt	NCT02120664	Condition	Cognitively Normal	INC	
11.txt	NCT02363504	Condition	schizophrenia	EXC	
11.txt	NCT02120664	Demographic	age	INC	has_value:>= 21 and <= 45 years;
11.txt	NCT02363504	Condition	bipolar disorder	EXC	
11.txt	NCT01421056	Drug	hypnotics	EXC	
11.txt	NCT02363504	Condition	psychiatric or neurological disorders	EXC	Specified_by:major depression;Specified_by:schizophrenia;has_TempMea:Past or present;Specified_by:brain infections;Specified_by:epilepsy;Specified_by:stroke;Specified_by:bipolar disorder;Specified_by:psychotic disorder;Specified_by:kidney dialysis;Specified_by:Menire's disease;Specified_by:brain trauma;Specified_by:electroshock therapy;Specified_by:multiple sclerosis;Specified_by:brain surgery;Specified_by:Parkinson's disease;
11.txt	NCT02120664	Condition	neurodegenerative disorders	EXC	has_TempMea:currently;Specified_by:AD;
11.txt	NCT02363504	Condition	major depression	EXC	
11.txt	NCT00825084	Measurement	clinical laboratory tests	INC	
11.txt	NCT02120664	Condition	AD	INC	modified_by:Clinically Diagnosed;
11.txt	NCT02363504	Procedure	brain surgery	EXC	
11.txt	NCT00825084	Measurement	Body Mass Index ( BMI )	INC	has_value:17.5 to 30.5 kg/m2;
11.txt	NCT02363504	Condition	brain trauma	EXC	
11.txt	NCT02363504	Condition	Parkinson's disease	EXC	
11.txt	NCT02363504	Condition	multiple sclerosis	EXC	
11.txt	NCT00884533	Drug	charbroiled meats	EXC	
11.txt	NCT00884533	Drug	brussel sprouts	EXC	
11.txt	NCT00825084	Condition	Pregnant	EXC	
11.txt	NCT02120664	Measurement	MMSE	INC	has_value:>= 27;
11.txt	NCT00884533	Drug	watercress	EXC	
11.txt	NCT00825084	Condition	nursing	EXC	
11.txt	NCT00884533	Drug	broccoli	EXC	
11.txt	NCT00825084	Measurement	QTc	EXC	has_value:exceeds 450 msec;
11.txt	NCT02420756	Procedure	amyloid PET	INC	
11.txt	NCT00884533	Drug	collard greens	EXC	
11.txt	NCT00884533	Drug	kale	EXC	
11.txt	NCT00825084	Measurement	QTc	EXC	has_value:> 450 msec;
11.txt	NCT02120664	Measurement	MMSE	INC	has_value:> 24 and  < 29;
11.txt	NCT02420756	Condition	cognitive impairment	INC	
11.txt	NCT00884533	Drug	kohlrabi	EXC	
11.txt	NCT00884533	Drug	vitamins	EXC	
11.txt	NCT00825084	Drug	prescription or nonprescription drugs	EXC	has_TempMea:within 7 days or 5 half-lives;
11.txt	NCT02120664	Condition	AD	EXC	is_negated:other than;
11.txt	NCT02420756	Measurement	complete blood count [CBC]	INC	
11.txt	NCT00884533	Drug	prescription or non-prescription drugs	EXC	has_TempMea:within fourteen days;
11.txt	NCT00825084	Drug	vitamins	EXC	has_TempMea:within 7 days or 5 half-lives;
11.txt	NCT00884533	Drug	St. John's Wort	EXC	
11.txt	NCT00825084	Drug	nonhormonal contraception	EXC	has_TempMea:at least 14 days;
11.txt	NCT02120664	Demographic	age	INC	has_value:>= 75 years;
11.txt	NCT00884533	Drug	CYP2C8	EXC	
11.txt	NCT02120664	Condition	Cognitively normal	INC	
11.txt	NCT02420756	Measurement	Clinical laboratory assessment	INC	has_TempMea:within the 12 months;Specified_by:complete blood count [CBC];Specified_by:standard blood chemistry profile;Specified_by:thyroid stimulating hormone [TSH];Specified_by:vitamin B12;
11.txt	NCT02420756	Measurement	amyloid PET status	INC	
11.txt	NCT00825084	Condition	childbearing potential	EXC	
11.txt	NCT02420756	Condition	Alzheimer's disease	INC	
11.txt	NCT02363504	Procedure	body tattoos	EXC	
11.txt	NCT00857415	Condition	AD	INC	
11.txt	NCT00825084	Observation	smoke	EXC	has_value:more than 5 cigarettes per day;
11.txt	NCT02120664	Condition	MCI	INC	
11.txt	NCT02120664	Condition	AD	INC	modified_by:possible;
11.txt	NCT02363504	Procedure	metal implants	EXC	
11.txt	NCT00857415	Condition	risk factors	INC	
11.txt	NCT02120664	Measurement	MMSE	INC	has_value:>= 16 and <= 26;
11.txt	NCT02363504	Condition	claustrophobia	EXC	
11.txt	NCT02120664	Condition	dementia	INC	
11.txt	NCT02363504	Procedure	brain surgery	EXC	
11.txt	NCT02363504	Procedure	cardiac pacemaker	EXC	
11.txt	NCT00884533	Drug	grapefruit-containing products	EXC	
11.txt	NCT02120664	Condition	dementia	INC	is_negated:not;
11.txt	NCT02420756	Condition	Cognitive complaint	INC	
11.txt	NCT00884533	Drug	mustard greens	EXC	
11.txt	NCT00825084	Procedure	12 -lead ECG	EXC	
11.txt	NCT02420756	Condition	cognitive impairment	INC	
11.txt	NCT00825084	Drug	investigational drug	EXC	has_TempMea:within 30 days or 5 half-lives;
11.txt	NCT02120664	Demographic	age	INC	has_value:>= 60 years;
11.txt	NCT02420756	Condition	dementia	INC	has_TempMea:within 24 months;
11.txt	NCT00884533	Drug	cytochrome CYP3A4 enzymes	EXC	
11.txt	NCT02120664	Condition	cognitive impairment	INC	Specified_by:dementia;
11.txt	NCT00857415	Condition	ApoE 4 allele	INC	Specified_by:AD;
11.txt	NCT02420756	Condition	MCI	INC	has_TempMea:within 24 months;
11.txt	NCT00857415	Condition	risk factors	INC	is_negated:no;
11.txt	NCT00751907	Measurement	lab values	EXC	Specified_by:creatinine;Specified_by:CK;modified_by:Elevated;
11.txt	NCT02120664	Condition	surgically sterile	EXC	is_negated:not;
11.txt	NCT00751907	Measurement	CK	EXC	
11.txt	NCT01421056	Condition	NINCDS-ADRDA criteria	EXC	
11.txt	NCT00857415	Condition	Cognitively and neurologically health	INC	
11.txt	NCT00751907	Drug	statin medications	EXC	
11.txt	NCT02120664	Condition	childbearing potential	EXC	
11.txt	NCT00857415	Demographic	age	INC	has_value:18 to 40 years;
11.txt	NCT02420756	Condition	dementia	EXC	
11.txt	NCT02420756	Drug	apolipoprotein E	EXC	
11.txt	NCT00751907	Condition	pregnant	EXC	has_TempMea:Currently;
11.txt	NCT02420756	Measurement	Body weight	EXC	has_value:exceeds PET scanner weight limit;
11.txt	NCT01421056	Procedure	MRI brain imaging	EXC	has_TempMea:obtained within 12 months;
11.txt	NCT00751907	Drug	grapefruit juice	EXC	has_value:more than 1 quart/day;
11.txt	NCT02420756	Observation	Life expectancy	EXC	has_value:less than 24 months;
11.txt	NCT01421056	Condition	focal lesions	EXC	modified_by:clinical significance;
11.txt	NCT02353845	Condition	Cognitive impairment	INC	modified_by:single or multiple domains;
11.txt	NCT02420756	Condition	Hip/pelvic fracture	EXC	has_TempMea:within the 12 months;
11.txt	NCT02363504	Condition	abuse of other substances	EXC	
11.txt	NCT00857415	Procedure	PET scan	INC	has_TempMea:10 -minute;
11.txt	NCT00751907	Condition	dementia	EXC	
11.txt	NCT00857415	Condition	AD	INC	
11.txt	NCT00751907	Drug	medications	EXC	
11.txt	NCT02420756	Condition	non-melanoma skin cancer	EXC	is_negated:excluding;
11.txt	NCT00751907	Drug	atorvastatin	EXC	
11.txt	NCT02353845	Condition	Memory loss complaint	INC	
11.txt	NCT01421056	Procedure	CT	EXC	has_TempMea:obtained within 12 months;
11.txt	NCT00751907	Measurement	creatinine	EXC	
11.txt	NCT02420756	Condition	Cancer	EXC	Specified_by:non-melanoma skin cancer;
11.txt	NCT00884533	Condition	pregnant	EXC	
11.txt	NCT00857415	Observation	life expectancy	INC	has_value:<= 6 months;
11.txt	NCT00884533	Condition	Lactating	EXC	
11.txt	NCT00751907	Demographic	ages	INC	has_value:40 - 65;
11.txt	NCT00884533	Drug	herbal	EXC	has_TempMea:within fourteen days;
11.txt	NCT00825084	Drug	dietary supplements	EXC	has_TempMea:within 7 days or 5 half-lives;
11.txt	NCT02420756	Measurement	standard blood chemistry profile	INC	
11.txt	NCT00884533	Drug	dietary supplements	EXC	has_TempMea:within fourteen days;
11.txt	NCT02120664	Condition	illness	EXC	modified_by:serious or unstable;has_TempMea:current;
11.txt	NCT02420756	Measurement	thyroid stimulating hormone [TSH]	INC	
11.txt	NCT02420756	Condition	psychological harm	EXC	modified_by:significant;
11.txt	NCT00931073	Condition	head trauma	EXC	modified_by:significant;
11.txt	NCT00931073	Drug	imidazole antifungal agents	EXC	
11.txt	NCT00931073	Condition	allergic	EXC	
11.txt	NCT00931073	Drug	omeprazole	EXC	
11.txt	NCT00931073	Condition	allergic	EXC	
11.txt	NCT02420756	Condition	subjective complaints	EXC	is_negated:not;
11.txt	NCT00857415	Condition	carrying an ApoE 4 allele	INC	is_negated:not;
11.txt	NCT00931073	Drug	proton pump inhibitors	EXC	modified_by:other;
11.txt	NCT00751907	Condition	adverse reaction	EXC	
11.txt	NCT01421056	Measurement	DSM-IV-TR	EXC	
11.txt	NCT00931073	Procedure	gastrectomy	EXC	
11.txt	NCT00751907	Condition	liver disease	EXC	
11.txt	NCT02120664	Procedure	radiopharmaceutical imaging or treatment	EXC	has_TempMea:within 7 days;
11.txt	NCT02420756	Condition	cognition	EXC	modified_by:Normal;
11.txt	NCT02363504	Condition	problems in daily life functioning	INC	is_negated:no;
11.txt	NCT00751907	Condition	Alzheimer's disease	INC	
11.txt	NCT02120664	Condition	traumatic brain injury	EXC	
11.txt	NCT00931073	Condition	condition	EXC	Specified_by:gastrectomy;
11.txt	NCT00751907	Drug	cholesterol lowering medication	EXC	has_TempMea:Current;
11.txt	NCT02120664	Drug	investigational medications	EXC	has_value:in the past 30 days;
11.txt	NCT02420756	Measurement	vitamin B12	INC	
11.txt	NCT02120664	Condition	brain lesion	EXC	
11.txt	NCT01421056	Procedure	MRI scan	INC	
11.txt	NCT02353845	Condition	thyroid disease	EXC	
11.txt	NCT02420756	Measurement	laboratory testing	INC	
11.txt	NCT02420756	Procedure	structural neuroimaging	INC	
11.txt	NCT02353845	Condition	stroke	EXC	
11.txt	NCT00931073	Condition	hypersensitivity	EXC	
11.txt	NCT00931073	Drug	antihistamines	EXC	modified_by:other;
11.txt	NCT00931073	Drug	Dimebon	EXC	
11.txt	NCT00931073	Drug	grapefruit	EXC	has_TempMea:within 7 days;
11.txt	NCT00857415	Condition	focal structural loss of brain matter	EXC	modified_by:major;
11.txt	NCT00931073	Drug	grapefruit containing products	EXC	has_TempMea:within 7 days;
11.txt	NCT01421056	Condition	infection	EXC	modified_by:clinical significance;
11.txt	NCT00857415	Condition	central nervous system ( CNS ) lymphoma	EXC	
11.txt	NCT01421056	Condition	cognitive deficits	EXC	
11.txt	NCT02363504	Condition	memory complaints	INC	
11.txt	NCT00931073	Drug	omeprazole	EXC	has_TempMea:currently;
11.txt	NCT02363504	Condition	dementia	INC	is_negated:no;
11.txt	NCT02420756	Procedure	cognitive testing	EXC	
11.txt	NCT01421056	Condition	Alzheimer's disease	EXC	
11.txt	NCT02363504	Condition	Alzheimer's disease	INC	modified_by:prodromal;
11.txt	NCT01421056	Condition	medical condition	EXC	
11.txt	NCT02363504	Condition	memory impairment	INC	
11.txt	NCT02353845	Condition	visual and hearing impairment	EXC	modified_by:severe;
11.txt	NCT01421056	Condition	stroke	EXC	
11.txt	NCT00857415	Condition	brain tumor	EXC	modified_by:primary;
11.txt	NCT02420756	Condition	etiologic cause	INC	modified_by:uncertain;
11.txt	NCT00857415	Condition	cognitive decline	INC	
11.txt	NCT02353845	Condition	general cognitive function	INC	modified_by:Normal or near-normal;
11.txt	NCT02420756	Condition	National Institutes of Aging-Alzheimer's Association criteria	INC	
11.txt	NCT00857415	Condition	progressive dementing disorder	INC	
11.txt	NCT00751907	Drug	investigational drug	EXC	has_TempMea:Current;modified_by:another;
11.txt	NCT02353845	Measurement	Clinical Dementia Rating ( CDR ) score	INC	has_value:0.5;
11.txt	NCT00931073	Drug	proton pump inhibitors	EXC	modified_by:other;has_TempMea:currently;
11.txt	NCT00931073	Drug	H2 -blockers	EXC	has_TempMea:currently;
11.txt	NCT00931073	Drug	antacids	EXC	has_TempMea:currently;
11.txt	NCT00931073	Condition	Pregnant	EXC	
11.txt	NCT00931073	Drug	CYP2C19 inhibitors	EXC	has_TempMea:currently;
11.txt	NCT00931073	Condition	childbearing potential	EXC	
11.txt	NCT00931073	Condition	nursing	EXC	
11.txt	NCT00884533	Condition	Healthy	INC	
11.txt	NCT00857415	Procedure	MRI scan	INC	
11.txt	NCT01421056	Measurement	Mini-Mental State Examination score	INC	has_value:higher than 24;
11.txt	NCT00931073	Procedure	nonhormonal contraception	EXC	has_TempMea:at least 14 days;
11.txt	NCT00857415	Observation	Wechsler Logical Memory I & II	INC	modified_by:age-appropriate normal range;
11.txt	NCT02353845	Condition	diseases	EXC	modified_by:Other;
11.txt	NCT00857415	Condition	head trauma	INC	
11.txt	NCT00884533	Demographic	aged	INC	has_value:between 18 and 45;
11.txt	NCT00857415	Condition	brain abnormality	INC	
11.txt	NCT01421056	Condition	Cognitive Impairment	INC	modified_by:amnestic or non-amnestic;modified_by:Mild;
11.txt	NCT02353845	Condition	cognitive impairment	EXC	Specified_by:stroke;Specified_by:thyroid disease;
11.txt	NCT00857415	Condition	neurologic, neurodegenerative or psychiatric disease	INC	
11.txt	NCT02120664	Condition	pathology	EXC	
11.txt	NCT02420756	Procedure	mental status testing	INC	
11.txt	NCT00751907	Condition	Contraindications	EXC	
11.txt	NCT02353845	Condition	dementia	INC	is_negated:Failure;
11.txt	NCT00751907	Procedure	MRI	EXC	
11.txt	NCT02420756	Procedure	general medical and neurological examination	INC	
11.txt	NCT00857415	Condition	HIV	EXC	modified_by:positive;has_TempMea:previous;
11.txt	NCT00884533	Condition	non child bearing potential	INC	
11.txt	NCT00857415	Condition	Creutzfeldt-Jakob disease ( CJD )	EXC	modified_by:positive;has_TempMea:previous;
11.txt	NCT01421056	Condition	Vitamin B12 or folate deficiency	EXC	
11.txt	NCT01421056	Condition	schizophrenia	EXC	has_TempMea:within 3 years;
11.txt	NCT00857415	Procedure	treatment procedure	EXC	has_TempMea:within 7 days;
11.txt	NCT01421056	Condition	childbearing potential	EXC	
11.txt	NCT00884533	Condition	alcohol, cotinine or drugs of abuse	EXC	
11.txt	NCT00857415	Condition	medical condition	INC	modified_by:terminal;
11.txt	NCT00884533	Measurement	Body weight	INC	has_value:greater than or equal to 45 kg;
11.txt	NCT00857415	Procedure	radiopharmaceutical imaging	EXC	has_TempMea:within 7 days;
11.txt	NCT00884533	Measurement	BMI	INC	has_value:within the range 19 - 32 inclusive;
11.txt	NCT02353845	Condition	impairment of daily life activities	INC	modified_by:minimum;
11.txt	NCT00857415	Drug	anti-amyloid immunotherapy	EXC	
11.txt	NCT01421056	Condition	peptic ulcer	EXC	has_TempMea:Current;
11.txt	NCT00857415	Drug	secretase inhibitor	EXC	
11.txt	NCT01421056	Condition	gastrointestinal bleeding	EXC	has_TempMea:within the last year;
11.txt	NCT01421056	Condition	unipolar and bipolar disorders	EXC	
11.txt	NCT00857415	Drug	amyloid targeting agent	EXC	Specified_by:anti-amyloid immunotherapy;Specified_by:secretase inhibitor;
11.txt	NCT00857415	Drug	investigational medications	EXC	
11.txt	NCT01421056	Condition	mood disorder	EXC	Specified_by:unipolar and bipolar disorders;has_TempMea:within 3 years;modified_by:recurrent;
11.txt	NCT00857415	Drug	investigational medications	EXC	has_TempMea:within the last 30 days;
11.txt	NCT00857415	Drug	chemotherapy	EXC	modified_by:high dose;
11.txt	NCT01421056	Condition	infarction	EXC	modified_by:clinical significance;
11.txt	NCT00857415	Procedure	respirator	EXC	has_TempMea:currently;
11.txt	NCT00884533	Condition	Cardiac conduction abnormalities	EXC	
11.txt	NCT00884533	Condition	myocardial infarction	EXC	
11.txt	NCT01421056	Procedure	MRI scan	EXC	
11.txt	NCT00857415	Procedure	life sustaining measures	EXC	Specified_by:respirator;Specified_by:chemotherapy;
11.txt	NCT00825084	Drug	alcohol	EXC	modified_by:regular;has_value:14 drinks/week;has_value:exceeding an average of 7 drinks/week;has_TempMea:within 6 months;
11.txt	NCT00884533	Condition	cardiac arrhythmias	EXC	
11.txt	NCT00884533	Condition	syncope	EXC	
11.txt	NCT00884533	Condition	hypertension	EXC	modified_by:uncontrolled;
11.txt	NCT01421056	Measurement	Modified Hachinski ischemic scale score	EXC	has_value:> 4;
11.txt	NCT00884533	Condition	heart disease	EXC	modified_by:unstable;
11.txt	NCT00857415	Condition	hepatitis	EXC	modified_by:positive;has_TempMea:previous;
11.txt	NCT00857415	Condition	Human Immunodeficiency Virus ( HIV ) infection	EXC	
11.txt	NCT01421056	Measurement	Geriatric Depression Scale ( 30 -point scale ) score	EXC	has_value:> 9;
11.txt	NCT00857415	Condition	Acquired Immune Deficiency Syndrome ( AIDS )	EXC	
11.txt	NCT01421056	Measurement	diameter	EXC	has_value:<= 10 mm;
11.txt	NCT01421056	Condition	cerebral microhemorrhages	EXC	has_value:more than 4;
11.txt	NCT00857415	Condition	infectious disease	EXC	modified_by:clinically significant;
11.txt	NCT01421056	Condition	lesions	EXC	
11.txt	NCT00884533	Measurement	systolic blood pressure	EXC	has_value:outside the range of 90 to 150 mmHg;
11.txt	NCT00825084	Condition	abnormalities	INC	modified_by:clinically relevant;is_negated:no;
11.txt	NCT00884533	Measurement	diastolic blood pressure	EXC	has_value:outside the range of 50 to 100 mmHg;
11.txt	NCT00884533	Condition	QTc prolongation	EXC	
11.txt	NCT00884533	Condition	cardiac arrest	EXC	modified_by:unexplained;
11.txt	NCT00884533	Drug	illicit drug	EXC	has_TempMea:within the past year;
11.txt	NCT00825084	Measurement	pulse rate measurement	INC	
11.txt	NCT00825084	Procedure	12 -lead ECG	INC	
11.txt	NCT00825084	Measurement	full physical examination	INC	Specified_by:blood pressure;Specified_by:12 -lead ECG;Specified_by:pulse rate measurement;Specified_by:clinical laboratory tests;
11.txt	NCT00825084	Measurement	blood pressure	INC	
11.txt	NCT00825084	Observation	medical history	INC	
11.txt	NCT02420756	Procedure	Head MRI	INC	has_TempMea:within 24 months;
11.txt	NCT00884533	Condition	alcohol abuse	EXC	has_TempMea:within the past year;
11.txt	NCT00857415	Condition	childbearing potential	EXC	
11.txt	NCT00884533	Measurement	pre-study test	EXC	modified_by:positive;
11.txt	NCT00857415	Condition	pregnant	EXC	
11.txt	NCT00857415	Condition	metastases	EXC	
11.txt	NCT00884533	Measurement	Alanine aminotransferase ( ALT )	EXC	has_value:greater than 2.5 times the ULN;
11.txt	NCT00825084	Condition	condition	EXC	Specified_by:active peptic ulcer;Specified_by:gastrectomy;
11.txt	NCT00825084	Condition	Healthy	INC	
11.txt	NCT00825084	Demographic	ages	INC	has_value:18 and 55 years, inclusive;
11.txt	NCT02420756	Condition	cognitive impairment	INC	
11.txt	NCT00825084	Condition	Healthy	INC	
11.txt	NCT02363504	Measurement	biomarkers	INC	
11.txt	NCT02420756	Observation	DSM-IV	INC	
11.txt	NCT00884533	Condition	aspartate aminotransferase ( AST )	EXC	has_value:greater than 2.5 times the ULN;
11.txt	NCT00884533	Measurement	alkaline phosphatase values	EXC	has_value:greater than 2.5 times the ULN;
11.txt	NCT00884533	Condition	hepatitis B or C or cirrhosis	EXC	
11.txt	NCT00884533	Condition	hepatobiliary disease	EXC	modified_by:severe;Specified_by:Child-Pugh Class B/C;Specified_by:hepatitis B or C or cirrhosis;
11.txt	NCT00884533	Measurement	total bilirubin values	EXC	has_value:> 1.5 times the upper limit of normal ( ULN );
11.txt	NCT00931073	Condition	hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic or allergic disease	EXC	modified_by:clinically significant;
11.txt	NCT00931073	Condition	seizure	EXC	has_TempMea:previous;
11.txt	NCT00931073	Condition	convulsion	EXC	has_TempMea:previous;
11.txt	NCT00884533	Condition	Child-Pugh Class B/C	EXC	
11.txt	NCT00884533	Condition	Hepatitis C	EXC	modified_by:positive;
11.txt	NCT00884533	Measurement	Hepatitis B	EXC	modified_by:positive;
11.txt	NCT00884533	Condition	Human Immunodeficiency Virus ( HIV )	EXC	
11.txt	NCT00884533	Drug	agents	EXC	Specified_by:grapefruit-containing products;has_TempMea:within 7 days;Specified_by:mustard greens;Specified_by:kohlrabi;Specified_by:kale;Specified_by:collard greens;Specified_by:broccoli;Specified_by:watercress;Specified_by:brussel sprouts;Specified_by:St. John's Wort;Specified_by:charbroiled meats;
12.txt	NCT01747213	Drug	oxybutynin	INC	
12.txt	NCT01747213	Condition	hypothyroidism	INC	
12.txt	NCT01747213	Condition	dyslipidemia	INC	
12.txt	NCT01747213	Drug	tricyclic antidepressants	INC	
12.txt	NCT01747213	Condition	type II diabetes	INC	
12.txt	NCT01747213	Drug	meclizine	INC	
12.txt	NCT01747213	Condition	hypertension	INC	
12.txt	NCT01747213	Drug	Medications	INC	Specified_by:meclizine;Specified_by:oxybutynin;Specified_by:pyridostigmine;Specified_by:tricyclic antidepressants;has_TempMea:within 4 weeks;
12.txt	NCT01747213	Condition	age-related disorders	INC	Specified_by:type II diabetes;Specified_by:dyslipidemia;Specified_by:hypertension;Specified_by:hypothyroidism;
12.txt	NCT01747213	Drug	pyridostigmine	INC	
12.txt	NCT01747213	Procedure	electrocardiogram ( EKG )	INC	
12.txt	NCT01747213	Condition	cholinergic or anticholinergic side effects	INC	modified_by:significant;
12.txt	NCT01747213	Measurement	clinical laboratory tests	INC	
12.txt	NCT01747213	Drug	Phenobarbital	INC	
12.txt	NCT01747213	Drug	Anti-convulsants	INC	Specified_by:carbamazepine;has_TempMea:within 2 months;Specified_by:phenytoin;Specified_by:Phenobarbital;
12.txt	NCT01747213	Drug	phenytoin	INC	
12.txt	NCT01747213	Condition	drug abuse and dependency	INC	
12.txt	NCT01747213	Observation	general physical and mental health	INC	modified_by:good;
12.txt	NCT01953705	Measurement	CDR	EXC	
12.txt	NCT01953705	Condition	dementia	EXC	
12.txt	NCT01747213	Measurement	vital signs	INC	
12.txt	NCT01747213	Measurement	baseline physical examination	INC	
12.txt	NCT01747213	Observation	history	INC	
12.txt	NCT01747213	Condition	asthma	INC	modified_by:active;has_TempMea:within the last 10 years;
12.txt	NCT01747213	Condition	allergy	INC	
12.txt	NCT01747213	Condition	medical and psychiatric condition	INC	Specified_by:asthma;modified_by:clinically significant;
12.txt	NCT01747213	Drug	investigational drug	INC	has_TempMea:within 30 days or 5 half-lives;
12.txt	NCT01747213	Measurement	total body weight	INC	has_value:> 50 kg ( 110 pounds );
12.txt	NCT01747213	Procedure	Donation or loss	INC	has_TempMea:within 56 days;has_value:400 mL or more;
12.txt	NCT01747213	Drug	drug	INC	
12.txt	NCT01703702	Measurement	laboratory test results	INC	
12.txt	NCT01747213	Condition	hypersensitivity	INC	
12.txt	NCT01747213	Condition	COPD	INC	
12.txt	NCT01747213	Drug	investigational study drug	INC	
12.txt	NCT01747213	Drug	tobacco products	INC	has_TempMea:in the past 3 months;
12.txt	NCT01747213	Drug	microcrystalline cellulose	INC	
12.txt	NCT01747213	Drug	Beta-Blockers	INC	
12.txt	NCT01747213	Drug	Corticosteroids	INC	modified_by:Systemic;
12.txt	NCT01747213	Drug	donepezil	INC	
12.txt	NCT01747213	Drug	memantine	INC	
12.txt	NCT01747213	Drug	Medications	INC	Specified_by:memantine;Specified_by:donepezil;
12.txt	NCT01747213	Condition	Alzheimer s disease	INC	
12.txt	NCT01747213	Drug	carbamazepine	INC	
12.txt	NCT01747213	Drug	Neuromuscular-Blocking Agents	INC	modified_by:non-depolarizing;
12.txt	NCT01747213	Drug	Succinylcholine	INC	
12.txt	NCT01747213	Condition	overlapping side effects	INC	
12.txt	NCT01703702	Condition	pathology	EXC	
12.txt	NCT01953705	Condition	brain tumor	EXC	
12.txt	NCT01747213	Drug	alcohol	INC	has_TempMea:within 48 hours;
12.txt	NCT01703702	Procedure	amyloid imaging scan	EXC	has_TempMea:previous;
12.txt	NCT01953705	Condition	disease	EXC	Specified_by:subdural hematoma;Specified_by:cranial arteritis;Specified_by:brain tumor;Specified_by:seizure disorder;modified_by:Significant;
12.txt	NCT01723670	Condition	cancer	EXC	
12.txt	NCT01953705	Condition	normal pressure hydrocephalus	EXC	
12.txt	NCT01747213	Condition	drugs of abuse	INC	
12.txt	NCT01723670	Condition	Vitamin B12 or folate deficiency	EXC	
12.txt	NCT01953705	Condition	Parkinson's disease	EXC	
12.txt	NCT01723670	Condition	Skin cancers	EXC	
12.txt	NCT01953705	Condition	AD	EXC	
12.txt	NCT01723670	Condition	stroke	EXC	
12.txt	NCT01953705	Condition	vascular dementia	EXC	
12.txt	NCT01747213	Measurement	urine test	INC	modified_by:positive;
12.txt	NCT01953705	Condition	seizure disorder	EXC	
12.txt	NCT01953705	Condition	subdural hematoma	EXC	
12.txt	NCT01747213	Measurement	hepatitis B surface antigen	INC	modified_by:positive;
12.txt	NCT01953705	Condition	cranial arteritis	EXC	
12.txt	NCT01747213	Measurement	hepatitis C antibody tests	INC	modified_by:positive;
12.txt	NCT01703702	Condition	diagnosis	EXC	modified_by:alternative;
12.txt	NCT01747213	Condition	HIV	INC	modified_by:positive;
12.txt	NCT01723670	Condition	schizophrenia	EXC	
12.txt	NCT01747213	Condition	systemic allergic disease	INC	Specified_by:atopic dermatitis;Specified_by:urticaria;
12.txt	NCT01723670	Condition	medical condition	EXC	
12.txt	NCT01747213	Condition	urticaria	INC	
12.txt	NCT01703702	Condition	illness	EXC	modified_by:serious or unstable;has_TempMea:current;
12.txt	NCT01747213	Drug	drug	INC	
12.txt	NCT01723670	Condition	Alzheimer's disease	EXC	
12.txt	NCT01723670	Condition	cognitive deficits	EXC	
12.txt	NCT01747213	Drug	carbidopa	INC	
12.txt	NCT01723670	Measurement	Mini-Mental State Examination score	INC	has_value:higher than 24;
12.txt	NCT01747213	Condition	allergy	INC	modified_by:significant;
12.txt	NCT01703702	Measurement	clinical examination	INC	
12.txt	NCT01723670	Condition	amnestic Mild Cognitive Impairment	INC	
12.txt	NCT01703702	Condition	surgically sterile	EXC	is_negated:not;
12.txt	NCT01747213	Condition	atopic dermatitis	INC	
12.txt	NCT01747213	Condition	Pregnant	INC	
12.txt	NCT01953705	Condition	dementing illness	EXC	Specified_by:Parkinson's disease;Specified_by:normal pressure hydrocephalus;Specified_by:AD;Specified_by:vascular dementia;
12.txt	NCT01747213	Condition	lactating	INC	
12.txt	NCT01723670	Condition	brain abnormalities	EXC	
12.txt	NCT01723670	Procedure	MRI scans	EXC	
12.txt	NCT02524405	Condition	multiple sclerosis	EXC	
12.txt	NCT01953705	Condition	CAD	EXC	
12.txt	NCT02524405	Procedure	eye surgery	EXC	Specified_by:intra-vitreal injections;
12.txt	NCT02524405	Procedure	intra-vitreal injections	EXC	
12.txt	NCT01953705	Condition	symptomatic CVD	EXC	modified_by:significantly;Specified_by:CAD;Specified_by:CHF;modified_by:Unstable;
12.txt	NCT01953705	Measurement	labs	EXC	modified_by:Abnormal;
12.txt	NCT01747213	Measurement	Serum Creatinine	INC	has_value:> 1.5 mg/dL;
12.txt	NCT01703702	Condition	dementia	INC	
12.txt	NCT02524405	Procedure	eye disease	EXC	modified_by:serious;
12.txt	NCT01747213	Measurement	Serum Glucose	INC	has_value:> 150mg/dL;
12.txt	NCT01703702	Condition	mild impairment	INC	
12.txt	NCT02524405	Condition	glaucoma	EXC	
12.txt	NCT01953705	Condition	thyroid disease	EXC	
12.txt	NCT01747213	Measurement	Alkaline Phosphatase	INC	
12.txt	NCT01953705	Condition	UTI	EXC	
12.txt	NCT01703702	Procedure	evaluation	EXC	has_TempMea:currently undergoing;
12.txt	NCT02524405	Condition	optic neuritis	EXC	
12.txt	NCT01953705	Condition	CHF	EXC	
12.txt	NCT01703702	Measurement	MMSE score	INC	has_value:16 to 24 inclusive;
12.txt	NCT01953705	Condition	dyspnea	EXC	
12.txt	NCT01747213	Measurement	supine heart rate	INC	has_value:greater than 100 bpm or less than or equal to 55 55 bpm;
12.txt	NCT01747213	Condition	childbearing potential	INC	
12.txt	NCT01703702	Condition	dementia	INC	
12.txt	NCT02524405	Procedure	treatment	EXC	
12.txt	NCT01953705	Condition	angina	EXC	modified_by:frequent;
12.txt	NCT01747213	Measurement	diastolic blood pressure	INC	has_value:outside;has_value:outside a range of 50 - 90 mmHg;
12.txt	NCT01703702	Condition	demented	INC	is_negated:not;
12.txt	NCT01747213	Measurement	systolic blood pressure	INC	has_value:range of 90 - 140 mmHg;has_value:outside;
12.txt	NCT01703702	Demographic	age	INC	has_value:>= 50 to <= 90 years;
12.txt	NCT01747213	Measurement	Liver function tests	INC	Specified_by:Bilirubin;Specified_by:ALT;Specified_by:AST;has_value:> 1.5 x the upper normal limit;
12.txt	NCT01953705	Condition	Major depression	EXC	
12.txt	NCT01747213	Measurement	Hb	INC	has_value:< 12 g/dL;
12.txt	NCT01703702	Demographic	age	INC	has_value:>= 50 to <= 90 years;
12.txt	NCT01953705	Condition	schizophrenia	EXC	
12.txt	NCT01953705	Condition	Alcohol or substance abuse	EXC	has_TempMea:within the last 2 years;
12.txt	NCT01747213	Measurement	WBC	INC	has_value:< 3000 /mm^3;
12.txt	NCT01723670	Drug	study prohibitive medication	EXC	
12.txt	NCT01723670	Measurement	kidney function	EXC	modified_by:Abnormal;
12.txt	NCT01953705	Observation	DSM-IV criteria	EXC	
12.txt	NCT01747213	Condition	laboratory abnormality	INC	modified_by:clinically significant;
12.txt	NCT01953705	Observation	DSM-IV criteria	EXC	
12.txt	NCT01703702	Procedure	treatment procedure	EXC	has_TempMea:within 7 days;
12.txt	NCT02524405	Procedure	laser	EXC	
12.txt	NCT01747213	Measurement	AST	INC	
12.txt	NCT02524405	Procedure	surgery	EXC	Specified_by:laser;has_TempMea:previous;
12.txt	NCT01953705	Condition	vitamin B12 deficiency	EXC	
12.txt	NCT01747213	Measurement	Bilirubin	INC	
12.txt	NCT01747213	Measurement	CBC	INC	Specified_by:WBC;Specified_by:Hb;Specified_by:Liver function tests;
12.txt	NCT01703702	Condition	cognitive impairment	INC	
12.txt	NCT01953705	Condition	psychiatric disorder	EXC	modified_by:major;modified_by:other;
12.txt	NCT01747213	Measurement	ALT	INC	
12.txt	NCT01703702	Measurement	MMSE score	INC	has_value:24 to 30 inclusive;
12.txt	NCT01703702	Condition	cognitive decline	INC	
12.txt	NCT02524405	Condition	lacunar infarcts	INC	has_value:more than 2;
12.txt	NCT02524405	Drug	Flutemetamol ( 18F ) Injection formulation	EXC	
12.txt	NCT01953705	Condition	non-metastatic skin cancers	EXC	Specified_by:melanoma;
12.txt	NCT02524405	Drug	radiopharmaceuticals	EXC	has_TempMea:within the past 12 months;
12.txt	NCT02524405	Condition	hypodensity	INC	
12.txt	NCT02524405	Condition	hypersensitivity	EXC	
12.txt	NCT01953705	Measurement	Gleason Grade	EXC	has_value:< 3;
12.txt	NCT01747213	Drug	Vitamin E	INC	has_TempMea:within 2 weeks;has_value:> 400IU/day;
12.txt	NCT01703702	Drug	anti-amyloid immunotherapy	EXC	
12.txt	NCT02524405	Procedure	CT	INC	
12.txt	NCT02524405	Drug	[18F]flutemetamol	EXC	
12.txt	NCT02524405	Condition	periventricular hyperintensities	INC	
12.txt	NCT01747213	Drug	Omega- 3 fatty acids	INC	has_TempMea:within 2 weeks;has_value:> 1000 mg/day;
12.txt	NCT01747213	Condition	father children	INC	
12.txt	NCT02524405	Procedure	MRI	INC	
12.txt	NCT01953705	Condition	localized prostate cancer	EXC	
12.txt	NCT01703702	Drug	amyloid targeting agent	EXC	
12.txt	NCT02524405	Measurement	Montreal Cognitive Assessment ( MoCA ) score	INC	has_value:>= 18;
12.txt	NCT02524405	Observation	intra-ocular pressure	EXC	Specified_by:Goldmann tonometry;has_value:greater than 5mmHg between the two eyes;
12.txt	NCT01953705	Procedure	MRI	EXC	
12.txt	NCT01747213	Drug	Anti-parkinsonian medications	INC	Specified_by:pergolide;Specified_by:selegiline;Specified_by:amantadine;Specified_by:bromocriptine;Specified_by:levodopa;Specified_by:carbidopa;
12.txt	NCT01703702	Condition	cognitive impairment	EXC	
12.txt	NCT02524405	Measurement	Goldmann tonometry	EXC	
12.txt	NCT01953705	Procedure	heart pacemaker	EXC	
12.txt	NCT01747213	Drug	levodopa	INC	
12.txt	NCT01703702	Condition	cognitive decline	EXC	has_TempMea:within the past 18 months;is_negated:Cannot;
12.txt	NCT02524405	Measurement	diameter	INC	has_value:> 1.5 cm;
12.txt	NCT02524405	Observation	Intra-ocular pressure	EXC	has_value:greater than 22mmHg;
12.txt	NCT01953705	Condition	age-related macular degeneration	EXC	
12.txt	NCT01953705	Condition	Contraindications	EXC	Specified_by:metal plates;Specified_by:objects;Specified_by:heart pacemaker;
12.txt	NCT01747213	Drug	Insulin	INC	
12.txt	NCT01703702	Condition	cognitive decline	EXC	
12.txt	NCT01953705	Condition	melanoma	EXC	
12.txt	NCT01747213	Drug	St. John's wort	INC	has_TempMea:within 2 weeks;
12.txt	NCT01953705	Condition	vision loss	EXC	modified_by:Progressive;
12.txt	NCT01747213	Drug	ginseng	INC	has_TempMea:within 2 weeks;
12.txt	NCT01703702	Condition	Alzheimer's disease	EXC	is_negated:not;
12.txt	NCT01703702	Drug	-secretase or  -secretase inhibitor	EXC	
12.txt	NCT01747213	Drug	Ginkgo biloba	INC	has_TempMea:within 2 weeks;
12.txt	NCT01703702	Procedure	radiopharmaceutical imaging	EXC	has_TempMea:within 7 days;
12.txt	NCT02524405	Condition	Contra-indication	EXC	
12.txt	NCT02524405	Procedure	retinal laser therapy	EXC	
12.txt	NCT01953705	Drug	medications	EXC	has_value:> 2;
12.txt	NCT02524405	Condition	diabetic retinopathy	EXC	
12.txt	NCT01953705	Condition	Clinical symptomatic orthostatic hypotension	EXC	
12.txt	NCT02524405	Measurement	HbA1c	EXC	has_value:>= 7.5;
12.txt	NCT01723670	Condition	mood disorder	EXC	modified_by:recurrent;
12.txt	NCT01953705	Condition	Hypertension	EXC	
12.txt	NCT01747213	Drug	neuroleptics	INC	modified_by:Typical or atypical;
12.txt	NCT01703702	Condition	non-neurodegenerative cause	INC	
12.txt	NCT02524405	Condition	diabetes	EXC	modified_by:Poorly controlled;
12.txt	NCT01953705	Measurement	blood pressure	EXC	has_value:> 150 - 90;
12.txt	NCT01747213	Measurement	Resting supine blood pressure	INC	Specified_by:diastolic blood pressure;Specified_by:systolic blood pressure;
12.txt	NCT01703702	Condition	cognitive impairment	INC	
12.txt	NCT02524405	Measurement	Fazekas score	INC	has_value:= 3;
12.txt	NCT02524405	Condition	claustrophobia	EXC	
12.txt	NCT01953705	Condition	cortical stroke	EXC	
12.txt	NCT01747213	Procedure	12 -lead EKG	INC	
12.txt	NCT01703702	Drug	investigational medications	EXC	
12.txt	NCT02524405	Procedure	MRI	EXC	is_negated:Unable;
12.txt	NCT01953705	Condition	Cancer	EXC	has_TempMea:within the last 5 years;
12.txt	NCT01703702	Drug	investigational medications	EXC	has_TempMea:within the last 30 days;
12.txt	NCT02524405	Procedure	MRI	EXC	
12.txt	NCT01747213	Condition	conduction disorders	INC	
12.txt	NCT01953705	Drug	insulin	EXC	
12.txt	NCT02524405	Condition	subcortical disease	INC	
12.txt	NCT02524405	Procedure	metal implant	EXC	
12.txt	NCT01747213	Condition	ventricular and/or atrial arrhythmias	INC	
12.txt	NCT01703702	Condition	brain lesion	EXC	
12.txt	NCT01703702	Procedure	PET scan	INC	has_TempMea:10 -minute;
12.txt	NCT01747213	Condition	abnormality	INC	modified_by:clinically significant;Specified_by:heart block;Specified_by:conduction disorders;Specified_by:ventricular and/or atrial arrhythmias;
12.txt	NCT01953705	Condition	Diabetes mellitus	EXC	
12.txt	NCT01747213	Condition	heart block	INC	
12.txt	NCT01703702	Condition	childbearing potential	EXC	
12.txt	NCT02524405	Condition	AD	INC	modified_by:early;modified_by:Mild;
12.txt	NCT01953705	Drug	SSRIs	EXC	
12.txt	NCT02524405	Measurement	MMSE score	INC	has_value:>= 20;
12.txt	NCT02524405	Condition	head trauma	EXC	modified_by:significant;
12.txt	NCT02524405	Condition	AD dementia	INC	modified_by:probable;
12.txt	NCT01953705	Drug	cimetidine	EXC	
12.txt	NCT01747213	Drug	clonazepam	INC	
12.txt	NCT01953705	Drug	beta-blockers	EXC	
12.txt	NCT01747213	Drug	diazepam	INC	
12.txt	NCT01747213	Drug	herbal/dietary supplements	INC	is_negated:not;modified_by:Routine or PRN consumption;
12.txt	NCT01747213	Drug	phenobarbital	INC	
12.txt	NCT02524405	Procedure	blood work screen	INC	
12.txt	NCT01953705	Drug	meds	EXC	has_value:> 2;
12.txt	NCT01747213	Drug	sedative hypnotics	INC	modified_by:within 102 hours;is_negated:not;
12.txt	NCT02524405	Condition	periventricular hyperintensities	EXC	
12.txt	NCT01953705	Drug	Neuroleptics, antiparkinsonian agents	EXC	modified_by:discounted;has_TempMea:five half-lives;
12.txt	NCT02524405	Condition	Non-AD	INC	is_negated:ruled out;
12.txt	NCT02524405	Condition	subcortical disease	EXC	
12.txt	NCT01953705	Drug	propranolol	EXC	
12.txt	NCT02524405	Procedure	brain imaging	INC	
12.txt	NCT02524405	Measurement	Fazekas score	EXC	has_value:= 3;
12.txt	NCT01953705	Drug	clonidine	EXC	
12.txt	NCT02524405	Condition	dementia	INC	
12.txt	NCT01747213	Drug	anxiolytics	INC	has_value:more frequently than 2 times per week;has_TempMea:within 4 weeks;modified_by:Short-acting;
12.txt	NCT02524405	Condition	dementia	INC	
12.txt	NCT02524405	Condition	Subjective memory complaints	EXC	
12.txt	NCT01953705	Drug	CNS active agents	EXC	
12.txt	NCT01747213	Drug	sedative hypnotics	INC	has_value:more frequently than 2 times per week;has_TempMea:within 4 weeks;
12.txt	NCT02524405	Condition	learning disability	EXC	modified_by:significant;
12.txt	NCT01953705	Condition	hypertension	EXC	modified_by:Active;
12.txt	NCT02524405	Condition	MCI	INC	
12.txt	NCT02524405	Procedure	Cupping	EXC	
12.txt	NCT02524405	Condition	age-related macular degeneration	EXC	modified_by:Wet/exudative;
12.txt	NCT01953705	Drug	Analgesics	EXC	modified_by:high doses;
12.txt	NCT01747213	Drug	pergolide	INC	
12.txt	NCT02524405	Condition	VaD	INC	
12.txt	NCT01953705	Drug	Sedatives	EXC	has_value:<= twice per week;
12.txt	NCT02524405	Condition	VaMCI	INC	
12.txt	NCT01953705	Procedure	metal plates	EXC	
12.txt	NCT01747213	Drug	amantadine	INC	
12.txt	NCT02524405	Measurement	Mini-Mental State Exam ( MMSE )106 score	INC	has_value:>= 20;
12.txt	NCT02524405	Condition	glaucoma	EXC	
12.txt	NCT01747213	Drug	bromocriptine	INC	
12.txt	NCT01703702	Condition	cognitive decline	EXC	is_negated:Cannot;
12.txt	NCT02061878	Condition	infection	EXC	modified_by:active;modified_by:Chronic;
12.txt	NCT02061878	Condition	drug/alcohol dependence or abuse	EXC	modified_by:Active;has_TempMea:in the last 12 months;
12.txt	NCT02524405	Condition	disc hemorrhage	EXC	
12.txt	NCT01747213	Drug	benzodiazepines	INC	modified_by:Long-acting;has_TempMea:within 4 weeks;
12.txt	NCT02524405	Condition	notch	EXC	
12.txt	NCT01747213	Drug	barbiturates	INC	Specified_by:clonazepam;Specified_by:diazepam;Specified_by:phenobarbital;has_TempMea:within 4 weeks;
12.txt	NCT02061878	Drug	triglycerides	EXC	has_value:> 3.5 mmol/L;modified_by:High;
12.txt	NCT02061878	Condition	Thyroid dysfunction	EXC	
12.txt	NCT02524405	Condition	amnestic or multi-domain MCI	INC	
12.txt	NCT02524405	Observation	cup/disc asymmetry	EXC	has_value:more than 0.2;
12.txt	NCT02524405	Measurement	MoCA score	INC	has_value:>= 18;
12.txt	NCT02524405	Observation	cup/disc ratio	EXC	has_value:0.7 or greater;
12.txt	NCT01747213	Drug	Narcotic analgesics	INC	has_TempMea:within 4 weeks;
12.txt	NCT02061878	Demographic	cholesterol	EXC	has_value:> 4.0 mmoL/L;modified_by:High;
12.txt	NCT02524405	Condition	abnormalities	EXC	
12.txt	NCT01747213	Drug	selegiline	INC	
12.txt	NCT01953705	Drug	CNS active meds	EXC	modified_by:stable doses;has_TempMea:at least 2 months;Specified_by:SSRIs;Specified_by:cimetidine;Specified_by:beta-blockers;
12.txt	NCT02524405	Condition	LBD	EXC	
12.txt	NCT01953705	Drug	warfarin	EXC	
12.txt	NCT02524405	Condition	PDD	INC	
12.txt	NCT02524405	Condition	subcortical ischemic disease	EXC	
12.txt	NCT01953705	Drug	Factor Xa inhibitors	EXC	
12.txt	NCT02524405	Measurement	Fazekas score	EXC	has_value:= 3;
12.txt	NCT01953705	Drug	Low molecular weight heparins	EXC	
12.txt	NCT02061878	Drug	antiplatelets	EXC	
12.txt	NCT02061878	Condition	Leukopenia	EXC	
12.txt	NCT02061878	Measurement	neutrophil count	EXC	modified_by:low;has_value:< 3 x 10^9/L;
12.txt	NCT02524405	Condition	subcortical lacunar infarcts	EXC	has_value:more than 2;
12.txt	NCT01747213	Measurement	urine pregnancy test	INC	modified_by:negative;
12.txt	NCT01747213	Measurement	Body mass index ( BMI )	INC	has_value:18.5 to 34.0, inclusive;
12.txt	NCT02524405	Condition	cortical stroke	EXC	
12.txt	NCT02524405	Measurement	diameter	EXC	has_value:> 1.5 cm;
12.txt	NCT02061878	Condition	Neurological or psychiatric disorders	EXC	
12.txt	NCT02524405	Observation	Hoehn & Yahr stage	INC	has_value:2 or 3;
12.txt	NCT02524405	Procedure	CT	EXC	
12.txt	NCT02524405	Measurement	MMSE score	INC	has_value:>= 20;
12.txt	NCT02524405	Procedure	MRI	EXC	
12.txt	NCT01747213	Measurement	Mini Mental State Examination ( MMSE )	INC	has_value:> 27;
12.txt	NCT02524405	Condition	hypodensity	EXC	
12.txt	NCT01703702	Procedure	PET scan	INC	has_TempMea:10 -minute;
12.txt	NCT02524405	Condition	Parkinson's Disease - Dementia	INC	modified_by:probable;
12.txt	NCT01747213	Demographic	Age	INC	has_value:greater than or equal to 55 years;
12.txt	NCT02524405	Condition	periventricular hyperintensities	EXC	
12.txt	NCT02524405	Condition	Dementia with Lewy Bodies	INC	modified_by:probable;
12.txt	NCT02524405	Procedure	CT	EXC	
12.txt	NCT02524405	Condition	LBD Spectrum DLB	INC	
12.txt	NCT02524405	Procedure	MRI	EXC	
12.txt	NCT01953705	Drug	systemic corticosteroids	EXC	modified_by:discounted;has_TempMea:five half-lives;
12.txt	NCT02524405	Condition	hypodensity	EXC	
12.txt	NCT01953705	Drug	narcotic analgesics	EXC	modified_by:discounted;has_TempMea:five half-lives;
12.txt	NCT02061878	Condition	Pregnancy	EXC	
12.txt	NCT01953705	Drug	omega 3 PUFA supplements	EXC	has_value:> 5 weight percent of total fatty acids;
12.txt	NCT02061878	Condition	HIV	EXC	
12.txt	NCT02061878	Condition	Blood borne disease	EXC	Specified_by:HIV;Specified_by:Hepatitis;
12.txt	NCT02524405	Observation	neuropsychological battery	INC	has_value:Within normal limits;
12.txt	NCT02061878	Condition	Hepatitis	EXC	
12.txt	NCT02061878	Observation	smoking	EXC	
12.txt	NCT02524405	Condition	AD	EXC	
12.txt	NCT01953705	Drug	Anticoagulation therapy	EXC	
12.txt	NCT02524405	Condition	American Heart Association-American Stroke Association ( AHA-ASA ) criteria	INC	
12.txt	NCT02061878	Drug	nicotine patches	EXC	is_negated:incapable;
12.txt	NCT02524405	Condition	PDD	EXC	
12.txt	NCT01953705	Drug	vitamin K agonist	EXC	
12.txt	NCT02524405	Condition	Mild Cognitive Impairment	INC	
12.txt	NCT01953705	Drug	Investigational drugs	EXC	has_value:within five half-lives;
12.txt	NCT02061878	Condition	drug allergy	EXC	
12.txt	NCT02524405	Measurement	MoCA score	INC	has_value:18 - 24;
12.txt	NCT02524405	Condition	MCI	EXC	
12.txt	NCT02524405	Condition	PD-MCI	INC	
12.txt	NCT02524405	Measurement	diameter	EXC	has_value:> 1.5 cm;
12.txt	NCT01953705	Drug	Cholinesterase inhibitors	EXC	Specified_by:Aricept;
12.txt	NCT01953705	Drug	Aricept	EXC	
12.txt	NCT02524405	Condition	infection	EXC	
12.txt	NCT01953705	Drug	screen plasma PUFA	EXC	has_value:> 5 weight percent of total fatty acids;
12.txt	NCT02524405	Measurement	MMSE score	INC	has_value:>= 20;
12.txt	NCT02524405	Condition	subcortical lacunar infarcts	EXC	has_value:more than 2;
12.txt	NCT02524405	Condition	brain tumor	EXC	
12.txt	NCT02061878	Drug	local anesthetic	EXC	
12.txt	NCT02524405	Condition	progressive supranuclear palsy	EXC	
12.txt	NCT01953705	Measurement	EPA + DHA	INC	
12.txt	NCT02061878	Drug	pain medication	EXC	
12.txt	NCT02524405	Condition	seizure disorder	EXC	
12.txt	NCT01953705	Measurement	Plasma PUFA	INC	Specified_by:EPA + DHA;has_value:< 110 ug/ml or < 5 weight percent;
12.txt	NCT02061878	Condition	Abnormalities	EXC	has_TempMea:within 12 months;
12.txt	NCT02524405	Condition	National Institute on Aging-Alzheimer's Association criteria	INC	
12.txt	NCT02524405	Condition	neurologic defaults	EXC	modified_by:persistent;
12.txt	NCT01953705	Observation	vision and hearing	INC	modified_by:Sufficient;
12.txt	NCT02061878	Procedure	EKG	EXC	modified_by:Abnormal;
12.txt	NCT02524405	Condition	focal lesions	EXC	Specified_by:tumours;modified_by:other;Specified_by:malformations;Specified_by:subdural hematomas;
12.txt	NCT02524405	Condition	head trauma	EXC	modified_by:significant;
12.txt	NCT01953705	Condition	depressive syndrome	INC	modified_by:significant;is_negated:absence;
12.txt	NCT02524405	Condition	subdural hematoma	EXC	
12.txt	NCT02524405	Condition	multiple sclerosis	EXC	
12.txt	NCT01953705	Measurement	Geriatric Depression Scale - 15	INC	has_value:< 6;
12.txt	NCT02524405	Condition	underlying disease	EXC	modified_by:Serious;
12.txt	NCT02524405	Condition	death	EXC	has_TempMea:over the next 2 years;
12.txt	NCT02524405	Condition	AD	INC	
12.txt	NCT02524405	Condition	National Institute on Aging-Alzheimer's Association ( NIA-AA ) core clinical criteria	INC	
12.txt	NCT02453763	Condition	deficits in hearing	EXC	
12.txt	NCT02453763	Condition	problems	EXC	
12.txt	NCT02524405	Condition	disease	EXC	
12.txt	NCT02524405	Condition	proposed Level I criteria	INC	
12.txt	NCT02453763	Condition	schizophrenia	EXC	
12.txt	NCT02524405	Condition	Huntington's disease	EXC	
12.txt	NCT01953705	Observation	Total WMH volume	INC	has_value:>= 6 cc;
12.txt	NCT02453763	Condition	bipolar disorder	EXC	
12.txt	NCT02524405	Condition	normal pressure hydrocephalus	EXC	
12.txt	NCT01953705	Demographic	Age	INC	has_value:80 and older;
12.txt	NCT02524405	Condition	neurologic disease	EXC	modified_by:Significant;Specified_by:normal pressure hydrocephalus;Specified_by:Huntington's disease;Specified_by:progressive supranuclear palsy;Specified_by:brain tumor;Specified_by:subdural hematoma;Specified_by:seizure disorder;Specified_by:multiple sclerosis;
12.txt	NCT01953705	Measurement	Clinical Dementia Rating	INC	has_value:= 0 or 0.5;
12.txt	NCT02524405	Condition	psychiatric illness	EXC	modified_by:Significant;
12.txt	NCT02524405	Condition	cardiac, pulmonary, renal, hepatic, endocrine, hematologic or active malignancy	EXC	modified_by:Unstable;
12.txt	NCT01953705	Condition	cognitive impairment	INC	modified_by:Non-demented or mild;
12.txt	NCT02453763	Condition	neurological disorder	EXC	
12.txt	NCT02453763	Condition	major depression	EXC	
12.txt	NCT02453763	Condition	neuroanatomic abnormality	EXC	
12.txt	NCT02453763	Condition	cognitive impairment	EXC	
12.txt	NCT02524405	Condition	aphasia	EXC	
12.txt	NCT02453763	Procedure	implanted metal device	EXC	
12.txt	NCT02524405	Condition	cognitive impairment	EXC	modified_by:Moderate - severe;
12.txt	NCT02453763	Condition	learning disorder	EXC	modified_by:language-based;
12.txt	NCT02524405	Measurement	MMSE score	EXC	has_value:< 20;
12.txt	NCT02453763	Condition	dementia	EXC	
12.txt	NCT02453763	Procedure	implanted cardiac pacemaker	EXC	
12.txt	NCT02453763	Measurement	mini-mental state exam	EXC	has_value:< 24;
12.txt	NCT02524405	Condition	glaucoma	EXC	
12.txt	NCT02524405	Drug	eyedrops	EXC	
12.txt	NCT02524405	Condition	sleep disorder	EXC	
12.txt	NCT02524405	Condition	Subcortical VCI	INC	
12.txt	NCT02524405	Condition	functional disability	EXC	modified_by:severe;
12.txt	NCT02453763	Observation	estimated verbal intelligence	EXC	has_value:< 70;
12.txt	NCT02524405	Procedure	clinical MRI	EXC	
12.txt	NCT02524405	Condition	AIDS	EXC	
12.txt	NCT02453763	Condition	seizure disorder	EXC	
12.txt	NCT02524405	Condition	AIDS related complications	EXC	
12.txt	NCT02453763	Drug	seizure inducing medication	EXC	
12.txt	NCT02453763	Condition	seizure disorder	EXC	
12.txt	NCT02524405	Condition	structural brain abnormalities	EXC	
12.txt	NCT02524405	Observation	Hoehn & Yahr stage	INC	has_value:2 or 3;
12.txt	NCT02524405	Condition	post-menopausal	INC	
12.txt	NCT02524405	Condition	alcohol or drug abuse	EXC	
12.txt	NCT02524405	Procedure	phlebotomy	INC	
12.txt	NCT02524405	Condition	glaucoma	EXC	
12.txt	NCT02524405	Condition	Substance abuse	EXC	has_TempMea:within the past year;
12.txt	NCT02524405	Demographic	age	INC	has_value:50 - 90 years;
12.txt	NCT02524405	Observation	corrected near visual acuity of Snellen	INC	has_value:20 - 70;
12.txt	NCT02524405	Observation	vision	INC	modified_by:Sufficient;
12.txt	NCT02524405	Observation	hearing	INC	modified_by:Sufficient;
12.txt	NCT02524405	Condition	infectious disease	EXC	modified_by:Unstable;
12.txt	NCT01953705	Procedure	objects	EXC	
12.txt	NCT02524405	Observation	vision	INC	modified_by:Sufficient;
12.txt	NCT02061878	Condition	healthy	INC	
12.txt	NCT02061878	Demographic	age	INC	has_value:21 - 50;
12.txt	NCT02061878	Condition	Contraindications	EXC	
12.txt	NCT02061878	Procedure	blood or CSF sampling	EXC	
12.txt	NCT02061878	Condition	Bleeding disorder	EXC	
12.txt	NCT02061878	Drug	anticoagulants	EXC	
12.txt	NCT02061878	Procedure	Blood donation	EXC	has_TempMea:within the past month;
12.txt	NCT02524405	Procedure	Brain MRI scan	EXC	
12.txt	NCT02524405	Condition	vascular dementia ( VaD )	INC	modified_by:probable;
12.txt	NCT02524405	Condition	vascular mild cognitive impairment ( VaMCI )	INC	modified_by:probable;
12.txt	NCT02524405	Condition	ischemic vascular disease	INC	
12.txt	NCT02524405	Condition	subdural hematomas	EXC	
12.txt	NCT02524405	Condition	malformations	EXC	
12.txt	NCT02524405	Condition	tumours	EXC	
13.txt	NCT01594346	Condition	dementia	EXC	
13.txt	NCT01013610	Measurement	laboratory tests	EXC	
13.txt	NCT01594346	Measurement	modified Hachinski score	EXC	has_value:> 4;
13.txt	NCT01013610	Observation	medical history	EXC	
13.txt	NCT01594346	Condition	major depression	EXC	has_TempMea:within 3 months;
13.txt	NCT01013610	Measurement	physical examination	EXC	
13.txt	NCT01594346	Condition	coagulopathy	EXC	
13.txt	NCT01594346	Drug	experimental medications	EXC	has_TempMea:within 2 months;
13.txt	NCT01594346	Drug	anticoagulants	EXC	has_TempMea:current;
13.txt	NCT01013610	Drug	experimental drugs	EXC	has_TempMea:within 30 days;
13.txt	NCT01013610	Measurement	hepatitis C virus ( HCV ) antibodies	EXC	modified_by:positive;
13.txt	NCT01013610	Measurement	human immunodeficiency virus ( HIV ) antibodies	EXC	modified_by:positive;
13.txt	NCT01013610	Measurement	hepatitis B surface antigen ( HBsAg )	EXC	modified_by:positive;
13.txt	NCT01594346	Drug	vitamin E	EXC	has_TempMea:during the previous 6 months;has_value:greater than 50 units per day;
13.txt	NCT01594346	Condition	allergy	EXC	
13.txt	NCT01013610	Condition	serologic findings	EXC	modified_by:positive;
13.txt	NCT01642420	Demographic	age	INC	has_value:50 to 90;
13.txt	NCT01594346	Drug	vitamin E	EXC	
13.txt	NCT01642420	Condition	MCI	INC	
13.txt	NCT01642420	Condition	AD	INC	
13.txt	NCT01013610	Condition	cardiovascular, hepatic, renal, respiratory, gastrointestinal, endocrine, immunologic, dermatologic, hematologic, neurologic or psychiatric disease	EXC	modified_by:unstable or uncontrolled;modified_by:significant;
13.txt	NCT01013610	Procedure	devices	EXC	has_TempMea:within 30 days;
13.txt	NCT01013610	Condition	dementia	INC	modified_by:possible or mild;
13.txt	NCT01013610	Measurement	Rosen-Modified Hachinski Ischemic score	INC	has_value:<= 4;
13.txt	NCT01013610	Measurement	DSM-IV	INC	
13.txt	NCT01013610	Measurement	laboratory test results	INC	has_value:clinical deviations from normal limits;
13.txt	NCT01642420	Procedure	EEG	INC	
13.txt	NCT01642420	Procedure	cerebrospinal fluid examination	INC	
13.txt	NCT01642420	Demographic	age	INC	has_value:50 to 90;
13.txt	NCT01642420	Measurement	MMSE score	INC	has_value:equal or above 26;
13.txt	NCT01642420	Measurement	ACE score	INC	has_value:equal or above 85;
13.txt	NCT01642420	Procedure	physical examination	INC	modified_by:Normal;
13.txt	NCT02546310	Condition	Healthy	INC	
13.txt	NCT01642420	Condition	abuse of alcohol, medication or drugs	EXC	has_TempMea:Former;modified_by:severe;
13.txt	NCT02546310	Measurement	physical examination	INC	
13.txt	NCT02546310	Measurement	vital signs	INC	
13.txt	NCT02546310	Procedure	12 -lead ECG	INC	
13.txt	NCT02546310	Measurement	haematology	INC	
13.txt	NCT02546310	Measurement	blood chemistry	INC	
13.txt	NCT02546310	Measurement	urinalysis	INC	
13.txt	NCT02546310	Procedure	pre-study psychological assessment	INC	
13.txt	NCT01642420	Procedure	blood samples	INC	modified_by:normal;
13.txt	NCT01642420	Procedure	CT	INC	modified_by:normal;
13.txt	NCT01642420	Condition	Pregnant	EXC	
13.txt	NCT01642420	Procedure	EEG examination	INC	modified_by:normal;
13.txt	NCT01642420	Condition	psychiatric disease	EXC	
13.txt	NCT01642420	Condition	breastfeeding	EXC	
13.txt	NCT01642420	Condition	depression	EXC	has_TempMea:former;
13.txt	NCT01642420	Drug	antidepressive treatment	EXC	has_TempMea:a leat 3 months duration;
13.txt	NCT00955422	Condition	contraindication	INC	
13.txt	NCT02494531	Observation	DSM-IV criteria	EXC	
13.txt	NCT00955422	Condition	brain disorder	INC	
13.txt	NCT00955422	Condition	Pregnant	INC	
13.txt	NCT00955422	Condition	Alzheimer s disease	INC	is_negated:other than;
13.txt	NCT00955422	Condition	medical or psychiatric illness	INC	modified_by:severe;has_TempMea:current;
13.txt	NCT01609348	Condition	Dementia	INC	
13.txt	NCT01609348	Condition	Parkinson's disease	EXC	
13.txt	NCT01760005	Drug	anticoagulation	EXC	
13.txt	NCT00955422	Condition	Alzheimer's disease	INC	
13.txt	NCT01609348	Condition	dementia	EXC	
13.txt	NCT01609348	Condition	stroke	EXC	
13.txt	NCT01760005	Condition	carcinoma in situ	EXC	is_negated:except;
13.txt	NCT01609348	Condition	brain disease	EXC	
13.txt	NCT01760005	Demographic	age	INC	has_value:Between 18 - 80 years;
13.txt	NCT01609348	Condition	post menopause	INC	has_TempMea:at least 2 years;
13.txt	NCT01609348	Condition	surgically sterilized	INC	has_TempMea:at least 2 years;
13.txt	NCT01760005	Demographic	age of cognitive symptom onset	INC	has_TempMea:within - 15 to + 10 years;
13.txt	NCT01609348	Condition	psychosis	EXC	modified_by:Clinically significant;
13.txt	NCT01609348	Condition	traumatic brain injury	EXC	
13.txt	NCT01609348	Condition	multiple sclerosis	EXC	
13.txt	NCT00955422	Condition	Healthy	INC	
13.txt	NCT01609348	Measurement	Clinical Dementia Rating Scale	INC	has_value:1 "mild" or 2 "moderate";
13.txt	NCT01609348	Condition	dAD	INC	
13.txt	NCT01609348	Condition	Alzheimer's disease	INC	
13.txt	NCT01609348	Measurement	Mini-Mental State Exam ( MMSE ) ( 82 ) score	INC	has_value:10 - 26 inclusive;
13.txt	NCT01013610	Drug	experimental drug	EXC	has_TempMea:within 30 days;
13.txt	NCT01609348	Condition	good health	INC	modified_by:Sufficiently;
13.txt	NCT01609348	Condition	cognitive impairment	INC	modified_by:severe;
13.txt	NCT01609348	Condition	neurologic diseases	EXC	
13.txt	NCT01609348	Drug	medication	EXC	
13.txt	NCT01642420	Condition	neuroinfection	EXC	has_TempMea:former;modified_by:severe;
13.txt	NCT01609348	Condition	NIMH( National Institute of Mental Health ) Consensus Criteria	INC	
13.txt	NCT01642420	Drug	Antipsychotic treatment	EXC	
13.txt	NCT01609348	Drug	memantine	EXC	modified_by:Initiation, discontinuation or dose changes;has_TempMea:use within the 4 weeks;
13.txt	NCT01642420	Condition	head trauma	EXC	modified_by:severe;has_TempMea:former;
13.txt	NCT01760005	Observation	visual and auditory abilities	INC	modified_by:Adequate;
13.txt	NCT02494531	Measurement	Clinical dementia Rating scale	INC	has_value:< or = 0.5;
13.txt	NCT01642420	Procedure	ECT treatment	EXC	has_TempMea:within the last 3 months;
13.txt	NCT02494531	Observation	Visual and auditory acuity	INC	modified_by:adequate;
13.txt	NCT01609348	Measurement	systolic blood pressure	EXC	has_value:> 180 mm Hg;
13.txt	NCT02494531	Condition	MCI	INC	
13.txt	NCT02494531	Demographic	Aged	INC	has_value:18 years and above;
13.txt	NCT01609348	Drug	venlafaxine	EXC	
13.txt	NCT01760005	Procedure	Magnetic Resonance Imaging ( MRI )	INC	modified_by:Able;
13.txt	NCT01609348	Condition	side effects	EXC	
13.txt	NCT01760005	Condition	Cognitively normal	INC	
13.txt	NCT01609348	Drug	venlafaxine	EXC	
13.txt	NCT01609348	Condition	contraindicated	EXC	
13.txt	NCT01760005	Measurement	Clinical Dementia Rating ( CDR )	INC	has_value:0 - 1 ( inclusive );
13.txt	NCT01609348	Observation	history	EXC	
13.txt	NCT01760005	Condition	mild cognitive impairment	INC	
13.txt	NCT01609348	Drug	antipsychotic treatment	EXC	
13.txt	NCT01760005	Condition	mild dementia	INC	
13.txt	NCT01609348	Drug	venlafaxine	EXC	
13.txt	NCT01642420	Condition	Neurologic or somatic disease	EXC	
13.txt	NCT01609348	Condition	congenital long Q-T syndrome	EXC	
13.txt	NCT01760005	Procedure	Positron Emission Tomography ( PET )	INC	modified_by:Able;
13.txt	NCT01609348	Drug	cholinesterase inhibitor	EXC	has_TempMea:use within the 4 weeks;modified_by:Initiation, discontinuation or dose changes;
13.txt	NCT01760005	Procedure	Lumbar Puncture ( LP )	INC	modified_by:Able;
13.txt	NCT01609348	Condition	depression	EXC	
13.txt	NCT01609348	Drug	venlafaxine	EXC	
13.txt	NCT01454453	Measurement	modified version of the UPDRS	INC	has_value:< 8;
13.txt	NCT01454453	Measurement	Modified Hachinski Ischaemia Scale	INC	has_value:<= 4;
13.txt	NCT02494531	Procedure	metal fragments	EXC	
13.txt	NCT01760005	Condition	cardiovascular disease	EXC	modified_by:clinically significant;
13.txt	NCT01454453	Condition	Alzheimer's	INC	
13.txt	NCT02494531	Procedure	artificial heart valves	EXC	
13.txt	NCT01454453	Condition	AD	INC	
13.txt	NCT02494531	Procedure	ear implants	EXC	
13.txt	NCT01454453	Condition	Schizophrenia	EXC	
13.txt	NCT02494531	Condition	Parkinson's disease	EXC	modified_by:treated;
13.txt	NCT02494531	Condition	Huntington disease	EXC	
13.txt	NCT01760005	Condition	metabolic/endocrine disorders	EXC	modified_by:clinically significant;
13.txt	NCT02494531	Condition	epilepsy	EXC	modified_by:treated;
13.txt	NCT01760005	Drug	Anticoagulants	EXC	
13.txt	NCT01760005	Condition	infectious disease	EXC	modified_by:clinically significant;
13.txt	NCT02494531	Condition	Neurological disease	EXC	
13.txt	NCT01454453	Demographic	age	INC	has_value:between 60 and 95 years;
13.txt	NCT01760005	Condition	immune disorder	EXC	modified_by:clinically significant;
13.txt	NCT02494531	Procedure	foreign objects	EXC	
13.txt	NCT01760005	Condition	hepatic/renal disorders	EXC	modified_by:clinically significant;
13.txt	NCT02494531	Procedure	MRI	EXC	
13.txt	NCT01454453	Condition	Schizophrenia	INC	
13.txt	NCT01454453	Condition	schizophrenia-like illness	INC	
13.txt	NCT01642420	Condition	MCI	EXC	
13.txt	NCT02494531	Measurement	Clinical Dementia Rating scale	INC	has_value:> 0.5;
13.txt	NCT01642420	Condition	AD	EXC	
13.txt	NCT01760005	Condition	significant abnormality	EXC	modified_by:other;
13.txt	NCT01642420	Procedure	anaesthesia	EXC	has_TempMea:within the last 3 months;
13.txt	NCT02494531	Condition	AD	INC	
13.txt	NCT01760005	Procedure	brain MRI scans	EXC	
13.txt	NCT02494531	Condition	AD	INC	
13.txt	NCT02546310	Measurement	Mini Mental State Examination ( MMSE ) Score	INC	has_value:>= 24;
13.txt	NCT02546310	Drug	Recreational drug	EXC	has_TempMea:within 3 months;
13.txt	NCT01760005	Procedure	oreign metal objects	EXC	
13.txt	NCT02494531	Procedure	pacemakers	EXC	
13.txt	NCT02546310	Observation	smoker	INC	modified_by:regular;
13.txt	NCT01454453	Measurement	Geriatric depression scale	INC	has_value:< 6;
13.txt	NCT01760005	Procedure	MRI scan	EXC	
13.txt	NCT02494531	Procedure	aneurysm clips	EXC	
13.txt	NCT01760005	Procedure	artificial heart valves	EXC	
13.txt	NCT01454453	Demographic	age	INC	has_value:between 60 and 95 years;
13.txt	NCT01760005	Procedure	ear implants	EXC	
13.txt	NCT02494531	Procedure	Brain MRI	EXC	
13.txt	NCT01760005	Procedure	pacemakers	EXC	
13.txt	NCT02494531	Condition	breast feeding	EXC	
13.txt	NCT02546310	Measurement	alcohol breath test	EXC	modified_by:Positive;
13.txt	NCT01454453	Measurement	Geriatric depression scale	INC	has_value:< 6;
13.txt	NCT01760005	Procedure	aneurysm clips	EXC	
13.txt	NCT02494531	Condition	Pregnant	EXC	
13.txt	NCT01454453	Drug	antipsychotic	EXC	has_TempMea:within the past 2 weeks;
13.txt	NCT01454453	Condition	traumatic brain injury	EXC	has_TempMea:current or past;
13.txt	NCT01454453	Condition	epilepsy	EXC	has_TempMea:current or past;
13.txt	NCT01454453	Condition	medical conditions	EXC	
13.txt	NCT01760005	Condition	progression	EXC	modified_by:significant;has_TempMea:the past 2 years;is_negated:no;
13.txt	NCT01454453	Condition	medical conditions	EXC	
13.txt	NCT02546310	Measurement	urine drug screen	EXC	modified_by:Positive;
13.txt	NCT02546310	Drug	pomegranate	EXC	
13.txt	NCT02546310	Drug	cranberry	EXC	
13.txt	NCT02546310	Drug	grapefruit	EXC	
13.txt	NCT02546310	Drug	star fruit	EXC	
13.txt	NCT02546310	Drug	exotic citrus fruits	EXC	
13.txt	NCT01454453	Drug	psychotropic medication	EXC	
13.txt	NCT01013610	Measurement	vital sign measurements	INC	has_value:clinical deviations from normal limits;
13.txt	NCT02546310	Drug	pomelos	EXC	
13.txt	NCT01454453	Condition	Alzheimer's	EXC	
13.txt	NCT01760005	Condition	pregnancy	EXC	
13.txt	NCT01013610	Procedure	ECG	INC	has_value:clinical deviations from normal limits;
13.txt	NCT02546310	Drug	caffeinated drinks	EXC	modified_by:large amounts;
13.txt	NCT01454453	Drug	antipsychotic medication	EXC	has_TempMea:6 weeks;
13.txt	NCT01760005	Procedure	implanted metal	EXC	
13.txt	NCT02546310	Drug	Seville oranges	EXC	
13.txt	NCT01454453	Condition	Schizophrenia	EXC	
13.txt	NCT01760005	Procedure	MRI scanning	EXC	
13.txt	NCT01013610	Measurement	physical examination	INC	has_value:clinical deviations from normal limits;
13.txt	NCT01760005	Measurement	urine or serum pregnancy test	EXC	modified_by:Positive;
13.txt	NCT01760005	Condition	pregnant	EXC	
13.txt	NCT01454453	Drug	oral drug	EXC	modified_by:other;has_TempMea:within the past 2 weeks;
13.txt	NCT01454453	Procedure	brain scan	EXC	
13.txt	NCT01454453	Procedure	brain scan	EXC	modified_by:ability;
13.txt	NCT01454453	Condition	epilepsy	EXC	has_TempMea:current or past;
13.txt	NCT01454453	Condition	Alzheimer's	EXC	
13.txt	NCT01454453	Condition	addiction	EXC	has_TempMea:current or past;
13.txt	NCT01760005	Drug	aspirin	EXC	modified_by:low dose;has_value:<= 325 mg;is_negated:except;
13.txt	NCT02494531	Condition	brain tumour	EXC	
13.txt	NCT01454453	Condition	traumatic brain injury	EXC	has_TempMea:current or past;
13.txt	NCT01760005	Drug	monoclonal antibody targeting beta amyloid peptide	EXC	has_TempMea:within the past six months;
13.txt	NCT02494531	Condition	subdural haematoma	EXC	
13.txt	NCT01454453	Drug	brain dopamine	EXC	
13.txt	NCT02494531	Condition	progressive supranuclear palsy	EXC	
13.txt	NCT02546310	Condition	neurological or psychiatric conditions	EXC	modified_by:significant;
13.txt	NCT01013610	Condition	condition	INC	modified_by:stable;has_TempMea:1 month ( 30 days );has_TempMea:1 month ( 30 days );
13.txt	NCT02546310	Condition	sudden death	EXC	
13.txt	NCT02546310	Condition	congenital long QT syndrome	EXC	
13.txt	NCT01760005	Condition	prostate cancer	EXC	is_negated:except;
13.txt	NCT02494531	Observation	psychiatric history	EXC	
13.txt	NCT01454453	Condition	psychiatric illness	EXC	has_TempMea:current or past;
13.txt	NCT01594346	Condition	inability	EXC	
13.txt	NCT01609348	Measurement	diastolic blood pressure	EXC	has_value:> 100 mm Hg;
13.txt	NCT01454453	Drug	antipsychotic medication	EXC	has_TempMea:6 weeks;
13.txt	NCT01760005	Condition	basal cell carcinoma	EXC	is_negated:except;
13.txt	NCT01760005	Condition	non-squamous skin carcinoma	EXC	is_negated:except;
13.txt	NCT02494531	Condition	Schizophrenia	EXC	
13.txt	NCT01013610	Drug	treatment	INC	modified_by:stable;has_TempMea:1 month ( 30 days );
13.txt	NCT02494531	Condition	persistent neurological deficits	EXC	
13.txt	NCT02494531	Condition	stroke	EXC	
13.txt	NCT01454453	Drug	drug	EXC	has_TempMea:in past 2 weeks;
13.txt	NCT01760005	Condition	cancer	EXC	has_TempMea:within the last 5 years;
13.txt	NCT02494531	Condition	head trauma	EXC	
13.txt	NCT01013610	Condition	Alzheimer's Disease	INC	modified_by:Mild;
13.txt	NCT02546310	Condition	claustrophobia	EXC	modified_by:significant;
13.txt	NCT00955422	Condition	Pregnant	INC	
13.txt	NCT00955422	Condition	childbearing potential	INC	
13.txt	NCT02546310	Condition	contraindications	EXC	
13.txt	NCT00955422	Condition	vascular dementia	INC	
13.txt	NCT02546310	Procedure	MRI	EXC	
13.txt	NCT02546310	Procedure	surgery involving metal implants	EXC	
13.txt	NCT01594346	Demographic	age	INC	has_value:50 years or older;
13.txt	NCT01013610	Measurement	Clinical Dementia Rating ( CDR ) total score	INC	has_value:0.5 or 1.0;
13.txt	NCT00955422	Condition	medical or psychiatric illness	INC	modified_by:severe;has_TempMea:current;
13.txt	NCT01594346	Condition	Down syndrome	INC	
13.txt	NCT01013610	Measurement	Mini-Mental State Examination ( MMSE )	INC	has_value:>= 18 - 26;
13.txt	NCT01013610	Condition	diseases	INC	has_TempMea:concomitant;
13.txt	NCT01013610	Drug	medication	INC	has_TempMea:concomitant;
13.txt	NCT02494531	Observation	DSM IV criteria	INC	
13.txt	NCT00955422	Condition	contraindication	INC	
13.txt	NCT01013610	Condition	illness	INC	modified_by:well controlled;modified_by:chronic;modified_by:stable;
13.txt	NCT00955422	Measurement	urine pregnancy test	INC	
13.txt	NCT01454453	Drug	psychotropic medication	EXC	
13.txt	NCT00955422	Demographic	age	INC	has_value:45 or older;
13.txt	NCT01013610	Demographic	aged	INC	has_value:60 years or older;
13.txt	NCT01594346	Drug	medications	INC	modified_by:stable;has_TempMea:more than 1 month;
13.txt	NCT01594346	Condition	Alzheimer disease	EXC	
13.txt	NCT01594346	Condition	medical/neurological condition	EXC	
13.txt	NCT01594346	Condition	dementia	EXC	
13.txt	NCT01013610	Condition	illness	INC	modified_by:chronic;modified_by:well controlled;modified_by:stable;
13.txt	NCT00955422	Condition	Parkinson's disease dementia	INC	
13.txt	NCT01594346	Measurement	Brief Praxis Test	EXC	has_value:< 20;
13.txt	NCT00955422	Condition	Huntington's disease	INC	
13.txt	NCT00955422	Condition	normal pressure hydrocephalus	INC	
13.txt	NCT00955422	Condition	Lewy body dementia	INC	
13.txt	NCT00955422	Condition	dementia	INC	
13.txt	NCT01013610	Condition	healthy	INC	
13.txt	NCT00955422	Condition	frontotemporal dementia	INC	
13.txt	NCT01013610	Condition	surgically sterilized	INC	has_TempMea:at least two years;
13.txt	NCT00955422	Condition	progressive memory impairment	INC	
13.txt	NCT01013610	Condition	postmenopausal	INC	has_TempMea:at least two years;
14.txt	NCT01078168	Condition	NINCDS-ADRDA criteria	INC	
14.txt	NCT01847586	Measurement	NINCDS-ADRDA	INC	
14.txt	NCT01847586	Condition	DSM-IV TR criteria	INC	
14.txt	NCT00094913	Demographic	age	INC	
14.txt	NCT00094913	Procedure	MRI	EXC	
14.txt	NCT00001662	Drug	CX516	INC	
14.txt	NCT00736775	Condition	NINCDS-ADRDA Criteria	INC	
14.txt	NCT00736775	Drug	prescription medications	INC	modified_by:Other;has_TempMea:>= 1 month;modified_by:stable;
14.txt	NCT00736775	Drug	AchE inhibitors+/-memantine	INC	
14.txt	NCT00736775	Condition	AD	INC	modified_by:probable;
14.txt	NCT00736775	Drug	AD treatments	INC	has_TempMea:>= 3 months;modified_by:stable;
14.txt	NCT00736775	Condition	reproductive potential	EXC	
14.txt	NCT01078168	Condition	brain injuries	EXC	
14.txt	NCT00094913	Demographic	ages	INC	has_value:50 and 90;
14.txt	NCT01078168	Condition	Non-AD neurodegenerative disorder	EXC	
14.txt	NCT01078168	Condition	cognitive impairment	EXC	modified_by:hereditary;
14.txt	NCT00001662	Condition	loss of hearing or eyesight	INC	modified_by:uncorrectable;
14.txt	NCT00001662	Condition	hypersensitivity	INC	
14.txt	NCT00001662	Drug	vehicle	INC	
14.txt	NCT01078168	Measurement	Geriatric Depression Scale	INC	has_value:<= 14;
14.txt	NCT00001662	Condition	hepatic, cardiovascular, gastrointestinal or hematological illness	INC	
14.txt	NCT01078168	Condition	Parkinson	EXC	
14.txt	NCT01078168	Condition	multimorbidity	EXC	
14.txt	NCT00094913	Drug	psychotropic and/or cognitively active medication	INC	modified_by:Discontinuance;has_TempMea:at least four weeks;
14.txt	NCT00094913	Demographic	ages	INC	has_value:20 and 49 years;
14.txt	NCT00001662	Drug	tacrine	INC	has_TempMea:within thirty days;
14.txt	NCT00001662	Drug	donepezil	INC	has_TempMea:within thirty days;
14.txt	NCT00736775	Condition	CNS disease	EXC	modified_by:clinically significant;
14.txt	NCT00001662	Condition	Depression	INC	
14.txt	NCT00736775	Drug	protein therapeutic targeting Abeta	EXC	
14.txt	NCT00001662	Drug	rivastigmine	INC	has_TempMea:within thirty days;
14.txt	NCT00001662	Drug	galantamine	INC	has_TempMea:within thirty days;
14.txt	NCT01078168	Measurement	MMSE	INC	has_value:27 - 14 points;
14.txt	NCT00001662	Drug	anti-depressants	INC	has_TempMea:within thirty days;
14.txt	NCT00001662	Condition	Dementia	INC	has_TempMea:at least one year;
14.txt	NCT00096473	Condition	Healthy	INC	
14.txt	NCT00096473	Drug	medication	INC	is_negated:not;has_TempMea:in past 3 months;
14.txt	NCT00096473	Condition	Alzheimer's Disease	INC	
14.txt	NCT00001662	Condition	Alzheimer's disease	INC	
14.txt	NCT00094913	Condition	alcoholism	EXC	modified_by:Significant;
14.txt	NCT00094913	Condition	neurological disorder	EXC	modified_by:serious;
14.txt	NCT00001662	Procedure	brain MRI	INC	has_TempMea:within 15 months;
14.txt	NCT00096473	Measurement	MMSE score	INC	has_value:1 - 12;
14.txt	NCT00094913	Condition	mental retardation	EXC	modified_by:significant;
14.txt	NCT00001662	Measurement	modified Hachinski Ischemia Score	INC	has_value:less than 4;
14.txt	NCT00094913	Condition	schizophrenia	EXC	
14.txt	NCT00094913	Condition	mania	EXC	
14.txt	NCT00096473	Condition	chronic diseases	INC	modified_by:controlled;modified_by:stabilized;
14.txt	NCT00001662	Procedure	electroencephalogram	INC	
14.txt	NCT00094913	Condition	psychiatric illness	EXC	
14.txt	NCT00094913	Condition	drug abuse	EXC	modified_by:Significant;
14.txt	NCT00094913	Condition	trauma	EXC	modified_by:significant;
14.txt	NCT00001662	Condition	Alzheimer's disease	INC	modified_by:probable;
14.txt	NCT01078168	Drug	hypoalbuminaemia	EXC	
14.txt	NCT00094913	Procedure	MRI	EXC	
14.txt	NCT00001662	Condition	ALZHEIMER'S DISEASE	INC	
14.txt	NCT01078168	Drug	acitretin	EXC	
14.txt	NCT01078168	Drug	osteoporosis	EXC	
14.txt	NCT00094913	Condition	brain damage	EXC	
14.txt	NCT01078168	Condition	organ ( esp. liver or renal ) dysfunction	EXC	modified_by:significant;
14.txt	NCT01078168	Condition	contraindication	EXC	
14.txt	NCT02079909	Drug	Razadyne	EXC	
14.txt	NCT00094913	Condition	lacunar infarcts	EXC	modified_by:significant;
14.txt	NCT00096473	Condition	Alzheimer's Disease	INC	
14.txt	NCT00001662	Measurement	Mini-Mental Status Examination total score	INC	has_value:between 12 and 26, inclusive;
14.txt	NCT00094913	Condition	seizures	EXC	modified_by:significant;
14.txt	NCT00094913	Condition	stroke	EXC	modified_by:significant;
14.txt	NCT00001662	Condition	Dementia	INC	modified_by:mild to moderate;
14.txt	NCT00094913	Condition	hydrocephalus	EXC	modified_by:significant;
14.txt	NCT01841125	Condition	Seizures	EXC	
14.txt	NCT01841125	Condition	arteriosclerosis	EXC	
14.txt	NCT00040378	Condition	neurological conditions	EXC	
14.txt	NCT00001662	Condition	epileptiform features	INC	is_negated:not;
14.txt	NCT01841125	Condition	psychiatric illness	EXC	modified_by:serious;
14.txt	NCT00040378	Condition	Alzheimer's disease	EXC	
14.txt	NCT01841125	Condition	angina pectoris	EXC	
14.txt	NCT00001662	Condition	atrophy	INC	
14.txt	NCT00094913	Measurement	fasting glucose levels	EXC	has_value:> 110 mg/dl;
14.txt	NCT01841125	Condition	myocardial infarction	EXC	
14.txt	NCT00040378	Condition	neurological or psychiatric illness	INC	is_negated:no;
14.txt	NCT01841125	Condition	medical illness	EXC	modified_by:serious;
14.txt	NCT01841125	Condition	heart failure	EXC	
14.txt	NCT00040378	Condition	good health	INC	
14.txt	NCT00094913	Condition	hypertensive, cardiac, pulmonary, vascular, metabolic or hematologic conditions	EXC	modified_by:clinically relevant;
14.txt	NCT00040378	Condition	frontotemporal dementia	EXC	
14.txt	NCT00001662	Condition	post-menopausal	INC	
14.txt	NCT00094913	Measurement	delayed paragraph recall z-scores	EXC	has_value:> 2;
14.txt	NCT01841125	Condition	organic affective disorder	EXC	
14.txt	NCT00040378	Condition	vascular dementia	EXC	
14.txt	NCT00001662	Procedure	Chest x-ray	INC	has_TempMea:within 15 months;
14.txt	NCT01841125	Procedure	brain surgery	EXC	
14.txt	NCT00040378	Condition	Pick's disease	EXC	
14.txt	NCT00001662	Procedure	Baseline electroencephalogram	INC	
14.txt	NCT00094913	Procedure	surgical clips	EXC	
14.txt	NCT01841125	Condition	organic brain disease	EXC	
14.txt	NCT00040378	Condition	dementia with Lewy bodies	EXC	
14.txt	NCT00001662	Condition	sterile	INC	
14.txt	NCT00094913	Condition	cognitive or memory impairment	EXC	
14.txt	NCT00001662	Demographic	ages	INC	has_value:between;has_value:40 and 85;
14.txt	NCT00094913	Procedure	prosthetic devices	EXC	
14.txt	NCT00040378	Condition	dementia	EXC	
14.txt	NCT00094913	Procedure	pacemaker	EXC	
14.txt	NCT00094913	Condition	Physical impairment	EXC	
14.txt	NCT00096473	Condition	Alzheimer's Disease	EXC	is_negated:other than;
14.txt	NCT00096473	Condition	depressive disorder	EXC	
14.txt	NCT00001662	Measurement	Modified Hachinski Ischemia Score	INC	has_value:less than 4;
14.txt	NCT00094913	Measurement	Modified Hachinski Ischemia Scale	EXC	has_value:4 or greater;
14.txt	NCT00096473	Condition	neurological or psychiatric diagnosis	EXC	modified_by:primary;
14.txt	NCT00094913	Condition	neuropathology	EXC	modified_by:significant;
14.txt	NCT00001662	Condition	epileptiform features	INC	modified_by:significant;is_negated:not;
14.txt	NCT00094913	Condition	depression	EXC	
14.txt	NCT00001662	Condition	deficits	INC	has_value:at least two;
14.txt	NCT00094913	Condition	focal signs	EXC	
14.txt	NCT00001662	Condition	Cognitive difficulties	INC	has_TempMea:at least one year;
14.txt	NCT00094913	Condition	primary depression	EXC	is_negated:exclude;
14.txt	NCT00096473	Condition	Alzheimer's Disease	EXC	is_negated:other than;
14.txt	NCT00001662	Procedure	Brain MRI	INC	has_TempMea:with 15 months;modified_by:normal;
14.txt	NCT00096473	Condition	Dementia	EXC	
14.txt	NCT01841125	Condition	schizophrenia	EXC	
14.txt	NCT00096473	Condition	organic diseases	EXC	
14.txt	NCT00094913	Measurement	Hamilton Depression Scale	EXC	has_value:16 or more;
14.txt	NCT00001662	Measurement	Folstein mini-mental status examination total score	INC	has_value:between 12 and 26;
14.txt	NCT00094913	Condition	cerebrovascular disease	EXC	
14.txt	NCT01841125	Condition	fertile	EXC	
14.txt	NCT00040378	Condition	loss of consciousness	EXC	has_value:over 30 minutes;
14.txt	NCT00001662	Condition	CNS infection	INC	modified_by:chronic;
14.txt	NCT00040378	Condition	blindness	EXC	is_negated:not;
14.txt	NCT01841125	Condition	liver failure	EXC	
14.txt	NCT00040378	Condition	head injury	EXC	is_negated:not;has_TempMea:within the past five years;
14.txt	NCT00001662	Condition	dementia	INC	has_TempMea:concurrent;
14.txt	NCT00040378	Condition	disability	EXC	modified_by:other;
14.txt	NCT01841125	Measurement	laboratory tests	EXC	
14.txt	NCT02051244	Condition	unclear media	EXC	
14.txt	NCT01841125	Condition	hypertension	EXC	modified_by:Uncontrolled;
14.txt	NCT00001662	Condition	folic acid deficiency	INC	has_value:less than 0.9 ng/mL;
14.txt	NCT01948791	Drug	AChEI	EXC	
14.txt	NCT00040378	Condition	anxiety disorder	EXC	is_negated:not;has_TempMea:in the past 4 months;
14.txt	NCT00001662	Measurement	depression rating scale( s )	INC	
14.txt	NCT00001662	Measurement	TSH	INC	has_value:greater than 6.0 microunits/mL;
14.txt	NCT00001662	Condition	luetic brain disease	INC	is_negated:excluded;
14.txt	NCT01841125	Condition	diabetes	EXC	modified_by:Uncontrolled;
14.txt	NCT00040378	Condition	alcohol or substance abuse	EXC	is_negated:not;has_TempMea:for the past 24 months;has_TempMea:current;
14.txt	NCT01841125	Condition	drug abuse	EXC	
14.txt	NCT00001662	Condition	hepatitis	INC	
14.txt	NCT00001662	Measurement	MHA-TP	INC	modified_by:positive;
14.txt	NCT01841125	Condition	drinking	EXC	modified_by:habitual;
14.txt	NCT00040378	Condition	depression	EXC	is_negated:not;has_TempMea:in the past 4 months;
14.txt	NCT00001662	Condition	hypothyroidism	INC	
14.txt	NCT00001662	Measurement	FTA-ABS	INC	modified_by:positive;
14.txt	NCT00001662	Procedure	neuroimaging study	INC	
14.txt	NCT00001662	Condition	serious infection	INC	modified_by:Acute;has_TempMea:within one year;
14.txt	NCT00040378	Condition	Huntington's disease	EXC	
14.txt	NCT00040378	Condition	stroke	EXC	
14.txt	NCT00001662	Condition	Hemispheric stroke	INC	
14.txt	NCT01841125	Procedure	CT	INC	has_TempMea:within 24 months;
14.txt	NCT01841125	Condition	abnormalities	EXC	
14.txt	NCT00040378	Condition	corticobasal degeneration	EXC	
14.txt	NCT00001662	Condition	hydrocephalus	INC	
14.txt	NCT01841125	Procedure	brain MRI	EXC	
14.txt	NCT01841125	Condition	brain atrophy	EXC	is_negated:other than;
14.txt	NCT00040378	Condition	cognitive and motor impairment	EXC	modified_by:significant;
14.txt	NCT00001662	Condition	dementia	INC	
14.txt	NCT01841125	Condition	NINCDS-ADRDA Criteria	INC	
14.txt	NCT01847586	Condition	Dementia of the Alzheimer type	EXC	has_TempMea:within the past 12 months;is_negated:other than;
14.txt	NCT01847586	Measurement	Mini Mental Status Examination score	EXC	has_value:16 or less;
14.txt	NCT01847586	Condition	Axis I diagnosis	EXC	
14.txt	NCT01841125	Condition	pregnant	EXC	
14.txt	NCT00040378	Condition	manic-depressive disorder	EXC	
14.txt	NCT00001662	Procedure	"epileptiform" baseline EEG	INC	
14.txt	NCT00040378	Condition	language difficulties	EXC	is_negated:not;
14.txt	NCT01841125	Condition	kidney failure	EXC	
14.txt	NCT00040378	Condition	schizophrenia	EXC	
14.txt	NCT00001662	Condition	loss of consciousness	INC	
14.txt	NCT01841125	Drug	memantin	EXC	
14.txt	NCT00040378	Condition	brain tumor	EXC	
14.txt	NCT00001662	Condition	seizure disorder	INC	
14.txt	NCT01847586	Condition	alcohol or other drug dependence	EXC	has_TempMea:current;has_TempMea:within 6 months;
14.txt	NCT01841125	Condition	dementia	EXC	
14.txt	NCT00040378	Condition	multiple sclerosis	EXC	
14.txt	NCT00001662	Condition	head trauma	INC	
14.txt	NCT00040378	Condition	deafness	EXC	is_negated:not;
14.txt	NCT00040378	Condition	epilepsy	EXC	
14.txt	NCT00001662	Condition	mass lesion	INC	
14.txt	NCT01948791	Drug	clinical trial drugs	EXC	modified_by:other;
14.txt	NCT01847586	Procedure	Electroconvulsive Therapy ( ECT )	EXC	has_TempMea:within 6 months;
14.txt	NCT01841125	Condition	test drug hypersensitivity	EXC	
14.txt	NCT00040378	Condition	Parkinson's disease	EXC	
14.txt	NCT01948791	Condition	NINCDS/ADRDA criteria	INC	
14.txt	NCT00001662	Condition	subdural hematoma	INC	
14.txt	NCT00001662	Condition	hepatic insufficiency	INC	
14.txt	NCT00001662	Measurement	SGPT or SGOT	INC	has_value:greater than 3 x upper limit of normal;
14.txt	NCT00040378	Drug	Aricept	EXC	is_negated:not;has_TempMea:currently;
14.txt	NCT01847586	Condition	contraindication	EXC	
14.txt	NCT02119546	Condition	Petersen's criteria	INC	
14.txt	NCT01847586	Demographic	Age	EXC	has_value:65 or above;
14.txt	NCT01847586	Procedure	TMS	EXC	
14.txt	NCT01847586	Condition	contraindication	EXC	
14.txt	NCT02051244	Procedure	cognitive test	INC	modified_by:able;
14.txt	NCT00001662	Condition	Depression	INC	
14.txt	NCT01948791	Condition	epilepsy	EXC	modified_by:uncontrolled;modified_by:Active;
14.txt	NCT02051244	Demographic	age	INC	has_value:60 and above;
14.txt	NCT02119546	Condition	NINCDS-ADRDA criteria	INC	
14.txt	NCT01847586	Procedure	TMS	EXC	
14.txt	NCT01948791	Condition	AD	EXC	modified_by:Severe;
14.txt	NCT00040378	Drug	Reminyl	EXC	is_negated:not;has_TempMea:currently;
14.txt	NCT00001662	Condition	neutropenia	INC	
14.txt	NCT01948791	Condition	cerebrovascular disease	EXC	
14.txt	NCT00040378	Drug	Hydergine	EXC	is_negated:not;has_TempMea:currently;
14.txt	NCT00001662	Measurement	white blood cell counts	INC	modified_by:normal;has_value:greater than or equal to 3.5 K/microliter;modified_by:low;
14.txt	NCT01948791	Condition	medical condition	INC	modified_by:stable;
14.txt	NCT00040378	Drug	Cognex	EXC	is_negated:not;has_TempMea:currently;
14.txt	NCT00001662	Measurement	total bilirubin	INC	has_value:greater than 2.0 mg/dL;
14.txt	NCT00040378	Drug	Exelon	EXC	is_negated:not;has_TempMea:currently;
14.txt	NCT01948791	Condition	dementia of the Alzheimer's type	INC	
14.txt	NCT01948791	Drug	memantine	EXC	
14.txt	NCT00001662	Condition	vitamin B12 deficiency	INC	has_value:less than 160 pg/mL;
14.txt	NCT00001662	Measurement	Hamilton Depression Rating Scale	INC	
14.txt	NCT01948791	Condition	DSM-IV criteria	INC	
14.txt	NCT01847586	Drug	Psychotropic medication	EXC	has_TempMea:at least 4 weeks;modified_by:stable dose;
14.txt	NCT01847586	Drug	sedative /hypnotics	EXC	is_negated:except for;
14.txt	NCT01847586	Condition	neurological disorder	EXC	modified_by:Other;
14.txt	NCT01847586	Condition	Axis I diagnosis	EXC	
14.txt	NCT01948791	Drug	huperzine A	INC	has_TempMea:at least 2 weeks;modified_by:stopped;
14.txt	NCT00001662	Measurement	serum creatinine	INC	has_value:greater than 2.0 mg/dL;
14.txt	NCT01948791	Drug	memantine	INC	has_TempMea:at least 2 weeks;modified_by:stopped;
14.txt	NCT01948791	Drug	donepezil	INC	modified_by:stopped;has_TempMea:at least 2 weeks;
14.txt	NCT00040378	Condition	depression	EXC	has_TempMea:previously;
14.txt	NCT00001662	Measurement	BUN	INC	has_value:greater than 40 mg/dL;
14.txt	NCT01948791	Drug	galantamine	INC	has_TempMea:at least 2 weeks;modified_by:stopped;
14.txt	NCT00040378	Condition	anxiety disorder	EXC	has_TempMea:previously;
14.txt	NCT01948791	Measurement	MMSE score	INC	
14.txt	NCT00040378	Condition	depression	EXC	
14.txt	NCT00001662	Measurement	creatinine clearance	INC	has_value:less than 25 mL/min;
14.txt	NCT00040378	Condition	anxiety disorder	EXC	
14.txt	NCT01948791	Condition	AD	INC	modified_by:probable;
14.txt	NCT00040378	Drug	treatment	EXC	is_negated:not;has_TempMea:currently;
14.txt	NCT00001662	Condition	renal insufficiency	INC	modified_by:severe;
14.txt	NCT01847586	Condition	adjustment disorder	EXC	is_negated:other than;
14.txt	NCT01847586	Condition	simple phobias	EXC	is_negated:other than;
14.txt	NCT00414622	Condition	Alzheimer	INC	modified_by:probable;
14.txt	NCT01993836	Condition	malignant hyperthermia	EXC	
14.txt	NCT01847586	Measurement	visual ability	EXC	modified_by:Corrected;
14.txt	NCT02119546	Measurement	CDR score	INC	has_value:0.5;
14.txt	NCT02119546	Condition	MCI	INC	
14.txt	NCT02119546	Condition	Alzheimer's disease	INC	
14.txt	NCT02079909	Drug	donepezil	INC	
14.txt	NCT01078168	Condition	AD	INC	modified_by:mild to moderate;
14.txt	NCT02079909	Drug	Aricept	INC	
14.txt	NCT02079909	Condition	Alzheimer's disease	INC	modified_by:Mild to moderate;
14.txt	NCT02079909	Condition	post-menopausal	INC	
14.txt	NCT01993836	Condition	allergy	EXC	
14.txt	NCT02079909	Condition	surgically sterile	INC	
14.txt	NCT01993836	Condition	contraindication	EXC	
14.txt	NCT02079909	Demographic	Age	INC	has_value:55 to 85 inclusive;
14.txt	NCT01993836	Drug	propofol	EXC	
14.txt	NCT01993836	Drug	isoflurane	EXC	
14.txt	NCT02051244	Condition	diseases	EXC	modified_by:other;
14.txt	NCT01948791	Condition	hypothyroidism	EXC	modified_by:Active;
14.txt	NCT02119546	Condition	neurological, musculoskeletal, cardio-pulmonary disorder	EXC	is_negated:excluded;
14.txt	NCT02119546	Condition	Alzheimer disease	INC	modified_by:probable;
14.txt	NCT01948791	Condition	asthma	EXC	
14.txt	NCT02051244	Condition	glaucoma	EXC	
14.txt	NCT02119546	Condition	cognitive dysfunction	EXC	
14.txt	NCT02119546	Condition	gait disorder	EXC	
14.txt	NCT02119546	Condition	Parkinson disease	EXC	
14.txt	NCT02119546	Condition	stroke	EXC	
14.txt	NCT02119546	Condition	arthritis	EXC	
14.txt	NCT01948791	Condition	medical condition	EXC	modified_by:progressive;modified_by:unstable;modified_by:advanced;modified_by:severe;
14.txt	NCT01993836	Condition	Pregnancy	EXC	
14.txt	NCT01066481	Condition	Alzheimer's disease	INC	modified_by:Mild-to-Moderate;
14.txt	NCT01948791	Measurement	Modified Hachinski Ischemic Scale ( MHIS )	EXC	has_value:> 4;
14.txt	NCT00001662	Condition	NINCDS-ADRDA criteria	INC	
14.txt	NCT01948791	Condition	Neurodegenerative disorders	EXC	modified_by:other;
14.txt	NCT02051244	Condition	cognitive impairment	EXC	modified_by:mild;
14.txt	NCT01993836	Demographic	age	INC	has_value:60 years;has_value:older;
14.txt	NCT01948791	Condition	CNS infection	EXC	
14.txt	NCT02051244	Condition	dense cataracts	EXC	
14.txt	NCT02051244	Measurement	Cognitive test scores	EXC	
14.txt	NCT01066481	Measurement	MMSE score	INC	has_value:10 - 24 inclusive;
14.txt	NCT01066481	Drug	cholinesterase-inhibitors	EXC	
14.txt	NCT02079909	Drug	drug	EXC	
14.txt	NCT01066481	Drug	anti-dementia drugs	EXC	has_TempMea:within 90 days;
14.txt	NCT02079909	Condition	dementia not of the Alzheimer's type	EXC	
14.txt	NCT01066481	Drug	NMDA receptor antagonists	EXC	
14.txt	NCT01066481	Condition	causes of dementia	EXC	modified_by:other;
14.txt	NCT01841125	Demographic	age	INC	has_value:over;has_value:50;
14.txt	NCT02079909	Drug	Exelon	EXC	
14.txt	NCT02079909	Drug	galantamine	EXC	
14.txt	NCT02079909	Condition	Alzheimer's disease	EXC	
14.txt	NCT02079909	Drug	olal rivastigmine	EXC	
14.txt	NCT02079909	Drug	donepezil	EXC	is_negated:other than;
14.txt	NCT02079909	Drug	rivastigmine transdermal system	EXC	is_negated:other than;
14.txt	NCT01841125	Condition	Olin depression	INC	
14.txt	NCT01841125	Condition	Alzheimer's disease	INC	
14.txt	NCT01841125	Measurement	clinical dementia rating ( CDR )	INC	has_value:0.5 to 2;
14.txt	NCT02079909	Drug	Exelon Patch	INC	
14.txt	NCT01841125	Condition	major depressive episode	INC	
14.txt	NCT02079909	Drug	Memantine	INC	
14.txt	NCT02079909	Drug	rivastigmine transdermal system	INC	
14.txt	NCT01841125	Measurement	MMSE	INC	has_value:10 - 26;
14.txt	NCT01841125	Measurement	K-MMSE	INC	
14.txt	NCT02079909	Condition	cardiac, hepatic or renal impairment	EXC	modified_by:clinically significant;
14.txt	NCT02079909	Drug	rivastigmine transdermal system	INC	
14.txt	NCT02079909	Drug	Namenda	INC	
14.txt	NCT02079909	Drug	donepezil	INC	
14.txt	NCT01841125	Measurement	GDS- 15	INC	has_value:>= 5 points;
14.txt	NCT01841125	Drug	Cholinesterase inhibitors	INC	modified_by:stable;has_TempMea:a minimum of four weeks or more;
14.txt	NCT01841125	Drug	Cholinesterase Inhibitors	INC	
14.txt	NCT01841125	Condition	Alzheimer's disease ( AD )	INC	
14.txt	NCT01841125	Procedure	MRI	INC	has_TempMea:within 24 months;
14.txt	NCT01847586	Demographic	Age	INC	has_value:65 or above;
14.txt	NCT01847586	Condition	Alzheimer's Disease	INC	has_TempMea:current;
14.txt	NCT01847586	Drug	acetylcholinesterase inhibitors	INC	has_TempMea:at least 3 months;modified_by:Stable does;
14.txt	NCT00040378	Procedure	treatment	EXC	modified_by:completed;has_TempMea:more than four months ago;
14.txt	NCT01841125	Drug	depression drugs	EXC	modified_by:other;has_TempMea:within 4 weeks;
14.txt	NCT01841125	Drug	Stablon	EXC	
14.txt	NCT01841125	Drug	SSRI	EXC	
14.txt	NCT01841125	Drug	wellbutrin	EXC	
14.txt	NCT01841125	Drug	TCA	EXC	
14.txt	NCT01841125	Condition	mental illness	EXC	modified_by:other;
14.txt	NCT01841125	Drug	ixel	EXC	
14.txt	NCT01841125	Condition	bipolar disorder	EXC	
15.txt	NCT01555827	Condition	Horton's disease	EXC	
15.txt	NCT01703117	Measurement	liver function test	EXC	modified_by:Abnormal;
15.txt	NCT01555827	Condition	Parkinson's disease	EXC	
15.txt	NCT01555827	Condition	Devic's disease	EXC	
15.txt	NCT01703117	Measurement	alanine aminotranferase ( ALT )	EXC	has_value:greater than 2 times the upper limit of normal;
15.txt	NCT01555827	Condition	multiple sclerosis	EXC	
15.txt	NCT02360657	Condition	disorders	EXC	modified_by:other;
15.txt	NCT01703117	Measurement	aspartate aminotransferase ( AST )	EXC	has_value:greater than 2 times the upper limit of normal;
15.txt	NCT01703117	Measurement	bilirubin	EXC	has_value:> 1.5 times the upper limit of normal;
15.txt	NCT01555827	Condition	diseases	EXC	
15.txt	NCT01555827	Condition	diabetes	EXC	
15.txt	NCT01555827	Condition	systemic and/or ocular diseases	EXC	
15.txt	NCT01555827	Condition	behavioural or cognitive symptoms	EXC	
15.txt	NCT01555827	Condition	neurodegenerative disorder	EXC	modified_by:other;
15.txt	NCT01703117	Condition	Parkinson's Disease	EXC	
15.txt	NCT01703117	Condition	brain disease	EXC	
15.txt	NCT01703117	Condition	brain trauma	EXC	modified_by:severe;
15.txt	NCT02360657	Condition	AD	EXC	
15.txt	NCT02360657	Condition	diseases	EXC	modified_by:other;
15.txt	NCT01703117	Condition	seizures	EXC	
15.txt	NCT01703117	Condition	stroke	EXC	
15.txt	NCT01703117	Condition	lacunar infarct	EXC	modified_by:clinically significant;
15.txt	NCT01555827	Condition	inflammatory neuropathies	EXC	
15.txt	NCT01555827	Condition	vascular ischemic neuropathies	EXC	
15.txt	NCT01555827	Condition	chronic intracranial hypertension	EXC	
15.txt	NCT01555827	Condition	pituitary tumors	EXC	
15.txt	NCT01703117	Condition	cortical infarct	EXC	
15.txt	NCT01703117	Condition	multiple lacunes	EXC	
15.txt	NCT01703117	Condition	focal lesions	EXC	
15.txt	NCT01703117	Condition	mental retardation	EXC	
15.txt	NCT01703117	Condition	multiple sclerosis	EXC	
15.txt	NCT01703117	Condition	CNS tumor	EXC	
15.txt	NCT01703117	Condition	normal pressure hydrocephalus	EXC	
15.txt	NCT01703117	Condition	subdural hematoma	EXC	
15.txt	NCT01703117	Condition	Huntington's disease	EXC	
15.txt	NCT01703117	Condition	Alzheimer's disease	INC	modified_by:mild;
15.txt	NCT01703117	Condition	Alzheimer's disease	INC	modified_by:mild;
15.txt	NCT01703117	Measurement	Clinical Dementia Ratings Scale ( CDR )	INC	has_value:0.5 or 1;
15.txt	NCT01703117	Measurement	Mini Mental State Examination ( MMSS )	INC	has_value:between 19 and 27;
15.txt	NCT01703117	Condition	neurological disorder	EXC	modified_by:serious;modified_by:other;
15.txt	NCT01703117	Measurement	Hba1c	EXC	has_value:higher than 7;
15.txt	NCT01703117	Condition	diabetes mellitus	EXC	modified_by:Uncontrolled;
15.txt	NCT01703117	Drug	Namenda	EXC	has_TempMea:at least 2 months;is_negated:not;
15.txt	NCT01703117	Condition	hypertension	EXC	modified_by:uncontrolled;modified_by:chronically;
15.txt	NCT02360657	Condition	contra-indications	EXC	
15.txt	NCT02360657	Procedure	Magnetic Resonance Imaging ( MRI )	EXC	
15.txt	NCT02360657	Condition	AD	EXC	
15.txt	NCT02360657	Condition	familial autosomal dominant AD	EXC	
15.txt	NCT02360657	Condition	dementia	EXC	
15.txt	NCT02360657	Condition	abnormality	EXC	modified_by:other;
15.txt	NCT02360657	Procedure	prostheses	EXC	
15.txt	NCT02360657	Procedure	implants	EXC	
15.txt	NCT01555827	Condition	dementia	EXC	
15.txt	NCT01555827	Measurement	MMSE score	EXC	has_value:<= 10;
15.txt	NCT01555827	Measurement	MMSE score	INC	has_value:> 10;
15.txt	NCT01555827	Condition	AD	EXC	modified_by:Severe;
15.txt	NCT00039702	Condition	NINCDS-ADRDA criteria	INC	
15.txt	NCT01703117	Drug	medications	EXC	
15.txt	NCT01555827	Condition	AD	EXC	
15.txt	NCT01703117	Procedure	coronary bypass surgery	EXC	
15.txt	NCT01504854	Demographic	Age	INC	has_value:50 years or older;
15.txt	NCT01172145	Procedure	neuroimaging	EXC	
15.txt	NCT01555827	Condition	disease	INC	modified_by:Light to moderate;
15.txt	NCT01504854	Condition	AD	INC	modified_by:probable;
15.txt	NCT01172145	Measurement	Frontal Systems Behavior Scale	INC	
15.txt	NCT02360657	Measurement	QTc	EXC	has_value:greater than 450 millisecond;
15.txt	NCT02360657	Measurement	vital signs	EXC	modified_by:abnormal;modified_by:clinically significant;
15.txt	NCT02360657	Procedure	12 -lead ECG	EXC	modified_by:abnormal;modified_by:clinically significant;
15.txt	NCT02360657	Measurement	physical- or neurological examination	EXC	modified_by:abnormal;modified_by:clinically significant;
15.txt	NCT02360657	Procedure	claustrophobia	EXC	
15.txt	NCT02360657	Procedure	pacemakers	EXC	
15.txt	NCT01555827	Condition	AD	EXC	
15.txt	NCT01703117	Condition	NINCDS-ADRDA criteria	INC	
15.txt	NCT01555827	Condition	Dementia of other cause	EXC	
15.txt	NCT01504854	Condition	focal brain lesion	EXC	has_TempMea:Current;has_TempMea:in past two years;
15.txt	NCT01504854	Condition	head injury with loss of consciousness	EXC	has_TempMea:Current;has_TempMea:in past two years;
15.txt	NCT01703117	Drug	methyldopa	EXC	
15.txt	NCT01703117	Drug	sulfasalazine	EXC	
15.txt	NCT01504854	Condition	epilepsy	EXC	has_TempMea:in past two years;has_TempMea:Current;
15.txt	NCT01703117	Drug	hepatotoxic drugs	EXC	has_TempMea:Currently;has_TempMea:concomitant;
15.txt	NCT01504854	Condition	stroke	EXC	modified_by:clinically significant;
15.txt	NCT01703117	Drug	allopurinol	EXC	
15.txt	NCT01703117	Condition	coronary artery disease	EXC	
15.txt	NCT01504854	Condition	psychosis	EXC	
15.txt	NCT01504854	Condition	aboratory finding	EXC	modified_by:significant clinical;
15.txt	NCT01703117	Condition	medical condition( s )	EXC	modified_by:serious;modified_by:co-existing;modified_by:unstable;
15.txt	NCT01703117	Condition	myocardial infarction	EXC	
15.txt	NCT01504854	Condition	psychiatric disorder	EXC	modified_by:major;
15.txt	NCT01504854	Condition	Non-AD dementia	EXC	
15.txt	NCT02360657	Procedure	pacemaker	EXC	
15.txt	NCT02360657	Condition	left bundle branch block	EXC	
15.txt	NCT01504854	Measurement	Modified Hachinski score	INC	has_value:less than or equal to 4;
15.txt	NCT02360657	Condition	atrio-ventricular [AV] block	EXC	has_value:second degree or highe;
15.txt	NCT01504854	Condition	DSM-IV criteria	EXC	
15.txt	NCT02360657	Condition	cognitive deficit	EXC	modified_by:possible;
15.txt	NCT01504854	Measurement	MMSE score	INC	has_value:between 14 and 26 ( inclusive );
15.txt	NCT02360657	Condition	mixed dementia	EXC	
15.txt	NCT01504854	Condition	AD	EXC	modified_by:Probable;
15.txt	NCT01703117	Drug	memantine	EXC	
15.txt	NCT01504854	Condition	Down syndrome	EXC	
15.txt	NCT02360657	Procedure	implantable cardioverter defibrillator	EXC	
15.txt	NCT01703117	Measurement	Hamilton Psychiatric Rating Scale	EXC	has_value:> 18;
15.txt	NCT01504854	Condition	neoplastic disease	EXC	modified_by:Active;
15.txt	NCT01703117	Condition	major depression	EXC	has_TempMea:Current;
15.txt	NCT01504854	Condition	hematologic, hepatic, cardiovascular, pulmonary, gastrointestinal, endocrine, metabolic, renal or other systemic disease	EXC	modified_by:clinically significant;modified_by:unstable;
15.txt	NCT01504854	Condition	laboratory abnormality	EXC	modified_by:clinically significant;modified_by:unstable;
15.txt	NCT01703117	Condition	vascular dementia	EXC	
15.txt	NCT01504854	Condition	prostate cancer	EXC	modified_by:stable;
15.txt	NCT01703117	Condition	Creutzfeldt-Jakob dementia	EXC	
15.txt	NCT01703117	Condition	schizophrenia	EXC	
15.txt	NCT01504854	Condition	breast cancer	EXC	
15.txt	NCT01703117	Condition	moderate-severe anxiety	EXC	
15.txt	NCT01504854	Condition	skin melanoma	EXC	
15.txt	NCT01703117	Condition	neuropsychiatric illnesses	EXC	modified_by:Significant;
15.txt	NCT01504854	Condition	cancer	EXC	has_TempMea:five years;
15.txt	NCT01703117	Condition	bipolar disorder	EXC	
15.txt	NCT01703117	Observation	smoker	EXC	has_TempMea:Current;
15.txt	NCT01703117	Condition	congestive heart failure	EXC	has_TempMea:within 6 months;
15.txt	NCT01504854	Condition	alcohol or substance abuse	EXC	
15.txt	NCT01504854	Drug	investigational drug	EXC	
15.txt	NCT01703117	Condition	angina	EXC	modified_by:unstable;
15.txt	NCT01504854	Condition	major depression	EXC	
15.txt	NCT01504854	Condition	bipolar disorder	EXC	
15.txt	NCT01703117	Drug	investigational or marketed drug	EXC	has_TempMea:within 30 days;
15.txt	NCT01703117	Drug	Aricept	INC	
15.txt	NCT01703117	Drug	donepezil	INC	modified_by:consistent dose;has_TempMea:at least 2 months;
15.txt	NCT01703117	Drug	Exelon	INC	
15.txt	NCT01703117	Drug	rivastigmine	INC	modified_by:consistent dose;has_TempMea:at least 2 months;
15.txt	NCT01703117	Drug	Razadyne	INC	
15.txt	NCT01703117	Drug	gum	EXC	
15.txt	NCT01703117	Drug	galantamine	INC	modified_by:consistent dose;has_TempMea:at least 2 months;
15.txt	NCT01703117	Drug	chewing tobacco	EXC	
15.txt	NCT01703117	Drug	nicotine patch	EXC	
15.txt	NCT01504854	Condition	disorder	EXC	modified_by:significant clinical;
15.txt	NCT01504854	Condition	Sensory impairment	EXC	
15.txt	NCT01703117	Drug	nicotine-containing products	EXC	has_TempMea:the past 2 months;
15.txt	NCT01504854	Drug	investigational agent	EXC	has_TempMea:within two months;
15.txt	NCT00039702	Condition	AD	INC	
15.txt	NCT01172145	Drug	cholinesterase inhibitor	INC	modified_by:stable dose;has_TempMea:at least 30 days;
15.txt	NCT00039702	Demographic	age	INC	has_value:between 50 and 65 years;
15.txt	NCT01703117	Condition	Alzheimer's disease	EXC	modified_by:Moderate-Severe;
15.txt	NCT01703117	Drug	riluzole treatment	EXC	has_TempMea:Previous;
15.txt	NCT01703117	Condition	dementias	EXC	modified_by:other;
15.txt	NCT01703117	Procedure	MRI	EXC	
15.txt	NCT00039702	Observation	nonsmokers	INC	
15.txt	NCT01703117	Condition	contra-indication	EXC	
15.txt	NCT00039702	Condition	ALZHEIMER'S DISEASE	INC	
15.txt	NCT01703117	Procedure	metal implants	EXC	
15.txt	NCT00039702	Measurement	Mini-Mental State Examination	INC	
15.txt	NCT01172145	Condition	focal brain lesion	EXC	
15.txt	NCT01703117	Condition	claustrophobia	EXC	modified_by:severe;
15.txt	NCT00039702	Condition	AD	INC	
15.txt	NCT00039702	Condition	demented	INC	modified_by:mild to moderately;
15.txt	NCT01172145	Condition	apathy	INC	modified_by:clinically elevated levels;
15.txt	NCT00039702	Measurement	Mattis Dementia Rating Scale	INC	
15.txt	NCT01172145	Condition	Major Depression	EXC	
15.txt	NCT00039702	Condition	AD	INC	
15.txt	NCT01703117	Drug	donepezil	EXC	has_value:longer than 5 years;
15.txt	NCT01504854	Condition	seizure	EXC	has_TempMea:within past five years;
15.txt	NCT01703117	Condition	HIV dementia	EXC	
15.txt	NCT01703117	Condition	dementia in other specified diseases	EXC	
15.txt	NCT01703117	Procedure	shunts	EXC	
15.txt	NCT01703117	Procedure	joint implants	EXC	
15.txt	NCT01703117	Procedure	pacemaker	EXC	
15.txt	NCT01703117	Condition	drug or alcohol abuse	EXC	has_TempMea:within the past 5 years;
15.txt	NCT01703117	Procedure	metal valves	EXC	
15.txt	NCT01703117	Drug	lamotrigine	EXC	
15.txt	NCT01703117	Drug	memantine	EXC	
15.txt	NCT01703117	Drug	opiates	EXC	
15.txt	NCT00039702	Condition	AD	INC	modified_by:probable;
15.txt	NCT01172145	Condition	Alzheimer's disease	INC	modified_by:mild to moderate;modified_by:Probable;
15.txt	NCT01703117	Drug	lithium	EXC	
15.txt	NCT00039702	Demographic	age of onset	INC	has_value:between 50 and 65 years;
15.txt	NCT00039702	Condition	ALZHEIMER'S DISEASE	INC	
15.txt	NCT01504854	Drug	resveratrol	EXC	
15.txt	NCT01703117	Drug	bupropion	EXC	
15.txt	NCT01703117	Condition	Lactose intolerance	EXC	
15.txt	NCT01504854	Condition	pregnancy	EXC	modified_by:possible;
15.txt	NCT01703117	Measurement	Weight	EXC	has_value:> 300 pounds;
15.txt	NCT01504854	Condition	Pregnancy	EXC	
15.txt	NCT01555827	Demographic	aged	INC	has_value:50 years or more;
15.txt	NCT01703117	Drug	amphetamines	EXC	
15.txt	NCT01703117	Drug	psychostimulants	EXC	
15.txt	NCT01555827	Condition	dementia	INC	
15.txt	NCT02360657	Measurement	physical examination	INC	
15.txt	NCT01703117	Drug	tricyclic antidepressants	EXC	
15.txt	NCT01703117	Drug	methylphenidates	EXC	
15.txt	NCT01703117	Drug	benzodiazepines	EXC	
15.txt	NCT01703117	Drug	illicit drugs	EXC	has_TempMea:Currently;
15.txt	NCT01703117	Drug	drug	EXC	modified_by:other;
15.txt	NCT01703117	Drug	MDMA	EXC	
15.txt	NCT02360657	Condition	Alzheimer's disease ( AD )	EXC	is_negated:other than;
15.txt	NCT01703117	Drug	cocaine	EXC	
15.txt	NCT01555827	Measurement	Isaac's set test	INC	has_value:>= norm for age and educational level;
15.txt	NCT01555827	Measurement	Free and Cued Selective Reminding Test	INC	
15.txt	NCT02360657	Condition	healthy	INC	
15.txt	NCT01555827	Measurement	MMSE	INC	has_value:>= norm for age and educational level;
15.txt	NCT02360657	Condition	brain disease	EXC	
15.txt	NCT01555827	Measurement	total recall	INC	has_value:>= 40;
15.txt	NCT02360657	Procedure	12 -lead electrocardiogram ( ECG )	INC	
15.txt	NCT01555827	Condition	Free recall	INC	has_value:>= 17;
15.txt	NCT02360657	Observation	medical history	INC	
15.txt	NCT02360657	Measurement	vital signs	INC	
15.txt	NCT01555827	Condition	NINCDS-ARDRA criteria51	INC	
15.txt	NCT00039702	Drug	AChe inhibitors	INC	
15.txt	NCT01703117	Drug	ecstasy	EXC	
15.txt	NCT01703117	Drug	opioids	EXC	modified_by:other;
15.txt	NCT01172145	Condition	substance abuse	EXC	modified_by:significant;
15.txt	NCT01703117	Drug	heroin	EXC	
15.txt	NCT00039702	Drug	galanthamine	INC	
15.txt	NCT01172145	Condition	head trauma	EXC	modified_by:significant;
15.txt	NCT02360657	Drug	medication	INC	modified_by:stable;
15.txt	NCT01703117	Measurement	urine drug test	EXC	
15.txt	NCT02360657	Measurement	amyloid deposition	INC	
15.txt	NCT01703117	Measurement	Serum creatinine	EXC	has_value:> 1.5 times the upper limit of normal;
15.txt	NCT01555827	Condition	AD	INC	modified_by:probable;
15.txt	NCT02360657	Measurement	body mass index	INC	has_value:between 18 and 35 kilogram per square meter, inclusive;
15.txt	NCT00039702	Condition	healthy	INC	
15.txt	NCT01555827	Condition	AD	INC	
15.txt	NCT02360657	Measurement	Cerebrospinal Fluid ( CSF ) Amyloid ( A )-beta 1 - 42 levels	INC	modified_by:low;
15.txt	NCT00039702	Drug	psychotropic drugs	INC	
15.txt	NCT02360657	Measurement	Clinical Dementia Rating Scale- Japanese version ( CDR-J ) score	INC	has_value:0;
15.txt	NCT00039702	Observation	Nonsmoking	INC	
15.txt	NCT00039702	Drug	Reminyl	INC	
15.txt	NCT01172145	Condition	loss of consciousness	EXC	has_value:> 10 minutes;
15.txt	NCT00039702	Drug	antidepressants	INC	
16.txt	NCT00076440	Procedure	ECG	INC	
16.txt	NCT00076440	Measurement	laboratory test	INC	
16.txt	NCT00076440	Drug	substances	INC	modified_by:other;has_TempMea:at least 60 days;has_TempMea:at least 90 days;modified_by:stable;modified_by:stopped;
16.txt	NCT02129348	Condition	post-menopausal	INC	
16.txt	NCT02129348	Condition	contraindication	EXC	
16.txt	NCT02129348	Measurement	physical examination	EXC	
16.txt	NCT02129348	Measurement	Neuropsychiatric Inventory ( NPI ) agitation/aggression subscale score	INC	has_value:> 4;
16.txt	NCT02129348	Condition	resting tremor	EXC	
16.txt	NCT02129348	Measurement	Folstein MMSE	INC	has_value:5 - 26 out of 30;
16.txt	NCT00495820	Observation	MINI	EXC	
16.txt	NCT02129348	Condition	AD	INC	modified_by:possible or probable;
16.txt	NCT00495820	Observation	Mini International Neuropsychiatric Inventory ( MINI )	EXC	
16.txt	NCT02129348	Drug	lithium treatment	EXC	
16.txt	NCT02129348	Condition	intolerability	EXC	
16.txt	NCT02129348	Procedure	ECG	EXC	
16.txt	NCT00076440	Drug	drug	INC	has_TempMea:12 hours;modified_by:interrupted;
16.txt	NCT00076440	Condition	cognition	INC	
16.txt	NCT00076440	Condition	Abnormalities	INC	
16.txt	NCT00076440	Condition	bladder outlet obstruction	INC	modified_by:Clinically significant;
16.txt	NCT02129348	Measurement	glomerular filtration rate	EXC	has_value:less than 44ml/min/ 1.73m2;
16.txt	NCT00076440	Condition	basal cell or squamous cell cancer of the skin	INC	is_negated:except;
16.txt	NCT02129348	Measurement	TSH	EXC	
16.txt	NCT02129348	Measurement	creatinine level	EXC	has_value:greater than 1.5 mg/100ml;
16.txt	NCT00076440	Condition	prostate cancer	INC	modified_by:known or suspected;
16.txt	NCT02129348	Measurement	T3	EXC	
16.txt	NCT02129348	Measurement	T4	EXC	
16.txt	NCT00076440	Condition	achalasia	INC	
16.txt	NCT02129348	Measurement	heart rate	EXC	has_value:< 50 bpm;
16.txt	NCT00076440	Condition	Sleep apnea	INC	
16.txt	NCT02129348	Measurement	blood pressure	EXC	has_value:> 150 - 90 mm Hg;
16.txt	NCT00076440	Condition	stricture	INC	
16.txt	NCT02129348	Procedure	MRI	EXC	
16.txt	NCT02129348	Condition	DSM-IV TR criteria	EXC	
16.txt	NCT02129348	Condition	falls	EXC	has_TempMea:in the last month;
16.txt	NCT02129348	Condition	DSM-IV TR criteria	EXC	
16.txt	NCT02129348	Drug	lithium	EXC	
16.txt	NCT02129348	Condition	functional impairment	EXC	
16.txt	NCT02129348	Condition	lithium treatment	EXC	
16.txt	NCT02129348	Condition	Contraindications	EXC	
16.txt	NCT00076440	Condition	breast cancer	INC	
16.txt	NCT02129348	Procedure	baseline EKG	EXC	
16.txt	NCT02129348	Measurement	thyroid function test	EXC	modified_by:abnormal;
16.txt	NCT00076440	Condition	condition	INC	has_TempMea:at least 6 months;
16.txt	NCT02129348	Condition	thyroid disease	EXC	modified_by:untreated;
16.txt	NCT02129348	Condition	contraindication	EXC	is_negated:no;
16.txt	NCT00076440	Measurement	T-score	INC	has_value:greater than - 2.0;
16.txt	NCT00495820	Drug	medications	INC	modified_by:stable;has_TempMea:at least four months;
16.txt	NCT02129348	Drug	antipsychotics	EXC	
16.txt	NCT00076440	Procedure	DEXA scan	INC	has_value:within normal limits;
16.txt	NCT02129348	Drug	antidepressants	EXC	
16.txt	NCT00076440	Condition	of vascular origin	INC	is_negated:not;
16.txt	NCT00495820	Drug	cholinesterase inhibitors	INC	
16.txt	NCT02129348	Drug	antidepressants	EXC	has_TempMea:concomitant;has_TempMea:at least 24 hours;
16.txt	NCT00076440	Measurement	Hamilton Depression Scale ( 17 -item version ) ( HamD ) score	INC	has_value:14 or less;
16.txt	NCT00495820	Drug	memantine	INC	
16.txt	NCT02129348	Drug	antipsychotics	EXC	has_TempMea:concomitant;has_TempMea:at least 24 hours;
16.txt	NCT00076440	Measurement	T-score	INC	has_value:- 2.0 or lower;
16.txt	NCT00495820	Condition	adverse events	EXC	has_TempMea:prior;modified_by:significant;
16.txt	NCT02129348	Condition	anxiety/insomnia	EXC	
16.txt	NCT00495820	Drug	methylphenidate	EXC	
16.txt	NCT02129348	Drug	non-benzodiazepine hypnotics	EXC	
16.txt	NCT00076440	Measurement	DEXA measure	INC	modified_by:abnormally low;
16.txt	NCT00495820	Condition	hypersensitivity	EXC	
16.txt	NCT02129348	Drug	lorazepam	EXC	has_value:up to 2 mg/day;
16.txt	NCT02129348	Drug	lithium	EXC	has_TempMea:concomitant;
16.txt	NCT00495820	Drug	methylphenidate	EXC	
16.txt	NCT02129348	Drug	psychotropic medication	EXC	
16.txt	NCT00495820	Drug	antidepressants	INC	
16.txt	NCT00495820	Measurement	Apathy Evaluation Scale ( AES ) score	INC	has_value:more than 40;
16.txt	NCT02129348	Condition	adverse renal effects	EXC	
16.txt	NCT02129348	Drug	diuretics	EXC	modified_by:higher doses;
16.txt	NCT02129348	Drug	Medications	EXC	
16.txt	NCT00076440	Drug	drug	INC	is_negated:never;
16.txt	NCT02129348	Drug	lithium	EXC	
16.txt	NCT00495820	Condition	dementia of the Alzheimer type	INC	
16.txt	NCT00495820	Measurement	Mini-mental state examination ( MMSE )	INC	has_value:> 18 but  < 29;
16.txt	NCT02129348	Condition	cardiac disease	EXC	modified_by:unstable;
16.txt	NCT00076440	Condition	AD	INC	modified_by:probable;
16.txt	NCT00495820	Drug	antidepressants	INC	
16.txt	NCT02129348	Drug	furosemide	EXC	has_value:greater than 10mg daily;
16.txt	NCT00009217	Condition	conceptual disorganization	INC	is_negated:excluding;
16.txt	NCT02129348	Drug	hydrochlorothiazide	EXC	has_value:greater than 25mg daily;has_value:greater than 25mg daily;
16.txt	NCT00076440	Measurement	HamD	INC	
16.txt	NCT00076440	Drug	medications	INC	has_TempMea:concomitant;
16.txt	NCT00495820	Condition	Major Depressive Disorder	EXC	
16.txt	NCT02129348	Condition	Lewy body disease	EXC	
16.txt	NCT00076440	Procedure	ECG	INC	
16.txt	NCT00076440	Condition	medical conditions	INC	modified_by:significant;is_negated:not;
16.txt	NCT00495820	Condition	frontotemporal dementia	EXC	
16.txt	NCT02129348	Condition	Parkinson's disease	EXC	
16.txt	NCT02129348	Condition	neurological disorder	EXC	modified_by:major;modified_by:other;
16.txt	NCT02129348	Drug	medications	EXC	is_negated:washed off;
16.txt	NCT00495820	Condition	malignant hypertension	EXC	
16.txt	NCT02129348	Condition	Clinical stroke	EXC	
16.txt	NCT00076440	Demographic	age	INC	has_value:Younger than 65 years;
16.txt	NCT00076440	Demographic	Female	INC	
16.txt	NCT00495820	Condition	seizure disorder	EXC	modified_by:uncontrolled;
16.txt	NCT00076440	Measurement	laboratory tests	INC	has_TempMea:within 45 days;
16.txt	NCT00495820	Drug	antipsychotics	EXC	has_TempMea:currently;
16.txt	NCT02129348	Condition	Huntington's disease	EXC	
16.txt	NCT02129348	Condition	amyotrophic lateral sclerosis	EXC	
16.txt	NCT00076440	Drug	drug	INC	is_negated:never;
16.txt	NCT02129348	Condition	multiple sclerosis	EXC	
16.txt	NCT00495820	Condition	psychosis	EXC	modified_by:active;
16.txt	NCT02129348	Condition	CNS infection	EXC	
16.txt	NCT00495820	Drug	amphetamine product	EXC	modified_by:other;
16.txt	NCT00495820	Drug	Dexedrine	EXC	
16.txt	NCT02129348	Condition	schizoaffective disorder	EXC	
16.txt	NCT00076440	Measurement	DEXA measure	INC	modified_by:abnormally low;
16.txt	NCT00495820	Drug	dextroamphetamine sulphate	EXC	
16.txt	NCT02129348	Condition	psychosis	EXC	modified_by:other;
16.txt	NCT00076440	Condition	osteoporosis/osteopenia	INC	
16.txt	NCT00495820	Drug	Adderall	EXC	has_TempMea:currently;
16.txt	NCT02129348	Drug	zolpidem	EXC	
16.txt	NCT00495820	Drug	amphetamine mixed salts	EXC	
16.txt	NCT02129348	Condition	schizophrenia	EXC	
16.txt	NCT00009217	Condition	agitation	INC	has_TempMea:current;
16.txt	NCT00009217	Condition	psychosis	INC	has_TempMea:current;
16.txt	NCT00009217	Condition	hallucinations	INC	
16.txt	NCT00009217	Condition	delusions	INC	
16.txt	NCT00009217	Measurement	minimum Brief Psychiatric Rating Scale ( BPRS ) psychosis factor score	INC	has_value:at least 4;
16.txt	NCT00076440	Procedure	treatment	INC	
16.txt	NCT02129348	Condition	major depression	EXC	has_TempMea:Current;
16.txt	NCT00009217	Condition	psychosis	INC	modified_by:moderate;
16.txt	NCT00495820	Condition	tachycardia	EXC	
16.txt	NCT02129348	Condition	suicidality	EXC	has_TempMea:Current;
16.txt	NCT00076440	Condition	osteoporosis/osteopenia	INC	
16.txt	NCT00495820	Condition	hypertension	EXC	modified_by:Uncontrolled;
16.txt	NCT02129348	Condition	alcohol or substance dependence	EXC	has_TempMea:past 6 months;has_TempMea:Current or recent;
16.txt	NCT00076440	Condition	osteoporosis/osteopenia	INC	
16.txt	NCT00495820	Measurement	BP	EXC	has_value:100;has_value:> 140 - 90;
16.txt	NCT02129348	Condition	bipolar 1 disorder	EXC	
16.txt	NCT00009217	Condition	psychosis factor	INC	
16.txt	NCT00076440	Procedure	treatment	INC	is_negated:not;
16.txt	NCT00076440	Condition	organ failure	INC	has_TempMea:Current;modified_by:significant;
16.txt	NCT02129348	Condition	illness	EXC	modified_by:active;
16.txt	NCT00076440	Measurement	PSA test result	INC	has_value:exceeds 4.0 ng/mL;
16.txt	NCT00495820	Drug	clonidine	EXC	
16.txt	NCT02129348	Condition	metastases	EXC	modified_by:active;
16.txt	NCT00009217	Measurement	CERAD Behavioral Rating Scale	INC	has_value:greater than 3;
16.txt	NCT00009217	Condition	Agitation	INC	has_value:at least 10 days per month;
16.txt	NCT00009217	Condition	Dementia	INC	
16.txt	NCT00009217	Condition	purposeless wandering	INC	
16.txt	NCT00009217	Condition	agitation	INC	
16.txt	NCT00009217	Condition	physical aggression	INC	
16.txt	NCT00076440	Drug	testosterone	INC	
16.txt	NCT00009217	Condition	verbal aggression	INC	
16.txt	NCT00076440	Condition	AD	INC	
16.txt	NCT01615666	Condition	memory	INC	modified_by:Normal;
16.txt	NCT00009217	Condition	NINCDS-ADRDA criteria	INC	
16.txt	NCT00009217	Drug	psychotropic medication	INC	is_negated:Free;has_TempMea:at least two weeks;
16.txt	NCT00076440	Condition	myocardial infarction	INC	has_TempMea:within 6 months;has_TempMea:recent;
16.txt	NCT00009217	Measurement	Columbia University Scale for Psychopathology in Alzheimer's Disease ( CUSPAD )	INC	has_value:at least 4;
16.txt	NCT00076440	Condition	condition	INC	modified_by:serious;modified_by:unstable;
16.txt	NCT01615666	Demographic	age	INC	has_value:50 years;has_value:older;
16.txt	NCT02129348	Measurement	QTc interval	EXC	has_value:> 460 ms;
16.txt	NCT01615666	Condition	rontotemporal dementia	INC	
16.txt	NCT01615666	Demographic	age	INC	has_value:older;has_value:60 years;
16.txt	NCT02129348	Condition	cancer	EXC	modified_by:successfully treated;
16.txt	NCT00076440	Condition	AD	INC	is_negated:other than;
16.txt	NCT00495820	Condition	structural cardiac defect	EXC	
16.txt	NCT00076440	Condition	neurological disease	INC	modified_by:Significant;
16.txt	NCT00495820	Condition	symptomatic cardiovascular disease	EXC	
16.txt	NCT02129348	Condition	residual neurological deficits	EXC	
16.txt	NCT00076440	Condition	psychiatric disease	INC	
16.txt	NCT00495820	Condition	cardiomyopathy	EXC	
16.txt	NCT02129348	Condition	cerebrovascular disease	EXC	
16.txt	NCT02129348	Condition	smallinfarcts	EXC	
16.txt	NCT00009217	Condition	medical condition	EXC	modified_by:Acute;modified_by:unstable;has_TempMea:within the past 1 year;
16.txt	NCT00009217	Condition	delirium	EXC	has_TempMea:within the past 1 year;modified_by:Acute;modified_by:unstable;
16.txt	NCT00009217	Condition	alcohol or substance abuse or dependence	EXC	has_TempMea:within the past 1 year;modified_by:Acute;modified_by:unstable;
16.txt	NCT00076440	Condition	National Institute of Neurological Disorders-Alzheimer's Disease and Related Disorders Association ( NINDS-ADRDA ) criteria	INC	
16.txt	NCT00495820	Condition	glaucoma	EXC	
16.txt	NCT02129348	Condition	cancer	EXC	
16.txt	NCT00076440	Condition	systemic illness	INC	has_TempMea:Current;modified_by:significant;
16.txt	NCT00495820	Drug	monoamine oxidase inhibitors ( MAOIs )	EXC	
16.txt	NCT00076440	Measurement	DSM-IV categories	INC	has_value:303.9 or 305;
16.txt	NCT00076440	Condition	Parkinson's disease	INC	
16.txt	NCT00495820	Condition	Tourette's syndrome	EXC	
16.txt	NCT00009217	Condition	stroke	EXC	
16.txt	NCT00076440	Condition	stroke	INC	
16.txt	NCT00495820	Condition	motor tics	EXC	
16.txt	NCT02129348	Condition	medical illness	EXC	modified_by:severe;modified_by:Acute;modified_by:unstable;
16.txt	NCT00076440	Condition	schizophrenia	INC	
16.txt	NCT00495820	Condition	arrhythmias	EXC	modified_by:unstable;
16.txt	NCT02129348	Condition	clinical stroke	EXC	
16.txt	NCT00076440	Condition	epilepsy	INC	
16.txt	NCT02129348	Condition	residual neurological deficits	EXC	
16.txt	NCT02129348	Condition	lacunes	EXC	
16.txt	NCT01615666	Condition	memory loss	INC	
16.txt	NCT00076440	Condition	major depression	INC	
16.txt	NCT02129348	Condition	periventricular disease	EXC	
16.txt	NCT00076440	Drug	antidepressants	INC	
16.txt	NCT00009217	Condition	vascular or Lewy body or frontotemporal dementia	EXC	
16.txt	NCT00076440	Drug	anxiolytics	INC	
16.txt	NCT00009217	Condition	dementias	EXC	modified_by:other;
16.txt	NCT00076440	Drug	sedatives	INC	
16.txt	NCT01615666	Condition	Seizures	EXC	has_TempMea:within the last five years;
16.txt	NCT00009217	Condition	multiple sclerosis	EXC	
16.txt	NCT01615666	Condition	frontotemporal dementia	EXC	is_negated:other than;
16.txt	NCT00009217	Condition	Huntington's disease	EXC	
16.txt	NCT00009217	Condition	Parkinson's disease	EXC	
16.txt	NCT00009217	Condition	psychotic disorder	EXC	
16.txt	NCT00009217	Condition	tardive dyskinesia	EXC	
16.txt	NCT00009217	Drug	Antipsychotic medication	EXC	has_TempMea:during 4 weeks;
16.txt	NCT00076440	Drug	nonsteroidal anti-inflammatory drugs	INC	
16.txt	NCT02129348	Demographic	Age	INC	has_value:55 - 95 years;
16.txt	NCT00009217	Condition	dementia	EXC	
16.txt	NCT00076440	Drug	statins	INC	
16.txt	NCT00076440	Drug	Aldomet	INC	
16.txt	NCT01615666	Procedure	MRI	EXC	
16.txt	NCT00076440	Drug	Vitamin E	INC	
16.txt	NCT01615666	Procedure	Ferrous ( magnetic ) or electronic implants	EXC	
16.txt	NCT00076440	Drug	centrally acting antihypertensive agents	INC	
16.txt	NCT00076440	Drug	clonidine	INC	
16.txt	NCT01615666	Condition	Claustrophobia	EXC	
16.txt	NCT00076440	Drug	hypnotics	INC	
16.txt	NCT01615666	Condition	head injury with loss of consciousness	EXC	has_TempMea:within the last five years;
16.txt	NCT00076440	Drug	anti-convulsants	INC	
16.txt	NCT02129348	Condition	standard NIA criteria	INC	
16.txt	NCT00076440	Drug	drug	INC	modified_by:discontinuation;has_TempMea:less than 90 days;modified_by:change in dose;
16.txt	NCT01615666	Condition	mild cognitive impairment	INC	modified_by:Normal;
16.txt	NCT00009217	Drug	haloperidol	EXC	
16.txt	NCT01615666	Condition	Alzheimer's disease	INC	
16.txt	NCT00009217	Condition	Contraindication	EXC	
16.txt	NCT00076440	Drug	cholinesterase inhibitor	INC	is_negated:Never;
16.txt	NCT01615666	Condition	frontotemporal dementia	INC	
16.txt	NCT00089882	Condition	Alzheimer's disease	EXC	
16.txt	NCT00089882	Condition	Alzheimer's disease	INC	
16.txt	NCT00089882	Condition	cognitive deficits	EXC	
16.txt	NCT00089882	Condition	anxiety	EXC	has_TempMea:currently;
16.txt	NCT00089882	Condition	depression	EXC	has_TempMea:currently;modified_by:untreated;
16.txt	NCT00076440	Drug	OTC	INC	
16.txt	NCT01615666	Condition	neurological disease	EXC	
16.txt	NCT00076440	Drug	neuroleptics	INC	
16.txt	NCT01615666	Condition	Alzheimer's disease	EXC	is_negated:other than;
16.txt	NCT00076440	Drug	drug	INC	
16.txt	NCT01615666	Condition	stroke	EXC	
16.txt	NCT00076440	Drug	cholinesterase inhibitor	INC	
16.txt	NCT01615666	Condition	physical health	INC	modified_by:General good;
16.txt	NCT00076440	Procedure	dosage	INC	has_TempMea:within 60 days;modified_by:Started or changed;
16.txt	NCT01615666	Condition	primary progressive aphasia	INC	
16.txt	NCT00076440	Drug	cholinesterase inhibitor	INC	has_TempMea:in the past;modified_by:discontinued;
16.txt	NCT00076440	Demographic	Male	INC	
16.txt	NCT00089882	Condition	mood disturbances	EXC	has_TempMea:currently;modified_by:severe;
16.txt	NCT00076440	Demographic	age	INC	has_value:65 years;has_value:older;
16.txt	NCT00076440	Condition	Abuse or dependence on alcohol or other substances	INC	
16.txt	NCT00076440	Measurement	serum gonadotropin ( Gn ) concentrations	INC	
16.txt	NCT00076440	Measurement	HamD score	INC	has_value:15 or higher;
16.txt	NCT00076440	Condition	AD	INC	modified_by:probable;
16.txt	NCT00076440	Drug	drug	INC	has_TempMea:at least 90 days;
16.txt	NCT00076440	Condition	AD	INC	
16.txt	NCT00076440	Condition	cancer	INC	has_TempMea:within the last 5 years;
16.txt	NCT00076440	Procedure	dosage	INC	modified_by:stable;
16.txt	NCT00076440	Procedure	Donated blood	INC	has_TempMea:within 30 days;
16.txt	NCT00495820	Condition	DSM-IV Text Revision ( TR ) criteria	INC	
16.txt	NCT00076440	Drug	cholinesterase inhibitor	INC	
16.txt	NCT00076440	Drug	Memantine	INC	
16.txt	NCT00076440	Drug	hypnotic or anxiolytic drug	INC	
16.txt	NCT00076440	Measurement	cognitive function	INC	
16.txt	NCT00076440	Drug	medications	INC	modified_by:other;
16.txt	NCT00076440	Drug	ginkgo biloba	INC	
16.txt	NCT00076440	Procedure	treatment	INC	has_TempMea:at least 3 weeks;
16.txt	NCT00076440	Drug	medications	INC	modified_by:other;
16.txt	NCT00076440	Drug	goserelin	INC	
16.txt	NCT00076440	Drug	danazol	INC	
16.txt	NCT00076440	Drug	investigational drugs	INC	has_TempMea:within 30 days or 5 half-lives;modified_by:other;
16.txt	NCT00076440	Drug	coumadin	INC	
16.txt	NCT00076440	Drug	anti-Parkinsonian medications	INC	
16.txt	NCT00076440	Drug	Vitamin E	INC	
16.txt	NCT00076440	Drug	drugs	INC	modified_by:other;has_TempMea:at least 60 days;modified_by:stable;has_TempMea:at least 90 days;modified_by:stopped;
16.txt	NCT02129348	Observation	history	EXC	
16.txt	NCT00076440	Measurement	Mini Mental State Examination ( MMSE ) score	INC	has_value:12 to 24 ( inclusive );
16.txt	NCT00009217	Condition	dementia	INC	
16.txt	NCT00009217	Demographic	age	INC	has_value:50 - 95 years;
16.txt	NCT00009217	Condition	Alzheimer's disease	INC	modified_by:probable;
16.txt	NCT00009217	Measurement	Folstein Mini-Mental State Exam score	INC	has_value:5 - 26, inclusive;
16.txt	NCT00009217	Condition	Intellectual impairment	INC	has_TempMea:at least six months;
16.txt	NCT00076440	Procedure	Brain imaging study	INC	
16.txt	NCT00076440	Procedure	MRI	INC	
16.txt	NCT00076440	Procedure	CT scan	INC	
16.txt	NCT00076440	Condition	AD	INC	
16.txt	NCT00076440	Procedure	PET	INC	
16.txt	NCT00076440	Condition	AD	INC	modified_by:probable;
16.txt	NCT00076440	Measurement	Rosen Modified Hachinski score	INC	has_value:4 or lower;
16.txt	NCT00076440	Condition	dementia	INC	
17.txt	NCT01560585	Condition	medical conditions	EXC	
17.txt	NCT01560585	Drug	statin/fibrate therapy	EXC	
17.txt	NCT01560585	Condition	Hypertriglyceridemia	EXC	
17.txt	NCT01560585	Condition	medical conditions	EXC	has_TempMea:concurrent;
17.txt	NCT01560585	Condition	immunosuppression	EXC	
17.txt	NCT01560585	Drug	tetracycline	EXC	has_TempMea:concurrent;
17.txt	NCT01560585	Drug	minocycline	EXC	has_TempMea:concurrent;
17.txt	NCT01560585	Demographic	age	INC	has_value:> 50 years;
17.txt	NCT01560585	Condition	cardiovascular disease	EXC	modified_by:unstable;
17.txt	NCT01560585	Condition	surgically sterile	INC	has_TempMea:at least 2 years;
17.txt	NCT01560585	Observation	Geriatric Depression Scale-short form	EXC	has_value:greater than or equal to five;
17.txt	NCT01560585	Condition	post-menopausal	INC	has_TempMea:at least 2 years;
17.txt	NCT01560585	Condition	AD	INC	modified_by:Probable;
17.txt	NCT01560585	Condition	psychosis	EXC	
17.txt	NCT01560585	Condition	DSM IV and NINCDS-ADRDA criteria	INC	
17.txt	NCT01560585	Condition	hallucinations	EXC	
17.txt	NCT00013650	Condition	cardiac dysfunction	INC	modified_by:severe;
17.txt	NCT01560585	Condition	Hypersensitivity	EXC	
17.txt	NCT01560585	Drug	retinoids	EXC	
17.txt	NCT01560585	Measurement	Mini Mental State Examination	INC	has_value:12 - 26 ( inclusive );
17.txt	NCT01560585	Condition	diabetes	EXC	modified_by:uncontrolled;
17.txt	NCT01560585	Drug	doxycycline	EXC	has_TempMea:concurrent;
17.txt	NCT02290912	Condition	Heart	EXC	
17.txt	NCT02290912	Condition	psychiatric condition	EXC	modified_by:other;
17.txt	NCT01560585	Drug	memantine	INC	modified_by:Stable;has_TempMea:3 months;modified_by:stable;
17.txt	NCT01560585	Drug	immunosuppressants	EXC	modified_by:other;
17.txt	NCT02290912	Measurement	Body mass index	EXC	has_value:> 41;
17.txt	NCT01560585	Drug	corticosteroids	EXC	
17.txt	NCT02290912	Condition	major depression	EXC	modified_by:chronic;modified_by:Untreated;
17.txt	NCT01560585	Drug	cholinesterase inhibitors	INC	has_TempMea:3 months;modified_by:Stable;modified_by:stable;
17.txt	NCT01560585	Drug	supplements	EXC	
17.txt	NCT01560585	Drug	Vitamin A supplements	EXC	has_value:beyond 100% RDA;
17.txt	NCT01560585	Drug	DHA	EXC	
17.txt	NCT02290912	Drug	cancer treatment	EXC	modified_by:Active;
17.txt	NCT01560585	Drug	anti-depressants	INC	has_TempMea:3 months;modified_by:stable;modified_by:Stable;
17.txt	NCT01560585	Drug	Warfarin	EXC	
17.txt	NCT01560585	Drug	Fish Oil	EXC	
17.txt	NCT01560585	Drug	chemotherapeutic agents	EXC	
17.txt	NCT01560585	Procedure	MRI	INC	
17.txt	NCT01560585	Condition	myelosuppression	EXC	
17.txt	NCT01560585	Procedure	PET	INC	
17.txt	NCT01560585	Procedure	Neuroimaging	INC	
17.txt	NCT01560585	Procedure	CT	INC	
17.txt	NCT01560585	Measurement	serum glucose	EXC	modified_by:increased;
17.txt	NCT01560585	Drug	Retinoids	EXC	
17.txt	NCT01560585	Condition	chest pain of unclear etiology	EXC	
17.txt	NCT01560585	Condition	medical contraindications	INC	is_negated:No;
17.txt	NCT01560585	Condition	inflammatory or infectious conditions	EXC	modified_by:chronic;
17.txt	NCT02290912	Condition	Dementia	EXC	
17.txt	NCT01560585	Measurement	Clinical laboratory values	INC	modified_by:clinically insignificant;has_value:within normal limits;modified_by:abnormal;
17.txt	NCT02290912	Condition	Pregnancy	EXC	
17.txt	NCT01560585	Drug	Drugs	EXC	
17.txt	NCT01560585	Condition	infection	EXC	modified_by:increased;
17.txt	NCT01560585	Condition	AD	INC	
17.txt	NCT00063310	Drug	anti-Parkinsonian medications	EXC	
17.txt	NCT00063310	Drug	hormone replacement therapy	EXC	
17.txt	NCT01479855	Drug	food additives	EXC	has_TempMea:last four weeks;modified_by:stopped;
17.txt	NCT00063310	Drug	coumadin	EXC	
17.txt	NCT00063310	Drug	non steroidal anti-inflammatory drugs	EXC	
17.txt	NCT01479855	Condition	brain vascular disturbance	EXC	
17.txt	NCT01560585	Condition	stroke	EXC	modified_by:clinically significant;
17.txt	NCT00063310	Drug	statins	EXC	
17.txt	NCT01479855	Drug	vitamins	EXC	has_TempMea:last four weeks;modified_by:stopped;
17.txt	NCT01560585	Measurement	Modified Hachinski Ischemia score	EXC	has_value:>= 4;
17.txt	NCT00063310	Drug	medications	INC	has_TempMea:concomitant;
17.txt	NCT01479855	Condition	Frontal Lobe Dementia	EXC	
17.txt	NCT00063310	Drug	treatment	INC	is_negated:not;
17.txt	NCT00063310	Drug	Vitamin E	EXC	
17.txt	NCT01479855	Condition	Dementia	EXC	
17.txt	NCT00063310	Condition	HamD	INC	
17.txt	NCT01560585	Condition	epilepsy	EXC	has_TempMea:in past two years;has_TempMea:Current;
17.txt	NCT00063310	Drug	medications	EXC	modified_by:other;
17.txt	NCT00013650	Condition	dementia	INC	modified_by:mild-moderate;
17.txt	NCT01560585	Condition	seizure	EXC	has_TempMea:Current;has_TempMea:in past two years;
17.txt	NCT00013650	Condition	Alzheimer's disease	INC	modified_by:probable;
17.txt	NCT00063310	Drug	investigational drugs	EXC	has_TempMea:within 30 days or 5 half-lives;modified_by:other;
17.txt	NCT00013650	Condition	DSM-IV and NINDS criteria	INC	
17.txt	NCT00063310	Measurement	laboratory tests	INC	has_TempMea:within 45 days;
17.txt	NCT00063310	Procedure	ECG	INC	
17.txt	NCT01479855	Measurement	MADRS	INC	
17.txt	NCT01560585	Condition	Dementia	EXC	
17.txt	NCT01560585	Condition	laboratory abnormality	EXC	
17.txt	NCT01479855	Measurement	Depression score	INC	has_value:below 9;
17.txt	NCT00063310	Condition	National Institute of Neurological Disorders-Alzheimer's Disease and Related Disorders Association ( NINDS-ADRDA ) criteria	INC	
17.txt	NCT01479855	Condition	Cognitive impairment	INC	
17.txt	NCT01560585	Condition	disease	EXC	modified_by:other;
17.txt	NCT01479855	Measurement	MMSE score	INC	has_value:24 or better;
17.txt	NCT01560585	Condition	medical or psychiatric condition	EXC	
17.txt	NCT00063310	Drug	Aldomet	EXC	
17.txt	NCT01560585	Condition	breastfeeding	EXC	
17.txt	NCT00063310	Drug	medications	EXC	modified_by:other;
17.txt	NCT01479855	Condition	Lewy Body Dementia	EXC	
17.txt	NCT00063310	Drug	treatment	INC	has_value:at least 3 weeks;
17.txt	NCT01479855	Condition	disease	EXC	modified_by:Acute or chronic;
17.txt	NCT01560585	Condition	Alzheimer's disease	EXC	is_negated:not;modified_by:probable;
17.txt	NCT00063310	Drug	clonidine	EXC	
17.txt	NCT01479855	Measurement	CRP	EXC	has_value:above 10;
17.txt	NCT01560585	Condition	Pregnancy	EXC	
17.txt	NCT00063310	Condition	dementia	INC	
17.txt	NCT00063310	Measurement	HamD score	EXC	has_value:15 or higher;
17.txt	NCT00063310	Condition	bone fracture	EXC	is_negated:not;
17.txt	NCT00013650	Drug	nonsteroidal medication	INC	has_TempMea:Recent;has_value:more than 3 doses per week;has_TempMea:at least one month;
17.txt	NCT01479855	Condition	thrombosis	EXC	
17.txt	NCT00063310	Condition	osteoporosis	EXC	
17.txt	NCT01560585	Drug	investigational agent	EXC	modified_by:another;has_TempMea:within two months;
17.txt	NCT00013650	Condition	insulin-treated diabetes mellitus	INC	
17.txt	NCT00063310	Condition	abuse or dependence on alcohol or other substances	EXC	
17.txt	NCT01560585	Condition	hematologic, hepatic, cardiovascular	EXC	modified_by:unstable;
17.txt	NCT00013650	Drug	aspirin	INC	modified_by:Low dose;
17.txt	NCT01560585	Drug	investigational new drug	EXC	
17.txt	NCT00063310	Measurement	T-score	EXC	has_value:<- 2.0;
17.txt	NCT00013650	Condition	hypersensitivity	INC	
17.txt	NCT01560585	Measurement	laboratory finding	EXC	
17.txt	NCT00063310	Measurement	DEXA measures	EXC	modified_by:abnormally low;
17.txt	NCT01560585	Condition	disorder	EXC	modified_by:significant clinical;
17.txt	NCT00063310	Drug	progesterone	EXC	is_negated:except;
17.txt	NCT00063310	Drug	danazol	EXC	
17.txt	NCT00013650	Condition	dementia	INC	modified_by:Severe;
17.txt	NCT01560585	Condition	DSM IV criteria	EXC	
17.txt	NCT00063310	Measurement	serum gonadotropin ( Gn ) concentrations	EXC	
17.txt	NCT00063310	Drug	estrogen	EXC	is_negated:except;
17.txt	NCT00013650	Measurement	CDR score	INC	has_value:greater than 2;
17.txt	NCT00013650	Measurement	Clinical Dementia Rating Scale	INC	
17.txt	NCT01560585	Condition	focal brain lesion	EXC	has_TempMea:in past two years;has_TempMea:Current;
17.txt	NCT00063310	Measurement	cognitive function	EXC	
17.txt	NCT00063310	Drug	goserelin	EXC	
17.txt	NCT01560585	Condition	head injury with loss of consciousness	EXC	has_TempMea:Current;has_TempMea:in past two years;
17.txt	NCT00063310	Measurement	cognition	EXC	
17.txt	NCT00063310	Drug	ginkgo biloba	INC	
17.txt	NCT00063310	Drug	Vitamin E	INC	
17.txt	NCT00063310	Drug	drugs	INC	modified_by:other;has_TempMea:at least 60 days;modified_by:stable;
17.txt	NCT00063310	Measurement	MMSE	INC	has_value:lower than 12 or higher than 24;
17.txt	NCT01560585	Condition	alcohol or substance abuse	EXC	modified_by:severe;
17.txt	NCT01479855	Observation	Cornell	INC	
17.txt	NCT00063310	Drug	substances	INC	modified_by:other;has_TempMea:at least 60 days;modified_by:stable;
17.txt	NCT00063310	Condition	osteoporosis	EXC	
17.txt	NCT01560585	Condition	Sensory impairment	EXC	
17.txt	NCT01479855	Condition	hemorrhage	EXC	
17.txt	NCT00063310	Condition	bone fracture	EXC	
17.txt	NCT01560585	Condition	bipolar disorder	EXC	
17.txt	NCT00063310	Condition	low bone mass density	EXC	
17.txt	NCT00013650	Drug	cytotoxic drug therapy	INC	has_value:more than 2 weeks;has_value:more than 10 weeks;has_TempMea:during the 10 weeks;has_TempMea:30 day period;
17.txt	NCT02290912	Condition	stroke	EXC	
17.txt	NCT01560585	Condition	psychosis	EXC	
17.txt	NCT00063310	Procedure	brain imaging study	INC	
17.txt	NCT00013650	Condition	vascular dementia	INC	modified_by:probable;
17.txt	NCT01560585	Condition	major depression	EXC	
17.txt	NCT00063310	Drug	treatment	EXC	is_negated:not;has_TempMea:at least 3 weeks;
17.txt	NCT00063310	Procedure	dual-energy x-ray absorpometry ( DEXA ) scan	INC	
17.txt	NCT01560585	Condition	psychiatric disorder	EXC	modified_by:major;
17.txt	NCT00063310	Condition	osteoporosis	EXC	
17.txt	NCT00013650	Condition	SLE	INC	
17.txt	NCT00013650	Condition	autoimmune disease	INC	
17.txt	NCT00013650	Condition	Medical conditions	INC	
17.txt	NCT01560585	Drug	behavioral medications	EXC	has_TempMea:at least 4 weeks;modified_by:stable doses;
17.txt	NCT00063310	Condition	AD	INC	modified_by:probable;
17.txt	NCT00063310	Condition	AD	INC	
17.txt	NCT00063310	Procedure	CT scan	INC	
17.txt	NCT00063310	Procedure	PET	INC	
17.txt	NCT00063310	Procedure	MRI	INC	
17.txt	NCT01028053	Condition	amnestic MCI	INC	
17.txt	NCT00013650	Condition	herpes zoster	INC	
17.txt	NCT00063310	Measurement	Rosen Modified Hachinski score	INC	has_value:4 or lower;
17.txt	NCT00013650	Condition	single functioning kidney	INC	
17.txt	NCT01560585	Condition	neoplastic disease	EXC	modified_by:Active;
17.txt	NCT00063310	Condition	AD	INC	modified_by:probable;
17.txt	NCT00013650	Condition	viral infection	INC	modified_by:serious;
17.txt	NCT00013650	Condition	hepatitis	INC	
17.txt	NCT00480870	Drug	experimental drug	EXC	is_negated:other than;
17.txt	NCT00013650	Drug	antimicrobial therapy	INC	
17.txt	NCT01560585	Drug	anxiolytics	EXC	
17.txt	NCT00480870	Condition	medical or psychiatric disease	EXC	modified_by:severe;modified_by:Other;
17.txt	NCT01560585	Drug	antidepressants	EXC	
17.txt	NCT00480870	Drug	psychoactive drugs	EXC	
17.txt	NCT00013650	Condition	infection	INC	modified_by:active or chronic;
17.txt	NCT01560585	Drug	antipsychotics	EXC	
17.txt	NCT00013650	Drug	CY	INC	
17.txt	NCT00480870	Condition	probability criteria of the Alzheimer's Disease and Related Disorders Association	INC	
17.txt	NCT01560585	Condition	pulmonary, gastrointestinal, endocrine, metabolic, renal or other systemic disease	EXC	
17.txt	NCT00063310	Measurement	DSM-IV categories	EXC	has_value:303.9 or 305;
17.txt	NCT00013650	Drug	nonsteroidal anti-inflammatory medication	INC	is_negated:not;
17.txt	NCT00063310	Condition	of vascular origin	INC	is_negated:not;
17.txt	NCT01560585	Condition	ventricular fibrillation	EXC	
17.txt	NCT00063310	Drug	hormone replacement therapy ( HRT )	INC	has_TempMea:at least 60 days;modified_by:stable;
17.txt	NCT00063310	Procedure	Absorptiometry	INC	has_value:within normal limits;
17.txt	NCT01560585	Measurement	total bilirubin	EXC	
17.txt	NCT00063310	Measurement	Hamilton Depression Scale ( 17 -item version ) ( HamD )	INC	has_value:less than 15;
17.txt	NCT00480870	Condition	causes of dementia	EXC	modified_by:Other;
17.txt	NCT00013650	Condition	Inflammatory conditions	INC	
17.txt	NCT01560585	Measurement	prothrombin	EXC	
17.txt	NCT00480870	Measurement	Brazilian version of the Clinical Dementia Rating	INC	
17.txt	NCT00013650	Drug	methotrexate	INC	has_TempMea:Current;
17.txt	NCT01560585	Measurement	AST	EXC	
17.txt	NCT00013650	Drug	warfarin	INC	has_TempMea:Current;
17.txt	NCT01560585	Measurement	ALT	EXC	
17.txt	NCT00063310	Procedure	donated blood	EXC	has_TempMea:within 30 days;
17.txt	NCT00013650	Drug	allopurinol	INC	has_TempMea:Current;
17.txt	NCT00480870	Condition	Alzheimer's disease	INC	
17.txt	NCT00013650	Drug	rifampin	INC	has_TempMea:Current;
17.txt	NCT01560585	Measurement	liver function test	EXC	modified_by:Abnormal;
17.txt	NCT00013650	Drug	aspirin	INC	
17.txt	NCT01560585	Condition	ventricular tachycardia	EXC	
17.txt	NCT00013650	Drug	nonsteroidal medication	INC	
17.txt	NCT01560585	Condition	laboratory abnormality	EXC	
17.txt	NCT01028053	Condition	Huntington's disease	EXC	
17.txt	NCT01028053	Condition	normal pressure hydrocephalus	EXC	
17.txt	NCT00013650	Condition	lymphopenia	INC	
17.txt	NCT00063310	Measurement	T- score	INC	has_value:no less than - 2.0;
17.txt	NCT01028053	Condition	brain tumor	EXC	
17.txt	NCT00063310	Measurement	DEXA measure	INC	modified_by:abnormally low;
17.txt	NCT00013650	Condition	myelosuppression	INC	
17.txt	NCT00063310	Condition	osteoporosis	INC	
17.txt	NCT00063310	Measurement	DEXA measure	INC	modified_by:abnormally low;
17.txt	NCT00063310	Condition	osteoporosis	INC	
17.txt	NCT01028053	Condition	head trauma	EXC	modified_by:significant;
17.txt	NCT00013650	Condition	gastrointestinal bleeding or perforation	INC	
17.txt	NCT01028053	Condition	subdural hematoma	EXC	
17.txt	NCT00013650	Condition	gastrointestinal ulceration	INC	has_TempMea:within the last 5 years;modified_by:active;
17.txt	NCT01028053	Condition	multiple sclerosis	EXC	
17.txt	NCT01028053	Condition	supranuclear palsy	EXC	
17.txt	NCT00013650	Condition	pulmonary dysfunction	INC	modified_by:severe;
17.txt	NCT01028053	Condition	seizure disorder	EXC	
17.txt	NCT01028053	Measurement	Modified Hachinski Ischemic Scale	INC	has_value:less than or equal to 4;
17.txt	NCT00013650	Condition	renal insufficiency	INC	
17.txt	NCT01028053	Measurement	MMSE score	INC	has_value:24 - 30;
17.txt	NCT00063310	Demographic	age	EXC	has_value:younger than 65 years;
17.txt	NCT00013650	Measurement	GFR	INC	has_value:less than one third of normal;
17.txt	NCT00063310	Condition	medical conditions	INC	modified_by:significant;
17.txt	NCT00063310	Condition	psychiatric disease	EXC	
17.txt	NCT00063310	Condition	neurological disease	EXC	modified_by:significant;
17.txt	NCT00063310	Condition	AD	EXC	is_negated:other than;
17.txt	NCT01028053	Condition	aMCI	EXC	is_negated:other than;modified_by:suspected;
17.txt	NCT00013650	Condition	benign prostatic hypertrophy	INC	modified_by:severe;
17.txt	NCT00063310	Condition	major depression	EXC	
17.txt	NCT01028053	Condition	Parkinson's disease	EXC	
17.txt	NCT00013650	Condition	immunosuppression	INC	
17.txt	NCT00063310	Procedure	ECG	EXC	
17.txt	NCT01028053	Condition	neurologic disease	EXC	modified_by:significant;
17.txt	NCT00013650	Condition	malignancy	INC	has_TempMea:pre-existent;
17.txt	NCT01028053	Condition	aMCI	INC	is_negated:excludes;
17.txt	NCT01028053	Procedure	non-contrast MRI	INC	
17.txt	NCT00013650	Condition	hepatic dysfunction	INC	modified_by:significant;
17.txt	NCT00063310	Condition	epilepsy	EXC	
17.txt	NCT00063310	Condition	schizophrenia	EXC	
17.txt	NCT00063310	Condition	stroke	EXC	
17.txt	NCT00063310	Condition	Parkinson's disease	EXC	
17.txt	NCT01028053	Condition	schizophrenia	EXC	
17.txt	NCT01028053	Condition	DSM-IV	EXC	
17.txt	NCT00063310	Condition	organ failure	EXC	modified_by:significant;has_TempMea:current;
17.txt	NCT00063310	Condition	systemic illness	EXC	modified_by:significant;has_TempMea:current;
17.txt	NCT01028053	Condition	behavioral problems	EXC	has_TempMea:within the prior 3 months;
17.txt	NCT02290912	Demographic	Age	INC	
17.txt	NCT01028053	Condition	psychotic features	EXC	has_TempMea:within the prior 3 months;
17.txt	NCT01028053	Condition	agitation	EXC	has_TempMea:within the prior 3 months;
17.txt	NCT01028053	Condition	DSM-IV criteria	EXC	
17.txt	NCT00063310	Condition	condition	EXC	modified_by:unstable;modified_by:serious;
17.txt	NCT01028053	Condition	structural brain abnormalities	EXC	
17.txt	NCT00063310	Drug	therapy	EXC	has_TempMea:at least 3 weeks;
17.txt	NCT00063310	Condition	myocardial infarction	EXC	has_TempMea:within 6 months;has_TempMea:recent;
17.txt	NCT01028053	Procedure	aneurysm clips	EXC	
17.txt	NCT00063310	Condition	cancer	EXC	has_TempMea:within the last 5 years;
17.txt	NCT01028053	Condition	neurologic deficits	EXC	modified_by:persistent;
17.txt	NCT00063310	Condition	basal cell or squamous cell cancer	EXC	is_negated:except;
17.txt	NCT00063310	Condition	cervical carcinoma in situ	EXC	is_negated:except;
17.txt	NCT01028053	Condition	bipolar disorder	EXC	has_TempMea:within the past year;
17.txt	NCT01028053	Procedure	MRI	EXC	
17.txt	NCT01028053	Condition	major depression	EXC	has_TempMea:within the past year;
17.txt	NCT01028053	Procedure	embedded metal fragments	EXC	
17.txt	NCT01028053	Procedure	pacemakers	EXC	
17.txt	NCT01028053	Procedure	artificial heart valves	EXC	
17.txt	NCT01028053	Procedure	metal implants	EXC	
17.txt	NCT00063310	Drug	tacrine	EXC	
17.txt	NCT00063310	Drug	cholinesterase inhibitor	EXC	has_TempMea:less than 90 days;
17.txt	NCT00063310	Drug	rivastigmine	EXC	
17.txt	NCT00063310	Drug	donepezil	EXC	
17.txt	NCT00063310	Drug	galantamine	EXC	
17.txt	NCT00063310	Drug	treatment	EXC	modified_by:stable;
17.txt	NCT00063310	Drug	cholinesterase inhibitor	EXC	is_negated:never;
17.txt	NCT00063310	Condition	condition	INC	has_TempMea:at least 6 months;
17.txt	NCT00063310	Demographic	age	INC	has_value:65 years;has_value:older;
17.txt	NCT00063310	Condition	AD	INC	modified_by:probable;
17.txt	NCT00063310	Drug	cholinesterase inhibitor	INC	has_TempMea:at least 90 days;modified_by:stable;
17.txt	NCT00063310	Drug	drug	EXC	modified_by:started;has_TempMea:within 60 days;modified_by:changed;
17.txt	NCT00063310	Drug	over the counter drug	EXC	
17.txt	NCT00063310	Drug	antidepressants	EXC	
17.txt	NCT00063310	Drug	neuroleptics	EXC	
17.txt	NCT00063310	Drug	sedatives	EXC	
17.txt	NCT00063310	Drug	anxiolytics	EXC	
17.txt	NCT00063310	Drug	anti-convulsants	EXC	
17.txt	NCT00063310	Drug	hypnotics	EXC	
17.txt	NCT00063310	Drug	centrally acting antihypertensive agents	EXC	
18.txt	NCT00688207	Condition	depression	EXC	modified_by:active;
18.txt	NCT00688207	Condition	major depressive disorder	EXC	has_TempMea:current;has_TempMea:in the past year;
18.txt	NCT00688207	Condition	bipolar affective disorder	EXC	
18.txt	NCT01142258	Condition	National Institute of Neurological and Communicative Disorders and Stroke/the Alzheimer's Disease and Related Disorders Association criteria	INC	
18.txt	NCT01142258	Condition	lacunar infarct	INC	has_value:more than 1;is_negated:no;
18.txt	NCT00688207	Condition	CNS disorder	EXC	modified_by:other;
18.txt	NCT00688207	Condition	dementia	EXC	
18.txt	NCT01841905	Drug	sedative agents	EXC	is_negated:not;has_TempMea:within 72 hours;
18.txt	NCT00688207	Condition	vascular dementia	EXC	modified_by:possible, probable or definite;
18.txt	NCT01841905	Drug	narcotic analgesics	EXC	has_TempMea:within 4 weeks;
18.txt	NCT01841905	Drug	neuroleptics	EXC	has_TempMea:within 4 weeks;has_TempMea:within 4 weeks;
18.txt	NCT00688207	Condition	cerebrovascular disease	EXC	
18.txt	NCT00688207	Condition	stroke	EXC	
18.txt	NCT00688207	Condition	hemorrhage	EXC	
18.txt	NCT01142258	Procedure	Computed tomography	INC	
18.txt	NCT01142258	Procedure	magnetic resonance imaging	INC	
18.txt	NCT01142258	Condition	intracranial disease	INC	modified_by:other;is_negated:no;
18.txt	NCT01142258	Condition	stroke	INC	is_negated:no;
18.txt	NCT01142258	Condition	memory problems	INC	
18.txt	NCT00688207	Condition	Type 2 diabetes mellitus	EXC	
18.txt	NCT00088673	Drug	Alzheimers disease therapies	INC	modified_by:conventional;
18.txt	NCT00688207	Drug	insulin	EXC	
18.txt	NCT00688207	Condition	Type 1 diabetes mellitus	EXC	
18.txt	NCT00088673	Measurement	Mini Mental State Examination ( MMSE )	INC	
18.txt	NCT00688207	Condition	secondary diabetes mellitus	EXC	
18.txt	NCT00688207	Condition	cirrhosis	EXC	
18.txt	NCT00688207	Condition	abnormality	EXC	modified_by:other;modified_by:clinically relevant;
18.txt	NCT00088673	Condition	dementia	INC	modified_by:mild to moderate;
18.txt	NCT00688207	Condition	DSM-IV criteria	EXC	
18.txt	NCT00088673	Condition	Alzheimers disease	INC	modified_by:probable;
18.txt	NCT00688207	Measurement	serum levels of thyroid stimulating hormone ( TSH )	EXC	modified_by:abnormally high or low;modified_by:clinically significant;
18.txt	NCT00088673	Observation	dose	INC	modified_by:stable;
18.txt	NCT00688207	Drug	insulin secretagogue	EXC	
18.txt	NCT00688207	Drug	sulfonylurea	EXC	
18.txt	NCT01962753	Condition	DSM-IV criteria	INC	
18.txt	NCT00688207	Drug	PPAR agonist	EXC	
18.txt	NCT00688207	Condition	New York Heart Association criteria	EXC	
18.txt	NCT00688207	Measurement	syphilis serology	EXC	modified_by:positive;
18.txt	NCT00688207	Condition	vitamin B12 deficiency	EXC	has_TempMea:current;
18.txt	NCT00688207	Condition	infectious or inflammatory/demyelinating CNS conditions	EXC	
18.txt	NCT00688207	Condition	Parkinson's disease	EXC	
18.txt	NCT00688207	Condition	NINCDS-ADRDA3 criteria	INC	has_TempMea:at least 3 months;
18.txt	NCT00688207	Condition	structural abnormality	EXC	
18.txt	NCT01841905	Drug	newly approved medications	EXC	modified_by:other;
18.txt	NCT00688207	Condition	epilepsy	EXC	
18.txt	NCT00688207	Condition	thyroid dysfunction	EXC	modified_by:active;
18.txt	NCT00688207	Condition	DSM-IV	EXC	
18.txt	NCT00688207	Condition	hypothyroidism	EXC	
18.txt	NCT00688207	Measurement	cardiac status	EXC	has_value:Class I to IV;
18.txt	NCT01962753	Condition	illness	EXC	modified_by:significant unstable;has_TempMea:current;
18.txt	NCT01841905	Drug	agents	EXC	
18.txt	NCT01962753	Condition	Alzheimer's disease	EXC	has_TempMea:past;
18.txt	NCT01841905	Drug	tropicamide	EXC	
18.txt	NCT00688207	Condition	angina	EXC	modified_by:unstable;
18.txt	NCT01841905	Drug	scopolamine	EXC	
18.txt	NCT01962753	Condition	Parkinson's disease	EXC	
18.txt	NCT01841905	Condition	hypersensitivity	EXC	
18.txt	NCT00688207	Condition	Q-wave myocardial infarction	EXC	
18.txt	NCT01841905	Drug	F- 18	EXC	
18.txt	NCT00088673	Drug	3APS	EXC	has_TempMea:Previous;
18.txt	NCT00688207	Condition	acute coronary syndrome	EXC	
18.txt	NCT00480220	Condition	NINCDS-ADRDA criteria	INC	
18.txt	NCT01962753	Condition	stroke	EXC	
18.txt	NCT00688207	Condition	non Q-wave myocardial infarction	EXC	
18.txt	NCT01962753	Drug	memantine	EXC	
18.txt	NCT01841905	Condition	Alzheimer's disease	EXC	
18.txt	NCT00688207	Procedure	cardiac surgery	EXC	
18.txt	NCT01962753	Drug	antidepressant	EXC	
18.txt	NCT01841905	Drug	tacrine	EXC	
18.txt	NCT00688207	Procedure	angiography plus stenting	EXC	
18.txt	NCT01841905	Drug	investigational drugs	EXC	has_TempMea:within 30 days or 5 half-lives;
18.txt	NCT01962753	Drug	AcethylCholinesterae inhibitor	EXC	
18.txt	NCT00688207	Procedure	intervention	EXC	modified_by:major;
18.txt	NCT00688207	Condition	arrhythmia	EXC	modified_by:significant;
18.txt	NCT00688207	Condition	cardiovascular event	EXC	has_TempMea:within the last 6 months;
18.txt	NCT00688207	Condition	congestive heart failure	EXC	
18.txt	NCT00088673	Condition	condition	EXC	modified_by:clinically significant;modified_by:uncontrolled;
18.txt	NCT01962753	Condition	therapeutic response	EXC	is_negated:without;modified_by:significant;
18.txt	NCT00088673	Condition	dementia	EXC	is_negated:other;
18.txt	NCT00688207	Drug	glitinide	EXC	
18.txt	NCT01962753	Drug	antidepressants	EXC	has_value:two;
18.txt	NCT00088673	Observation	Life expectancy	EXC	has_value:less than 2 years;
18.txt	NCT00688207	Measurement	HbA1c	EXC	has_value:>= 8.5%;
18.txt	NCT01962753	Condition	psychotic disorder	EXC	modified_by:other;
18.txt	NCT00088673	Drug	investigational drug	EXC	has_TempMea:within 30 days;
18.txt	NCT00688207	Procedure	percutaneous coronary intervention	EXC	
18.txt	NCT00688207	Procedure	vascular surgery	EXC	
18.txt	NCT01962753	Procedure	Metallic foreign body eye	EXC	
18.txt	NCT00088673	Condition	medical disease	EXC	modified_by:other;modified_by:significant;
18.txt	NCT00688207	Procedure	intervention	EXC	
18.txt	NCT01841905	Condition	myocardial infarction	EXC	has_TempMea:in the past year;
18.txt	NCT01962753	Condition	diabetes	EXC	modified_by:uncontrolled;
18.txt	NCT01841905	Condition	cholinergic side effects	EXC	modified_by:significant;
18.txt	NCT01841905	Condition	non-metastatic skin cancers	EXC	
18.txt	NCT01962753	Condition	progressive disease	EXC	
18.txt	NCT01841905	Drug	antidepressant	EXC	modified_by:Initiation or change;has_TempMea:within the 4 weeks;
18.txt	NCT00688207	Measurement	total bilirubin values	EXC	has_value:> 1.5 times the upper limit of normal;
18.txt	NCT00688207	Drug	drugs	EXC	
18.txt	NCT01841905	Condition	systemic cancer	EXC	has_TempMea:within the past 5 years;
18.txt	NCT01841905	Condition	medical condition	EXC	modified_by:unstable;
18.txt	NCT01962753	Drug	antidepressants	EXC	
18.txt	NCT01841905	Drug	systemic corticosteroids	EXC	has_TempMea:within 3 months;
18.txt	NCT00688207	Measurement	alkaline phosphatase values	EXC	has_value:> 2.5 times the upper limit of normal;
18.txt	NCT01962753	Measurement	blood pressure	EXC	has_value:greater than or equal to 180 - 100;
18.txt	NCT01962753	Condition	head trauma	EXC	
18.txt	NCT00688207	Condition	Alzheimer's disease	INC	modified_by:mild;
18.txt	NCT00688207	Measurement	GFR	EXC	has_value:<= 50ml/min;
18.txt	NCT01841905	Condition	cardiovascular disease	EXC	modified_by:severe;modified_by:unstable;
18.txt	NCT01962753	Condition	loss of consciousness	EXC	has_value:greater than or equal to 15 minutes;
18.txt	NCT00688207	Measurement	MMSE score	INC	has_value:18 to 26 inclusive;
18.txt	NCT00688207	Measurement	haemoglobin	EXC	has_value:< 11 g/dL;has_value:< 10 g/dL;
18.txt	NCT01962753	Condition	lung disease	EXC	modified_by:chronic;
18.txt	NCT00688207	Condition	hepatitis B or C	EXC	
18.txt	NCT01962753	Condition	hypoxia	EXC	
18.txt	NCT00688207	Condition	Alzheimer's disease	INC	modified_by:probable;
18.txt	NCT00688207	Condition	Child-Pugh Class B/C	EXC	
18.txt	NCT01841905	Drug	antidepressants	EXC	modified_by:stable doses;has_TempMea:at least 4 weeks;
18.txt	NCT00688207	Condition	hepatobiliary disease	EXC	modified_by:severe;
18.txt	NCT01962753	Procedure	cochlear implants	EXC	
18.txt	NCT01962753	Procedure	pacemaker	EXC	
18.txt	NCT00688207	Measurement	hepatitis B virus	EXC	
18.txt	NCT01962753	Procedure	neurostimulator	EXC	
18.txt	NCT01841905	Drug	anti-convulsants	EXC	has_TempMea:within 2 months;
18.txt	NCT01962753	Procedure	MRI	EXC	
18.txt	NCT01841905	Drug	warfarin	EXC	has_TempMea:within 4 weeks;
18.txt	NCT01638949	Condition	deficits	INC	
18.txt	NCT01962753	Procedure	implanted electronic medical	EXC	
18.txt	NCT01841905	Drug	Coumadin	EXC	
18.txt	NCT01962753	Drug	treatment	EXC	has_TempMea:current;
18.txt	NCT01841905	Drug	donepezil	EXC	
18.txt	NCT01962753	Condition	Contraindications	EXC	
18.txt	NCT01841905	Drug	FDA approved medications	EXC	has_TempMea:prior;
18.txt	NCT01841905	Condition	systemic illness	EXC	modified_by:significant;
18.txt	NCT01962753	Condition	cranial aneurysm	EXC	
18.txt	NCT01841905	Drug	Medications	EXC	
18.txt	NCT00688207	Measurement	ALT	EXC	has_value:> 2.5 times the upper limit of normal;
18.txt	NCT01962753	Condition	Contraindications	EXC	
18.txt	NCT00688207	Measurement	AST	EXC	has_value:> 2.5 times the upper limit of normal;
18.txt	NCT01962753	Procedure	Metal heart valve	EXC	
18.txt	NCT01962753	Procedure	Vascular clips	EXC	
18.txt	NCT01841905	Condition	cholinergic or anticholinergic side effects	EXC	has_TempMea:within 4 weeks;modified_by:significant;
18.txt	NCT00688207	Procedure	bone marrow transplant	EXC	
18.txt	NCT00688207	Measurement	hepatitis C virus	EXC	
18.txt	NCT00688207	Measurement	HIV test	EXC	
18.txt	NCT01841905	Measurement	systolic BP	EXC	has_value:> 170;
18.txt	NCT00688207	Condition	pre-menopausal	INC	
18.txt	NCT01638949	Condition	deficits of the episodic memory	INC	
18.txt	NCT01841905	Condition	hypertension	EXC	modified_by:Uncontrolled;
18.txt	NCT00688207	Condition	surgically sterile	INC	
18.txt	NCT00688207	Observation	history	EXC	
18.txt	NCT01841905	Condition	diabetes mellitus	EXC	modified_by:uncontrolled;
18.txt	NCT01638949	Condition	Healthy	INC	
18.txt	NCT00688207	Condition	dementia	EXC	
18.txt	NCT01841905	Condition	liver disease	EXC	modified_by:clinically significant;has_TempMea:within the past 2 years;
18.txt	NCT01638949	Condition	memory complaints	INC	is_negated:without;
18.txt	NCT00688207	Measurement	Pregnancy testing	INC	
18.txt	NCT00688207	Condition	psychiatric illness	EXC	modified_by:significant;
18.txt	NCT00688207	Measurement	pregnancy test	INC	modified_by:negative;
18.txt	NCT01638949	Condition	NINCDS-ADRDA	INC	
18.txt	NCT00688207	Measurement	pregnancy testing	INC	
18.txt	NCT00688207	Condition	condition	EXC	modified_by:other;
18.txt	NCT00688207	Condition	postmenopausal	INC	has_TempMea:< 1 year;
18.txt	NCT01841905	Measurement	diastolic BP	EXC	has_value:> 100;
18.txt	NCT01638949	Condition	Healthy	INC	
18.txt	NCT00688207	Condition	gastro-intestinal, hepatic or renal disease	EXC	
18.txt	NCT00688207	Condition	peripheral oedema	EXC	modified_by:Clinically significant;
18.txt	NCT01638949	Condition	memory complaints	INC	is_negated:without;
18.txt	NCT00688207	Observation	menstrual period	INC	is_negated:without;
18.txt	NCT01841905	Condition	obstructive pulmonary disease	EXC	modified_by:Clinically significant;
18.txt	NCT01841905	Condition	asthma	EXC	
18.txt	NCT01962753	Condition	encephalitis	EXC	
18.txt	NCT00088673	Condition	National Institute of Neurological and Communicative Disorders and Stroke/Alzheimers Disease and Related Disorders Association ( NINCDS-ADRDA criteria )	INC	
18.txt	NCT01962753	Condition	cancer	EXC	has_TempMea:< 1 year;modified_by:treated;has_TempMea:recently;
18.txt	NCT00688207	Demographic	aged	INC	has_value:>= 50 and  <= 90 years;
18.txt	NCT01841905	Condition	angina	EXC	
18.txt	NCT01841905	Condition	Congestive Heart Failure ( CHF )	EXC	
18.txt	NCT01962753	Procedure	brain surgery	EXC	
18.txt	NCT00688207	Measurement	Hachinski Ischemia Score	INC	has_value:<= 4;
18.txt	NCT00688207	Condition	anaemia	EXC	modified_by:Clinically significant;
18.txt	NCT01142258	Measurement	mean time immobile	INC	has_value:less than 7 hours per night;
18.txt	NCT01142258	Condition	sleep disorder	INC	
18.txt	NCT01142258	Condition	AD	INC	
18.txt	NCT01142258	Condition	Sleep disturbance	INC	
18.txt	NCT00688207	Condition	post-menopausal	INC	has_TempMea:> 1 year;
18.txt	NCT01142258	Condition	co-morbidities	INC	modified_by:Other;
18.txt	NCT01841905	Condition	Insulin-requiring diabetes	EXC	
18.txt	NCT01638949	Condition	Healthy	INC	
18.txt	NCT00688207	Condition	drug or alcohol abuse or dependence	EXC	
18.txt	NCT01142258	Condition	depression	INC	
18.txt	NCT01962753	Condition	lacunar stroke	EXC	
18.txt	NCT01142258	Condition	delirium	INC	
18.txt	NCT01841905	Condition	gastrointestinal disorder	EXC	modified_by:Clinically significant;modified_by:unstable;has_TempMea:within two years;
18.txt	NCT01962753	Condition	stroke	EXC	
18.txt	NCT00688207	Measurement	diastolic blood pressure	EXC	has_value:> 95 or  < 60 mmHg;
18.txt	NCT01142258	Condition	chronic pain	INC	
18.txt	NCT01962753	Condition	altered cerebral metabolism	EXC	
18.txt	NCT00688207	Measurement	Systolic blood pressure	EXC	has_value:> 165 or  < 90 mmHg;
18.txt	NCT00688207	Demographic	males	EXC	has_value:< 11 g/dL;
18.txt	NCT00688207	Drug	Alzheimer's therapy	INC	is_negated:not;has_TempMea:in the last 30 days;
18.txt	NCT00688207	Demographic	females	EXC	has_value:< 10 g/dL;
18.txt	NCT01841905	Drug	Sinemet	EXC	
18.txt	NCT01638949	Condition	global cognitive function	INC	modified_by:abnormal;
18.txt	NCT01841905	Drug	anti-Parkinsonian medications	EXC	has_TempMea:within 2 months;
18.txt	NCT01638949	Condition	Alzheimer's disease	INC	modified_by:mild to moderate;
18.txt	NCT00688207	Condition	bundle branch block	INC	
18.txt	NCT01142258	Drug	medication	INC	
18.txt	NCT01142258	Drug	medications	INC	modified_by:Stable;has_TempMea:4 weeks;
18.txt	NCT01142258	Condition	Sleep disturbance	EXC	
18.txt	NCT01142258	Condition	delirium	EXC	
18.txt	NCT01841905	Drug	benzodiazepines	EXC	modified_by:long-acting;has_TempMea:within 4 weeks;
18.txt	NCT01142258	Condition	illness	EXC	modified_by:acute;
18.txt	NCT01841905	Drug	barbiturates	EXC	has_TempMea:within 4 weeks;modified_by:long-acting;
18.txt	NCT01638949	Condition	neurological, psychiatric, endocrine, hepatic or infectious complaint	EXC	modified_by:chronic;
18.txt	NCT00688207	Measurement	QTc B or QTc F	INC	has_value:< 480msec;
18.txt	NCT00688207	Condition	peripheral trauma	INC	is_negated:excluding;
18.txt	NCT01142258	Condition	psychiatric disease	EXC	
18.txt	NCT00688207	Measurement	QTc F	INC	has_value:< 450msec;
18.txt	NCT01841905	Drug	pergolide	EXC	
18.txt	NCT01638949	Condition	cognitive impairments	EXC	modified_by:sudden;
18.txt	NCT00688207	Condition	focal changes	INC	is_negated:without;
18.txt	NCT01841905	Drug	selegiline	EXC	
18.txt	NCT01638949	Condition	Alzheimer's disease	EXC	is_negated:opposed;modified_by:slow and gradual;
18.txt	NCT00688207	Condition	AD	INC	is_negated:excluding;
18.txt	NCT01841905	Drug	amantadine	EXC	
18.txt	NCT01638949	Measurement	MMSE	INC	has_value:>= 15;
18.txt	NCT00688207	Procedure	Neurological exam	INC	
18.txt	NCT01841905	Drug	bromocriptine	EXC	
18.txt	NCT01638949	Condition	memory complaints	INC	
18.txt	NCT01962753	Condition	thalamic	EXC	is_negated:without;
18.txt	NCT01841905	Condition	coagulopathy	EXC	modified_by:clinically significant;has_TempMea:within the past 2 years;
18.txt	NCT01638949	Condition	SCI	INC	
18.txt	NCT00688207	Procedure	Brain CT	INC	has_TempMea:within the past 12 months;
18.txt	NCT00688207	Condition	schizophrenia	EXC	
18.txt	NCT01841905	Condition	vitamin K deficiency	EXC	has_TempMea:within the past 2 years;modified_by:clinically significant;
18.txt	NCT00688207	Condition	postmenopausal	INC	has_TempMea:less than 1 year;
18.txt	NCT01142258	Condition	movement disorder	EXC	modified_by:Clinically significant;
18.txt	NCT00688207	Condition	child-bearing potential	INC	
18.txt	NCT01142258	Condition	akinesia	EXC	
18.txt	NCT01142258	Condition	medical condition	EXC	modified_by:Unstable;
18.txt	NCT01142258	Condition	agitation	EXC	modified_by:Severe;
18.txt	NCT01142258	Drug	psychotropic or sleep medications	EXC	modified_by:Discontinuation;has_TempMea:within 2 weeks;
18.txt	NCT01142258	Drug	trazodone	EXC	
18.txt	NCT01841905	Drug	methyldopa	EXC	modified_by:centrally active;has_TempMea:within 4 weeks;
18.txt	NCT01638949	Condition	Alzheimer's disease	INC	modified_by:probable;
18.txt	NCT00688207	Condition	Alzheimer's disease	INC	is_negated:other than;
18.txt	NCT01841905	Drug	clonidine	EXC	modified_by:centrally active;has_TempMea:within 4 weeks;
18.txt	NCT01841905	Drug	beta-blockers	EXC	modified_by:centrally active;has_TempMea:within 4 weeks;
18.txt	NCT01638949	Condition	Alzheimer's	INC	
18.txt	NCT01142258	Condition	sleep disturbances	EXC	
18.txt	NCT01841905	Drug	narcotics	EXC	modified_by:centrally active;has_TempMea:within 4 weeks;
18.txt	NCT00688207	Condition	cause of dementia	INC	is_negated:no;modified_by:other;
18.txt	NCT01638949	Condition	memory complaint	INC	
18.txt	NCT00688207	Measurement	urine or serum pregnancy test	INC	
18.txt	NCT01841905	Condition	obstructive uropathy	EXC	modified_by:Clinically significant;
18.txt	NCT01638949	Condition	amnestic MCI	INC	has_TempMea:current;
18.txt	NCT00688207	Procedure	MRI scan	INC	has_TempMea:within the past 12 months;
18.txt	NCT01638949	Condition	memory complaint	INC	
18.txt	NCT01841905	Condition	narrow-angle glaucoma	EXC	
18.txt	NCT01638949	Condition	MCI	INC	
18.txt	NCT00688207	Measurement	QTc	INC	
18.txt	NCT00480220	Condition	concomitant disorder	EXC	has_TempMea:two years;
18.txt	NCT01638949	Procedure	metallic object	EXC	
18.txt	NCT01841905	Demographic	ages	INC	has_value:55 and 80 years old ( inclusive );
18.txt	NCT00480220	Condition	dementia	EXC	
18.txt	NCT01841905	Measurement	MMSE total score	INC	has_value:> 27;
18.txt	NCT01638949	Condition	claustrophobia	EXC	
18.txt	NCT01841905	Condition	AD	INC	
18.txt	NCT01841905	Condition	risk factors	INC	has_value:Two;
18.txt	NCT01841905	Condition	Subjective memory complaints	INC	
18.txt	NCT01982578	Measurement	Mini-Mental State Examinations ( MMSE ) score	INC	has_value:between over 24 inclusive;
18.txt	NCT00088673	Condition	post-menopausal	INC	has_TempMea:at least 2 years;
18.txt	NCT00088673	Condition	non-childbearing potential	INC	
18.txt	NCT01982578	Measurement	blood analyses	EXC	
18.txt	NCT01982578	Condition	prodromal AD	INC	
18.txt	NCT00088673	Condition	surgically sterilized	INC	
18.txt	NCT01982578	Condition	mild cognitive impairment ( MCI )	INC	
18.txt	NCT00088673	Demographic	age	INC	has_value:50 years and older;
18.txt	NCT01962753	Condition	striatal	EXC	is_negated:without;
18.txt	NCT00480220	Condition	AD	EXC	is_negated:other than;
18.txt	NCT00688207	Condition	NINDS-AIREN6 criteria	EXC	
18.txt	NCT01638949	Condition	disease	EXC	modified_by:major;
18.txt	NCT01841905	Condition	disease	INC	
18.txt	NCT01841905	Drug	anxiolytics	EXC	modified_by:short-acting;has_value:more frequently than 2 times per week;has_TempMea:within 4 weeks;
18.txt	NCT01841905	Drug	Permitted medications	INC	modified_by:stable;has_TempMea:at least 1 month;
18.txt	NCT01841905	Drug	antidepressants	INC	modified_by:stable doses;
18.txt	NCT01841905	Condition	anticholinergic side effects	INC	modified_by:significant;is_negated:lacking;
18.txt	NCT00480220	Condition	disease	INC	modified_by:mild to moderate;
18.txt	NCT01638949	Condition	cons-indications	EXC	
18.txt	NCT00480220	Measurement	MMSE score	EXC	has_value:less than 12 or over 26;
18.txt	NCT01638949	Procedure	MRI	EXC	
18.txt	NCT01638949	Drug	medication	EXC	
18.txt	NCT01638949	Condition	alcohol or drugs abuse	EXC	
18.txt	NCT00480220	Condition	AD	INC	modified_by:probable or possible;
18.txt	NCT00480220	Measurement	MMSE score	INC	has_value:between 12 and 26;
18.txt	NCT01638949	Condition	cancer	EXC	modified_by:severe;
18.txt	NCT01841905	Drug	sedative-hypnotics	EXC	has_value:more frequently than 2 times per week;modified_by:short-acting;has_TempMea:within 4 weeks;
18.txt	NCT01638949	Condition	diabetes	EXC	modified_by:uncontrolled;
18.txt	NCT01638949	Condition	lung, heart, metabolic, hematologic, endocrine disease	EXC	
18.txt	NCT01841905	Condition	major depression	INC	has_TempMea:within the past year;is_negated:not;
18.txt	NCT00688207	Condition	absorption	EXC	
18.txt	NCT01841905	Drug	Estrogen replacement therapy	INC	
18.txt	NCT01962753	Condition	alcoholism	EXC	
18.txt	NCT01962753	Condition	drug addiction	EXC	
18.txt	NCT01841905	Measurement	visual and auditory acuity	INC	modified_by:Adequate;
18.txt	NCT01841905	Condition	general health	INC	modified_by:Good;
18.txt	NCT01962753	Condition	mania	EXC	has_TempMea:current or past;
18.txt	NCT01962753	Condition	schizophrenia	EXC	has_TempMea:current or past;
18.txt	NCT01962753	Condition	Major depression with psychotic features	EXC	
18.txt	NCT01962753	Condition	Depressive episode resistant	EXC	
18.txt	NCT01962753	Measurement	MMSE	EXC	has_value:less than or equal to 17;
18.txt	NCT01841905	Condition	abnormalities	INC	modified_by:clinically significant;is_negated:without;
18.txt	NCT01841905	Drug	Vitamin E	INC	
18.txt	NCT01841905	Drug	Vitamin supplements	INC	
18.txt	NCT01982578	Measurement	CSF levels of AB, p-TAU	INC	
18.txt	NCT00688207	Condition	distribution	EXC	
18.txt	NCT01841905	Condition	insult	EXC	modified_by:other;
18.txt	NCT01841905	Condition	traumatic brain injury	EXC	modified_by:major;
18.txt	NCT01982578	Condition	AD	INC	
18.txt	NCT01841905	Condition	DSM-IV	EXC	
18.txt	NCT01841905	Condition	neurologic disease	EXC	modified_by:other;
18.txt	NCT01841905	Measurement	Mini Mental State Examination ( MMSE )total score	EXC	has_value:< 27;
18.txt	NCT01962753	Measurement	MINI and HDRS score	INC	has_value:10 or over;
18.txt	NCT01962753	Condition	Major depression	INC	
18.txt	NCT01982578	Condition	hormone dependent neoplasia	EXC	
18.txt	NCT01982578	Drug	isoflavones	EXC	
18.txt	NCT01982578	Condition	Thyroid abnormalities	EXC	
18.txt	NCT01982578	Condition	Immune abnormalities	EXC	
18.txt	NCT01841905	Drug	narcotics	EXC	
18.txt	NCT01841905	Drug	antipsychotic medications	EXC	
18.txt	NCT01841905	Condition	Axis I psychiatric disorder	EXC	modified_by:another;has_TempMea:within the past year;
18.txt	NCT01841905	Condition	major depression	EXC	modified_by:Poorly-controlled;has_TempMea:within the past year;
18.txt	NCT01841905	Condition	agitation	EXC	has_TempMea:within the last 3 months;
18.txt	NCT01841905	Condition	Psychotic features	EXC	has_TempMea:within the last 3 months;
18.txt	NCT01142258	Demographic	age	INC	has_value:Fifty-five years;has_value:older;
18.txt	NCT01142258	Condition	Alzheimer's disease	INC	modified_by:probable;
18.txt	NCT01142258	Measurement	Hachinski Ischemia Scale score	INC	has_value:less than 5;
18.txt	NCT01142258	Measurement	Mini-Mental State Examination score	INC	has_value:O to 26;
18.txt	NCT01841905	Condition	behavioral problems	EXC	has_TempMea:within the last 3 months;
18.txt	NCT00688207	Observation	metabolism	EXC	
18.txt	NCT01841905	Condition	schizophrenia	EXC	
18.txt	NCT00688207	Measurement	excretion	EXC	
18.txt	NCT01841905	Condition	DSM IV criteria	EXC	
18.txt	NCT01841905	Condition	DSM IV criteria	EXC	
18.txt	NCT01841905	Condition	alcohol or substance abuse or dependence	EXC	has_TempMea:within the past 2 years;
19.txt	NCT02137460	Condition	Diagnostic and Statistical Manual-IV ( DSM-IV ) criteria	INC	
19.txt	NCT02518412	Condition	psychosis	EXC	
19.txt	NCT02518412	Condition	diseases	EXC	
19.txt	NCT02518412	Condition	Psychiatric disorders	EXC	
19.txt	NCT02518412	Condition	major depression	EXC	
19.txt	NCT02518412	Condition	Stroke	EXC	
19.txt	NCT02518412	Condition	Cancer	EXC	
19.txt	NCT02137460	Condition	National Institute of Aging and the Alzheimer's Association ( NIA-AA )	INC	
19.txt	NCT02349191	Procedure	abdominal surgery	EXC	has_TempMea:previous;
19.txt	NCT02349191	Condition	hypertension ( HTN )	EXC	modified_by:uncontrollable;
19.txt	NCT02349191	Measurement	platelets	EXC	has_value:> 125000;
19.txt	NCT00408525	Procedure	implants	EXC	
19.txt	NCT02349191	Measurement	white blood cell	EXC	has_value:< 4000;
19.txt	NCT00408525	Condition	memory dysfunction	INC	modified_by:subjective;
19.txt	NCT02349191	Condition	disorder	EXC	has_TempMea:previous;
19.txt	NCT02349191	Procedure	craniotomy	EXC	has_TempMea:in the past;
19.txt	NCT01430286	Measurement	Perceived Stress Scale 14 items	INC	has_value:12 or over;
19.txt	NCT02349191	Procedure	major surgery	EXC	has_TempMea:Recent;has_TempMea:within the past 6 months;
19.txt	NCT01430286	Condition	NINCDS/ADRDA	INC	
19.txt	NCT00082602	Drug	galantamine	EXC	
19.txt	NCT00082602	Procedure	MRI scan	EXC	has_TempMea:within the last 12 months;modified_by:significant;
19.txt	NCT00082602	Condition	injuries	EXC	
19.txt	NCT00408525	Condition	memory dysfunction	INC	is_negated:no;
19.txt	NCT00408525	Observation	clinical evaluation	INC	
19.txt	NCT01434940	Condition	Alzheimer	INC	
19.txt	NCT02349191	Condition	Alzheimer's disease	EXC	is_negated:other than;
19.txt	NCT01434940	Measurement	MMSE	INC	
19.txt	NCT01434940	Condition	NINCDS-ADRDA ( National Institute of Neurological and Communicative Disorders and Stroke -Alzheimer's Disease and Related Disorders Association ) criteria	INC	
19.txt	NCT01434940	Condition	AD	INC	
19.txt	NCT02349191	Condition	central nervous system ( CNS ) disorder	EXC	modified_by:significant;
19.txt	NCT02349191	Drug	anti-platelet medications	EXC	is_negated:other then;
19.txt	NCT01434940	Condition	AD	INC	is_negated:without;
19.txt	NCT01434940	Measurement	MADRS score	INC	has_value:< 25;
19.txt	NCT02349191	Condition	head injury	EXC	modified_by:significant;
19.txt	NCT02349191	Condition	stroke	EXC	
19.txt	NCT01434940	Condition	psychiatric disorder	INC	is_negated:without;
19.txt	NCT02349191	Condition	transient ischemic attack	EXC	
19.txt	NCT02518412	Condition	injuries	EXC	
19.txt	NCT02349191	Condition	non-prescribed drugs of abuse	EXC	
19.txt	NCT00814801	Drug	drugs	EXC	
19.txt	NCT02349191	Drug	cholinesterase inhibitors	EXC	modified_by:inability;
19.txt	NCT02518412	Measurement	cognitive / neuropsychological testing	INC	
19.txt	NCT02349191	Drug	cholinesterase inhibitors	EXC	has_TempMea:within the last 30 days;
19.txt	NCT01434940	Measurement	MMSE ( Mini Mental State Examination )	INC	has_value:>= 18;
19.txt	NCT02349191	Drug	anticoagulants	EXC	
19.txt	NCT02349191	Condition	drug or alcohol abuse/dependence	EXC	
19.txt	NCT00082602	Condition	convulsions	EXC	
19.txt	NCT00408525	Measurement	Mini-Mental State Exam	EXC	has_value:less than 25 - 30;
19.txt	NCT00082602	Condition	epilepsy	EXC	
19.txt	NCT01430286	Condition	AD	INC	
19.txt	NCT00408525	Condition	Dementia	EXC	
19.txt	NCT01430286	Demographic	Age	INC	has_value:over 18 years old;
19.txt	NCT00082602	Condition	hypersensitivity	EXC	modified_by:severe;
19.txt	NCT00082602	Condition	focal signs	EXC	modified_by:multiple;
19.txt	NCT00408525	Measurement	Neuropsychological test battery	INC	modified_by:normal;
19.txt	NCT02349191	Procedure	plastic surgery	EXC	
19.txt	NCT00082602	Procedure	neurological examination	EXC	
19.txt	NCT00408525	Demographic	Ages	INC	has_value:40 - 85;
19.txt	NCT00408525	Condition	cognition	EXC	
19.txt	NCT00408525	Condition	Medical, psychiatric and neurologic conditions	EXC	
19.txt	NCT01600469	Condition	Alzheimer's	INC	modified_by:mild;
19.txt	NCT01430286	Procedure	psychotherapy	INC	has_TempMea:Ongoing;
19.txt	NCT00082602	Condition	febrile convulsions	EXC	has_TempMea:childhood;is_negated:except for;
19.txt	NCT00408525	Drug	medication	EXC	has_TempMea:Current;
19.txt	NCT01600469	Condition	mild cognitive impairment	INC	
19.txt	NCT01430286	Condition	Physical or mental disease	INC	
19.txt	NCT01434940	Condition	cognitive disorders	INC	
19.txt	NCT02349191	Condition	Major depressive disorder	EXC	
19.txt	NCT01434940	Measurement	MADRS score	INC	has_value:< 25;
19.txt	NCT02349191	Condition	schizophrenia	EXC	
19.txt	NCT01434940	Condition	depression	INC	
19.txt	NCT01434940	Condition	psychiatric condition	INC	modified_by:other;
19.txt	NCT01430286	Condition	DSM IV-TR	INC	
19.txt	NCT02349191	Condition	loss of consciousness	EXC	modified_by:other;has_value:>= 15 minutes;modified_by:unexplained or recurrent;
19.txt	NCT01434940	Condition	AD	INC	is_negated:without;
19.txt	NCT01434940	Demographic	age	EXC	has_value:under 60;
19.txt	NCT02349191	Condition	extra pyramidal signs	EXC	modified_by:severe;
19.txt	NCT01434940	Measurement	MMSE	INC	has_value:> 20;
19.txt	NCT02349191	Condition	bipolar disorder	EXC	
19.txt	NCT02349191	Condition	epilepsy	EXC	
19.txt	NCT02349191	Condition	psychotic disorders	EXC	modified_by:other;modified_by:other;
19.txt	NCT00082602	Condition	urinary outflow obstruction	EXC	modified_by:Clinically significant;
19.txt	NCT01054976	Condition	dementia	EXC	
19.txt	NCT01600469	Condition	physical illnesses	EXC	modified_by:major;
19.txt	NCT00082602	Condition	hepatic, renal, pulmonary, metabolic or endocrine disturbances	EXC	modified_by:Clinically significant;
19.txt	NCT01054976	Drug	Acetylcholine esterase inhibitors	EXC	has_TempMea:within 30 days;
19.txt	NCT00814801	Condition	National Institute of Neurological and Communicative Disorders and the Alzheimer's Disease and Related Disorders Association ( NINCDS-ADRDA ) criteria	INC	
19.txt	NCT00082602	Condition	myocardial infarction	EXC	has_TempMea:within the past 6 months;
19.txt	NCT01054976	Condition	Dementia	EXC	
19.txt	NCT00814801	Measurement	Alzheimer's Disease Assessment Scale - Japan cognitive subscale ( ADAS-J cog ) score	INC	has_value:at least 18;
19.txt	NCT01054976	Condition	head trauma	EXC	
19.txt	NCT00082602	Condition	cardiovascular diseases	EXC	modified_by:clinically significant;has_TempMea:within the past 6 months;
19.txt	NCT01054976	Condition	Huntington's disease	EXC	
19.txt	NCT00814801	Measurement	Mini-Mental Status Examination ( MMSE ) score	INC	has_value:10 - 22 inclusive;
19.txt	NCT00082602	Procedure	cardiac surgery	EXC	has_TempMea:within the past 6 months;
19.txt	NCT01054976	Condition	Down syndrome	EXC	
19.txt	NCT00082602	Condition	cardiovascular disease	EXC	has_TempMea:Current;modified_by:clinically significant;
19.txt	NCT01054976	Condition	Parkinson's disease	EXC	
19.txt	NCT00814801	Condition	Alzheimer's disease	INC	
19.txt	NCT01054976	Condition	Pick's disease	EXC	
19.txt	NCT01054976	Condition	Neurodegenerative diseases	EXC	
19.txt	NCT01600469	Condition	visual or hearing impairment	EXC	modified_by:severe;
19.txt	NCT00082602	Condition	schizophrenia	EXC	has_TempMea:current;
19.txt	NCT00408525	Procedure	Surgical clips	EXC	
19.txt	NCT00082602	Condition	bipolar disorder	EXC	has_TempMea:current;
19.txt	NCT00408525	Condition	hypertension	EXC	modified_by:uncontrolled;
19.txt	NCT01600469	Measurement	CDR	INC	has_value:0.5 or 1;
19.txt	NCT00082602	Condition	major depression	EXC	has_TempMea:current;
19.txt	NCT00408525	Condition	Claustrophobia	EXC	
19.txt	NCT00408525	Condition	cerebrovascular disease	EXC	
19.txt	NCT01600469	Measurement	MMSE	INC	has_value:between 17 - 26;
19.txt	NCT00082602	Condition	psychiatric disease	EXC	modified_by:clinically significant;has_TempMea:Current;
19.txt	NCT02137460	Condition	dementia	INC	
19.txt	NCT02137460	Condition	MCI ( amnestic )	INC	
19.txt	NCT02137460	Condition	AD dementia	INC	modified_by:Probable;
19.txt	NCT00082602	Condition	Peptic ulcer disease	EXC	
19.txt	NCT01054976	Measurement	K-MMSE ( Korean - Mini Mental State Exam )	INC	has_value:10 to 24;
19.txt	NCT01600469	Condition	epilepsy	EXC	
19.txt	NCT02137460	Demographic	Age	INC	has_value:55 - 90;
19.txt	NCT01600469	Condition	dementia with psychotic features	EXC	
19.txt	NCT01600469	Condition	Parkinson disease	EXC	
19.txt	NCT02137460	Measurement	Clinical Dementia Rating ( CDR )	INC	has_value:= 0.5;
19.txt	NCT00082602	Condition	behavioral disturbances	EXC	modified_by:uncontrolled;modified_by:moderate to severe;
19.txt	NCT01054976	Condition	Alzheimer's disease	INC	
19.txt	NCT01600469	Condition	major depressive disorder	EXC	
19.txt	NCT00408525	Procedure	Pacemakers	EXC	
19.txt	NCT00408525	Procedure	implanted electronic devices	EXC	modified_by:other;
19.txt	NCT01600469	Condition	substance abuse/dependence	EXC	
19.txt	NCT01600469	Measurement	Hachinski Ischemic Score	EXC	has_value:> 4;
19.txt	NCT01054976	Condition	brain tumor	EXC	
19.txt	NCT00814801	Condition	brain injury	EXC	
19.txt	NCT00082602	Condition	atrio-ventricular block	EXC	has_value:> first degree;
19.txt	NCT01054976	Condition	nerve syphilis	EXC	
19.txt	NCT00814801	Condition	multi-infarct dementia	EXC	
19.txt	NCT01054976	Condition	meningitis	EXC	
19.txt	NCT00814801	Condition	strokes	EXC	
19.txt	NCT02137460	Demographic	Age	INC	has_value:55 - 90;
19.txt	NCT02137460	Measurement	Clinical Dementia Rating ( CDR )	INC	has_value:= 0;
19.txt	NCT00082602	Measurement	diastolic blood pressure	EXC	has_value:> 110 mmHg;
19.txt	NCT02518412	Condition	Alzheimers disease	INC	
19.txt	NCT02137460	Demographic	Age	INC	has_value:20 - 55;
19.txt	NCT02349191	Condition	AD	INC	modified_by:mild;
19.txt	NCT02518412	Condition	cognitive impairment and decline	INC	
19.txt	NCT00082602	Measurement	systolic blood pressure	EXC	has_value:> 170 mmHg;
19.txt	NCT02349191	Measurement	Montreal Cognitive Assessment ( MoCA ) score	INC	has_value:11 to 18;
19.txt	NCT00814801	Drug	cholinesterase inhibitors	EXC	
19.txt	NCT02137460	Measurement	Clinical Dementia Rating ( CDR )	INC	has_value:= 0;
19.txt	NCT00814801	Condition	cerebral circulation/metabolism	EXC	
19.txt	NCT02349191	Demographic	age	INC	has_value:between 60 to 85 years;
19.txt	NCT00082602	Condition	high blood pressure	EXC	modified_by:Uncontrolled;
19.txt	NCT00814801	Condition	cardiovascular disease	EXC	modified_by:clinically significant;
19.txt	NCT01054976	Condition	encephalitis	EXC	
19.txt	NCT00082602	Condition	mitral or aortic valvular disease	EXC	modified_by:Severe;
19.txt	NCT01054976	Condition	epilepsy	EXC	
19.txt	NCT00814801	Condition	cerebrovascular disease	EXC	modified_by:active;
19.txt	NCT00082602	Drug	anti-angina medication	EXC	has_TempMea:within the last 3 months;
19.txt	NCT01054976	Condition	cerebral hypoxia	EXC	
19.txt	NCT00082602	Condition	angina	EXC	
19.txt	NCT01054976	Condition	dementia	EXC	
19.txt	NCT00814801	Condition	cognitive dysfunction	INC	modified_by:onset and progression;has_TempMea:at least 6 months;
19.txt	NCT00082602	Condition	coronary artery disease	EXC	
19.txt	NCT01054976	Condition	brain damage	EXC	
19.txt	NCT00814801	Condition	neurodegenerative diseases	EXC	
19.txt	NCT02137460	Condition	psychiatric illness	INC	modified_by:major;has_TempMea:presence;has_TempMea:Past;
19.txt	NCT02137460	Condition	bipolar disorder	INC	
19.txt	NCT02137460	Condition	schizophrenia	INC	
19.txt	NCT02137460	Condition	alcohol/substance abuse	INC	
19.txt	NCT00082602	Condition	atrial fibrillation	EXC	
19.txt	NCT01054976	Condition	hypoxic brain damage	EXC	
19.txt	NCT00814801	Condition	cerebral damage	EXC	
19.txt	NCT00082602	Condition	bradycardia	EXC	has_value:< 50/min;
19.txt	NCT01054976	Condition	shock	EXC	
19.txt	NCT00814801	Condition	lack of oxygen	EXC	
19.txt	NCT00082602	Condition	near syncope	EXC	
19.txt	NCT01054976	Condition	hypoxic brain damage	EXC	
19.txt	NCT00814801	Condition	Parkinsonism	EXC	
19.txt	NCT02137460	Condition	dependence	INC	
19.txt	NCT00082602	Condition	alterations of mental status	EXC	modified_by:other;
19.txt	NCT01054976	Condition	addiction	EXC	
19.txt	NCT00814801	Condition	cognitive dysfunction	EXC	
19.txt	NCT00082602	Condition	cardiac disease	EXC	
19.txt	NCT01054976	Condition	hypoxic brain damage	EXC	
19.txt	NCT00814801	Condition	Lewy bodies disease	EXC	
19.txt	NCT00082602	Condition	syncope	EXC	
19.txt	NCT01054976	Procedure	surgery	EXC	
19.txt	NCT00814801	Condition	dementia	EXC	
19.txt	NCT01054976	Condition	hypoxic brain damage	EXC	
19.txt	NCT00814801	Condition	Alzheimer's disease	EXC	is_negated:other than;
19.txt	NCT00082602	Condition	decompensated congestive heart failure	EXC	
19.txt	NCT01054976	Procedure	cardiopulmonary resuscitation	EXC	
19.txt	NCT00082602	Condition	drug or alcohol abuse	EXC	has_TempMea:within the last year;
19.txt	NCT02349191	Condition	neck calcifications	EXC	
19.txt	NCT02137460	Condition	delirium	INC	
19.txt	NCT02137460	Condition	Contraindications	INC	
19.txt	NCT02137460	Condition	neurologic or medical condition	INC	modified_by:Significant;
19.txt	NCT02349191	Procedure	abdominal, cranial or neck radiotherapy	EXC	has_TempMea:Previous;
19.txt	NCT02137460	Procedure	pacemaker	INC	
19.txt	NCT02137460	Procedure	MRI scan	INC	
19.txt	NCT02137460	Condition	claustrophobia	INC	
19.txt	NCT02137460	Drug	investigational drug	INC	
19.txt	NCT00082602	Drug	choline agonists	EXC	
19.txt	NCT02349191	Measurement	Complete blood count ( CBC )	EXC	
19.txt	NCT02137460	Condition	visual or hearing difficulty	INC	modified_by:Significant;
19.txt	NCT00082602	Drug	identical agents	EXC	
19.txt	NCT00082602	Condition	hypersensitivity	EXC	
19.txt	NCT02349191	Measurement	glycoslated Hb ( A1C )	EXC	has_value:> 7;
19.txt	NCT00082602	Drug	cholinesterase inhibitors	EXC	
19.txt	NCT02349191	Condition	liver disease	EXC	modified_by:uncontrolled;
19.txt	NCT00082602	Condition	drug allergy	EXC	modified_by:severe;
19.txt	NCT02349191	Condition	diabetes mellitus	EXC	
19.txt	NCT00082602	Condition	childbearing potential	EXC	
19.txt	NCT02349191	Condition	heart disease	EXC	modified_by:uncontrolled;
19.txt	NCT02349191	Condition	renal disease	EXC	modified_by:uncontrolled;
19.txt	NCT02349191	Measurement	ASA	INC	has_value:<= 3;
19.txt	NCT00082602	Condition	hypotension	EXC	modified_by:sustained;
19.txt	NCT02137460	Condition	pregnancy	INC	
19.txt	NCT00082602	Condition	Alzheimer's Disease	INC	
19.txt	NCT02137460	Condition	breast-feeding	INC	
19.txt	NCT00082602	Condition	dementia	EXC	
19.txt	NCT00082602	Demographic	Age	INC	has_value:>= 60 years;
19.txt	NCT00082602	Condition	dementia	INC	modified_by:mild to moderate;
19.txt	NCT00082602	Measurement	Mini Mental State Examination ( MMSE ) score	INC	has_value:10 - 24 inclusive;
19.txt	NCT00082602	Condition	Alzheimer's disease	EXC	
19.txt	NCT02349191	Condition	cancer	EXC	
19.txt	NCT02349191	Drug	cancer therapy	EXC	has_TempMea:undergoing;
19.txt	NCT00082602	Drug	Reminyl	EXC	has_TempMea:during the 30 days;
19.txt	NCT02349191	Observation	Life expectancy	EXC	has_value:< 2 years;
19.txt	NCT00082602	Drug	Namenda	EXC	has_TempMea:during the 30 days;
19.txt	NCT00082602	Drug	metrifonate	EXC	has_TempMea:during the 30 days;
19.txt	NCT00082602	Drug	Exelon	EXC	has_TempMea:during the 30 days;
19.txt	NCT02349191	Condition	dementia	INC	is_negated:other than;
19.txt	NCT00082602	Drug	Cognex	EXC	has_TempMea:during the 30 days;
19.txt	NCT02349191	Condition	medical illnesses	INC	modified_by:well controlled;
19.txt	NCT00082602	Drug	Aricept	EXC	has_TempMea:during the 30 days;
19.txt	NCT02349191	Drug	chemotherapy	EXC	has_TempMea:Previous;
19.txt	NCT00082602	Condition	Neurodegenerative disorders	EXC	
19.txt	NCT00082602	Condition	cognitive decline	INC	has_TempMea:at least six months;modified_by:gradual;modified_by:progressive;
19.txt	NCT01434940	Condition	neuropsychological sequelae	INC	is_negated:without;
19.txt	NCT00082602	Condition	cognitive impairment	EXC	
19.txt	NCT00082602	Condition	trauma	EXC	modified_by:chronic;
19.txt	NCT00082602	Condition	cerebral trauma	EXC	modified_by:Acute;
19.txt	NCT00082602	Condition	hypoxic cerebral damage	EXC	
19.txt	NCT00082602	Condition	Vitamin deficiency states	EXC	
19.txt	NCT00082602	Condition	cerebral hypoperfusion	EXC	modified_by:acute or chronic;
19.txt	NCT01434940	Condition	cognitive impairment	INC	is_negated:without;
19.txt	NCT01434940	Condition	psychiatric pathology	INC	modified_by:other;is_negated:without;
19.txt	NCT01434940	Condition	depression	INC	
19.txt	NCT01434940	Measurement	MADRS ( Montgomery and Asberg Depression Rating Scale ) score	INC	has_value:> 25;
19.txt	NCT00082602	Condition	folate, vitamin B12 or other B complex deficiencies	EXC	
19.txt	NCT00082602	Condition	Neurosyphilis	EXC	
19.txt	NCT00082602	Condition	cerebral abscesses	EXC	
19.txt	NCT00082602	Drug	investigational medication	EXC	has_TempMea:within the last 30 days;
19.txt	NCT00082602	Condition	infections	EXC	modified_by:other;
19.txt	NCT00082602	Condition	encephalitides	EXC	
19.txt	NCT00082602	Condition	meningitis	EXC	
19.txt	NCT00082602	Drug	bromide	EXC	
19.txt	NCT00082602	Condition	AIDS	EXC	
19.txt	NCT00082602	Condition	cerebral neoplasia	EXC	modified_by:Primary or metastatic;
19.txt	NCT01434940	Condition	eye disease	INC	is_negated:without;
19.txt	NCT01434940	Measurement	visual acuity	INC	has_value:> 9 - 10;
19.txt	NCT01320527	Condition	bipolar disorder	EXC	modified_by:known or suspected;
19.txt	NCT01320527	Condition	Alzheimer's disease	INC	
19.txt	NCT01320527	Condition	Mild Cognitive Impairment	INC	
19.txt	NCT00082602	Condition	endocrine or metabolic disease	EXC	modified_by:Significant;
19.txt	NCT00082602	Condition	thyroid, parathyroid or pituitary disease	EXC	modified_by:uncontrolled;modified_by:untreated;
19.txt	NCT00082602	Condition	Cushing's syndrome	EXC	
19.txt	NCT00082602	Condition	renal failure	EXC	modified_by:severe;
19.txt	NCT00082602	Condition	Mental retardation	EXC	
19.txt	NCT00082602	Condition	diabetes mellitus	EXC	modified_by:uncontrolled;
19.txt	NCT02137460	Condition	Alzheimer's disease ( AD )	INC	
19.txt	NCT02349191	Procedure	OT surgery	EXC	
19.txt	NCT02137460	Condition	mild cognitive impairment ( MCI )	INC	
19.txt	NCT02137460	Condition	AD	INC	
19.txt	NCT02137460	Demographic	Age	INC	has_value:55 - 90;
19.txt	NCT02137460	Measurement	Clinical Dementia Rating ( CDR	INC	has_value:= 0.5 or 1;
19.txt	NCT01054976	Condition	criteria of DSM-IV, NINCDS-ADRDA	INC	
19.txt	NCT00082602	Condition	oligophrenia	EXC	
19.txt	NCT00082602	Condition	Multi-infarct dementia	EXC	
19.txt	NCT00082602	Condition	cerebrovascular disease	EXC	modified_by:clinically active;
19.txt	NCT00082602	Condition	cerebrovascular event	EXC	modified_by:significant;
19.txt	NCT00082602	Procedure	CT	EXC	has_TempMea:within the last 12 months;modified_by:significant;
19.txt	NCT00082602	Condition	physical or neurologic deficit	EXC	
19.txt	NCT00082602	Condition	multiple ischemic attacks	EXC	
2.txt	NCT00088751	Condition	Symptomatic cardiovascular disease	INC	
2.txt	NCT00088751	Condition	TIA	INC	has_TempMea:recent;
2.txt	NCT00088751	Condition	claudication	INC	
2.txt	NCT02260700	Measurement	serum chemistry panel	INC	has_value:outside the normal reference ranges;
2.txt	NCT00088751	Condition	angina	INC	
2.txt	NCT02260700	Measurement	liver enzymes	INC	
2.txt	NCT00088751	Condition	syncope	INC	
2.txt	NCT02260700	Condition	healthy	INC	
2.txt	NCT00088751	Condition	TIAs	INC	
2.txt	NCT02260700	Measurement	clinical laboratory tests	INC	
2.txt	NCT00088751	Condition	hyper or hypotension	INC	modified_by:uncontrolled;
2.txt	NCT00088751	Condition	contraindication	INC	
2.txt	NCT00088751	Condition	tic disorder	INC	
2.txt	NCT02260700	Measurement	hematology	INC	has_value:outside the normal reference ranges;
2.txt	NCT02260700	Measurement	urinalysis	INC	has_value:outside the normal reference ranges;
2.txt	NCT00088751	Procedure	lumbar puncture	INC	
2.txt	NCT00088751	Demographic	child-bearing age	INC	
2.txt	NCT00088751	Procedure	blood draws	INC	
2.txt	NCT02260700	Measurement	physical examination	INC	
2.txt	NCT00088751	Measurement	pregnancy test	INC	
2.txt	NCT02260700	Observation	medical history	INC	
2.txt	NCT02260700	Condition	healthy	INC	
2.txt	NCT00088751	Condition	psychosis	INC	modified_by:severe;
2.txt	NCT00088751	Condition	substance abuse	INC	has_TempMea:recent;
2.txt	NCT02260700	Procedure	ECG	INC	is_negated:not;modified_by:Minor deviations;modified_by:clinical significance;
2.txt	NCT02260700	Measurement	vital signs	INC	
2.txt	NCT02260700	Procedure	12 -lead electrocardiogram ( ECG )	INC	
2.txt	NCT00088751	Measurement	QTc prolongation	INC	
2.txt	NCT00088751	Procedure	baseline EKG	INC	
2.txt	NCT00088751	Drug	stimulant	INC	modified_by:negative;
2.txt	NCT00088751	Measurement	Communication Functional Ratings - Swallowing Domain	INC	has_value:2 or less;
2.txt	NCT01979432	Demographic	aged	INC	has_value:>=  70 years;
2.txt	NCT01979432	Condition	clinical CVD	INC	is_negated:free;
2.txt	NCT00088751	Condition	FTD	INC	
2.txt	NCT00088751	Condition	Lund-Manchester criteria	INC	
2.txt	NCT00088751	Condition	Semantic Dementia	INC	
2.txt	NCT00088751	Condition	Primary Progressive Aphasia	INC	
2.txt	NCT00088751	Demographic	Ages	INC	has_value:45 to 95 years old;
2.txt	NCT00088751	Measurement	CDR	INC	has_value:1 to 2;
2.txt	NCT01979432	Condition	atherosclerosis	INC	
2.txt	NCT01979432	Condition	cognitive impairment	INC	is_negated:without;
2.txt	NCT01979432	Measurement	MMSE	INC	has_value:>= 24;
2.txt	NCT01979432	Condition	CVD diseases	EXC	
2.txt	NCT01979432	Condition	angina	EXC	
2.txt	NCT01979432	Condition	coronary artery disease	EXC	
2.txt	NCT01979432	Condition	myocardial infarction	EXC	
2.txt	NCT02260700	Procedure	pacemaker	EXC	modified_by:permanent;
2.txt	NCT02260700	Procedure	implantable cardioverter defibrillator	EXC	modified_by:permanent;
2.txt	NCT02260700	Condition	Left Bundle Branch Block	EXC	
2.txt	NCT02260700	Measurement	QTc	EXC	has_value:greater than (>) 450msec;
2.txt	NCT02260700	Measurement	vital signs	EXC	modified_by:abnormal;modified_by:clinically significant;
2.txt	NCT02260700	Procedure	12 lead ECG	EXC	modified_by:abnormal;modified_by:clinically significant;
2.txt	NCT02260700	Condition	liver or renal insufficiency	EXC	modified_by:current;
2.txt	NCT02260700	Measurement	physical examination	EXC	modified_by:abnormal;modified_by:clinically significant;
2.txt	NCT01979432	Condition	critical limb ischemia	EXC	
2.txt	NCT02260700	Condition	black-outs	EXC	modified_by:unexplained;
2.txt	NCT01979432	Condition	neurodegenerative, locomotor and ophtalmological diseases	EXC	
2.txt	NCT01979432	Condition	clinical peripheral artery disease	EXC	
2.txt	NCT01979432	Condition	claudication	EXC	
2.txt	NCT02260700	Condition	fits	EXC	
2.txt	NCT01979432	Condition	TIA	EXC	
2.txt	NCT02260700	Condition	epilepsy	EXC	
2.txt	NCT01979432	Condition	carotid revascularization	EXC	
2.txt	NCT02260700	Condition	vasovagal collapse	EXC	is_negated:other than;
2.txt	NCT02509117	Condition	Healthy	INC	
2.txt	NCT02608021	Measurement	MMSE scores	INC	
2.txt	NCT02608021	Condition	Cognitively Normal ( CN )	INC	
2.txt	NCT02260700	Drug	vitamins	EXC	has_TempMea:within 14 days;
2.txt	NCT02260700	Drug	mineral supplements	EXC	has_TempMea:within 14 days;
2.txt	NCT02260700	Drug	over-the-counter medication	EXC	has_TempMea:within 14 days;
2.txt	NCT02260700	Drug	herbal medication	EXC	has_TempMea:within 14 days;
2.txt	NCT02260700	Condition	cardiac, vascular, pulmonary, gastrointestinal, endocrine, neurologic, hematologic, rheumatologic, psychiatric or metabolic disturbances	EXC	
2.txt	NCT01979432	Condition	cerebrovascular disease	EXC	
2.txt	NCT01979432	Condition	stroke	EXC	
2.txt	NCT02260700	Condition	spontaneous, prolonged or severe bleeding of unclear origin	EXC	
2.txt	NCT02260700	Drug	paracetamol	EXC	is_negated:not;
2.txt	NCT01979432	Procedure	coronary revascularization	EXC	
2.txt	NCT02608021	Condition	mental illness	EXC	
2.txt	NCT02608021	Condition	drug or alcohol abuse	EXC	
2.txt	NCT02608021	Condition	stroke	EXC	
2.txt	NCT02608021	Condition	learning disability	EXC	
2.txt	NCT02608021	Condition	neurologic conditions	EXC	modified_by:other;
2.txt	NCT02608021	Condition	trauma	EXC	modified_by:severe;
2.txt	NCT02608021	Condition	clinical depression	EXC	modified_by:medically controlled;
2.txt	NCT02608021	Condition	aMCI	INC	
2.txt	NCT02608021	Measurement	MMSE scores	INC	
2.txt	NCT02608021	Condition	Amnestic Mild Cognitive Impairment ( aMCI )	INC	
2.txt	NCT02608021	Measurement	CDR	INC	
2.txt	NCT02260700	Condition	abnormalities	INC	
2.txt	NCT02608021	Measurement	GDS	INC	
2.txt	NCT02260700	Condition	deviations from normal	INC	is_negated:not;modified_by:clinically significant;
2.txt	NCT00088751	Condition	FTD	INC	modified_by:Mild-to-moderate;
2.txt	NCT00088751	Condition	FTD	INC	
2.txt	NCT00088751	Condition	dementia	INC	
2.txt	NCT00088751	Condition	Lewy body dementia	INC	
2.txt	NCT00088751	Condition	AD	INC	
2.txt	NCT00088751	Condition	dementia associated with Parkinson's disease	INC	
2.txt	NCT00088751	Condition	vascular dementia	INC	
2.txt	NCT02608021	Measurement	vision and hearing	INC	modified_by:Normal;modified_by:corrected-to-normal;
2.txt	NCT00088751	Condition	Progressive Supranuclear Palsy	INC	
2.txt	NCT02608021	Measurement	GDS	INC	
2.txt	NCT00088751	Condition	Corticobasal Degeneration	INC	
2.txt	NCT02608021	Measurement	CDR	INC	
2.txt	NCT02608021	Condition	Pregnancy	EXC	
2.txt	NCT02608021	Procedure	MRI	EXC	
2.txt	NCT00088751	Measurement	CDR	INC	has_value:3;
2.txt	NCT00088751	Condition	dementia	INC	modified_by:Severe;
2.txt	NCT00088751	Condition	allergy	INC	
2.txt	NCT00088751	Condition	adverse reaction	INC	modified_by:serious;
2.txt	NCT00088751	Drug	dextroamphetamine	INC	
2.txt	NCT02509117	Measurement	Body Mass Index ( BMI )	INC	has_value:17.5 to 30.5 kg/m2;
2.txt	NCT00088751	Drug	quetiapine	INC	
2.txt	NCT00088751	Drug	methylphenidate	INC	
2.txt	NCT02509117	Demographic	ages	INC	has_value:65 and 85 years, inclusive;
2.txt	NCT00088751	Drug	stimulant	INC	
2.txt	NCT02509117	Demographic	ages	INC	has_value:18 and 55 years;
2.txt	NCT02608021	Condition	breastfeeding	EXC	
2.txt	NCT02509117	Condition	non-childbearing potential	INC	
2.txt	NCT02608021	Condition	detached retinas	EXC	
2.txt	NCT02608021	Condition	occlusive cataracts	EXC	
2.txt	NCT02608021	Condition	ophthalmologic/visual problems	EXC	
2.txt	NCT02608021	Condition	legal blindness	EXC	
2.txt	NCT00088751	Drug	dextroamphetamine	INC	
2.txt	NCT00088751	Drug	modafinil	INC	
2.txt	NCT00088751	Drug	pemoline	INC	
2.txt	NCT01979432	Measurement	ADL	INC	has_value:= 6;
2.txt	NCT00088751	Drug	antipsychotic medication	INC	modified_by:typical or atypical;
2.txt	NCT00088751	Drug	prochlorperazine	INC	
2.txt	NCT02608021	Procedure	tattoos	EXC	
2.txt	NCT00088751	Drug	metoclopromide	INC	
2.txt	NCT02608021	Procedure	metal/foreign objects	EXC	modified_by:other;
2.txt	NCT02608021	Procedure	pulse oximeters	EXC	
2.txt	NCT00088751	Drug	MAO	INC	has_TempMea:currently;has_TempMea:within 14 days;
2.txt	NCT02608021	Procedure	EKG leads	EXC	
2.txt	NCT02608021	Procedure	aneurysm clips	EXC	
2.txt	NCT02608021	Procedure	cochlear implants	EXC	
2.txt	NCT02608021	Procedure	pacemakers	EXC	
2.txt	NCT00088751	Drug	Furazolidone	INC	
2.txt	NCT02509117	Condition	medical or psychiatric condition	EXC	modified_by:severe;modified_by:acute or chronic;
2.txt	NCT00088751	Drug	norepinephrine	INC	
2.txt	NCT00088751	Drug	Guanethidine	INC	
2.txt	NCT00088751	Drug	tricyclic antidepressants	INC	
2.txt	NCT00088751	Drug	sibutramine	INC	
2.txt	NCT00088751	Drug	carbonic anhydrase inhibitors	INC	
2.txt	NCT00088751	Drug	Carbamazepine	INC	
2.txt	NCT02260700	Measurement	BMI	INC	has_value:between 18 and 30 kg/m^2, ( inclusive );
2.txt	NCT02608021	Measurement	standard neuropsychological scores	INC	has_TempMea:recent;has_TempMea:within 1 year;
2.txt	NCT02260700	Measurement	Body mass index	INC	
2.txt	NCT02509117	Condition	behavior or laboratory abnormality	EXC	
2.txt	NCT02509117	Measurement	total body weight	INC	has_value:> 50 kg ( 110 lbs );
2.txt	NCT00088751	Drug	clozapine	INC	
2.txt	NCT00088751	Drug	thioridazine	INC	
2.txt	NCT00088751	Drug	lithium	INC	
2.txt	NCT00088751	Condition	CVA	INC	
2.txt	NCT00088751	Condition	CVA	INC	
2.txt	NCT00088751	Condition	atrial fibrillation	INC	
2.txt	NCT00088751	Condition	risk	INC	modified_by:significantly increased;
2.txt	NCT02509117	Condition	untreated	EXC	is_negated:excluding;
2.txt	NCT02509117	Condition	suicidal ideation	EXC	has_TempMea:within the past year;modified_by:active;has_TempMea:recent;
2.txt	NCT02509117	Condition	drug allergies	EXC	
2.txt	NCT02509117	Condition	asymptomatic, seasonal allergies	EXC	is_negated:excluding;
2.txt	NCT02509117	Condition	hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic or allergic disease	EXC	modified_by:clinically significant;
20.txt	NCT00285025	Condition	dementia	EXC	
20.txt	NCT01388478	Condition	Myocardial infarction	EXC	has_TempMea:in the last two years;
20.txt	NCT00285025	Drug	cholinesterase inhibitors	INC	modified_by:stable dose;has_TempMea:minimum of 6 months;
20.txt	NCT01388478	Condition	infection	EXC	has_TempMea:within the last 30 days;modified_by:Clinically-significant;
20.txt	NCT00285025	Condition	Alzheimers disease	EXC	is_negated:not;
20.txt	NCT00285025	Condition	delirium	EXC	is_negated:not;
20.txt	NCT00285025	Condition	Delusions	EXC	is_negated:not;
20.txt	NCT01388478	Condition	hypertension	EXC	modified_by:Uncontrolled;has_TempMea:within the last 6 months;
20.txt	NCT01388478	Condition	angina	EXC	
20.txt	NCT01388478	Condition	coronary artery disease	EXC	modified_by:active;has_TempMea:in the last two years;
20.txt	NCT00285025	Condition	psychosis	EXC	is_negated:not;
20.txt	NCT00285025	Condition	depression	EXC	is_negated:not;
20.txt	NCT00285025	Condition	psychiatric disorder	EXC	modified_by:significant;modified_by:other;
20.txt	NCT01388478	Condition	neurological disease	EXC	modified_by:Significant;
20.txt	NCT00285025	Drug	rivastigmine	EXC	is_negated:other than;
20.txt	NCT00285025	Drug	donepezil	EXC	is_negated:other than;
20.txt	NCT00285025	Drug	galantamine	EXC	is_negated:other than;
20.txt	NCT00285025	Condition	pregnant	EXC	
20.txt	NCT01388478	Condition	stroke	EXC	
20.txt	NCT01707719	Demographic	Age	INC	
20.txt	NCT01388478	Condition	systemic illness	EXC	has_TempMea:Current;modified_by:clinically-significant;
20.txt	NCT01388478	Condition	AD	EXC	is_negated:other than;
20.txt	NCT00285025	Condition	child bearing potential	EXC	
20.txt	NCT00285025	Condition	breast-feeding	EXC	
20.txt	NCT00285025	Measurement	serum bHCG pregnancy test	EXC	modified_by:negative;
20.txt	NCT00285025	Drug	CYP3A4 strong inhibitors	EXC	
20.txt	NCT00285025	Condition	cardiovascular, respiratory, renal, hematological, endocrinological, neurological or other somatic disease	EXC	modified_by:Severe;modified_by:unstable;
20.txt	NCT00285025	Measurement	physical examination	EXC	
20.txt	NCT00285025	Observation	history	EXC	
20.txt	NCT00702780	Demographic	Age	INC	has_value:40 - 90 years;
20.txt	NCT00702780	Measurement	Clinical Dementia Rating ( CDR )	INC	has_value:0.5 - 2;
20.txt	NCT00702780	Measurement	Modified Hachinski Ischemic Score	INC	has_value:less than 4;
20.txt	NCT00702780	Condition	Dementia	INC	
20.txt	NCT00702780	Condition	DSM-IV criteria	INC	
20.txt	NCT00285025	Measurement	laboratory	EXC	
20.txt	NCT00285025	Procedure	ECG tests	EXC	
20.txt	NCT00285025	Condition	medical disorder	EXC	modified_by:clinically significant;modified_by:unstable;
20.txt	NCT00285025	Measurement	metabolism	EXC	
20.txt	NCT00285025	Measurement	absorption	EXC	
20.txt	NCT00285025	Measurement	excretion	EXC	
20.txt	NCT00299988	Condition	major depression	EXC	modified_by:Untreated;
20.txt	NCT00299988	Drug	IVIg treatment	EXC	has_TempMea:in past 6 months;
20.txt	NCT00299988	Condition	autoimmune or neuroimmunologic disorder	EXC	modified_by:Active;
20.txt	NCT00299988	Condition	psychiatric disorders	EXC	modified_by:major;modified_by:other;
20.txt	NCT00299988	Condition	coagulopathy	EXC	
20.txt	NCT00299988	Measurement	platelet counts	EXC	has_value:< 100000;
20.txt	NCT01388478	Condition	DSM-IV criteria	EXC	
20.txt	NCT00299988	Drug	aspirin	EXC	has_value:81 milligrams daily;is_negated:excluding;
20.txt	NCT01388478	Condition	drug or alcohol abuse	EXC	has_TempMea:within the last 2 years;
20.txt	NCT01388478	Condition	non-metastatic basal or squamous cell carcinoma	EXC	is_negated:except;
20.txt	NCT00299988	Drug	non-steroidal anti-inflammatory drugs ( NSAIDs )	EXC	modified_by:Chronic;has_value:more than thrice weekly;
20.txt	NCT01388478	Condition	cancer	EXC	has_TempMea:within the last 5 years;
20.txt	NCT01388478	Condition	pain	EXC	modified_by:Significant;
20.txt	NCT00299988	Drug	investigational treatment	EXC	has_TempMea:within 3 months;
20.txt	NCT01388478	Condition	Insulin dependent diabetes mellitus	EXC	
20.txt	NCT00299988	Condition	AD	EXC	
20.txt	NCT00299988	Condition	migraines	EXC	modified_by:Active;
20.txt	NCT00299988	Condition	HIV	EXC	modified_by:Positive;
20.txt	NCT00299988	Measurement	serology	EXC	modified_by:Positive;
20.txt	NCT00299988	Measurement	Hepatitis B or C	EXC	modified_by:Positive;
20.txt	NCT00299988	Drug	immunosuppressive drugs	EXC	
20.txt	NCT00299988	Condition	headaches	EXC	modified_by:frequent;has_value:3 or more times per week;
20.txt	NCT01707719	Condition	malnutrition	EXC	
20.txt	NCT01049555	Condition	depression	INC	is_negated:no;
20.txt	NCT01126099	Condition	angina	EXC	modified_by:unstable;
20.txt	NCT01707719	Measurement	body mass index	EXC	
20.txt	NCT01707719	Drug	vitamin	EXC	
20.txt	NCT01049555	Condition	rigidit musculaire	INC	
20.txt	NCT01707719	Drug	mineral supplements	EXC	
20.txt	NCT01707719	Condition	syphilis	EXC	
20.txt	NCT01049555	Measurement	UPDRS III	INC	
20.txt	NCT01126099	Drug	medications	INC	modified_by:Stable;has_TempMea:for 2 weeks;
20.txt	NCT01707719	Condition	thyroid function abnormalities	EXC	
20.txt	NCT01049555	Condition	tremblements	INC	
20.txt	NCT01126099	Condition	hypotension	EXC	has_TempMea:preexisting;
20.txt	NCT01707719	Drug	Hormonal replacement therapy	EXC	
20.txt	NCT01126099	Measurement	systolic BP	EXC	has_value:less than 110;
20.txt	NCT01707719	Observation	Smoking	EXC	
20.txt	NCT01049555	Drug	psychotrop treatment	EXC	
20.txt	NCT01126099	Condition	myocardial infarction	EXC	has_TempMea:recent;
20.txt	NCT01707719	Condition	Metabolic syndrome	EXC	
20.txt	NCT01707719	Condition	diabetes	EXC	
20.txt	NCT01049555	Condition	DSM IV-R criteria	INC	
20.txt	NCT01707719	Measurement	total protein levels	EXC	
20.txt	NCT01049555	Drug	cholinergic treatment	INC	modified_by:dose stable;has_TempMea:3 months;
20.txt	NCT01049555	Condition	Alzheimer's disease	INC	
20.txt	NCT01707719	Condition	neoplasia	EXC	has_TempMea:Recent;has_TempMea:< 1 year;
20.txt	NCT01049555	Condition	NINCDS-ADRDA criteria	INC	
20.txt	NCT01707719	Condition	NINCDS-ADRDA criteria	INC	
20.txt	NCT00299988	Condition	disease	EXC	has_TempMea:current;
20.txt	NCT01707719	Condition	dementia	INC	is_negated:without;
20.txt	NCT01388478	Condition	musculoskeletal disorder	EXC	
20.txt	NCT01707719	Condition	Alzheimer's disease	INC	
20.txt	NCT00299988	Condition	disorder	EXC	has_TempMea:current;
20.txt	NCT01126099	Condition	Disruptive agitated behaviors	INC	has_value:at least twice a week;
20.txt	NCT01049555	Condition	motor anomaly	INC	is_negated:no;
20.txt	NCT01707719	Measurement	serology	EXC	modified_by:positive;
20.txt	NCT01126099	Condition	Alzheimer's Disease	INC	modified_by:Probable or Possible;
20.txt	NCT01707719	Condition	Vitamin B12 deficiency	EXC	
20.txt	NCT01049555	Measurement	Mini Mental Test Examination ( MMSE )	INC	has_value:> 20;
20.txt	NCT01126099	Drug	Psychoactive medications	EXC	
20.txt	NCT01481558	Condition	Apathy	EXC	
20.txt	NCT01126099	Drug	Exclusionary medications	EXC	
20.txt	NCT01126099	Drug	vardenafil	EXC	
20.txt	NCT01481558	Measurement	Mini Mental State Examination scores	EXC	has_value:from 10 to 20;
20.txt	NCT01126099	Drug	tadalafil	EXC	
20.txt	NCT01126099	Drug	antidepressants	EXC	
20.txt	NCT01481558	Drug	alcohol	EXC	
20.txt	NCT01126099	Drug	benzodiazepines	EXC	
20.txt	NCT00299988	Drug	psychoactive medications	INC	modified_by:stable doses;has_TempMea:at least 6 weeks;
20.txt	NCT01481558	Drug	psychotropic drugs	EXC	
20.txt	NCT01126099	Drug	anticonvulsants	EXC	
20.txt	NCT01481558	Procedure	Metallic clip	EXC	
20.txt	NCT01126099	Drug	mood stabilizers	EXC	
20.txt	NCT01126099	Drug	psychoactive medication	EXC	
20.txt	NCT01481558	Condition	Clinical instability	EXC	
20.txt	NCT01126099	Drug	antipsychotics	EXC	
20.txt	NCT00299988	Drug	approved AD medications	INC	modified_by:stable doses;has_TempMea:at least 3 months;
20.txt	NCT01481558	Condition	Epilepsy	EXC	
20.txt	NCT01481558	Measurement	Apathy Scale	EXC	has_value:equal or higher to 14;
20.txt	NCT01126099	Condition	medical condition	EXC	modified_by:unstable;
20.txt	NCT01707719	Condition	rheumatoid arthritis	EXC	
20.txt	NCT01049555	Drug	antidepressant	EXC	
20.txt	NCT01126099	Measurement	systolic BP	EXC	modified_by:drop;has_value:>= 20 mmHg;
20.txt	NCT01707719	Condition	illness	EXC	modified_by:other;modified_by:acute;
20.txt	NCT01049555	Drug	antipsychotic	EXC	
20.txt	NCT01049555	Drug	hypnotic	EXC	
20.txt	NCT01126099	Condition	orthostatic hypotension	EXC	
20.txt	NCT01707719	Condition	inflammatory disease	EXC	modified_by:Chronic;
20.txt	NCT01049555	Drug	anxiolytic	EXC	
20.txt	NCT00702780	Condition	NINCDS-ADRDA criteria	INC	
20.txt	NCT00702780	Condition	Alzheimer's disease	INC	modified_by:Probable;
20.txt	NCT00702780	Drug	donepezil medication	INC	has_TempMea:Current ongoing;modified_by:stable doses;has_value:5 - 10 mg/day;has_TempMea:at least 2 months;
20.txt	NCT01126099	Drug	trazodone	EXC	
20.txt	NCT00299988	Measurement	Mini Mental State Examination ( MMSE ) score	INC	has_value:14 - 26 inclusive;
20.txt	NCT01481558	Condition	Alzheimer's Disease	EXC	modified_by:Possible;
20.txt	NCT01126099	Drug	sildenafil	EXC	
20.txt	NCT01481558	Condition	NINCDS-ADRDA	EXC	
20.txt	NCT00299988	Condition	Alzheimer's disease ( AD )	INC	modified_by:probable;modified_by:mild to moderate;
20.txt	NCT01481558	Condition	DSM-IV	EXC	
20.txt	NCT01126099	Drug	alpha- 1 blockers	EXC	modified_by:other;
20.txt	NCT01049555	Procedure	actigraphy recording	EXC	
20.txt	NCT00702780	Condition	delirium	INC	
20.txt	NCT01126099	Drug	prazosin	EXC	has_TempMea:current;
20.txt	NCT01481558	Condition	Dementia	EXC	
20.txt	NCT01126099	Condition	panic disorder	EXC	
20.txt	NCT01126099	Condition	substance abuse	EXC	
20.txt	NCT00299988	Condition	renal disease	EXC	modified_by:Active;
20.txt	NCT00702780	Condition	altered consciousness	INC	
20.txt	NCT00702780	Condition	confusion	INC	
20.txt	NCT00702780	Condition	stroke	INC	
20.txt	NCT00702780	Condition	Parkinson's disease	INC	
20.txt	NCT00702780	Condition	normal pressure hydrocephalus	INC	
20.txt	NCT00702780	Condition	brain tumor	INC	
20.txt	NCT01388478	Measurement	Rosen Modified Hachinski score	INC	has_value:4 or less;
20.txt	NCT00702780	Condition	infectious or inflammatory brain disease	INC	
20.txt	NCT01388478	Condition	Alzheimer's Disease ( AD )	INC	modified_by:Possible/probable;
20.txt	NCT00702780	Condition	cerebrovascular diseases	INC	modified_by:serious;
20.txt	NCT00299988	Condition	angina	EXC	modified_by:unstable;
20.txt	NCT00299988	Condition	congestive heart failure	EXC	modified_by:Untreated;
20.txt	NCT00299988	Condition	Immunoglobulin A ( IgA ) deficiency	EXC	
20.txt	NCT01388478	Demographic	Age	INC	has_value:55 years or older;
20.txt	NCT00299988	Measurement	serum viscosity levels	EXC	modified_by:Abnormally high;
20.txt	NCT01126099	Condition	schizophrenia	EXC	modified_by:lifetime;
20.txt	NCT01126099	Drug	buspirone	EXC	
20.txt	NCT00299988	Drug	antidepressants	INC	
20.txt	NCT01126099	Condition	psychoactive medication-free	EXC	
20.txt	NCT00299988	Drug	antipsychotics	INC	
20.txt	NCT00285025	Drug	cognitive enhancer	EXC	
20.txt	NCT00702780	Condition	depressive disorder	INC	modified_by:Current;modified_by:major;
20.txt	NCT00285025	Drug	disease modifier	EXC	
20.txt	NCT00702780	Condition	psychiatric illnesses	INC	modified_by:other;modified_by:major;
20.txt	NCT00702780	Condition	medical illnesses	INC	modified_by:unstable;modified_by:serious;
20.txt	NCT00702780	Drug	antidepressant medications	INC	has_TempMea:within the previous 4 weeks;
20.txt	NCT01126099	Condition	hallucinations	EXC	
20.txt	NCT00299988	Condition	surgically sterilized	INC	
20.txt	NCT00702780	Condition	alcohol or other substance dependence	INC	
20.txt	NCT01126099	Condition	delusions	EXC	
20.txt	NCT00299988	Condition	Non-Alzheimer dementia	EXC	
20.txt	NCT01126099	Condition	distressing psychotic symptoms	EXC	modified_by:persistent;modified_by:uncontrolled;
20.txt	NCT00299988	Condition	post-menopausal	INC	
20.txt	NCT01126099	Condition	mania	EXC	has_TempMea:current;
20.txt	NCT01126099	Condition	depression	EXC	has_TempMea:current;
20.txt	NCT00299988	Procedure	Neuroimaging	INC	
20.txt	NCT01126099	Condition	delirium	EXC	has_TempMea:current;
20.txt	NCT00299988	Measurement	Clinical laboratory values	INC	has_value:within normal limits;modified_by:clinically insignificant;modified_by:abnormal;
20.txt	NCT01388478	Condition	microhemorrhages	INC	
20.txt	NCT00702780	Procedure	MRI scan	INC	
20.txt	NCT01388478	Condition	hemorrhage	INC	has_value:> 1 cubic cm;
20.txt	NCT00702780	Condition	conditions	INC	
20.txt	NCT00702780	Procedure	cerebrovascular clip	INC	
20.txt	NCT00702780	Procedure	pacemaker	INC	
20.txt	NCT00299988	Condition	Thrombosis	EXC	has_TempMea:in the past year;
20.txt	NCT00702780	Condition	focal brain lesions	INC	
20.txt	NCT00702780	Condition	claustrophobia	INC	
20.txt	NCT00702780	Condition	lacunes	INC	
20.txt	NCT00702780	Procedure	MRI	INC	
20.txt	NCT00702780	Measurement	Fazeka scale	INC	has_value:grade 2 or more;
20.txt	NCT00702780	Condition	white matter hyperintensity lesions	INC	
20.txt	NCT01388478	Measurement	visual and auditory abilities	INC	modified_by:Adequate;
20.txt	NCT01388478	Condition	arachnoid cyst	INC	
20.txt	NCT00299988	Condition	cancer	EXC	modified_by:Active;
20.txt	NCT01388478	Condition	brain tumor	INC	
20.txt	NCT00299988	Condition	basal cell carcinoma	EXC	is_negated:except;
20.txt	NCT01388478	Condition	vascular malformation	INC	
20.txt	NCT01388478	Condition	space occupying lesion	INC	
20.txt	NCT01388478	Condition	cerebral contusion encephalomalacia	INC	
20.txt	NCT01388478	Condition	aneurysm	INC	
20.txt	NCT00299988	Measurement	Modified Hachinski score	EXC	has_value:> 5;
20.txt	NCT01388478	Procedure	Imaging Study	INC	
20.txt	NCT00299988	Condition	myocardial infarction	EXC	has_TempMea:recent;
20.txt	NCT01388478	Procedure	CT	INC	
20.txt	NCT00285025	Demographic	Age	INC	has_value:> 50 years;
20.txt	NCT01388478	Procedure	MRI	INC	
20.txt	NCT00299988	Condition	arrhythmia	EXC	modified_by:Unstable;
20.txt	NCT00285025	Condition	DSM-IV 290.0	INC	
20.txt	NCT00285025	Condition	Dementia of Alzheimers Type	INC	
20.txt	NCT00285025	Condition	DSM-IV criteria	INC	
20.txt	NCT00285025	Condition	NINCDS-ADRDA criteria	INC	
20.txt	NCT00285025	Condition	AD	INC	modified_by:Probable;
20.txt	NCT01388478	Condition	single prior infarct	INC	has_value:> 1 cubic cm;
20.txt	NCT00285025	Measurement	Mini-Mental State Examination score	INC	has_value:> 12 and < 26;
20.txt	NCT00299988	Condition	diabetes	EXC	modified_by:Poorly controlled;
20.txt	NCT01388478	Condition	cognitive decline	INC	
20.txt	NCT01388478	Condition	multiple lacunar infarcts	INC	
20.txt	NCT00299988	Condition	hypertension	EXC	modified_by:poorly controlled;modified_by:Untreated;
20.txt	NCT00299988	Condition	hypercholesterolemia	EXC	modified_by:poorly controlled;modified_by:Untreated;
20.txt	NCT01388478	Condition	abnormalities	INC	modified_by:significant;is_negated:absence;
20.txt	NCT01388478	Condition	AD	INC	
21.txt	NCT01119638	Condition	Signs and symptoms	INC	has_value:daily;has_TempMea:during the week;
21.txt	NCT00678431	Condition	seizures	EXC	has_TempMea:Current;has_TempMea:in the past 2 years;
21.txt	NCT00678431	Condition	immediate confusion after the injury	EXC	has_TempMea:Current;has_TempMea:in the past 2 years;
21.txt	NCT00551161	Procedure	intraocular metallic shards	EXC	
21.txt	NCT00678431	Condition	head injury with loss of consciousness	EXC	has_TempMea:Current;has_TempMea:in the past 2 years;
21.txt	NCT00551161	Procedure	object	EXC	
21.txt	NCT00678431	Condition	DSM-IV	EXC	
21.txt	NCT00678431	Condition	psychosis	EXC	
21.txt	NCT00678431	Condition	major psychiatric disorder	EXC	has_TempMea:Current;
21.txt	NCT00551161	Condition	drug abuse	EXC	modified_by:known or suspected;has_TempMea:within the past 5 years;
21.txt	NCT00551161	Condition	claustrophobic	EXC	
21.txt	NCT00551161	Procedure	MRI	EXC	modified_by:unable;
21.txt	NCT00678431	Condition	major depression	EXC	
21.txt	NCT00678431	Condition	alcohol or substance abuse	EXC	
21.txt	NCT00678431	Condition	bipolar disorder	EXC	
21.txt	NCT00678431	Condition	deafness	EXC	
21.txt	NCT00551161	Condition	basal or squamous cell carcinoma	EXC	
21.txt	NCT00678431	Condition	Blindness	EXC	
21.txt	NCT00551161	Procedure	MRI scan	EXC	
21.txt	NCT00678431	Condition	disability	EXC	modified_by:other;
21.txt	NCT00678431	Condition	language difficulties	EXC	
21.txt	NCT00551161	Condition	local dermatological tumors	EXC	
21.txt	NCT00857649	Condition	Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revised ( DSM IV TR ) criteria	INC	
21.txt	NCT00678431	Demographic	female	EXC	
21.txt	NCT00551161	Procedure	cochlear implants	EXC	
21.txt	NCT00551161	Procedure	cardiac pacemakers	EXC	
21.txt	NCT00551161	Procedure	deep brain stimulators	EXC	
21.txt	NCT00551161	Procedure	MRI	EXC	
21.txt	NCT00551161	Procedure	implanted ferromagnetic material or devices	EXC	
21.txt	NCT00551161	Condition	contraindications	EXC	modified_by:other;
21.txt	NCT00678431	Condition	menopause	EXC	is_negated:no;
21.txt	NCT00551161	Drug	treatment	EXC	has_TempMea:within the year;
21.txt	NCT00678431	Drug	medications containing aluminum hydroxide	EXC	
21.txt	NCT00678431	Drug	Alternagel	EXC	
21.txt	NCT00678431	Drug	anti-ulcer antacids	EXC	
21.txt	NCT00678431	Drug	Alu-tab	EXC	
21.txt	NCT00678431	Drug	Amphojel	EXC	
21.txt	NCT00678431	Drug	Mylanta	EXC	
21.txt	NCT00678431	Drug	Maalox	EXC	
21.txt	NCT00678431	Condition	NINCDS/ADRDA criteria	INC	
21.txt	NCT00678431	Condition	AD	INC	modified_by:probable;
21.txt	NCT00678431	Demographic	Age	INC	has_value:greater than or equal to 50 years;
21.txt	NCT00678431	Measurement	MMSE	INC	has_value:between 12 and 26, inclusive;
21.txt	NCT00678431	Condition	medical condition	INC	modified_by:Stable;has_TempMea:3 months;
21.txt	NCT00551161	Demographic	age	INC	has_value:at least 50 years;
21.txt	NCT00551161	Condition	surgically sterile	INC	has_TempMea:at least two years;
21.txt	NCT00551161	Condition	postmenopausal	INC	has_TempMea:at least two years;
21.txt	NCT00551161	Condition	NINCDS-ADRDA criteria	INC	
21.txt	NCT00551161	Condition	Alzheimer's disease	INC	has_TempMea:current;modified_by:probable;
21.txt	NCT00551161	Measurement	Mini-Mental State Examination ( MMSE ) score	INC	has_value:at least 15 and not greater than 26;
21.txt	NCT00456417	Condition	cerebrovascular disease	EXC	modified_by:significant;
21.txt	NCT00456417	Condition	diffuse Lewy body dementia	EXC	
21.txt	NCT00456417	Condition	neurodegenerative disease	EXC	modified_by:another;
21.txt	NCT00456417	Condition	Parkinson's disease	EXC	
21.txt	NCT00456417	Condition	non-child bearing potential	INC	
21.txt	NCT00456417	Measurement	laboratory value	EXC	modified_by:abnormal;modified_by:clinically significant;
21.txt	NCT00456417	Measurement	urine or blood pregnancy test	INC	modified_by:negative;
21.txt	NCT00551161	Drug	cholinesterase drug	EXC	modified_by:dose;modified_by:change;
21.txt	NCT00842673	Condition	B12 or folate deficiency	EXC	
21.txt	NCT00551161	Drug	cholinesterase inhibitor	EXC	has_value:more than one;has_TempMea:currently;
21.txt	NCT00842673	Condition	dementia due to non-Alzheimer's etiology	INC	is_negated:rule out;
21.txt	NCT00551161	Drug	rivastigmine	EXC	
21.txt	NCT00842673	Procedure	MRI	INC	has_TempMea:within the past 12 months;
21.txt	NCT00551161	Drug	galantamine	EXC	
21.txt	NCT00551161	Drug	cholinesterase inhibitor	EXC	modified_by:unstable dose;
21.txt	NCT00842673	Condition	Alzheimer's disease	INC	modified_by:mild to moderate;
21.txt	NCT00551161	Drug	donepezil	EXC	
21.txt	NCT00842673	Procedure	CT	INC	has_TempMea:within the past 12 months;
21.txt	NCT00551161	Drug	cholinesterase inhibitor	EXC	
21.txt	NCT00551161	Condition	contraindicated	EXC	
21.txt	NCT00842673	Condition	hematologic/oncologic disorders	EXC	has_TempMea:recent;
21.txt	NCT00842673	Condition	hepatic disease	EXC	modified_by:chronic;
21.txt	NCT00456417	Condition	excretion	EXC	
21.txt	NCT00456417	Procedure	gastrointestinal surgery	EXC	
21.txt	NCT00456417	Condition	drug absorption distribution	EXC	
21.txt	NCT00456417	Condition	metabolism	EXC	
21.txt	NCT00456417	Condition	medical or psychiatric illness	EXC	modified_by:clinically significant;modified_by:unstable;
21.txt	NCT00456417	Condition	disorder	EXC	
21.txt	NCT00456417	Condition	gastrointestinal, cardiovascular, hepatic, renal, hematological, neoplastic, endocrine, neurological, immunodeficiency, pulmonary or other disorder or disease	EXC	modified_by:clinically significant;
21.txt	NCT00551161	Procedure	EKG	INC	modified_by:normal;
21.txt	NCT00551161	Measurement	Physical examination	INC	modified_by:normal;
21.txt	NCT01119638	Condition	dementia of the Alzheimer's type	INC	
21.txt	NCT00551161	Measurement	laboratory evaluations	INC	modified_by:normal;
21.txt	NCT01119638	Measurement	Mini-Mental State Examination ( MMSE )	INC	has_value:between 5 and 26;
21.txt	NCT00551161	Drug	galantamine	INC	modified_by:stable dose;has_TempMea:at least three months;
21.txt	NCT00551161	Drug	investigational drug	EXC	has_TempMea:within 30 days or 5 half-lives;
21.txt	NCT00551161	Drug	donepezil	INC	modified_by:stable dose;has_TempMea:at least three months;
21.txt	NCT00551161	Drug	amantadine	EXC	
21.txt	NCT00551161	Drug	rivastigmine	INC	modified_by:stable dose;has_TempMea:at least three months;
21.txt	NCT00551161	Drug	investigational drug	EXC	
21.txt	NCT01119638	Condition	hallucinations	INC	
21.txt	NCT00551161	Procedure	MRI scan	INC	
21.txt	NCT01119638	Condition	aggression	INC	
21.txt	NCT01119638	Condition	delusions	INC	
21.txt	NCT00551161	Drug	amantadine	EXC	
21.txt	NCT00551161	Condition	hypersensitivity	EXC	
21.txt	NCT00551161	Drug	memantine	EXC	
21.txt	NCT01119638	Drug	antipsychotic drugs	INC	
21.txt	NCT00551161	Condition	drug allergy	EXC	modified_by:severe;
21.txt	NCT00842673	Condition	Dementia	EXC	
21.txt	NCT00551161	Condition	hypersensitivity	EXC	modified_by:severe;
21.txt	NCT00842673	Condition	organic disease	EXC	modified_by:other;
21.txt	NCT00842673	Condition	myocardial infarction	EXC	has_TempMea:with the past year;
21.txt	NCT00551161	Drug	neramexane	EXC	
21.txt	NCT00551161	Drug	memantine	EXC	
21.txt	NCT00551161	Drug	rimantadine	EXC	
21.txt	NCT00551161	Drug	lactose	EXC	
21.txt	NCT00456417	Condition	Pregnancy	EXC	
21.txt	NCT00551161	Condition	right bundle branch block	EXC	
21.txt	NCT01119638	Measurement	Neuropsychiatric Inventory ( NPI )	INC	
21.txt	NCT00551161	Condition	hypertension	EXC	modified_by:controlled;
21.txt	NCT01119638	Condition	agitation	INC	
21.txt	NCT00551161	Condition	pulmonary, gastrointestinal, renal, hepatic, endocrine or cardiovascular system disease	EXC	modified_by:clinically significant;modified_by:active;
21.txt	NCT01119638	Condition	aberrant motor behavior	INC	
21.txt	NCT00551161	Condition	diabetes	EXC	modified_by:controlled;
21.txt	NCT01119638	Drug	cholinesterase inhibitor	EXC	
21.txt	NCT01119638	Drug	antidepressant medication	EXC	
21.txt	NCT00551161	Condition	thyroid disease	EXC	
21.txt	NCT01119638	Condition	dementia	EXC	modified_by:other;
21.txt	NCT01119638	Condition	schizophrenia	EXC	
21.txt	NCT00551161	Condition	alcoholism	EXC	modified_by:known or suspected;has_TempMea:within the past 5 years;
21.txt	NCT01119638	Condition	delirium	EXC	
21.txt	NCT01119638	Condition	psychotic disorder	EXC	modified_by:primary;
21.txt	NCT00551161	Condition	vitamin B12 deficiency	EXC	modified_by:Clinically significant;
21.txt	NCT01119638	Condition	aggression	INC	
21.txt	NCT00551161	Condition	large cortical stroke	INC	
21.txt	NCT01119638	Condition	psychosis	INC	
21.txt	NCT00551161	Condition	Alzheimer's disease	INC	
21.txt	NCT01119638	Condition	agitation	INC	
21.txt	NCT00551161	Measurement	Vision and hearing	INC	modified_by:sufficient;
21.txt	NCT01119638	Condition	dementia	INC	modified_by:severe;
21.txt	NCT00551161	Observation	findings	INC	modified_by:abnormal;modified_by:clinically significant;is_negated:not;
21.txt	NCT00678431	Drug	medications	INC	modified_by:Stable doses;has_TempMea:4 weeks;
21.txt	NCT00678431	Drug	cholinesterase inhibitors	INC	
21.txt	NCT00551161	Procedure	MRIs	INC	
21.txt	NCT01119638	Condition	delusions	INC	
21.txt	NCT01119638	Condition	hallucinations	INC	
21.txt	NCT00678431	Measurement	physical exam	INC	
21.txt	NCT00551161	Condition	space-occupying brain lesions	INC	modified_by:other;
21.txt	NCT00678431	Observation	medical history	INC	
21.txt	NCT01119638	Condition	agitation	INC	
21.txt	NCT00678431	Measurement	neurologic exam	INC	
21.txt	NCT00551161	Condition	tumor	INC	
21.txt	NCT00551161	Condition	seizure disorder	EXC	
21.txt	NCT00551161	Condition	stroke	EXC	
21.txt	NCT00857649	Measurement	Mini Mental State Examination ( MMSE ) total score	INC	has_value:>= 5 and  <= 15;
21.txt	NCT00551161	Condition	Parkinson's disease	EXC	
21.txt	NCT00857649	Measurement	MMSE total score	INC	has_value:>= 8 and  <= 18;
21.txt	NCT00678431	Measurement	clinical laboratory tests	INC	
21.txt	NCT00678431	Measurement	Modified Hachinski	INC	has_value:< 4;
21.txt	NCT00678431	Procedure	MRI	INC	
21.txt	NCT00678431	Procedure	CT	INC	
21.txt	NCT00857649	Measurement	NPI agitation/aggression subitem score	INC	has_value:>= 1;
21.txt	NCT00678431	Condition	memory impairment	INC	
21.txt	NCT00551161	Condition	schizophrenia	EXC	
21.txt	NCT00678431	Condition	lacune	INC	has_value:One;
21.txt	NCT00551161	Condition	DSM-IV Axis I disorder	EXC	has_TempMea:current;
21.txt	NCT00857649	Measurement	Neuropsychiatric Inventory ( NPI ) total score	INC	has_value:>= 13;
21.txt	NCT00678431	Condition	focal lesion	INC	modified_by:clinically significant;is_negated:absence;
21.txt	NCT00551161	Condition	Alzheimer's disease	EXC	is_negated:other than;
21.txt	NCT00857649	Condition	cognitive decline	INC	
21.txt	NCT00551161	Condition	hydrocephalus	EXC	
21.txt	NCT00551161	Condition	head injury with loss of consciousness	EXC	
21.txt	NCT00857649	Measurement	MMSE score	INC	has_value:16 or 17;
21.txt	NCT01119638	Drug	study drugs	EXC	
21.txt	NCT00551161	Measurement	systolic blood pressure	EXC	has_value:greater then than 180 mm Hg or less then 90 mm Hg;modified_by:sitting;
21.txt	NCT00551161	Condition	renal impairment	EXC	modified_by:severe;
21.txt	NCT01119638	Drug	escitalopram	EXC	
21.txt	NCT00551161	Measurement	creatinine clearance	EXC	has_value:< 35 mL/min;
21.txt	NCT01119638	Condition	contraindications	EXC	
21.txt	NCT00678431	Condition	liver disease	EXC	modified_by:Active;
21.txt	NCT00678431	Measurement	serum transaminase	EXC	modified_by:persistent elevation;
21.txt	NCT00678431	Condition	renal disease	EXC	modified_by:Severe;
21.txt	NCT00551161	Condition	neurological disorders	EXC	has_TempMea:within the past five years;modified_by:other;
21.txt	NCT00857649	Condition	dementia	INC	modified_by:moderate to severe;
21.txt	NCT00678431	Condition	diabetes mellitus	EXC	
21.txt	NCT00857649	Condition	dementia of the Alzheimer's type	INC	
21.txt	NCT00551161	Measurement	diastolic blood pressure	EXC	modified_by:sitting;has_value:greater than 100 mm Hg or less than 50 mm Hg;
21.txt	NCT00857649	Condition	National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association ( NINDS-ADRDA ) criteria	INC	
21.txt	NCT00857649	Condition	Alzheimer's Disease ( AD )	INC	modified_by:probable;
21.txt	NCT00551161	Condition	Alzheimer's disease	EXC	is_negated:inconsistent;modified_by:probable;
21.txt	NCT00551161	Procedure	brain scan	EXC	
21.txt	NCT00456417	Condition	National Institute of Neurological and Communicative Disorders and Stroke/Alzheimer's Disease and Related Disorders Association ( NINCDS/ADRDA ) criteria	INC	
21.txt	NCT00551161	Procedure	MRI	EXC	
21.txt	NCT00456417	Measurement	Mini-Mental Status Exam score	INC	has_value:> 16 and < 25;
21.txt	NCT00551161	Measurement	modified Hachinski ischemia score	EXC	has_value:greater than 4;
21.txt	NCT00678431	Measurement	blood glucose	EXC	has_value:> 150 mg/dl;
21.txt	NCT00456417	Condition	Alzheimer's disease	INC	
21.txt	NCT00678431	Condition	neoplastic disease	EXC	modified_by:Active;
21.txt	NCT00678431	Condition	skin tumors	EXC	
21.txt	NCT00678431	Condition	melanoma	EXC	is_negated:other than;
21.txt	NCT00551161	Condition	disease	EXC	modified_by:active;
21.txt	NCT00551161	Condition	oncological diagnosis	EXC	has_TempMea:currently;
21.txt	NCT00551161	Condition	hematological or solid tumor	EXC	
21.txt	NCT00456417	Measurement	Geriatric Depression Scales ( GDS )	INC	has_value:<= 10;
21.txt	NCT00551161	Procedure	CT	EXC	
21.txt	NCT00456417	Measurement	Modified Hachinski Ischemia Scale score	INC	has_value:<= 4;
21.txt	NCT00551161	Condition	schizoaffective disorder	EXC	
21.txt	NCT00857649	Condition	vascular dementia	INC	is_negated:not;
21.txt	NCT00551161	Condition	bipolar disorder	EXC	
21.txt	NCT00678431	Condition	prostate cancer	EXC	modified_by:stable;
21.txt	NCT00857649	Measurement	modified Hachinski Ischaemia Scale score	INC	has_value:> 4;is_negated:not;
21.txt	NCT00678431	Condition	cancers	EXC	modified_by:other;modified_by:stable;
21.txt	NCT00678431	Drug	investigational agent	EXC	has_TempMea:within 2 months;modified_by:another;
21.txt	NCT00551161	Condition	organic disease	EXC	modified_by:other;
21.txt	NCT00678431	Condition	stroke	EXC	modified_by:clinically significant;
21.txt	NCT00551161	Condition	dementia	EXC	
21.txt	NCT00857649	Condition	neurological disorders	EXC	modified_by:other;
21.txt	NCT00857649	Drug	memantine	EXC	has_TempMea:previous;
21.txt	NCT00551161	Condition	panic disorder	EXC	modified_by:current;
21.txt	NCT00857649	Condition	disease	EXC	modified_by:active;modified_by:clinically significant;
21.txt	NCT00551161	Condition	post-traumatic stress disorder	EXC	modified_by:current;
21.txt	NCT00551161	Condition	major depressive episode	EXC	modified_by:current;
21.txt	NCT00551161	Condition	psychosis	EXC	modified_by:current;
22.txt	NCT00087789	Procedure	investigational devices	EXC	has_TempMea:30 days;
22.txt	NCT00087789	Procedure	surgery	EXC	
22.txt	NCT00087789	Drug	investigational agents	EXC	has_TempMea:30 days;
22.txt	NCT00087789	Drug	Prozac or Ginkgo biloba	EXC	has_TempMea:within 14 days;
22.txt	NCT00087789	Drug	aspirin	EXC	has_TempMea:within 14 days;
22.txt	NCT00087789	Drug	gene transfer products	EXC	
22.txt	NCT00087789	Measurement	Hamilton Depression Scale score	INC	has_value:<= 12;
22.txt	NCT00087789	Drug	acetylcholinesterase inhibitors	INC	
22.txt	NCT00087789	Condition	Alzheimer's disease	INC	
22.txt	NCT00087789	Drug	standard-of-care medications	INC	has_TempMea:3 months;modified_by:stable;
22.txt	NCT00087789	Condition	depressive episode	INC	modified_by:major;has_TempMea:within the last 2 years;is_negated:no;
22.txt	NCT00087789	Procedure	MRI	EXC	is_negated:cannot;
22.txt	NCT00087789	Procedure	PET	EXC	is_negated:cannot;
22.txt	NCT01428453	Drug	low-molecular-weight heparin	EXC	
22.txt	NCT00087789	Condition	subdural hematoma	INC	
22.txt	NCT01428453	Condition	cutaneous or soft tissue infection	EXC	
22.txt	NCT00087789	Condition	generalized lesions	INC	
22.txt	NCT01428453	Condition	coagulation disorders	EXC	modified_by:other;
22.txt	NCT01428453	Drug	coumarin-derived anti-coagulants	EXC	
22.txt	NCT00087789	Condition	focal	INC	modified_by:other;
22.txt	NCT01428453	Condition	Thrombocytopenia	EXC	
22.txt	NCT00087789	Condition	tumor	INC	modified_by:negative;
22.txt	NCT00087789	Condition	infarction	INC	modified_by:negative;
22.txt	NCT01428453	Procedure	lumbar puncture	EXC	
22.txt	NCT01428453	Procedure	insertion of CSF catheter	EXC	
22.txt	NCT00087789	Condition	infection	INC	modified_by:negative;
22.txt	NCT01428453	Procedure	lumbar puncture	EXC	
22.txt	NCT01428453	Procedure	spinal surgery	EXC	has_TempMea:Previous;
22.txt	NCT00087789	Condition	ntervening neurological disease	INC	is_negated:without;
22.txt	NCT00087789	Condition	v hydrocephalus	INC	
22.txt	NCT00087789	Condition	health	INC	modified_by:Good;
22.txt	NCT00087789	Measurement	visual and auditory acuity	INC	modified_by:Adequate;
22.txt	NCT00087789	Condition	Beck Depression Inventory	INC	has_value:< 15;
22.txt	NCT00087789	Condition	medical or psychological conditions	INC	modified_by:clinically significant;is_negated:no;
22.txt	NCT00087789	Procedure	MRI	INC	
22.txt	NCT01428453	Condition	contraindication	EXC	
22.txt	NCT01428453	Measurement	isolated bilirubin	EXC	has_value:> 1.5x ULN;
22.txt	NCT00469456	Condition	AD	EXC	is_negated:not;
22.txt	NCT01428453	Measurement	bilirubin	EXC	has_value:> 1.5X ULN;
22.txt	NCT00087789	Measurement	ALT	EXC	
22.txt	NCT00469456	Procedure	imaging results	EXC	has_TempMea:Previous;
22.txt	NCT01428453	Measurement	Alkaline phosphatase ( AP )	EXC	has_value:> 1.5X ULN;
22.txt	NCT00087789	Measurement	Liver serum transaminases	EXC	has_value:> 5 times the upper limit of normal;
22.txt	NCT00469456	Condition	AD	EXC	is_negated:other than;
22.txt	NCT00087789	Measurement	AST	EXC	
22.txt	NCT00087789	Condition	alcohol abuse or dependence	EXC	has_TempMea:within the last two years;
22.txt	NCT00469456	Condition	Axis I disorder	EXC	has_TempMea:Current;
22.txt	NCT01428453	Measurement	creatinine clearance	EXC	has_value:< 30 ml/min;
22.txt	NCT01428453	Measurement	direct bilirubin	EXC	has_value:< 35%;
22.txt	NCT00469456	Measurement	Modified Hachinski Ischemia Score	EXC	has_value:greater than 4;
22.txt	NCT00087789	Measurement	hemoglobin	EXC	has_value:< 9mg/dL;
22.txt	NCT00087789	Measurement	total and/or direct bilirubin	EXC	has_value:> 1.5 mg/dL;
22.txt	NCT00469456	Condition	AD	INC	modified_by:probable;
22.txt	NCT00469456	Condition	National Institute of Neurological and Communicative Disorders and Stroke--Alzheimer's Disease and Related Disorders Association ( NINCDS-ADRDA ) criteria	INC	
22.txt	NCT00087789	Condition	cancer	EXC	has_TempMea:within the last five years;
22.txt	NCT01428453	Measurement	intracranial pressure	EXC	modified_by:increased;
22.txt	NCT01428453	Condition	cerebral mass	EXC	
22.txt	NCT00087789	Measurement	syphilis antibody test	INC	modified_by:negative;
22.txt	NCT00087789	Measurement	serum B12, thyroid function tests	INC	modified_by:Normal;
22.txt	NCT01428453	Measurement	aspartate transaminase ( AST )	EXC	has_value:> 1.5 x the upper limit of normal ( ULN );
22.txt	NCT00087789	Condition	basal or squamous cell skin cancer	EXC	is_negated:except;
22.txt	NCT00469456	Measurement	Mini Mental State Examination ( MMSE ) score	INC	has_value:10 to 19;
22.txt	NCT00087789	Condition	cervical carcinoma in situ	EXC	is_negated:except;
22.txt	NCT01428453	Condition	hypothyroidism	EXC	
22.txt	NCT00814697	Observation	Controlled Word Association ( CFL ) Category Naming	INC	has_value:below 50%;
22.txt	NCT01428453	Condition	thyroid dysfunction	EXC	modified_by:active;
22.txt	NCT01428453	Condition	neurosyphilis	EXC	is_negated:ruled out;
22.txt	NCT00814697	Observation	60 item naming section of the Boston Diagnostic Aphasia	INC	has_value:at or below 30;
22.txt	NCT00087789	Condition	medical condition ( s )	EXC	modified_by:severe;modified_by:unstable;
22.txt	NCT01428453	Drug	immunosuppressants	EXC	has_TempMea:within the last 30 days;modified_by:other;
22.txt	NCT00814697	Condition	Alzheimer's disease	INC	modified_by:probable or possible;
22.txt	NCT01428453	Measurement	syphilis serology	EXC	modified_by:positive;
22.txt	NCT01428453	Drug	systemic steroids	EXC	has_TempMea:within the last 30 days;
22.txt	NCT01428453	Condition	dementia	EXC	
22.txt	NCT01428453	Drug	phenothiazines	EXC	has_TempMea:Current;
22.txt	NCT00087789	Drug	narcotic analgesics	EXC	has_TempMea:within 14 days;has_value:more frequently than two times per week;
22.txt	NCT00087789	Drug	benzodiazepines	EXC	modified_by:long-acting;has_TempMea:within 14 days;has_value:more frequently than two times per week;
22.txt	NCT01428453	Drug	MAO inhibitors	EXC	has_TempMea:Current;
22.txt	NCT00087789	Drug	antipsychotics	EXC	has_value:more frequently than two times per week;has_TempMea:within 14 days;
22.txt	NCT01428453	Measurement	serum levels of thyroid stimulating hormone ( TSH )	EXC	modified_by:abnormally high or low;
22.txt	NCT01428453	Drug	butyrophenones	EXC	has_TempMea:Current;
22.txt	NCT00814697	Procedure	pacemakers	EXC	is_negated:not;
22.txt	NCT00087789	Drug	neuroleptics	EXC	has_value:more frequently than two times per week;has_TempMea:within 14 days;
22.txt	NCT00814697	Condition	AD	EXC	has_TempMea:newly;
22.txt	NCT00087789	Drug	anti-Parkinsonian medications	EXC	has_value:more frequently than two times per week;has_TempMea:within 14 days;
22.txt	NCT01428453	Drug	barbiturates	EXC	has_TempMea:Current;
22.txt	NCT00087789	Drug	psychostimulants	EXC	has_value:more frequently than two times per week;has_TempMea:within 14 days;
22.txt	NCT00087789	Drug	Centrally active beta-blockers	EXC	has_TempMea:within 14 days;has_value:more frequently than two times per week;
22.txt	NCT01428453	Measurement	physical	EXC	
22.txt	NCT01428453	Measurement	laboratory	EXC	
22.txt	NCT00469456	Condition	alcohol or drug abuse	EXC	has_TempMea:in the past 5 years;
22.txt	NCT00087789	Measurement	serology for HBV or HCV	EXC	modified_by:positive;
22.txt	NCT01428453	Procedure	ECG examination	EXC	
22.txt	NCT00469456	Condition	systemic disease	EXC	modified_by:Clinically significant;
22.txt	NCT01428453	Condition	abnormality	EXC	modified_by:clinically significant;modified_by:Other;
22.txt	NCT00469456	Condition	neurologic disorders	EXC	modified_by:other;
22.txt	NCT00087789	Measurement	PT and PTT	EXC	has_value:> 2 times the upper limit of normal;
22.txt	NCT00087789	Measurement	creatinine clearance	EXC	has_value:< 30 mL/min;
22.txt	NCT00469456	Drug	commercial memantine	EXC	has_TempMea:Previous;
22.txt	NCT01428453	Condition	vitamin B12 deficiency	EXC	has_TempMea:current;
22.txt	NCT01428453	Procedure	surgery	EXC	modified_by:major;has_TempMea:within the study period;modified_by:Planned;
22.txt	NCT00087789	Condition	systemic illness	EXC	modified_by:significant;
22.txt	NCT01428453	Measurement	neurological	EXC	
22.txt	NCT00469456	Condition	medication	EXC	modified_by:excluded;
22.txt	NCT00087789	Measurement	platelet count	EXC	has_value:< 100000/mm3;
22.txt	NCT01428453	Condition	depression	EXC	has_TempMea:current;modified_by:active;
22.txt	NCT00087789	Measurement	absolute neutrophil count	EXC	has_value:< 1500 cells/mm3;
22.txt	NCT01428453	Condition	intracerebral haemorrhage	EXC	
22.txt	NCT00814697	Condition	depression	EXC	modified_by:uncontrolled;is_negated:not;
22.txt	NCT01428453	Condition	condition	EXC	modified_by:other;
22.txt	NCT01428453	Condition	coagulopathy	EXC	
22.txt	NCT01428453	Drug	hypnotics	EXC	modified_by:other;modified_by:stable dose;has_TempMea:at least 2 months;
22.txt	NCT01428453	Condition	CNS vasculitis	EXC	
22.txt	NCT01428453	Condition	non-ST-elevation MI	EXC	
22.txt	NCT01428453	Drug	modafinil	EXC	
22.txt	NCT00814697	Procedure	rTMS	EXC	
22.txt	NCT00087789	Drug	Warfarin	EXC	has_TempMea:within 14 days;
22.txt	NCT01428453	Measurement	cardiac enzyme elevation	EXC	
22.txt	NCT01428453	Drug	potent Pgp inhibitors	EXC	has_TempMea:Current;
22.txt	NCT00034762	Condition	dementia of the Alzheimer's type	INC	
22.txt	NCT00087789	Drug	coumadin	EXC	
22.txt	NCT01428453	Condition	cardiovascular event	EXC	has_TempMea:Recent;has_TempMea:< 6 months;
22.txt	NCT01428453	Drug	ketoconazole	EXC	
22.txt	NCT01428453	Condition	ST-elevation MI	EXC	
22.txt	NCT01428453	Drug	rifampin	EXC	
22.txt	NCT00814697	Condition	medical condition	EXC	modified_by:other;
22.txt	NCT00087789	Condition	cholinergic or anticholinergic side effects	EXC	modified_by:significant;
22.txt	NCT00814697	Condition	epilepsy	EXC	is_negated:not;
22.txt	NCT01428453	Drug	potent inhibitors of CYP3A4	EXC	has_TempMea:Current;
22.txt	NCT00814697	Condition	implanted metal objects	EXC	is_negated:not;
22.txt	NCT00087789	Drug	medication	EXC	modified_by:Other;
22.txt	NCT00814697	Condition	migraines	EXC	is_negated:not;
22.txt	NCT00087789	Drug	standard treatment	EXC	modified_by:initiation or change in dose;
22.txt	NCT00814697	Condition	seizures	EXC	is_negated:not;
22.txt	NCT00087789	Condition	Alzheimer's disease	EXC	
22.txt	NCT01428453	Condition	contributing factor to dementia	EXC	
22.txt	NCT01428453	Drug	MAO inhibitors	EXC	is_negated:other than;
22.txt	NCT01428453	Drug	antidepressants	EXC	
22.txt	NCT00087789	Drug	anxiolytics	EXC	modified_by:short-acting;has_TempMea:within 14 days;has_value:more frequently than two times per week;
22.txt	NCT01428453	Condition	alcohol or other substance abuse	EXC	
22.txt	NCT01428453	Drug	"conventional" antipsychotic	EXC	modified_by:other;has_TempMea:within 30 days or 5 half-lives;
22.txt	NCT00087789	Drug	barbiturates	EXC	has_TempMea:within 14 days;has_value:more frequently than two times per week;
22.txt	NCT01428453	Condition	DSM-IV criteria	EXC	
22.txt	NCT00087789	Drug	hypertensive agents	EXC	has_TempMea:within 14 days;has_value:more frequently than two times per week;
22.txt	NCT00811122	Condition	cognitively impaired	INC	is_negated:not;
22.txt	NCT00811122	Condition	complaint of memory loss	INC	is_negated:without;
22.txt	NCT00811122	Measurement	neuropsychological test	INC	
22.txt	NCT00811122	Measurement	Modified Mini-Mental State Examination	INC	
22.txt	NCT01428453	Condition	hypertension	EXC	modified_by:uncontrolled;
22.txt	NCT01428453	Drug	sedatives	EXC	modified_by:other;modified_by:stable dose;has_TempMea:at least 2 months;
22.txt	NCT00087789	Condition	cholinergic side effects	EXC	modified_by:significant;
22.txt	NCT00811122	Measurement	3MS-R	INC	
22.txt	NCT01428453	Condition	cerebral arteriovenous malformation	EXC	
22.txt	NCT00087789	Drug	tricyclics	EXC	
22.txt	NCT00811122	Condition	FTD	INC	
22.txt	NCT01428453	Condition	cerebral amyloid angiopathy	EXC	
22.txt	NCT01428453	Drug	risperidone	EXC	
22.txt	NCT00087789	Drug	antidepressants	EXC	
22.txt	NCT00811122	Condition	FTD	INC	
22.txt	NCT01428453	Drug	benzodiazepines	EXC	
22.txt	NCT00814697	Drug	medications	EXC	is_negated:not;
22.txt	NCT01428453	Drug	thyroid hormones	EXC	
22.txt	NCT00087789	Drug	herbal products	EXC	
22.txt	NCT00811122	Condition	AD	INC	
22.txt	NCT01428453	Condition	intra cerebral haemorrhage	EXC	
22.txt	NCT01428453	Drug	atypical antipsychotics	EXC	
22.txt	NCT00087789	Condition	Alzheimer's disease	EXC	
22.txt	NCT00087789	Drug	sedative hypnotics	EXC	has_value:more frequently than two times per week;has_TempMea:within 14 days;
22.txt	NCT01428453	Procedure	cognitive rehabilitation	EXC	has_TempMea:in the 6 months;
22.txt	NCT00087789	Condition	NINCDS/ADRDA criteria	INC	
22.txt	NCT01428453	Condition	hypertension	EXC	modified_by:Poorly controlled;
22.txt	NCT01428453	Drug	Investigational medications	EXC	has_TempMea:during the 60 days;
22.txt	NCT00087789	Measurement	modified Hachinski Ischemia Scale	INC	has_value:<= 4;
22.txt	NCT00811122	Condition	frontotemporal dementia	INC	
22.txt	NCT00811122	Condition	Neary criteria	INC	
22.txt	NCT00811122	Condition	NINCDS-ADRDA criteria	INC	
22.txt	NCT00811122	Condition	AD	INC	
22.txt	NCT00811122	Condition	AD	INC	modified_by:probable;
22.txt	NCT00811122	Condition	National Institute of Neurological and Communicative Disorders and Stroke ( NINCDS )	INC	
22.txt	NCT01428453	Measurement	QTcB interval	EXC	has_value:> 450 msec;
22.txt	NCT01428453	Drug	anti-amyloid monoclonal antibodies [mAbs]	EXC	is_negated:exception;
22.txt	NCT00087789	Procedure	surgery	INC	
22.txt	NCT00811122	Condition	AD	INC	
22.txt	NCT01428453	Measurement	QTcB	EXC	has_value:> 480 msec;
22.txt	NCT00087789	Procedure	MRI/PET imaging	INC	
22.txt	NCT00811122	Condition	associated cognitive symptoms	EXC	
22.txt	NCT01428453	Drug	pharmacotherapy	EXC	
22.txt	NCT01428453	Drug	investigational drug	EXC	
22.txt	NCT00087789	Condition	neurological or medical abnormalities	INC	is_negated:No;modified_by:significant;
22.txt	NCT00811122	Condition	Alzheimer's Disease and Related Disorders Association ( ADRDA )	INC	
22.txt	NCT00087789	Condition	contraindicating	INC	
22.txt	NCT01428453	Measurement	diastolic blood pressure	EXC	has_value:> 110mmHg;
22.txt	NCT01428453	Drug	investigational drug	EXC	has_TempMea:within 5 half-lives;
22.txt	NCT01428453	Measurement	systolic blood pressure	EXC	has_value:> 160mmHg;
22.txt	NCT01428453	Procedure	symptomatic AD treatment	EXC	
22.txt	NCT00087789	Measurement	Mini-Mental State Exam ( MMSE ) score	INC	has_value:range of 16 to 28, inclusive;
22.txt	NCT01428453	Drug	cyclosporin	EXC	
22.txt	NCT01428453	Procedure	percutaneous coronary intervention	EXC	
22.txt	NCT01428453	Procedure	coronary revascularization	EXC	
22.txt	NCT01428453	Drug	itraconazole	EXC	
22.txt	NCT00087789	Drug	nonsteroidal anti-inflammatory drugs	EXC	has_TempMea:within 14 days;
22.txt	NCT01428453	Procedure	ECG	EXC	modified_by:changes;
22.txt	NCT01428453	Drug	ketoconazole	EXC	
22.txt	NCT00034762	Measurement	BEHAVE-AD psychosis subscale	INC	has_value:2 or more;
22.txt	NCT00811122	Condition	transient ischemic attack ( TIA )	EXC	
22.txt	NCT00034762	Measurement	Mini-Mental State Examination ( MMSE ) score	INC	has_value:5 to 23;
22.txt	NCT01428453	Condition	cause of dementia	EXC	
22.txt	NCT00811122	Condition	stroke	EXC	
22.txt	NCT00811122	Condition	risk	EXC	modified_by:high;
22.txt	NCT00811122	Condition	head injury with loss of consciousness	EXC	
22.txt	NCT00811122	Condition	seizures	EXC	
22.txt	NCT01428453	Procedure	carotid surgery	EXC	has_TempMea:prior;
22.txt	NCT01428453	Drug	quinine	EXC	
22.txt	NCT00034762	Drug	risperidone	EXC	
22.txt	NCT01428453	Procedure	stenting procedure	EXC	has_TempMea:prior;
22.txt	NCT01428453	Drug	carvedilol	EXC	
22.txt	NCT00087789	Condition	Alzheimer's disease	INC	
22.txt	NCT01428453	Condition	resuscitated sudden death	EXC	
22.txt	NCT01428453	Drug	quinidine	EXC	
22.txt	NCT00034762	Condition	neuroleptic malignant syndrome	EXC	
22.txt	NCT00811122	Condition	depression	EXC	modified_by:treated;is_negated:other than;
22.txt	NCT01428453	Drug	bepridil	EXC	
22.txt	NCT00034762	Condition	hypersensitivity	EXC	
22.txt	NCT01428453	Condition	stroke	EXC	
22.txt	NCT01428453	Drug	verapamil	EXC	
22.txt	NCT00034762	Measurement	cognitive function	EXC	
22.txt	NCT01428453	Condition	etiology	EXC	
22.txt	NCT01428453	Drug	spironolactone	EXC	
22.txt	NCT01428453	Drug	loperamide	EXC	
22.txt	NCT01428453	Procedure	coronary artery bypass graft	EXC	
22.txt	NCT01428453	Drug	diltiazem	EXC	
22.txt	NCT00034762	Condition	Disease	EXC	
22.txt	NCT01428453	Condition	adult asthma	EXC	
22.txt	NCT01428453	Condition	reactive airway disease	EXC	
22.txt	NCT00811122	Condition	Axis I psychiatric diagnoses	EXC	
22.txt	NCT01428453	Condition	bronchospasm	EXC	has_TempMea:in the past 6 months;
22.txt	NCT01428453	Condition	suicide risk	EXC	modified_by:significant;
22.txt	NCT01428453	Condition	adverse events	EXC	modified_by:moderate;is_negated:not;
22.txt	NCT00811122	Condition	hypertension	EXC	modified_by:uncontrolled;
22.txt	NCT00811122	Condition	heart/liver/renal failure	EXC	modified_by:uncontrolled;
22.txt	NCT00811122	Measurement	serum glucose level	EXC	has_value:greater than 180 mg/dl;
22.txt	NCT01428453	Condition	allergic reaction	EXC	modified_by:severe;
22.txt	NCT01428453	Measurement	C-SSRS	EXC	has_value:type 4 or 5;
22.txt	NCT01428453	Condition	anaphylaxis	EXC	
22.txt	NCT01428453	Drug	anti-asthmatic medication ( s )	EXC	has_TempMea:currently;modified_by:regular;
22.txt	NCT01428453	Condition	suicidal ideation	EXC	has_TempMea:in the last 2 months;
22.txt	NCT01428453	Condition	suicidal behaviour	EXC	has_TempMea:in the last 6 months;
22.txt	NCT01428453	Drug	study agent	EXC	
22.txt	NCT01428453	Condition	bundle branch block	EXC	
22.txt	NCT00811122	Procedure	FDG-PET imaging	EXC	
22.txt	NCT00811122	Condition	conditions	EXC	modified_by:other;
22.txt	NCT01428453	Condition	AD	EXC	
22.txt	NCT01428453	Procedure	ECG	EXC	
22.txt	NCT00811122	Procedure	FDG-PET	EXC	
22.txt	NCT00811122	Condition	claustrophobic	EXC	
22.txt	NCT01428453	Procedure	Magnetic Resonance Imaging [MRI]	INC	
22.txt	NCT00811122	Procedure	11C PIB-PET imaging	EXC	
22.txt	NCT01428453	Procedure	Computed Tomography [CT]	INC	
22.txt	NCT01428453	Measurement	baseline eye exam	EXC	
22.txt	NCT01428453	Condition	Alzheimer's disease	INC	modified_by:possible;
22.txt	NCT01428453	Drug	mAb	EXC	has_TempMea:at least 5 half-lives;
22.txt	NCT01428453	Condition	glaucoma	EXC	
22.txt	NCT01428453	Condition	diabetes	EXC	modified_by:uncontrolled;
22.txt	NCT01428453	Drug	anti-amyloid mAbs	EXC	
22.txt	NCT01428453	Measurement	HbA1c	EXC	has_value:> 12.0;
22.txt	NCT01428453	Drug	investigational drug	EXC	
22.txt	NCT01428453	Drug	monoclonal antibody	EXC	has_TempMea:in the past;
22.txt	NCT01428453	Condition	National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders Association ( NINCDS-ADRDA ) criteria	INC	
22.txt	NCT01428453	Measurement	B surface antigen	EXC	
22.txt	NCT01428453	Condition	cerebrovascular disease ( CVD )	INC	modified_by:significant;has_TempMea:within the last 12 months;
22.txt	NCT01428453	Measurement	hepatitis C antibody	EXC	
22.txt	NCT01428453	Demographic	age	INC	has_value:between 50 and 80 years;
22.txt	NCT01428453	Condition	viral hepatitis	EXC	modified_by:chronic;
22.txt	NCT01428453	Measurement	Mini-Mental Status Examination ( MMSE ) score	INC	has_value:between 20 and 26;
22.txt	NCT01428453	Measurement	blood tests	EXC	modified_by:Abnormal;
22.txt	NCT01428453	Measurement	Alanine transaminase ( ALT )	EXC	has_value:> 1.5 x the upper limit of normal ( ULN );
22.txt	NCT01428453	Condition	hepatic disorders	EXC	modified_by:chronic;modified_by:other;
22.txt	NCT01428453	Drug	Alzheimer's disease therapy	INC	has_TempMea:at least 6 months;has_TempMea:ongoing;modified_by:stable dosing;
22.txt	NCT01428453	Drug	memantine	INC	
22.txt	NCT01428453	Drug	AChEIs	INC	
22.txt	NCT01428453	Condition	hypersensitivity	EXC	
22.txt	NCT01428453	Condition	same	EXC	has_TempMea:recent or remote;
22.txt	NCT01428453	Measurement	Clinical Dementia Rating Scale ( CDR ) score	INC	has_value:0.5 or 1.0;
22.txt	NCT00811122	Condition	FTD	INC	
22.txt	NCT00811122	Condition	medical conditions	EXC	has_TempMea:within five years;
22.txt	NCT01428453	Condition	anaemia	EXC	modified_by:clinically significant;
22.txt	NCT01428453	Measurement	haematology	EXC	
22.txt	NCT01428453	Measurement	urinalysis	EXC	
22.txt	NCT01428453	Condition	abnormalities	EXC	modified_by:Significant;
22.txt	NCT01428453	Measurement	clinical chemistry	EXC	
22.txt	NCT01428453	Measurement	bilirubin	EXC	modified_by:fractionated;
22.txt	NCT01428453	Condition	structural or developmental abnormality	EXC	
22.txt	NCT01428453	Condition	CNS disorder	EXC	modified_by:other;
22.txt	NCT01428453	Condition	infectious, degenerative or inflammatory/demyelinating CNS conditions	EXC	
22.txt	NCT01428453	Condition	epilepsy	EXC	
22.txt	NCT01428453	Condition	frontotemporal dementia	EXC	
22.txt	NCT01428453	Condition	Parkinson's disease	EXC	
22.txt	NCT00811122	Condition	AD	INC	
22.txt	NCT00811122	Drug	Cholinesterase inhibitors	INC	
22.txt	NCT00811122	Drug	memantine	INC	
22.txt	NCT00811122	Condition	AD	INC	
22.txt	NCT00811122	Drug	symptomatic drugs	INC	
22.txt	NCT00811122	Condition	Healthy	INC	
22.txt	NCT00811122	Condition	non-depressed	INC	
22.txt	NCT00811122	Condition	non-demented	INC	
22.txt	NCT01428453	Procedure	devices	EXC	has_TempMea:during the 60 days;
22.txt	NCT01428453	Condition	psychiatric illness	EXC	modified_by:significant;
22.txt	NCT01428453	Condition	bipolar affective disorder	EXC	
22.txt	NCT01428453	Condition	schizophrenia	EXC	
22.txt	NCT01428453	Condition	DSM-IV	EXC	
22.txt	NCT01428453	Condition	depressive disorder	EXC	has_TempMea:in the past year;modified_by:major;
23.txt	NCT00216515	Condition	disorders	EXC	modified_by:severe;
23.txt	NCT02073318	Observation	The International Statistical Classification of Diseases and Related Health Problems 10th Revision ( ICD- 10 )	INC	
23.txt	NCT01928420	Condition	non-excluded medication	INC	modified_by:Stable doses;
23.txt	NCT00216515	Drug	investigational drugs	EXC	has_TempMea:within the past 1 month;
23.txt	NCT00216515	Condition	diabetes mellitus	EXC	modified_by:uncontrolled;
23.txt	NCT00216515	Condition	allergy	EXC	
23.txt	NCT00216515	Condition	hypersensitivity	EXC	
23.txt	NCT01928420	Condition	OGTT criteria	EXC	
23.txt	NCT01928420	Drug	excluded antidiabetic medication	EXC	
23.txt	NCT01928420	Condition	Diabetes Mellitus	EXC	
23.txt	NCT01928420	Condition	hepatic insufficiency	INC	is_negated:No;
23.txt	NCT00216515	Drug	cholinesterase inhibitor	EXC	
23.txt	NCT02537496	Demographic	Age	INC	has_value:55 years or above;
23.txt	NCT02537496	Condition	AD	INC	modified_by:Probable;
23.txt	NCT01928420	Condition	NINCDS/ADRDA criteria	INC	
23.txt	NCT02537496	Drug	Cognitive enhancers	INC	has_TempMea:the last 3 months;modified_by:stable dose;
23.txt	NCT02537496	Condition	NIA-AA criteria	INC	
23.txt	NCT00439010	Condition	gastrointestinal, cardiovascular, hepatic, renal, hematological, neoplastic, endocrine, neurological, immunodeficiency, pulmonary or other disorder or disease	EXC	modified_by:clinically significant;
23.txt	NCT01928420	Drug	NMDA ( N-methyl-D-asparate ) antagonist	INC	modified_by:stable dose;has_TempMea:at least 12 weeks;
23.txt	NCT01928420	Drug	cholinesterase inhibitor	INC	modified_by:stable dose;has_TempMea:at least 12 weeks;
23.txt	NCT01928420	Condition	AD	INC	modified_by:probable;
23.txt	NCT01928420	Measurement	MMSE	INC	has_value:between 12 - 27;
23.txt	NCT02537496	Measurement	visual acuity	INC	modified_by:enough;modified_by:Corrected;
23.txt	NCT02537496	Demographic	Age	INC	has_value:55 or above;
23.txt	NCT02537496	Measurement	visual acuity	INC	modified_by:Corrected;
23.txt	NCT02537496	Condition	AD	EXC	
23.txt	NCT02537496	Condition	healthy	INC	
23.txt	NCT02537496	Measurement	MOCA score	EXC	has_value:< 10;
23.txt	NCT00216515	Demographic	aged	INC	has_value:50 years or older;
23.txt	NCT00216515	Condition	Alzheimer's disease	INC	
23.txt	NCT00216515	Condition	DSM-IV15	INC	
23.txt	NCT00216515	Condition	NINCDS-ADRDA16	INC	
23.txt	NCT00216515	Measurement	standard MMSE-K	INC	has_value:10 to 26;
23.txt	NCT00216515	Condition	Dementia	INC	
23.txt	NCT00216515	Drug	AChEI	EXC	
23.txt	NCT02537496	Condition	DSM IV - TR	EXC	
23.txt	NCT02537496	Condition	mood disorder	EXC	has_TempMea:in the last 3 months;has_TempMea:current;
23.txt	NCT02537496	Condition	DSM IV - TR	EXC	
23.txt	NCT02537496	Condition	DSM IV - TR	EXC	
23.txt	NCT02537496	Condition	DSM IV - TR	EXC	
23.txt	NCT02537496	Condition	anxiety disorder	EXC	has_TempMea:in the last 3 months;has_TempMea:current;
23.txt	NCT00948766	Drug	rivastigmine patch	EXC	modified_by:dose;has_TempMea:current;
23.txt	NCT00948766	Drug	Peripheral anticholinergics	EXC	has_TempMea:during the previous 4 weeks;modified_by:stable dose;
23.txt	NCT02073318	Condition	dementia	INC	
23.txt	NCT02073318	Condition	Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition ( DSM-IV )	INC	
23.txt	NCT01928420	Drug	treatment	EXC	has_TempMea:current;
23.txt	NCT01928420	Condition	CHF	EXC	
23.txt	NCT01928420	Condition	congestive heart failure	EXC	
23.txt	NCT01928420	Condition	Cardiac disease	EXC	
23.txt	NCT01928420	Condition	hepatic or renal disease	EXC	modified_by:Active;
23.txt	NCT01928420	Condition	myocardial infarction	EXC	has_TempMea:recent;
23.txt	NCT02073318	Condition	stroke	EXC	has_TempMea:Recent;
23.txt	NCT02073318	Condition	neuromuscular or musculoskeletal disease	EXC	modified_by:Other;
23.txt	NCT02073318	Condition	exercise contraindications	EXC	modified_by:other;
23.txt	NCT02073318	Condition	cardiopulmonary disease	EXC	
23.txt	NCT02073318	Procedure	orthopedic surgery	EXC	has_TempMea:Recent;
23.txt	NCT01928420	Condition	hypoglycemia	EXC	
23.txt	NCT02073318	Condition	fracture	EXC	has_TempMea:Recent;
23.txt	NCT00948766	Condition	vascular dementia	EXC	modified_by:probable or possible;has_TempMea:current;
23.txt	NCT02537496	Condition	neurodevelopmental disorder	EXC	
23.txt	NCT02537496	Procedure	Electroconvulsive Therapy treatment	EXC	
23.txt	NCT01928420	Condition	bipolar disorder	EXC	
23.txt	NCT02537496	Condition	intellectual disability	EXC	
23.txt	NCT01928420	Condition	major depressive episode	EXC	
23.txt	NCT01928420	Condition	mental illness	EXC	has_TempMea:within the past two years;modified_by:Major;
23.txt	NCT02537496	Condition	primary psychotic disorder	EXC	has_TempMea:current;has_TempMea:lifetime;
23.txt	NCT01928420	Condition	psychotic disorders	EXC	
23.txt	NCT02537496	Condition	febrile seizure	EXC	is_negated:other than;
23.txt	NCT01928420	Drug	sulfonylureas	EXC	
23.txt	NCT01928420	Drug	meglintinides	EXC	
23.txt	NCT02537496	Condition	seizure	EXC	has_TempMea:infancy;
23.txt	NCT01928420	Drug	oral hypoglycemic agents	EXC	has_TempMea:Current;
23.txt	NCT01928420	Condition	stroke	EXC	modified_by:clinically significant;
23.txt	NCT01928420	Drug	investigational drug	EXC	modified_by:another;has_TempMea:within the past two months;
23.txt	NCT02537496	Condition	substance use disorder	EXC	has_TempMea:in the last 3 months;has_TempMea:current;
23.txt	NCT01928420	Condition	seizure	EXC	has_TempMea:within the past two years;
23.txt	NCT01928420	Condition	head trauma with disturbance of consciousness	EXC	has_TempMea:within the past two years;
23.txt	NCT02537496	Drug	Psychotropic medication	EXC	has_TempMea:at least 4 weeks;modified_by:stable dose;
23.txt	NCT02537496	Condition	neurological disorder	EXC	modified_by:other;
23.txt	NCT00948766	Condition	AD	EXC	is_negated:other than;
23.txt	NCT02537496	Condition	Adjustment disorder	EXC	is_negated:other than;
23.txt	NCT00948766	Condition	medical or neurological condition	EXC	has_TempMea:current;
23.txt	NCT00948766	Condition	sick-sinus syndrome	EXC	
23.txt	NCT02537496	Drug	hypnotics	EXC	is_negated:except;
23.txt	NCT00948766	Condition	urinary obstruction	EXC	modified_by:Clinically significant;
23.txt	NCT00948766	Condition	bradycardia	EXC	
23.txt	NCT02537496	Drug	sedative	EXC	is_negated:except;
23.txt	NCT02537496	Procedure	TMS	EXC	
23.txt	NCT02537496	Drug	Benzodiazepines	EXC	has_TempMea:Currently;
23.txt	NCT02537496	Condition	contraindication	EXC	
23.txt	NCT01928420	Drug	drugs with significant anticholinergic or antihistaminic properties	EXC	has_TempMea:Current;
23.txt	NCT02537496	Drug	Anticonvulsants	EXC	has_TempMea:Currently;
23.txt	NCT01928420	Drug	insulin	EXC	has_TempMea:past;has_value:longer than two weeks;has_TempMea:Current;
23.txt	NCT00216515	Drug	Tacrine	EXC	
23.txt	NCT00216515	Drug	Rivastigmine	EXC	
23.txt	NCT00216515	Drug	Donepezil	EXC	
23.txt	NCT00216515	Drug	drug	EXC	has_TempMea:within 15 days;
23.txt	NCT00216515	Condition	dementia	EXC	
23.txt	NCT00216515	Condition	Neurodegenerative diseases	EXC	
23.txt	NCT02537496	Condition	simple phobias	EXC	is_negated:other than;
23.txt	NCT00216515	Condition	Pick's disease	EXC	
23.txt	NCT02537496	Condition	healthy	EXC	
23.txt	NCT00948766	Condition	National Institute of Neurological Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association ( NINCDS/ADRDA ) criteria	INC	
23.txt	NCT00216515	Condition	Parkinson's disease	EXC	
23.txt	NCT02537496	Condition	DSM IV - TR	EXC	
23.txt	NCT00948766	Measurement	Mini-Mental State Examination ( MMSE ) score	INC	has_value:>= 3 and <= 12;
23.txt	NCT00948766	Condition	Alzheimer's disease ( AD )	INC	modified_by:probable;
23.txt	NCT00216515	Condition	Huntington's disease	EXC	
23.txt	NCT02537496	Condition	medical condition/circumstances	EXC	modified_by:other;
23.txt	NCT00439010	Condition	Alzheimer's diseas	INC	
23.txt	NCT02537496	Condition	medical condition/circumstances	EXC	modified_by:other;
23.txt	NCT00948766	Drug	cholinergic compounds	EXC	modified_by:other;
23.txt	NCT00948766	Drug	Succinylcholine-type muscle relaxants	EXC	has_TempMea:during the previous 2 weeks;
23.txt	NCT00216515	Condition	Dementia	EXC	
23.txt	NCT00216515	Condition	Down syndrome	EXC	
23.txt	NCT00216515	Condition	dementia	EXC	
23.txt	NCT00216515	Condition	head trauma	EXC	
23.txt	NCT00216515	Condition	cerebral hypoxia	EXC	
23.txt	NCT00216515	Condition	brain damage	EXC	
23.txt	NCT00216515	Procedure	cardiopulmonary resuscitation	EXC	
23.txt	NCT00948766	Condition	major organ system toxicity	EXC	
23.txt	NCT00948766	Condition	cardiovascular disease	EXC	modified_by:unstable;has_TempMea:current;modified_by:severe;
23.txt	NCT00216515	Condition	hypoxic brain damage	EXC	
23.txt	NCT00216515	Procedure	surgery	EXC	
23.txt	NCT00216515	Condition	hypoxic brain damage	EXC	
23.txt	NCT00439010	Measurement	Geriatric Depression Scales ( GDS )	INC	has_value:<= 10;
23.txt	NCT00948766	Drug	drug	EXC	has_TempMea:during the previous 4 weeks;
23.txt	NCT00439010	Measurement	Modified Hachinski Ischemia Scale score	INC	has_value:<= 4;
23.txt	NCT00948766	Drug	investigational drug	EXC	has_TempMea:during the previous 4 weeks;
23.txt	NCT00439010	Condition	National Institute of Neurological and Communicative Disorders and Stroke/Alzheimer's Disease and Related Disorders Association ( NINCDS/ADRDA ) criteria	INC	
23.txt	NCT00439010	Measurement	Mini-Mental Status Exam score	INC	has_value:< 25;
23.txt	NCT00948766	Drug	Lithium	EXC	has_TempMea:during the previous 2 weeks;
23.txt	NCT00948766	Condition	malignancy	EXC	has_TempMea:within the past 5 years;
23.txt	NCT02537496	Condition	febrile seizure	EXC	is_negated:other than;
23.txt	NCT00948766	Condition	conduction defects	EXC	
23.txt	NCT02537496	Condition	seizure	EXC	has_TempMea:infancy;
23.txt	NCT00216515	Condition	hypoxic brain damage	EXC	
23.txt	NCT00216515	Condition	hypoxic brain damage	EXC	
23.txt	NCT00216515	Condition	addiction	EXC	
23.txt	NCT00216515	Condition	brain tumor	EXC	
23.txt	NCT00216515	Condition	shock	EXC	
23.txt	NCT00216515	Condition	meningitis	EXC	
23.txt	NCT00216515	Condition	nerve syphilis	EXC	
23.txt	NCT00216515	Condition	brain tumor	EXC	
23.txt	NCT02537496	Procedure	TMS	EXC	
23.txt	NCT00948766	Drug	rivastigmine	EXC	
23.txt	NCT00216515	Condition	encephalitis	EXC	
23.txt	NCT00948766	Drug	drugs	EXC	
23.txt	NCT02537496	Drug	Benzodiazepines	EXC	has_TempMea:Currently;
23.txt	NCT00948766	Condition	skin lesion/disorder	EXC	modified_by:active;has_TempMea:Current;
23.txt	NCT00216515	Condition	amentia	EXC	
23.txt	NCT02537496	Condition	contraindication	EXC	
23.txt	NCT00948766	Condition	exaggerated pharmacological sensitivity or hypersensitivity	EXC	
23.txt	NCT02537496	Drug	Anticonvulsants	EXC	has_TempMea:Currently;
23.txt	NCT00439010	Measurement	laboratory value	EXC	modified_by:clinically significant;modified_by:abnormal;
23.txt	NCT00948766	Drug	memantine	EXC	modified_by:stable;has_TempMea:at least 3 months;
23.txt	NCT00216515	Condition	epilepsy	EXC	
23.txt	NCT00216515	Condition	psychiatric	EXC	modified_by:major;
23.txt	NCT00216515	Condition	schizophrenia	EXC	
23.txt	NCT00216515	Condition	major depression	EXC	
23.txt	NCT00216515	Condition	peptic ulcer	EXC	
23.txt	NCT00216515	Condition	treatment-resistant gastric	EXC	
23.txt	NCT00216515	Condition	hepatic, renal, lung, endocrinal or metabolic disease	EXC	modified_by:clinically serious;
23.txt	NCT00439010	Measurement	excretion	EXC	
23.txt	NCT00439010	Measurement	absorption distribution	EXC	
23.txt	NCT00948766	Drug	Selegiline	EXC	modified_by:stable dose;has_TempMea:during the previous 4 weeks;
23.txt	NCT00439010	Measurement	metabolism	EXC	
23.txt	NCT00439010	Condition	disorder	EXC	
23.txt	NCT00948766	Drug	tricyclic and tetracyclic antidepressants	EXC	
23.txt	NCT00439010	Procedure	gastrointestinal surgery	EXC	
23.txt	NCT00948766	Drug	approved treatments	EXC	modified_by:other;has_TempMea:during the previous 2 weeks;
23.txt	NCT00439010	Condition	medical or psychiatric illness	EXC	modified_by:clinically significant;modified_by:unstable;
23.txt	NCT00948766	Drug	anticholinergic drugs	EXC	
23.txt	NCT00948766	Drug	Rivastigmine	EXC	modified_by:transdermal patch;modified_by:oral;has_TempMea:during the previous 2 weeks;
23.txt	NCT00439010	Condition	non-child bearing potential	INC	
23.txt	NCT00216515	Condition	thyroid	EXC	
23.txt	NCT00216515	Condition	pituitary	EXC	
23.txt	NCT00948766	Drug	donepezil	EXC	has_TempMea:during the previous 2 weeks;
23.txt	NCT00216515	Condition	parathyroid	EXC	
23.txt	NCT00948766	Drug	galantamine	EXC	has_TempMea:during the previous 2 weeks;
23.txt	NCT00216515	Condition	diabetes mellitus	EXC	
23.txt	NCT00216515	Condition	renal failure	EXC	
23.txt	NCT00216515	Procedure	heart surgery	EXC	has_TempMea:within 6 months;
23.txt	NCT00216515	Condition	myocardial infarction	EXC	
23.txt	NCT00439010	Condition	cerebrovascular disease	EXC	modified_by:significant;
23.txt	NCT00216515	Condition	congestive heart failure	EXC	modified_by:untreated;
23.txt	NCT00948766	Drug	pyridostigmine	EXC	
23.txt	NCT00948766	Condition	Alzheimer's disease	EXC	
23.txt	NCT00439010	Condition	Parkinson's disease	EXC	
23.txt	NCT00948766	Drug	tacrine	EXC	
23.txt	NCT00439010	Condition	diffuse Lewy body dementia	EXC	
23.txt	NCT00948766	Drug	physostigmine	EXC	
23.txt	NCT00439010	Measurement	urine or blood pregnancy test	INC	modified_by:negative;
23.txt	NCT00439010	Condition	neurodegenerative disease	EXC	
23.txt	NCT00948766	Drug	cholinesterase inhibitors	EXC	modified_by:other;has_TempMea:during the previous 2 weeks;
3.txt	NCT01827982	Condition	sterilized	INC	
3.txt	NCT01827982	Condition	postmenopausal	INC	
3.txt	NCT01827982	Demographic	age	INC	has_value:between 55 and 75 years;has_value:inclusive;
3.txt	NCT02008357	Condition	alcohol or drug abuse/dependence	EXC	has_TempMea:within the past 5 years;modified_by:chronic;
3.txt	NCT01827982	Demographic	Male	INC	
3.txt	NCT01827982	Condition	medical or psychiatric illness	EXC	modified_by:Clinically significant;
3.txt	NCT01827982	Condition	Alcohol or substance abuse	EXC	
3.txt	NCT02434393	Demographic	age	INC	has_value:65+ years;
3.txt	NCT02434393	Condition	Major Depressive Disorder	INC	
3.txt	NCT02434393	Condition	unipolar type	INC	
3.txt	NCT02008357	Condition	DSM	EXC	
3.txt	NCT02434393	Condition	DSM-IV	INC	
3.txt	NCT01827982	Condition	nicotine or caffeine use	EXC	modified_by:excessive;
3.txt	NCT01827982	Drug	vaccine	EXC	
3.txt	NCT01827982	Drug	investigational drug	EXC	
3.txt	NCT02008357	Condition	toxic epidermal necrolysis	EXC	
3.txt	NCT01827982	Procedure	invasive medical device	EXC	
3.txt	NCT02008357	Condition	erythema multiforme major	EXC	
3.txt	NCT02008357	Condition	linear immunoglobulin A dermatosis	EXC	
3.txt	NCT01827982	Condition	bleeding of unclear origin or of blood clotting	EXC	modified_by:prolonged;modified_by:severe;modified_by:spontaneous;
3.txt	NCT01827982	Condition	anemia	EXC	has_TempMea:Current;
3.txt	NCT02008357	Condition	bipolar disorder	EXC	has_TempMea:within the past 2 years;
3.txt	NCT02008357	Condition	Diagnostic and Statistical Manual of Mental Disorders ( DSM )	EXC	
3.txt	NCT02008357	Condition	major depression	EXC	has_TempMea:within the past 2 years;
3.txt	NCT02008357	Condition	exfoliative dermatitis	EXC	
3.txt	NCT01827982	Condition	lower back pain	EXC	
3.txt	NCT01827982	Condition	scoliosis	EXC	
3.txt	NCT01827982	Procedure	back surgery	EXC	modified_by:major;
3.txt	NCT01827982	Drug	local anesthetics	EXC	
3.txt	NCT01827982	Condition	Allergic	EXC	
3.txt	NCT01827982	Procedure	fundoscopy	EXC	
3.txt	NCT01827982	Drug	iodine	EXC	
3.txt	NCT02180269	Measurement	Body mass index	INC	has_value:between 18 and 30 kilogram ( kg ) per square meter;
3.txt	NCT02180269	Measurement	Blood pressure	INC	
3.txt	NCT02180269	Condition	healthy	INC	
3.txt	NCT02180269	Measurement	physical and neurological examination	INC	
3.txt	NCT02180269	Observation	medical history	INC	
3.txt	NCT02180269	Measurement	vital signs	INC	
3.txt	NCT02180269	Procedure	12 -lead electrocardiogram ( ECG )	INC	
3.txt	NCT01827982	Condition	intracranial pressure	EXC	modified_by:Increased;
3.txt	NCT01029132	Condition	NINCDS-ADRDA	INC	
3.txt	NCT01029132	Condition	AD	INC	modified_by:probable;
3.txt	NCT01029132	Measurement	Korean version Mini-Mental State Examination scores	INC	has_value:between 10 and 26;
3.txt	NCT01029132	Condition	cognitive decline	INC	modified_by:gradual in onset;has_TempMea:at least 6 months;modified_by:progressive;
3.txt	NCT02434393	Procedure	MRI	INC	
3.txt	NCT02434393	Measurement	Visual and auditory acuity	INC	modified_by:adequate;
3.txt	NCT02434393	Measurement	BMI	INC	has_value:<=  38;
3.txt	NCT02434393	Procedure	MRI	INC	
3.txt	NCT02434393	Procedure	PET scan	INC	
3.txt	NCT02434393	Condition	Dementia	EXC	
3.txt	NCT02434393	Condition	axis 1 psychiatric disorders	EXC	modified_by:other;has_TempMea:Current;
3.txt	NCT02434393	Measurement	Hamilton Depression Rating Scale score	INC	has_value:>=  15;
3.txt	NCT01029132	Condition	trauma	EXC	
3.txt	NCT01029132	Condition	behavioral disturbances	EXC	modified_by:severe;
3.txt	NCT01029132	Condition	Cerebral injuries	EXC	
3.txt	NCT02434393	Condition	systemic illness	EXC	modified_by:significant;
3.txt	NCT01029132	Condition	Psychiatric disorder	EXC	
3.txt	NCT02434393	Condition	DSM-IV criteria	EXC	
3.txt	NCT01029132	Condition	Parkinson's disease	EXC	
3.txt	NCT01029132	Condition	Huntington's disease	EXC	
3.txt	NCT02434393	Condition	alcohol or substance abuse or dependence	EXC	has_TempMea:within the past 2 years;
3.txt	NCT02434393	Procedure	surgical procedures	EXC	
3.txt	NCT01029132	Condition	cerebrovascular disease	EXC	modified_by:Clinically active;
3.txt	NCT02434393	Drug	Investigational agents	EXC	has_TempMea:one month;is_negated:prohibited;
3.txt	NCT01029132	Condition	hypoxia	EXC	
3.txt	NCT02434393	Condition	medical condition	EXC	modified_by:unstable;
3.txt	NCT01029132	Condition	ischemia	EXC	
3.txt	NCT02434393	Condition	neurological diseases	EXC	modified_by:significant;
3.txt	NCT02434393	Drug	psychotherapy treatment	EXC	has_TempMea:Undergoing;
3.txt	NCT02434393	Procedure	electroconvulsive therapy	EXC	has_TempMea:within the past 6 months;
3.txt	NCT02434393	Measurement	MMSE	EXC	has_value:< 25;
3.txt	NCT02434393	Condition	cortical stroke	EXC	
3.txt	NCT01029132	Condition	AD	EXC	is_negated:other than;
3.txt	NCT02434393	Condition	traumatic brain injury	EXC	
3.txt	NCT02434393	Condition	Parkinson's disease	EXC	
3.txt	NCT01029132	Condition	neurodegenerative diseases	EXC	
3.txt	NCT02434393	Condition	epilepsy	EXC	
3.txt	NCT02518243	Condition	Sensory deficit	EXC	
3.txt	NCT02434393	Condition	multiple lacunes	EXC	
3.txt	NCT02518243	Measurement	neuropsychological tests	EXC	
3.txt	NCT02518243	Condition	sensory or motor deficit	EXC	
3.txt	NCT02434393	Condition	focal lesions	EXC	modified_by:other;
3.txt	NCT02518243	Drug	antipsychotic	EXC	
3.txt	NCT02434393	Procedure	ear implants	EXC	
3.txt	NCT02008357	Measurement	Mini-Mental State Examination ( MMSE ) score	INC	has_value:25 to 30;
3.txt	NCT02434393	Procedure	metal fragments	EXC	
3.txt	NCT02518243	Drug	anxiolytic	EXC	
3.txt	NCT02434393	Procedure	aneurysm clips	EXC	
3.txt	NCT02518243	Drug	antidepressant	EXC	
3.txt	NCT02434393	Procedure	artificial heart valves	EXC	
3.txt	NCT02518243	Drug	treatment psychotropic	EXC	modified_by:new;has_TempMea:in the week;
3.txt	NCT02518243	Drug	hypnotic	EXC	
3.txt	NCT02434393	Procedure	pacemakers	EXC	
3.txt	NCT02434393	Condition	lacunes	EXC	
3.txt	NCT02518243	Condition	Alzheimer's disease	INC	
3.txt	NCT02434393	Drug	radioactive agents	EXC	has_TempMea:Current or recent;
3.txt	NCT02518243	Condition	NINCDS-ADRDA	INC	
3.txt	NCT02434393	Procedure	amyloid imaging with florbetapir	EXC	
3.txt	NCT01029132	Condition	physical conditions	EXC	modified_by:Other;
3.txt	NCT01029132	Condition	seizure disorder	EXC	
3.txt	NCT02008357	Condition	conditions	EXC	modified_by:other;
3.txt	NCT02180269	Condition	liver or renal impairment	EXC	modified_by:significant;has_TempMea:current;
3.txt	NCT02434393	Condition	infection	EXC	
3.txt	NCT02180269	Condition	cardiac, vascular, pulmonary, gastrointestinal, endocrine, neurologic, hematologic, rheumatologic, psychiatric, dermatological ( at the puncture site ) or metabolic disturbances	EXC	
3.txt	NCT02434393	Condition	infarction	EXC	
3.txt	NCT02518243	Condition	Alzheimer's disease	INC	modified_by:typical or atypical;
3.txt	NCT02180269	Condition	spontaneous, prolonged and severe bleeding of unclear origin	EXC	
3.txt	NCT02518243	Measurement	Mini Mental Test ( MMSE )	INC	has_value:>= 16;
3.txt	NCT02434393	Procedure	MRI scans	EXC	
3.txt	NCT02434393	Drug	total radiation dose exposure	EXC	has_value:exceed the limits of annual and total dose;
3.txt	NCT02180269	Condition	epilepsy	EXC	
3.txt	NCT02008357	Drug	memantine	EXC	
3.txt	NCT01827982	Condition	Healthy	INC	
3.txt	NCT02180269	Condition	fits	EXC	
3.txt	NCT02180269	Condition	human immunodeficiency virus ( HIV ) antigen/antibody	EXC	modified_by:positive;
3.txt	NCT02180269	Condition	HIV	EXC	modified_by:positive;
3.txt	NCT01887535	Condition	general health	INC	modified_by:Good;
3.txt	NCT02008357	Condition	infectious disease	EXC	has_TempMea:within the last 5 years;modified_by:serious;
3.txt	NCT01029132	Drug	psychotropic medications	EXC	
3.txt	NCT01887535	Measurement	Body mass index ( BMI )	INC	has_value:between 18 and 32 kg/m2, inclusive;
3.txt	NCT02180269	Measurement	diastolic	INC	has_value:no higher than 90 mm Hg;
3.txt	NCT02434393	Condition	psychotic features	INC	is_negated:without;
3.txt	NCT02008357	Condition	illness	EXC	modified_by:serious or unstable;has_TempMea:current;
3.txt	NCT02180269	Measurement	systolic	INC	has_value:between 90 and 150 millimeter of mercury ( mm Hg );
3.txt	NCT02008357	Condition	cardiovascular, hepatic, renal, gastroenterologic, respiratory, endocrinologic, neurologic, psychiatric, immunologic or hematologic disease	EXC	
3.txt	NCT02008357	Measurement	global Clinical Dementia Rating ( CDR ) scale score	INC	has_value:0;
3.txt	NCT02434393	Procedure	foreign objects	EXC	
3.txt	NCT02008357	Condition	protracted loss of consciousness	EXC	
3.txt	NCT01887535	Condition	sterilized	INC	
3.txt	NCT01887535	Condition	postmenopausal	INC	
3.txt	NCT01887535	Condition	medical or psychiatric illness	EXC	modified_by:Clinically significant;
3.txt	NCT01887535	Condition	Alcohol or substance abuse	EXC	
3.txt	NCT01887535	Drug	investigational drug	EXC	
3.txt	NCT02008357	Drug	prescription acetylcholinesterase inhibitor	EXC	
3.txt	NCT02434393	Condition	surgically sterile	EXC	has_TempMea:two years;
3.txt	NCT01887535	Condition	nicotine or caffeine use	EXC	modified_by:excessive;
3.txt	NCT02008357	Drug	AChEI	EXC	
3.txt	NCT02008357	Procedure	florbetapir positron emission tomography ( PET ) scan	INC	
3.txt	NCT02434393	Condition	of childbearing potential	EXC	
3.txt	NCT01887535	Drug	vaccine	EXC	
3.txt	NCT02008357	Condition	brain amyloid pathology	INC	
3.txt	NCT02434393	Condition	post-menopausal	EXC	has_TempMea:two years;
3.txt	NCT02008357	Measurement	Logical Memory II score	INC	has_value:6 to 18;
3.txt	NCT02434393	Condition	Pregnant	EXC	
3.txt	NCT02434393	Condition	lactating	EXC	
3.txt	NCT02434393	Condition	claustrophobia	EXC	
3.txt	NCT02008357	Condition	basal cell carcinoma	EXC	
3.txt	NCT02008357	Condition	cervical carcinoma in situ	EXC	
3.txt	NCT01887535	Procedure	invasive medical device	EXC	
3.txt	NCT02008357	Condition	in situ prostate cancer	EXC	
3.txt	NCT01887535	Condition	scoliosis	EXC	
3.txt	NCT01887535	Condition	lower back pain	EXC	
3.txt	NCT02434393	Measurement	Hamilton Depression Rating Scale ( HDRS )	EXC	
3.txt	NCT01887535	Procedure	back surgery	EXC	modified_by:major;
3.txt	NCT01887535	Condition	Allergic	EXC	
3.txt	NCT01887535	Drug	iodine	EXC	
3.txt	NCT01887535	Drug	local anesthetics	EXC	
3.txt	NCT02008357	Condition	post-treatment hypersensitivity reactions	EXC	modified_by:severe;
3.txt	NCT02008357	Condition	drug allergies	EXC	modified_by:severe;modified_by:clinically significant;modified_by:multiple;
3.txt	NCT02008357	Condition	human immunodeficiency virus ( HIV )	EXC	
3.txt	NCT02008357	Condition	neurosyphilis	EXC	
3.txt	NCT02008357	Condition	meningitis	EXC	
3.txt	NCT01827982	Measurement	Body mass index	INC	has_value:between 18 and 30 kg/m2;
3.txt	NCT02434393	Condition	depressive episode	INC	has_value:six week minimum duration;has_TempMea:current;
3.txt	NCT01827982	Condition	general health	INC	modified_by:Good;
3.txt	NCT02008357	Condition	encephalitis	EXC	
3.txt	NCT01827982	Demographic	Male	INC	
3.txt	NCT01827982	Demographic	age	INC	has_value:inclusive;has_value:between 18 and 54 years;
3.txt	NCT01827982	Measurement	Body mass index	INC	has_value:between 18 and 32 kg/m2;
3.txt	NCT02008357	Condition	cutaneous squamous cell carcinoma in situ	EXC	is_negated:exception;modified_by:resected;
3.txt	NCT02434393	Condition	suicidal ideation	EXC	
3.txt	NCT02008357	Condition	malignant disease	EXC	has_TempMea:within the last 5 years;modified_by:primary or recurrent;
3.txt	NCT02434393	Condition	Simple Phobias and Generalized Anxiety Disorder	EXC	is_negated:exception;
3.txt	NCT02434393	Drug	anti-depressant	EXC	has_TempMea:Undergoing;
3.txt	NCT02008357	Condition	head trauma	EXC	
3.txt	NCT02434393	Procedure	Amyloid imaging	INC	
4.txt	NCT01835717	Condition	brain tumors	EXC	
4.txt	NCT01302340	Drug	antidepressives	EXC	has_TempMea:within 6 weeks;modified_by:Changes in dosage;
4.txt	NCT01835717	Condition	brain damage	EXC	modified_by:acquired;
4.txt	NCT02267057	Condition	epilepsy	EXC	modified_by:Uncontrolled;
4.txt	NCT01835717	Procedure	radiotherapy	EXC	
4.txt	NCT02267057	Condition	schizoaffective disorder	EXC	
4.txt	NCT01835717	Drug	cerebral chemotherapy	EXC	
4.txt	NCT02267057	Condition	bipolar disorder	EXC	
4.txt	NCT01835717	Condition	Alzheimer's disease	EXC	
4.txt	NCT01835717	Demographic	onset age	EXC	has_value:< 60 years;modified_by:early;
4.txt	NCT02267057	Condition	injury	EXC	modified_by:Severe;
4.txt	NCT02267057	Condition	anaemia	EXC	modified_by:Severe;
4.txt	NCT02267057	Condition	Renal failure	EXC	
4.txt	NCT02267057	Condition	liver impairment	EXC	modified_by:Severe;
4.txt	NCT01302340	Condition	Alzheimer's Disease ( AD )	INC	
4.txt	NCT01302340	Condition	Vascular Dementia ( VD )	INC	
4.txt	NCT02267057	Condition	mental disorder	EXC	modified_by:severe;modified_by:other;
4.txt	NCT01302340	Condition	NINCDS-AIREN	INC	
4.txt	NCT01302340	Condition	NINCDS-ADRDA	INC	
4.txt	NCT01302340	Measurement	Clinical Dementia Rating score	INC	has_value:between 0.5 and 3;
4.txt	NCT01302340	Condition	mixed	INC	
4.txt	NCT02267057	Condition	Schizophrenia	EXC	
4.txt	NCT02267057	Measurement	NPI subscale	EXC	has_value:>= 8;
4.txt	NCT02267057	Condition	aggression	EXC	
4.txt	NCT02267057	Condition	aggression	EXC	modified_by:Severe;
4.txt	NCT02267057	Condition	dementia	EXC	
4.txt	NCT01302340	Condition	aggression	INC	
4.txt	NCT01302340	Condition	agitation	INC	
4.txt	NCT01302340	Condition	Lewy Body Dementia ( LBD )	EXC	
4.txt	NCT01302340	Condition	NPS symptoms	INC	
4.txt	NCT01302340	Condition	Fronto-Temporal Dementia ( FTD )	EXC	
4.txt	NCT01302340	Condition	psychiatric disorder	EXC	modified_by:Major;
4.txt	NCT01835717	Demographic	aged	INC	has_value:between 45 and 65 years;
4.txt	NCT01835717	Condition	Cognitive impairment	EXC	
4.txt	NCT01835717	Measurement	MMSE	EXC	has_value:< 26;
4.txt	NCT01835717	Measurement	MIS	EXC	has_value:< 6;
4.txt	NCT01835717	Measurement	Barcelona Test II	EXC	has_value:< 68;
4.txt	NCT01302340	Condition	concomitant illness	EXC	modified_by:Severe;
4.txt	NCT01302340	Condition	arrhythmias	EXC	
4.txt	NCT01302340	Condition	seizure	EXC	
4.txt	NCT01302340	Condition	sinus arrhythmia	EXC	is_negated:except;
4.txt	NCT01302340	Measurement	heart failure New York Heart Association ( NYHA )	EXC	has_value:class III or IV;
4.txt	NCT01302340	Condition	atrial fibrillation	EXC	is_negated:except;
4.txt	NCT01302340	Drug	Tri Cyclic Antidepressives ( TCA )	EXC	has_TempMea:within 30 days;
4.txt	NCT02267057	Condition	medical disease	EXC	modified_by:severe;modified_by:Advanced;
4.txt	NCT02267057	Observation	expected survival	EXC	has_value:less than six months;
4.txt	NCT02267057	Drug	buprenorphine transdermal patch	EXC	
4.txt	NCT02267057	Condition	adverse reaction	EXC	
4.txt	NCT02267057	Drug	paracetamol	EXC	
4.txt	NCT02267057	Condition	comatose state	EXC	
4.txt	NCT02267057	Condition	allergy	EXC	
4.txt	NCT02267057	Condition	psychiatric or neurological disorder	EXC	modified_by:severe;
4.txt	NCT02267057	Measurement	Hb	EXC	has_value:< 8.5 mmol/l;
4.txt	NCT02414607	Measurement	CDR score	INC	has_value:0.5;
4.txt	NCT00547560	Condition	nonchildbearing potential	INC	
4.txt	NCT00966966	Condition	cardiovascular, hepatic, renal, respiratory, gastrointestinal ( GI ), endocrine, immunologic, dermatologic, hematologic, neurologic or psychiatric disease	EXC	modified_by:significant;
4.txt	NCT01302340	Drug	benzodiazepines	EXC	has_TempMea:within 2 weeks;modified_by:changes in dosage;
4.txt	NCT00547560	Demographic	age	INC	has_value:greater than or equal to 65 years;
4.txt	NCT00966966	Condition	disorder	EXC	
4.txt	NCT01302340	Drug	antipsychotics	EXC	modified_by:changes in dosage;has_TempMea:within 2 weeks;
4.txt	NCT00547560	Condition	postmenopausal	INC	has_TempMea:greater than or equal to 1 year;
4.txt	NCT02414607	Measurement	MMSE	INC	has_value:at least 24;
4.txt	NCT00547560	Condition	surgically sterile	INC	has_TempMea:greater than or equal to 1 year;
4.txt	NCT00966966	Measurement	physical examination findings	INC	
4.txt	NCT00966966	Condition	Healthy	INC	
4.txt	NCT00966966	Observation	medical history	INC	
4.txt	NCT00966966	Measurement	body weight	INC	has_value:greater than 50 kg;
4.txt	NCT00966966	Measurement	Body mass index	INC	has_value:in the range of 18 to 30 kg/m2;
4.txt	NCT01302340	Drug	opioids	EXC	has_TempMea:within 30 days;
4.txt	NCT00966966	Procedure	digital 12 -lead ECG readings	INC	
4.txt	NCT00966966	Measurement	clinical laboratory test results	INC	
4.txt	NCT00966966	Measurement	vital sign measurements	INC	
4.txt	NCT02414607	Condition	Alzheimer's disease	EXC	
4.txt	NCT02414607	Condition	Alzheimer's disease	EXC	
4.txt	NCT02414607	Drug	cholinesterase inhibitors	EXC	
4.txt	NCT02005991	Demographic	age	INC	has_value:no older than 55 years;
4.txt	NCT02414607	Drug	honeysuckle	EXC	
4.txt	NCT02414607	Condition	cognitive decline	EXC	
4.txt	NCT02005991	Demographic	age	INC	has_value:at least 18 years;
4.txt	NCT02414607	Condition	cognitive performance	EXC	
4.txt	NCT02005991	Condition	breastfeeding	EXC	is_negated:not;
4.txt	NCT01835717	Condition	cognition	EXC	
4.txt	NCT02414607	Drug	drugs	EXC	modified_by:other;modified_by:changes;has_TempMea:Currently;
4.txt	NCT02005991	Condition	pregnant	EXC	is_negated:not;
4.txt	NCT02414607	Condition	MCI	EXC	is_negated:not;
4.txt	NCT02005991	Measurement	Body Mass Index ( BMI )	INC	has_value:between 17.5 and 30.5;
4.txt	NCT02414607	Condition	sensitivity	EXC	
4.txt	NCT02414607	Drug	elderberry products	EXC	
4.txt	NCT00547560	Measurement	pregnancy test result	INC	modified_by:negative;has_TempMea:within 48 hours;
4.txt	NCT00547560	Measurement	FSH	INC	has_value:greater than or equal to 38 mIU/mL;
4.txt	NCT02414607	Demographic	Age	INC	has_value:50 or older;
4.txt	NCT01835717	Measurement	category fluency ( animals )	EXC	has_value:< 12;
4.txt	NCT01835717	Measurement	CDR	EXC	has_value:> 0;
4.txt	NCT01835717	Condition	Functional status impairment	EXC	
4.txt	NCT02414607	Condition	Pregnancy	EXC	has_TempMea:Current;
4.txt	NCT00547560	Measurement	body weight	INC	has_value:> 50 kg;
4.txt	NCT02414607	Condition	allergy	EXC	
4.txt	NCT01835717	Condition	Neurodevelopmental and/or psychomotor disorder	EXC	
4.txt	NCT02414607	Condition	Bleeding disorder	EXC	
4.txt	NCT01835717	Condition	auditory and/or visual impairment	EXC	modified_by:Severe;
4.txt	NCT00547560	Condition	surgically sterile	INC	
4.txt	NCT02414607	Condition	Diabetes	EXC	
4.txt	NCT00547560	Measurement	Body mass index ( BMI )	INC	has_value:18.0 to 30.0 kg/m2;
4.txt	NCT01594541	Condition	dementia	INC	
4.txt	NCT02005991	Drug	alcohol	EXC	is_negated:not;
4.txt	NCT01594541	Condition	Mild Cognitive Impairment	INC	
4.txt	NCT02256072	Demographic	Age	INC	has_value:65 and older;
4.txt	NCT01835717	Condition	renal failure	EXC	
4.txt	NCT01835717	Condition	diseases	EXC	modified_by:Significant;has_TempMea:currently;
4.txt	NCT01835717	Condition	liver cirrhosis	EXC	
4.txt	NCT01835717	Procedure	oxygen therapy	EXC	
4.txt	NCT01835717	Condition	lung disease	EXC	modified_by:chronic;
4.txt	NCT01835717	Procedure	solid organ transplantation	EXC	
4.txt	NCT01594541	Measurement	Hcy score	EXC	has_value:lower than 11;
4.txt	NCT01835717	Procedure	hemodialysis	EXC	
4.txt	NCT01835717	Condition	parenchymal lesion	EXC	
4.txt	NCT01835717	Condition	fibromyalgia	EXC	
4.txt	NCT01594541	Condition	dementia	EXC	modified_by:severe;
4.txt	NCT02256072	Measurement	Brief Cognitive screener	EXC	has_value:< 4 questions correctly;
4.txt	NCT01594541	Condition	allergy/intolerance	EXC	
4.txt	NCT02256072	Measurement	Brief Cognitive screener	INC	has_value:>= 4 questions correctly;
4.txt	NCT01594541	Drug	Cerefolin NAC	EXC	
4.txt	NCT01594541	Measurement	minimum MOST score	INC	has_value:5 but not over 23;
4.txt	NCT02256072	Demographic	age	EXC	has_value:65;has_value:Less than;
4.txt	NCT02414607	Condition	terminal illness	EXC	
4.txt	NCT01835717	Condition	cognitive abilities	EXC	
4.txt	NCT02414607	Condition	condition	EXC	
4.txt	NCT02005991	Condition	medical or psychiatric condition	EXC	modified_by:acute or chronic;modified_by:severe;
4.txt	NCT01835717	Condition	cancer in treatment	EXC	modified_by:active;
4.txt	NCT01835717	Condition	disease	EXC	modified_by:other;
4.txt	NCT01835717	Condition	psychiatric disorders	EXC	modified_by:Major;
4.txt	NCT01835717	Condition	major depression	EXC	
4.txt	NCT01835717	Condition	DSM-IV-TR	EXC	
4.txt	NCT01835717	Condition	schizophrenia	EXC	
4.txt	NCT02414607	Condition	MS	EXC	
4.txt	NCT01835717	Condition	bipolar disorder	EXC	
4.txt	NCT01594541	Demographic	ages	INC	has_value:55 and 89 years old;
4.txt	NCT02005991	Drug	illicit drugs	EXC	is_negated:not;
4.txt	NCT02414607	Condition	drug abuse	EXC	
4.txt	NCT01835717	Condition	dementia	EXC	
4.txt	NCT02414607	Condition	neurodegenerative diseases	EXC	
4.txt	NCT02005991	Condition	seasonal allergies	EXC	modified_by:mild;is_negated:except;
4.txt	NCT02414607	Condition	psychiatric disorders	EXC	modified_by:major;modified_by:comorbid;
4.txt	NCT02005991	Condition	drug allergies	EXC	
4.txt	NCT02414607	Condition	schizophrenia	EXC	
4.txt	NCT02005991	Condition	blood, kidney, glandular, lung, stomach, intestine, heart, blood vessel, liver, psychiatric, nerve or allergic problems	EXC	
4.txt	NCT01835717	Condition	Parkinson's disease	EXC	
4.txt	NCT02267057	Measurement	CSDD	INC	has_value:>= 8;
4.txt	NCT01835717	Condition	Neurological disorders	EXC	
4.txt	NCT01835717	Condition	epilepsy	EXC	
4.txt	NCT01835717	Condition	stroke	EXC	
4.txt	NCT01835717	Condition	diseases	EXC	
4.txt	NCT01835717	Condition	seizures	EXC	modified_by:frequent;has_TempMea:in the past year;has_value:> 1/month;
4.txt	NCT01835717	Condition	multiple sclerosis	EXC	
4.txt	NCT02267057	Condition	Psychosis	EXC	
4.txt	NCT02267057	Condition	medical disease/disorder	EXC	modified_by:Advanced severe;
4.txt	NCT02267057	Observation	expected survival	EXC	has_value:less than 6 months;
4.txt	NCT02267057	Condition	suicide risk	EXC	
4.txt	NCT02267057	Condition	contra-indicated	EXC	
4.txt	NCT02267057	Drug	study drugs	EXC	
4.txt	NCT01594541	Condition	medical illness	EXC	modified_by:Unstable;
4.txt	NCT01835717	Condition	neurological disease	EXC	modified_by:serious;modified_by:other;
4.txt	NCT01594541	Condition	cardiovascular, hepatic, renal, respiratory, endocrine, neurological or hematological disease	EXC	
4.txt	NCT01835717	Condition	Brain injury	EXC	
4.txt	NCT01835717	Condition	cognition	EXC	
4.txt	NCT01835717	Condition	head trauma	EXC	
4.txt	NCT01835717	Condition	hemorrhagic stroke	EXC	
4.txt	NCT01835717	Condition	extraaxial macroscopic large vessel ischemic stroke	EXC	
4.txt	NCT01835717	Procedure	brain surgery	EXC	
4.txt	NCT02267057	Condition	depression	INC	has_value:>= 4 week;
4.txt	NCT02267057	Measurement	FAST score	INC	has_value:> 4;
4.txt	NCT02267057	Condition	dementia	INC	modified_by:probable or possible;
4.txt	NCT02267057	Condition	Diagnostic and Statistical Manual of Mental Disorders ( DSM-IV )	INC	
5.txt	NCT02256306	Drug	antipsychotics	EXC	modified_by:atypical;
5.txt	NCT02256306	Drug	benzodiazepines	EXC	modified_by:short-acting;
5.txt	NCT02256306	Drug	medications	EXC	modified_by:other;
5.txt	NCT02256306	Procedure	cognitive assessment	EXC	
5.txt	NCT02256306	Drug	dose	EXC	is_negated:no;has_TempMea:within the 72 hours;
5.txt	NCT00675090	Drug	selegiline	EXC	has_TempMea:within the previous month;
5.txt	NCT01800214	Procedure	MRI	EXC	
5.txt	NCT02322021	Procedure	PET scan	INC	
5.txt	NCT00675090	Drug	Tacrine	EXC	
5.txt	NCT00675090	Drug	memantine	EXC	has_TempMea:within the previous month;
5.txt	NCT01800214	Condition	contraindications	EXC	Specified_by:MRI;
5.txt	NCT00675090	Drug	GSK239512	EXC	
5.txt	NCT00675090	Drug	cholinesterase inhibitors	EXC	has_TempMea:within the previous month;
5.txt	NCT00675090	Condition	excretion	EXC	
5.txt	NCT00675090	Condition	hypersensitivity	EXC	
5.txt	NCT02256306	Condition	cognition	EXC	
5.txt	NCT00675090	Condition	AD	EXC	is_negated:No;
5.txt	NCT00675090	Condition	AD	EXC	
5.txt	NCT02322021	Condition	AD pathology	INC	
5.txt	NCT02322021	Condition	cognitive decline	INC	is_negated:not;
5.txt	NCT02256306	Procedure	magnetic resonance imaging	EXC	
5.txt	NCT02256306	Procedure	3T MRI	EXC	
5.txt	NCT02256306	Procedure	pacemaker	EXC	
5.txt	NCT02256306	Procedure	clip	EXC	
5.txt	NCT02256306	Condition	Claustrophobia	EXC	
5.txt	NCT02256306	Procedure	metallic surgical implant	EXC	
5.txt	NCT00675090	Condition	absorption	EXC	
5.txt	NCT00675090	Observation	distribution	EXC	
5.txt	NCT00675090	Condition	metabolism	EXC	
5.txt	NCT01862640	Condition	pulmonary or cerebral embolism	EXC	
5.txt	NCT00675090	Drug	sedative medications	EXC	modified_by:chronic;has_TempMea:the past 4 weeks;has_value:>= 4 days per week;
5.txt	NCT01862640	Condition	stroke	EXC	
5.txt	NCT00675090	Drug	CYP3A4 inhibitors	EXC	
5.txt	NCT01862640	Condition	transient ischemic attack	EXC	
5.txt	NCT00675090	Drug	excipients	EXC	
5.txt	NCT00675090	Drug	carbamazepine	EXC	
5.txt	NCT00675090	Drug	Pgp inhibitors	EXC	
5.txt	NCT00675090	Condition	condition	EXC	modified_by:other;
5.txt	NCT01862640	Condition	memory impairment	EXC	modified_by:other;
5.txt	NCT00675090	Drug	lithium	EXC	
5.txt	NCT00675090	Condition	Depression	EXC	
5.txt	NCT01862640	Condition	Alzheimer's disease	EXC	is_negated:not;
5.txt	NCT00675090	Drug	valproate	EXC	
5.txt	NCT00675090	Condition	Dementia	EXC	
5.txt	NCT01862640	Condition	Axis I disorder	EXC	
5.txt	NCT00675090	Drug	investigational treatment	EXC	has_TempMea:in the previous 3 months;modified_by:other;
5.txt	NCT01862640	Condition	DSM-IV-TR criteria	EXC	
5.txt	NCT01862640	Condition	neurological, hepatic, renal, metabolic, hematological, immunological, cardiovascular, pulmonary, gastrointestinal or psychiatric disorders	EXC	modified_by:clinically significant;
5.txt	NCT00675090	Drug	SSRI	EXC	
5.txt	NCT00675090	Drug	DNRI	EXC	
5.txt	NCT00675090	Drug	modulators	EXC	
5.txt	NCT02322021	Procedure	device	INC	has_TempMea:within 60 days;
5.txt	NCT00675090	Drug	mood stabilization drugs	EXC	
5.txt	NCT02322021	Condition	pregnancy	INC	
5.txt	NCT00675090	Drug	dopaminergic antagonists	EXC	modified_by:typical or atypical;
5.txt	NCT00675090	Drug	anti-psychotic drugs	EXC	has_TempMea:in the last month;has_TempMea:currently;
5.txt	NCT02322021	Drug	treatment	INC	has_TempMea:in the past 5 years;
5.txt	NCT00675090	Drug	MAO inhibitors	EXC	
5.txt	NCT00675090	Condition	causes of dementia	EXC	modified_by:probable;modified_by:other;
5.txt	NCT01862640	Condition	dementia	INC	
5.txt	NCT00675090	Drug	tricyclic antidepressants	EXC	
5.txt	NCT00675090	Drug	SNRI	EXC	
5.txt	NCT00675090	Demographic	Age	INC	has_value:>= 50 and above;
5.txt	NCT02256306	Condition	NIA-AA criteria	INC	
5.txt	NCT02322021	Condition	TB	INC	is_negated:no;
5.txt	NCT02256306	Condition	Alzheimer's disease	INC	modified_by:probable;
5.txt	NCT00675090	Condition	Alzheimer's disease	INC	modified_by:probable;
5.txt	NCT02322021	Condition	Tuberculosis ( TB )	INC	
5.txt	NCT00675090	Measurement	MMSE score	INC	has_value:12 to 26;has_value:16 - 26;
5.txt	NCT00000176	Condition	breast cancer	EXC	
5.txt	NCT02322021	Drug	live vaccine	INC	has_TempMea:in the 3 months;
5.txt	NCT02256306	Measurement	Hepatitis B	EXC	modified_by:Positive;
5.txt	NCT02256306	Measurement	Hepatitis C	EXC	modified_by:Positive;
5.txt	NCT02322021	Condition	ophthalmic shingles	INC	
5.txt	NCT02256306	Condition	Pregnancy	EXC	
5.txt	NCT02322021	Condition	ocular Herpes Simplex Virus ( HSV ) infection	INC	
5.txt	NCT00675090	Condition	surgically sterile	INC	
5.txt	NCT02256306	Measurement	Mini-Mental State Examination ( MMSE ) score	INC	has_value:12 - 24;
5.txt	NCT00675090	Condition	post-menopausal	INC	
5.txt	NCT00000176	Condition	memory problems	INC	
5.txt	NCT01862640	Condition	epilepsy	EXC	
5.txt	NCT00000176	Drug	estrogen	INC	is_negated:not;has_TempMea:currently;
5.txt	NCT01862640	Condition	insulin-dependent diabetes mellitus ( IDDM )	EXC	modified_by:uncontrolled;
5.txt	NCT01862640	Condition	hypertension	EXC	modified_by:uncontrolled;
5.txt	NCT00000176	Condition	Healthy	INC	
5.txt	NCT00675090	Procedure	MRI scans	EXC	has_TempMea:in the past 12 months;
5.txt	NCT02322021	Condition	viral hepatitis	INC	modified_by:chronic;
5.txt	NCT00000176	Drug	estrogen	EXC	has_TempMea:Current;
5.txt	NCT01862640	Condition	seizures	EXC	
5.txt	NCT02322021	Condition	immunodeficiency disorders	INC	
5.txt	NCT00000176	Condition	neurological impairment	EXC	modified_by:Significant;
5.txt	NCT00675090	Procedure	CT	EXC	has_TempMea:in the past 12 months;
5.txt	NCT02322021	Measurement	clinical laboratory tests	INC	modified_by:deviation from normal;modified_by:Clinically significant;
5.txt	NCT02322021	Measurement	physical examination	INC	modified_by:deviation from normal;modified_by:Clinically significant;
5.txt	NCT00675090	Condition	nocturnal wandering	EXC	
5.txt	NCT02322021	Measurement	vital signs	INC	modified_by:deviation from normal;modified_by:Clinically significant;
5.txt	NCT00675090	Condition	nocturnal confusion / disorientation / agitation	EXC	
5.txt	NCT00675090	Condition	sleep disturbance	EXC	modified_by:significant;
5.txt	NCT02256306	Condition	intolerance	EXC	has_TempMea:Prior;
5.txt	NCT02256306	Drug	anticoagulant therapy	EXC	has_TempMea:concurrent;
5.txt	NCT02322021	Procedure	Electrocardiograms ( ECGs )	INC	
5.txt	NCT00675090	Condition	seizures	EXC	modified_by:known or suspected;has_TempMea:within last 6 months;
5.txt	NCT02256306	Condition	IgA deficiency	EXC	
5.txt	NCT02322021	Measurement	prolonged QT interval	INC	has_value:greater than 450 msec;
5.txt	NCT02256306	Condition	atrial fibrillation	EXC	modified_by:uncontrolled;
5.txt	NCT02256306	Drug	intravenous fluids	EXC	
5.txt	NCT02322021	Drug	immunosuppressive or immunomodulatory therapy	INC	
5.txt	NCT00675090	Condition	depression	EXC	has_TempMea:current;
5.txt	NCT02322021	Measurement	T helper cell	INC	modified_by:below normal;
5.txt	NCT00675090	Condition	bipolar affective disorder	EXC	
5.txt	NCT02256306	Condition	Anaphylaxis	EXC	
5.txt	NCT02322021	Condition	inflammatory disease	INC	modified_by:chronic;
5.txt	NCT02256306	Condition	adverse reaction	EXC	has_TempMea:Prior;
5.txt	NCT02322021	Condition	infection	INC	modified_by:active;has_TempMea:within the last 4 weeks;
5.txt	NCT00675090	Condition	psychiatric illness	EXC	modified_by:significant;
5.txt	NCT02256306	Condition	HIV	EXC	modified_by:Positive;
5.txt	NCT00675090	Condition	schizophrenia	EXC	
5.txt	NCT02256306	Condition	Stroke	EXC	
5.txt	NCT01800214	Condition	Parkinsonism	EXC	is_negated:other than;
5.txt	NCT02322021	Condition	NIA-AA	INC	
5.txt	NCT02322021	Measurement	Immunoglobulin ( Ig ) IgG, IgA or IgM levels	INC	modified_by:below normal;
5.txt	NCT00675090	Condition	AD	EXC	
5.txt	NCT02256306	Condition	Congestive heart failure	EXC	
5.txt	NCT01800214	Condition	alcohol or substance abuse or dependence	EXC	has_TempMea:within the past 2 years;
5.txt	NCT02256306	Condition	Renal failure	EXC	
5.txt	NCT02322021	Measurement	B cell absolute counts	INC	modified_by:below normal;
5.txt	NCT02256306	Condition	blood coagulation disorder	EXC	
5.txt	NCT01800214	Demographic	Age	EXC	has_value:between 50 - 90;
5.txt	NCT00675090	Condition	psychiatric features	EXC	modified_by:other;
5.txt	NCT02256306	Condition	hypercoagulability	EXC	
5.txt	NCT00675090	Measurement	Cornell Scale	EXC	has_value:>= 8;
5.txt	NCT02322021	Measurement	cytotoxic T cell	INC	modified_by:below normal;
5.txt	NCT02256306	Drug	human blood product	EXC	
5.txt	NCT02322021	Condition	Type 1 or Type 2 diabetes mellitus	INC	modified_by:well controlled;
5.txt	NCT02256306	Condition	Alzheimer's disease	EXC	
5.txt	NCT02322021	Condition	ECG abnormalities	INC	modified_by:other;modified_by:clinically significant;
5.txt	NCT00675090	Condition	cardiovascular, gastro-intestinal, hepatic or renal disease	EXC	modified_by:significant;
5.txt	NCT01800214	Condition	memory complaints	EXC	modified_by:significant;is_negated:No;
5.txt	NCT01800214	Measurement	Mini-Mental State Exam ( MMSE )	EXC	has_value:> 24;
5.txt	NCT02256306	Drug	antipsychotics	EXC	modified_by:typical or atypical;
5.txt	NCT01800214	Condition	psychiatric or neurological illness	EXC	
5.txt	NCT02322021	Condition	Medical conditions	INC	modified_by:stably controlled;
5.txt	NCT00675090	Condition	abnormalities	EXC	modified_by:Clinically significant;
5.txt	NCT02256306	Drug	opioids	EXC	modified_by:long-acting;
5.txt	NCT02322021	Condition	basal or squamous cell carcinoma in situ of the skin	INC	is_negated:except;
5.txt	NCT00675090	Condition	alcohol or other substance abuse	EXC	
5.txt	NCT02256306	Drug	benzodiazepines	EXC	has_value:daily;has_TempMea:Concurrent;
5.txt	NCT01800214	Condition	alcohol or substance abuse or dependence	EXC	has_TempMea:within the past 2 years;
5.txt	NCT02322021	Condition	localized prostate cancer	INC	is_negated:except;
5.txt	NCT00675090	Condition	Diagnostic and Statistical Manual of Mental Disorders - Substance related disorders ( DSM-IV ) criteria	EXC	
5.txt	NCT02322021	Condition	Malignant neoplasms	INC	has_TempMea:within 5 years;
5.txt	NCT00675090	Condition	medical or psychiatric condition	EXC	
5.txt	NCT02256306	Drug	intravenous immunoglobulin	EXC	has_TempMea:during the 6 months;
5.txt	NCT02256306	Drug	investigational agent	EXC	modified_by:last dose;has_TempMea:at least 6 months;
5.txt	NCT00675090	Condition	abnormality	EXC	modified_by:other;modified_by:clinically relevant;
5.txt	NCT02256306	Drug	human blood product	EXC	has_TempMea:during the 6 months;
5.txt	NCT02322021	Drug	medications	INC	has_TempMea:concomitant;
5.txt	NCT00675090	Condition	febrile seizures	EXC	has_TempMea:in childhood;
5.txt	NCT02322021	Condition	left bundle branch block	INC	
5.txt	NCT02322021	Condition	torsade de pointes	INC	
5.txt	NCT00675090	Condition	loss of consciousness	EXC	modified_by:significant;modified_by:unexplained;has_TempMea:within last 6 months;
5.txt	NCT02256306	Drug	Antiplatelet drugs	EXC	has_TempMea:concurrent;
5.txt	NCT02256306	Drug	aspirin	EXC	
5.txt	NCT02256306	Drug	clopidogrel	EXC	
5.txt	NCT01800214	Drug	antidepressant	EXC	
5.txt	NCT01800214	Drug	psychoactive medications	EXC	has_TempMea:Current;
5.txt	NCT01800214	Drug	chronic anxiolytics	EXC	
5.txt	NCT01800214	Drug	neuroleptics	EXC	
5.txt	NCT02322021	Condition	AD	INC	
5.txt	NCT01800214	Drug	sedative hypnotics	EXC	
5.txt	NCT02322021	Condition	AD dementia	INC	
5.txt	NCT02322021	Condition	cardiac arrhythmias	INC	
5.txt	NCT02322021	Condition	Prodromal AD	INC	
5.txt	NCT02322021	Measurement	blood pressure	INC	modified_by:persistent low or high;
5.txt	NCT00675090	Demographic	age	EXC	modified_by:ceased;has_value:10;
5.txt	NCT02256306	Drug	memantine	EXC	modified_by:stable dose;has_TempMea:at least one month;
5.txt	NCT02322021	Condition	MCI	INC	
5.txt	NCT02322021	Measurement	heart rate	INC	modified_by:persistent low or high;
5.txt	NCT02256306	Drug	memantine	EXC	modified_by:Initiation or change in the dosage;
5.txt	NCT02256306	Drug	cholinesterase inhibitor	EXC	modified_by:stable dose;has_TempMea:at least one month;
5.txt	NCT00675090	Drug	anti-epileptic medications	EXC	is_negated:not;
5.txt	NCT00675090	Condition	seizure	EXC	modified_by:other;
5.txt	NCT02256306	Drug	cholinesterase inhibitor	EXC	modified_by:Initiation or change in the dosage;
5.txt	NCT02322021	Measurement	urine drug test	INC	modified_by:positive;
5.txt	NCT00675090	Condition	hypertension	EXC	modified_by:controlled;has_TempMea:at least 4 weeks;
5.txt	NCT02322021	Condition	MCI	INC	
5.txt	NCT02322021	Condition	cognitive impairment	INC	has_TempMea:within 6 months;
5.txt	NCT00675090	Measurement	systolic BP	EXC	has_value:< 160 mmHg;
5.txt	NCT02322021	Condition	dementia	INC	modified_by:mild to moderate;
5.txt	NCT00675090	Observation	medical history	EXC	
5.txt	NCT02322021	Procedure	Positron Emission Tomography ( PET )	INC	modified_by:Amyloid positive;
5.txt	NCT02322021	Demographic	age	INC	has_value:50 to 85 years;
5.txt	NCT02322021	Drug	excipients	INC	
5.txt	NCT00675090	Measurement	diastolic	EXC	has_value:< 60 mmHg;
5.txt	NCT02322021	Drug	Acetylcholinesterase Inhibitor ( AChEI )	INC	has_TempMea:at least 12 weeks;modified_by:stable dose;
5.txt	NCT02322021	Condition	Hypersensitivity	INC	
5.txt	NCT00675090	Measurement	Systolic BP	EXC	has_value:< 100 mmHg;
5.txt	NCT02322021	Drug	study drug	INC	
5.txt	NCT02322021	Drug	investigational medication	INC	has_TempMea:5 half-lives;
5.txt	NCT00675090	Measurement	diastolic	EXC	has_value:< 95 mmHg;
5.txt	NCT02322021	Drug	investigational drug	INC	has_TempMea:within 60 days;
5.txt	NCT02322021	Condition	cardiac, respiratory, gastrointestinal, renal disease	INC	
5.txt	NCT00675090	Measurement	laboratory tests	EXC	
5.txt	NCT02322021	Drug	memantine	INC	modified_by:stable dose;has_TempMea:at least 12 weeks;
5.txt	NCT00675090	Condition	liver disease	EXC	modified_by:active;
5.txt	NCT02322021	Drug	AChEIs	INC	is_negated:no;
5.txt	NCT02322021	Drug	memantine	INC	is_negated:no;
5.txt	NCT00675090	Measurement	diastolic	EXC	has_value:>= 95 mmHg;
5.txt	NCT02322021	Drug	recreational drugs	INC	has_TempMea:current;
5.txt	NCT02322021	Drug	medications	INC	has_TempMea:concomitant;modified_by:permitted;modified_by:chronically used;has_TempMea:at least 4 weeks;modified_by:stable doses;
5.txt	NCT02322021	Condition	drug or alcohol dependency or abuse	INC	has_TempMea:within 2 years;
5.txt	NCT00675090	Measurement	systolic BP	EXC	has_value:>= 160;
5.txt	NCT02322021	Condition	vitiligo	INC	
5.txt	NCT00675090	Condition	hypertension	EXC	modified_by:Uncontrolled;
5.txt	NCT02322021	Condition	Hypopigmentation conditions	INC	
5.txt	NCT02322021	Condition	albinism	INC	
5.txt	NCT00675090	Condition	thyroid disease	EXC	modified_by:uncontrolled;
5.txt	NCT02322021	Condition	neurological condition	INC	
5.txt	NCT02322021	Condition	co-morbidities	INC	
5.txt	NCT01862640	Condition	agitation	INC	has_TempMea:at least 2 weeks;
5.txt	NCT02322021	Condition	cognitive impairment	INC	
5.txt	NCT02322021	Observation	medical history	INC	
5.txt	NCT01862640	Measurement	MMSE score	INC	has_value:5 to 22;
5.txt	NCT02322021	Condition	cerebrovascular disease	INC	
5.txt	NCT02322021	Procedure	MRI	INC	
5.txt	NCT02322021	Measurement	neurological examination	INC	
5.txt	NCT02322021	Condition	transient ischemic attacks	INC	has_TempMea:within 12 months;
5.txt	NCT01862640	Condition	Alzheimer's disease	INC	
5.txt	NCT01862640	Condition	dementia	EXC	
5.txt	NCT01862640	Procedure	MRI	INC	
5.txt	NCT01862640	Procedure	CT scan	INC	
5.txt	NCT01862640	Measurement	agitation/aggression item of the NPI-NH	INC	has_value:>= 4;
5.txt	NCT02322021	Condition	stroke	INC	has_TempMea:within 12 months;
5.txt	NCT02322021	Condition	depression	INC	
5.txt	NCT02322021	Drug	PET tracer	INC	
5.txt	NCT02322021	Condition	epilepsy	INC	
5.txt	NCT02322021	Condition	childbearing potential	INC	
5.txt	NCT02322021	Condition	major depression	INC	
5.txt	NCT02322021	Condition	hallucinations	INC	
5.txt	NCT02322021	Drug	Beta Secretase Cleaving Enzyme ( BACE ) inhibitors	INC	modified_by:other;
5.txt	NCT02322021	Condition	suicidal behavior	INC	has_TempMea:within 6 months;
5.txt	NCT02322021	Condition	suicidal ideation	INC	has_TempMea:within 6 months;
5.txt	NCT01862640	Condition	NINCDS-ADRDA	INC	
5.txt	NCT01862640	Condition	Alzheimer's disease	INC	modified_by:probable;
5.txt	NCT01862640	Demographic	age	INC	has_value:55 to 90 years;
5.txt	NCT02322021	Condition	lactating	INC	
5.txt	NCT02322021	Condition	pregnant	INC	
5.txt	NCT02322021	Condition	suicidal behavior	INC	
5.txt	NCT02322021	Measurement	serum vitamin B12	INC	modified_by:Abnormally low;
5.txt	NCT02322021	Measurement	Thyroid stimulating hormone	INC	has_value:above the normal range;
5.txt	NCT02322021	Condition	hepatic impairment	INC	
5.txt	NCT02322021	Condition	liver disease	INC	
5.txt	NCT02322021	Condition	Gilbert's syndrome	INC	is_negated:excluded;is_negated:not;
5.txt	NCT01800214	Demographic	Age	INC	has_value:between 40 and 90 ( inclusive );
5.txt	NCT01800214	Measurement	Visual and auditory acuity	INC	modified_by:adequate;
5.txt	NCT01800214	Measurement	Mini-Mental State Exam ( MMSE ) score	INC	has_value:> 10;
5.txt	NCT01800214	Condition	causes of dementia	EXC	modified_by:secondary;modified_by:Possible;
5.txt	NCT01800214	Condition	neurological or psychiatric illness	EXC	modified_by:concomitant;
5.txt	NCT01800214	Condition	stroke	EXC	is_negated:other than;
5.txt	NCT02322021	Procedure	MRI	INC	is_negated:Not;
5.txt	NCT02322021	Procedure	PET scanning	INC	is_negated:Not;
5.txt	NCT02322021	Procedure	Lumbar Puncture ( LP )	INC	
5.txt	NCT02322021	Procedure	CSF	INC	is_negated:Not;
5.txt	NCT02322021	Condition	visual or hearing impairment	INC	modified_by:Severe;
6.txt	NCT00951834	Measurement	ASAT/ALAT	EXC	has_value:> 3.5 x higher than the upper reference value;
6.txt	NCT01825330	Condition	Pharmacological immunosuppression	EXC	
6.txt	NCT00951834	Condition	Liver dysfunction	EXC	
6.txt	NCT01825330	Drug	benzodiazepines	EXC	has_TempMea:2 weeks;
6.txt	NCT01825330	Drug	barbiturates	EXC	has_TempMea:2 weeks;
6.txt	NCT00951834	Measurement	Cl	EXC	Specified_by:female;
6.txt	NCT00951834	Demographic	male	EXC	
6.txt	NCT01825330	Condition	medical condition	EXC	modified_by:Unstable;
6.txt	NCT00951834	Measurement	Cl	EXC	has_value:< 110ml/min;
6.txt	NCT01825330	Condition	Mental retardation	EXC	
6.txt	NCT00951834	Condition	Creatinin-Clearance	EXC	
6.txt	NCT01825330	Drug	investigational agent	EXC	has_TempMea:within 6 months;
6.txt	NCT00951834	Measurement	Bilirubin	EXC	has_value:> 2.0 mg/dl;
6.txt	NCT00951834	Measurement	WBC	EXC	has_value:< 2.5/nl;
6.txt	NCT00951834	Measurement	HB	EXC	has_value:< 8.5 g/dl;
6.txt	NCT00951834	Condition	Marrow dysfunction	EXC	
6.txt	NCT00951834	Condition	Kidney dysfunction	EXC	
6.txt	NCT00951834	Measurement	Thrombocytes	EXC	has_value:< 125/nl;
6.txt	NCT01231971	Condition	seizure disorder	EXC	
6.txt	NCT01231971	Condition	subdural hematoma	EXC	
6.txt	NCT01231971	Condition	brain tumor	EXC	
6.txt	NCT01231971	Condition	progressive supranuclear palsy	EXC	
6.txt	NCT01231971	Condition	Huntington's disease	EXC	
6.txt	NCT01825330	Condition	DSM-IV	EXC	
6.txt	NCT01231971	Condition	normal pressure hydrocephalus	EXC	
6.txt	NCT01231971	Condition	Parkinson's disease	EXC	
6.txt	NCT01825330	Condition	neurological or psychiatric condition	EXC	has_TempMea:now or in the past;modified_by:other;
6.txt	NCT00951834	Condition	medical, psychiatric or other condition	EXC	
6.txt	NCT01231971	Condition	multi-infarct dementia	EXC	
6.txt	NCT01825330	Condition	Alcoholism or drug addiction	EXC	has_TempMea:within last 5 years;modified_by:addicted;modified_by:in remission;
6.txt	NCT00951834	Condition	alcohol or drug abuse	EXC	
6.txt	NCT01231971	Condition	multiple sclerosis	EXC	
6.txt	NCT01825330	Condition	sleep deprivation	EXC	modified_by:severe;
6.txt	NCT01825330	Procedure	metal implants	EXC	
6.txt	NCT00951834	Drug	antimycotics of the azol-type	EXC	
6.txt	NCT00951834	Demographic	female	EXC	
6.txt	NCT01825330	Condition	depression	EXC	has_TempMea:now or in the past;
6.txt	NCT00951834	Drug	cytochrom P450 3A4 -inhibitors or -inductors	EXC	has_TempMea:current;
6.txt	NCT01825330	Condition	Contraindication	EXC	
6.txt	NCT01825330	Procedure	TMS treatment	EXC	
6.txt	NCT01825330	Condition	Contraindication	EXC	
6.txt	NCT00951834	Drug	hepatotoxic medication	EXC	modified_by:long-term;
6.txt	NCT01825330	Procedure	MRI scanning	EXC	
6.txt	NCT00951834	Drug	additives of Sunphenon EGCg	EXC	
6.txt	NCT01825330	Condition	Epileptic Seizures	EXC	
6.txt	NCT00951834	Drug	elements of Sunphenon EGCg	EXC	
6.txt	NCT01825330	Condition	Epilepsy	EXC	
6.txt	NCT00951834	Condition	allergy	EXC	
6.txt	NCT01825330	Condition	bipolar disorder	EXC	has_TempMea:now or in the past;
6.txt	NCT01825330	Condition	psychotic disorders	EXC	has_TempMea:now or in the past;
6.txt	NCT00951834	Drug	macrolide-antibiotics	EXC	
6.txt	NCT01231971	Drug	Cholinesterase inhibitors	INC	modified_by:stable;
6.txt	NCT01825330	Condition	abnormal thyroid function	EXC	
6.txt	NCT01231971	Drug	memantine	INC	modified_by:stable;
6.txt	NCT01231971	Drug	sedative hypnotics	INC	is_negated:excluded;
6.txt	NCT01231971	Condition	subdural hematoma	EXC	
6.txt	NCT01825330	Condition	substance abuse	EXC	
6.txt	NCT01231971	Condition	multiple sclerosis	EXC	
6.txt	NCT01825330	Condition	vitamin B12 deficiency	EXC	
6.txt	NCT01231971	Drug	neuroleptics	INC	is_negated:excluded;
6.txt	NCT01231971	Condition	progressive supranuclear palsy	EXC	
6.txt	NCT01825330	Condition	stroke	EXC	
6.txt	NCT01231971	Drug	chronic anxiolytics	INC	is_negated:excluded;
6.txt	NCT01231971	Condition	seizure disorder	EXC	
6.txt	NCT01825330	Condition	brain lesions	EXC	
6.txt	NCT01231971	Drug	psychoactive medication	INC	has_TempMea:at least 4 weeks;modified_by:Washout;
6.txt	NCT01231971	Condition	normal pressure hydrocephalus	EXC	
6.txt	NCT01231971	Drug	antidepressants	INC	is_negated:excluded;
6.txt	NCT01231971	Condition	brain tumor	EXC	
6.txt	NCT01825330	Condition	epilepsy	EXC	
6.txt	NCT01231971	Condition	neurologic defaults	EXC	modified_by:persistent;
6.txt	NCT01825330	Condition	head trauma	EXC	
6.txt	NCT01825330	Condition	cerebrovascular condition	EXC	
6.txt	NCT01231971	Condition	head trauma	EXC	modified_by:significant;
6.txt	NCT01825330	Condition	neurodegenerative disease	EXC	modified_by:other;
6.txt	NCT01231971	Condition	Alzheimer's disease	EXC	is_negated:other than;modified_by:incipient;
6.txt	NCT01231971	Condition	neurologic disease	EXC	modified_by:significant;
6.txt	NCT01825330	Procedure	metal implants	EXC	is_negated:exception;
6.txt	NCT01231971	Condition	neurologic defaults	EXC	modified_by:persistent;
6.txt	NCT01825330	Procedure	implanted brain stimulators	EXC	
6.txt	NCT01231971	Condition	structural brain abnormalities	EXC	
6.txt	NCT01825330	Procedure	aneurysm clips	EXC	
6.txt	NCT01231971	Condition	head trauma	EXC	modified_by:significant;
6.txt	NCT01825330	Procedure	cochlear implants	EXC	
6.txt	NCT01231971	Condition	Parkinson's disease	EXC	
6.txt	NCT01231971	Condition	multi-infarct dementia	EXC	
6.txt	NCT01825330	Condition	neurological/psychiatric disorder	EXC	
6.txt	NCT01231971	Drug	Gingko biloba	INC	
6.txt	NCT01231971	Condition	Huntington's disease	EXC	
6.txt	NCT01825330	Condition	AD	EXC	is_negated:other than;
6.txt	NCT01825330	Condition	medical disorder	EXC	
6.txt	NCT01231971	Drug	Estrogen replacement therapy	INC	
6.txt	NCT01825330	Procedure	TMS treatment	EXC	has_TempMea:in the past;
6.txt	NCT01231971	Condition	anticholinergic side effects	INC	is_negated:lacking;modified_by:significant;
6.txt	NCT01231971	Condition	head trauma	EXC	modified_by:significant;
6.txt	NCT01231971	Procedure	not	EXC	
6.txt	NCT01231971	Condition	contraindications	INC	is_negated:no;
6.txt	NCT01231971	Condition	multiple sclerosis	EXC	
6.txt	NCT01825330	Drug	medication that lower the seizure threshold	EXC	has_TempMea:Currently;
6.txt	NCT01231971	Procedure	MRI	INC	
6.txt	NCT01231971	Drug	Antidepressants	INC	
6.txt	NCT01255163	Procedure	LP	INC	
6.txt	NCT01231971	Condition	seizure disorder	EXC	
6.txt	NCT01231971	Measurement	neuropsychological measures	EXC	has_value:more than one time per year;
6.txt	NCT01231971	Drug	Permitted Medications	INC	modified_by:Stability;
6.txt	NCT01231971	Condition	subdural hematoma	EXC	
6.txt	NCT01825330	Condition	heart disease	EXC	modified_by:Significant;
6.txt	NCT01231971	Drug	antidepressants	INC	is_negated:excluded;
6.txt	NCT01231971	Procedure	FDG PET scan	EXC	Specified_by:not;modified_by:able;
6.txt	NCT00951834	Condition	DSM-IV and NINCDS/ADRDA, Dubois-criteria 2007	INC	
6.txt	NCT01231971	Procedure	Washout	INC	has_TempMea:at least 4 weeks;
6.txt	NCT01231971	Condition	memory complaints	INC	is_negated:free;
6.txt	NCT01231971	Drug	neuroleptics	INC	is_negated:excluded;
6.txt	NCT01231971	Procedure	amyloid imaging with Florbetapir F 18	EXC	Specified_by:not;modified_by:able;
6.txt	NCT01231971	Drug	Gingko biloba	INC	
6.txt	NCT01231971	Condition	neurologic defaults	EXC	modified_by:persistent;
6.txt	NCT01231971	Drug	psychoactive medication	INC	
6.txt	NCT00951834	Condition	AD	INC	modified_by:early stage;
6.txt	NCT01231971	Measurement	Clinical Dementia Rating ( CDR )	INC	has_value:= 0.5 or 1.0;
6.txt	NCT01231971	Condition	multi-infarct dementia	EXC	
6.txt	NCT01231971	Procedure	ADNI-GO	INC	
6.txt	NCT01231971	Measurement	Mini-Mental State Exam ( MMSE ) score	INC	has_value:between 20 and 26 ( inclusive );
6.txt	NCT01825330	Condition	head trauma	EXC	
6.txt	NCT01231971	Condition	Parkinson's disease	EXC	
6.txt	NCT01231971	Measurement	memory function score	INC	modified_by:Abnormal;
6.txt	NCT01231971	Condition	neurologic disease	EXC	modified_by:significant;
6.txt	NCT01231971	Measurement	Wechsler Memory Scale	INC	
6.txt	NCT01231971	Condition	Alzheimer's disease	EXC	is_negated:other than;
6.txt	NCT01825330	Procedure	neurosurgery	EXC	has_TempMea:previous;
6.txt	NCT01231971	Condition	subjective memory concern	INC	
6.txt	NCT01231971	Condition	structural brain abnormalities	EXC	
6.txt	NCT01825330	Condition	multiple sclerosis	EXC	
6.txt	NCT01231971	Condition	brain tumor	EXC	
6.txt	NCT01825330	Procedure	Implanted medication pumps	EXC	
6.txt	NCT01231971	Condition	AD	INC	modified_by:probable;
6.txt	NCT01231971	Condition	progressive supranuclear palsy	EXC	
6.txt	NCT01825330	Condition	Intracardiac lines	EXC	
6.txt	NCT01231971	Condition	Huntington's disease	EXC	
6.txt	NCT01825330	Measurement	neurological exam	EXC	
6.txt	NCT01231971	Condition	normal pressure hydrocephalus	EXC	
6.txt	NCT01825330	Procedure	Cardiac pacemakers	EXC	
6.txt	NCT01825330	Measurement	intracranial pressure	EXC	modified_by:increased;
6.txt	NCT01255163	Condition	renal impairment	INC	modified_by:Severe;
6.txt	NCT01231971	Condition	infarction	EXC	
6.txt	NCT01231971	Condition	Cognitively	INC	modified_by:normal;
6.txt	NCT01231971	Condition	impairment	INC	is_negated:absence;modified_by:significant;
6.txt	NCT01231971	Procedure	MRI scan	EXC	
6.txt	NCT00951834	Drug	Gingko-	EXC	
6.txt	NCT01255163	Measurement	oral glucose tolerance test	INC	has_value:> 200 mg/dl at two hours;
6.txt	NCT01231971	Condition	infection	EXC	
6.txt	NCT02021682	Condition	infection	EXC	modified_by:Active;
6.txt	NCT01255163	Measurement	fasting blood glucose	INC	has_value:= or > 126 mg/dl;modified_by:elevated;
6.txt	NCT01231971	Condition	Cognitively Normal ( CN )	INC	
6.txt	NCT00951834	Drug	anti-dementiva	EXC	modified_by:other;
6.txt	NCT02021682	Drug	anticoagulation therapy	EXC	modified_by:Active;
6.txt	NCT00951834	Drug	Donepezil	EXC	is_negated:except;
6.txt	NCT00951834	Measurement	Cockcroft-Gault-Formula	EXC	
6.txt	NCT01231971	Drug	Antidepressants	INC	
6.txt	NCT02021682	Drug	anti-epileptics	EXC	
6.txt	NCT01255163	Condition	renal disease	INC	modified_by:end-stage;
6.txt	NCT01231971	Procedure	pacemakers	EXC	
6.txt	NCT01825330	Demographic	age	INC	has_value:60 - 90 years;
6.txt	NCT01255163	Measurement	creatinine clearance	INC	has_value:< 30 ml/min;
6.txt	NCT01231971	Condition	multiple lacunes	EXC	is_negated:excluded;
6.txt	NCT02021682	Drug	benzodiazepines	EXC	
6.txt	NCT01231971	Condition	lacunes	EXC	is_negated:excluded;
6.txt	NCT02021682	Drug	muscarinic agents	EXC	
6.txt	NCT00951834	Condition	medical condition	EXC	modified_by:instable;
6.txt	NCT01231971	Drug	Permitted Medications	INC	modified_by:Stability;has_TempMea:4 weeks;
6.txt	NCT01231971	Condition	focal lesions	EXC	modified_by:other;
6.txt	NCT02021682	Condition	syncope	EXC	has_TempMea:Recent;
6.txt	NCT00951834	Condition	familial autosomal-dominant inherited AD	EXC	
6.txt	NCT02021682	Condition	Meningitis	EXC	
6.txt	NCT00951834	Drug	natural extracts	EXC	modified_by:other;
6.txt	NCT01231971	Measurement	Clinical Dementia Rating ( CDR )	INC	has_value:= 0;
6.txt	NCT01231971	Measurement	Mini-Mental State Exam ( MMSE ) score	INC	has_value:between 24 and 30 ( inclusive );
6.txt	NCT01231971	Drug	memantine	INC	modified_by:stable;
6.txt	NCT01231971	Drug	radioactive agents	EXC	has_TempMea:Current or recent;
6.txt	NCT01231971	Measurement	Wechsler Memory Scale	INC	
6.txt	NCT01231971	Drug	Cholinesterase inhibitors	INC	modified_by:stable;
6.txt	NCT01231971	Measurement	total radiation dose exposure	EXC	has_value:exceed the limits of annual and total dose commitment;
6.txt	NCT00951834	Measurement	MMSE	INC	has_value:20 - 26;
6.txt	NCT01231971	Drug	chronic anxiolytics	INC	is_negated:excluded;
6.txt	NCT00951834	Demographic	age	INC	has_value:60 - 100;
6.txt	NCT01231971	Measurement	memory function score	INC	modified_by:Normal;
6.txt	NCT01231971	Drug	sedative hypnotics	INC	is_negated:excluded;
6.txt	NCT01255163	Condition	diabetes	INC	
6.txt	NCT01231971	Measurement	Memory Box score	INC	has_value:0;
6.txt	NCT01231971	Condition	Early Mild Cognitive Impairment ( EMCI )	INC	
6.txt	NCT00951834	Drug	medication	INC	modified_by:stable;
6.txt	NCT01255163	Condition	diabetes	INC	
6.txt	NCT02021682	Condition	Clotting disorder	EXC	
6.txt	NCT00951834	Drug	NSAIDs	EXC	
6.txt	NCT01231971	Condition	Mild Cognitive Impairment ( MCI )	INC	
6.txt	NCT02021682	Measurement	PET/ PIB scores	INC	
6.txt	NCT01255163	Condition	substance abuse	INC	
6.txt	NCT02021682	Demographic	Age	INC	has_value:60 or greater;
6.txt	NCT01825330	Condition	loss of consciousness	EXC	
6.txt	NCT02021682	Measurement	Clinical Dementia Rating ( CDR )	INC	
6.txt	NCT00951834	Drug	Aricept	INC	
6.txt	NCT00951834	Drug	Pfizer Pharma GmbH	INC	
6.txt	NCT00951834	Drug	Donepezil	INC	has_TempMea:at least 3 months to maximum 6 months;
6.txt	NCT01255163	Condition	hypoglycemia	INC	modified_by:repeated;
6.txt	NCT01231971	Drug	medication	EXC	has_TempMea:Currently;
6.txt	NCT01231971	Condition	subjective memory concern	INC	modified_by:significant;
6.txt	NCT01255163	Condition	medullary thyroid carcinoma	INC	
6.txt	NCT01231971	Condition	obsessive-compulsive disorder	EXC	
6.txt	NCT01825330	Condition	AD	INC	
6.txt	NCT01255163	Condition	Multiple Endocrine Neoplasia syndrome type 2	INC	
6.txt	NCT01231971	Condition	attention deficit disorder	EXC	
6.txt	NCT01825330	Drug	cholinesterase inhibitors	INC	has_TempMea:at least 3 months;
6.txt	NCT01825330	Drug	memantine	INC	has_TempMea:at least 3 months;
6.txt	NCT01255163	Drug	Exendin- 4	INC	
6.txt	NCT01231971	Measurement	Clinical Dementia Rating ( CDR )	INC	has_value:= 0;
6.txt	NCT01255163	Demographic	age	INC	has_value:> 65;
6.txt	NCT01231971	Condition	systemic illness	EXC	modified_by:significant;
6.txt	NCT01231971	Procedure	Washout	INC	has_TempMea:at least 4 weeks;
6.txt	NCT01231971	Measurement	Mini-Mental State Exam ( MMSE ) score	INC	has_value:between 24 and 30 ( inclusive );
6.txt	NCT01231971	Condition	alcohol or substance abuse or dependence	EXC	has_TempMea:within the past 2 years;
6.txt	NCT01255163	Condition	dementia	INC	
6.txt	NCT01825330	Measurement	CDR	EXC	has_value:0, 0.5 or 3;
6.txt	NCT01255163	Measurement	Body mass index ( BMI )	INC	has_value:< 20;
6.txt	NCT01231971	Measurement	memory function score	INC	modified_by:Normal;
6.txt	NCT01231971	Condition	schizophrenia	EXC	
6.txt	NCT01231971	Measurement	Wechsler Memory Scale	INC	
6.txt	NCT01825330	Procedure	dose	INC	modified_by:stable;
6.txt	NCT01825330	Drug	Ginko-biloba	INC	has_TempMea:at least 3 months;
6.txt	NCT00951834	Measurement	clinical-anamnestic	EXC	
6.txt	NCT01231971	Drug	antidepressants	INC	is_negated:excluded;
6.txt	NCT01255163	Drug	Exendin- 4	INC	has_TempMea:Current or previous;
6.txt	NCT01255163	Measurement	creatinine clearance	INC	has_value:30 to 50 ml/min;
6.txt	NCT01231971	Drug	Gingko biloba	INC	
6.txt	NCT01231971	Procedure	ear implants	EXC	
6.txt	NCT01825330	Condition	Alzheimer's Disease	INC	modified_by:mild or moderate;
6.txt	NCT01231971	Drug	psychoactive medication	INC	has_TempMea:at least 4 weeks;
6.txt	NCT01231971	Procedure	metal fragments	EXC	
6.txt	NCT01231971	Condition	anticholinergic side effects	INC	is_negated:lacking;modified_by:significant;
6.txt	NCT01231971	Procedure	aneurysm clips	EXC	
6.txt	NCT00951834	Condition	psychiatric/neurologic disorders	EXC	modified_by:primary;modified_by:other;
6.txt	NCT01255163	Condition	renal impairment	INC	modified_by:moderate;
6.txt	NCT01231971	Drug	Estrogen replacement therapy	INC	
6.txt	NCT01231971	Procedure	artificial heart valves	EXC	
6.txt	NCT00951834	Procedure	MRI	EXC	
6.txt	NCT01255163	Condition	MCI	INC	
6.txt	NCT01255163	Condition	Memory deficit	INC	
6.txt	NCT01255163	Condition	AD	INC	modified_by:early;
6.txt	NCT01255163	Measurement	Hamilton Depression Scale score	INC	has_value:ess than or equal to 12;
6.txt	NCT01255163	Condition	upper GI, hepatic or gallbladder disease	INC	modified_by:active;
6.txt	NCT01231971	Condition	memory concern	INC	modified_by:Significant;
6.txt	NCT00951834	Measurement	paraclinical manifestations	EXC	
6.txt	NCT01255163	Measurement	neuropsychological or clinical testing	INC	
6.txt	NCT01231971	Measurement	Cognitive Change Index score	INC	has_value:more than or equal to 16;
6.txt	NCT01825330	Measurement	vision and hearing	INC	modified_by:Normal to near-normal;
6.txt	NCT01255163	Measurement	CSF A beta 42	INC	has_value:< 192 (+- 10%) pg/ml;
6.txt	NCT01255163	Condition	pancreatitis	INC	
6.txt	NCT01231971	Drug	sedative hypnotics	INC	is_negated:excluded;
6.txt	NCT01231971	Condition	bipolar disorder	EXC	has_TempMea:within the past 1 year;
6.txt	NCT01231971	Condition	Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition ( DSM-IV )	EXC	
6.txt	NCT01231971	Drug	neuroleptics	INC	is_negated:excluded;
6.txt	NCT01231971	Drug	chronic anxiolytics	INC	is_negated:excluded;
6.txt	NCT01231971	Condition	Major depression	EXC	has_TempMea:within the past 1 year;
6.txt	NCT01825330	Measurement	ADAS-Cog	INC	has_value:above 17;
6.txt	NCT01255163	Procedure	doses	INC	modified_by:stable;
6.txt	NCT01825330	Condition	DSM-IV criteria	INC	
6.txt	NCT01231971	Procedure	foreign objects	EXC	
6.txt	NCT01825330	Measurement	MMSE score	INC	has_value:18 to 26;
6.txt	NCT01255163	Condition	Alzheimer's disease	INC	
6.txt	NCT01255163	Drug	sodium acetate trihydrate	INC	
6.txt	NCT01231971	Procedure	lumbar puncture	EXC	
6.txt	NCT01255163	Drug	water	INC	
6.txt	NCT01231971	Condition	anticholinergic side effects	INC	is_negated:lacking;modified_by:significant;
6.txt	NCT01231971	Drug	Estrogen replacement therapy	INC	
6.txt	NCT01231971	Drug	investigational agents	EXC	has_TempMea:one month;
6.txt	NCT01255163	Drug	Medications	INC	modified_by:stable;has_TempMea:at least 4 weeks;
6.txt	NCT01255163	Drug	antidepressants	INC	
6.txt	NCT01255163	Condition	disease states	INC	is_negated:no;modified_by:additional;
6.txt	NCT01255163	Drug	chronic anxiolytics	INC	
6.txt	NCT00066157	Measurement	Mini Mental State Examination score	INC	has_value:greater than 15 - 30;
6.txt	NCT01231971	Condition	subjective memory concern	INC	
6.txt	NCT01231971	Condition	neurologic disease	EXC	modified_by:significant;
6.txt	NCT00066157	Condition	dementias	INC	is_negated:without;modified_by:other;
6.txt	NCT01231971	Drug	chronic anxiolytics	INC	is_negated:excluded;
6.txt	NCT01231971	Measurement	total radiation dose exposure	EXC	has_value:exceed the limits of annual and total dose commitment;
6.txt	NCT01255163	Drug	sedative hypnotics	INC	
6.txt	NCT01231971	Drug	sedative hypnotics	INC	is_negated:excluded;
6.txt	NCT00066157	Condition	Postmenopausal	INC	
6.txt	NCT01231971	Drug	antidepressants	INC	is_negated:excluded;
6.txt	NCT01231971	Procedure	amyloid imaging with Florbetapir F 18	EXC	is_negated:Exclusion;
6.txt	NCT00066157	Condition	Alzheimer's disease	INC	
6.txt	NCT01231971	Drug	neuroleptics	INC	is_negated:excluded;
6.txt	NCT01231971	Drug	radioactive agents	EXC	has_TempMea:Current or recent;
6.txt	NCT01231971	Drug	Gingko biloba	INC	
6.txt	NCT01231971	Drug	psychoactive medication	INC	
6.txt	NCT01231971	Procedure	FDG PET scan	EXC	is_negated:Exclusion;
6.txt	NCT01231971	Condition	National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders Association ( NINCDS/ADRDA ) criteria	INC	
6.txt	NCT01255163	Measurement	SD	INC	has_value:3.9;
6.txt	NCT01825330	Condition	agitation	EXC	modified_by:Severe;
6.txt	NCT01255163	Measurement	mean BMI	INC	has_value:25.8;
6.txt	NCT01231971	Measurement	Memory Box score	INC	has_value:0;
6.txt	NCT01231971	Condition	medical condition	EXC	modified_by:unstable;
6.txt	NCT01255163	Drug	Cholinesterase inhibitors	INC	modified_by:started;
6.txt	NCT01255163	Drug	memantine	INC	modified_by:started;
6.txt	NCT01255163	Condition	general health	INC	modified_by:Good;
6.txt	NCT01255163	Drug	investigational treatments	INC	
6.txt	NCT01255163	Drug	mannitol	INC	
6.txt	NCT01231971	Drug	warfarin	EXC	has_TempMea:Current;
6.txt	NCT01255163	Drug	glacial acetic acid	INC	
6.txt	NCT01231971	Drug	Antidepressants	INC	
6.txt	NCT01231971	Drug	dabigatran	EXC	Specified_by:warfarin;
6.txt	NCT01255163	Drug	Exendin- 4	INC	
6.txt	NCT01231971	Drug	chronic anxiolytics	EXC	
6.txt	NCT01255163	Condition	neurological disease	INC	modified_by:Other;modified_by:significant;
6.txt	NCT01255163	Drug	metacresol	INC	
6.txt	NCT01231971	Drug	Permitted Medications	INC	modified_by:Stability;has_TempMea:4 weeks;
6.txt	NCT01231971	Drug	sedative hypnotics	EXC	
6.txt	NCT01255163	Measurement	weight loss	INC	
6.txt	NCT01231971	Drug	antidepressants	EXC	
6.txt	NCT01255163	Condition	Allergy	INC	
6.txt	NCT01231971	Condition	memory impairment	INC	is_negated:absence;modified_by:significant;
6.txt	NCT01231971	Drug	neuroleptics	EXC	
6.txt	NCT01231971	Condition	Cognitively	INC	
6.txt	NCT01231971	Condition	abnormalities in B12 or TFTs	EXC	modified_by:Clinically significant;
6.txt	NCT01231971	Drug	psychoactive medications	EXC	has_TempMea:Current;
6.txt	NCT00066157	Condition	blot clots	EXC	
6.txt	NCT01255163	Condition	Parkinson s disease	INC	
6.txt	NCT00066157	Condition	Diabetes	EXC	
6.txt	NCT00066157	Condition	Heart disease	EXC	
6.txt	NCT01231971	Drug	Permitted Medications	INC	modified_by:Stability;
6.txt	NCT01255163	Condition	Frontotemporal Dementia	INC	
6.txt	NCT01255163	Condition	Multi-infarct Dementia	INC	
6.txt	NCT01231971	Condition	AD	INC	is_negated:cannot;
6.txt	NCT01255163	Condition	Normal Pressure Hydrocephalus	INC	
6.txt	NCT01255163	Condition	Huntington s disease	INC	
6.txt	NCT01255163	Condition	Progressive Supranuclear Palsy	INC	
6.txt	NCT01255163	Condition	brain tumor	INC	
6.txt	NCT01255163	Condition	Subdural Hematoma	INC	
6.txt	NCT00066157	Procedure	psychometric testing	EXC	modified_by:inability;
6.txt	NCT01231971	Drug	Estrogen replacement therapy	INC	
6.txt	NCT01255163	Condition	Epilepsy	INC	
6.txt	NCT00066157	Condition	vision or hearing problems	EXC	modified_by:Severe;
6.txt	NCT00066157	Drug	Tobacco	EXC	
6.txt	NCT00066157	Condition	hepatitis	EXC	
6.txt	NCT01231971	Condition	anticholinergic side effects	INC	is_negated:lacking;modified_by:significant;
6.txt	NCT00066157	Condition	stroke	EXC	
6.txt	NCT00066157	Condition	Liver problems	EXC	
6.txt	NCT01231971	Drug	Antidepressants	INC	
6.txt	NCT02021682	Drug	experimental treatment	EXC	has_TempMea:Currently;
6.txt	NCT01255163	Drug	substances	INC	
6.txt	NCT01255163	Condition	Multiple Sclerosis	INC	
6.txt	NCT01255163	Measurement	weight loss	INC	has_value:average 5.3 kg;
6.txt	NCT01231971	Measurement	memory function score	INC	modified_by:Abnormal;
6.txt	NCT01255163	Measurement	size	INC	has_value:> 3 mm;
6.txt	NCT01255163	Condition	head trauma	INC	modified_by:significant;
6.txt	NCT01255163	Condition	structural brain abnormalities	INC	
6.txt	NCT01255163	Condition	neurologic defaults	INC	modified_by:persistent;
6.txt	NCT01255163	Condition	neuroimaging abnormalities	INC	modified_by:Significant;
6.txt	NCT01231971	Measurement	Memory Box score	INC	has_value:at least 0.5;
6.txt	NCT01255163	Procedure	MRI scan	INC	
6.txt	NCT00066157	Condition	deep vein thrombosis	EXC	
6.txt	NCT01231971	Procedure	ADNI1	INC	has_value:at least one year;
6.txt	NCT00066157	Condition	cancer of reproductive tissues	EXC	
6.txt	NCT01255163	Drug	Exendin- 4	INC	
6.txt	NCT01231971	Measurement	Clinical Dementia Rating ( CDR )	INC	has_value:= 0.5;
6.txt	NCT01255163	Measurement	95% CI	INC	has_value:6 to 4.5 kg;
6.txt	NCT01231971	Measurement	Wechsler Memory Scale	INC	
6.txt	NCT01231971	Measurement	Mini-Mental State Exam ( MMSE ) score	INC	has_value:between 24 and 30 ( inclusive );
6.txt	NCT01255163	Condition	infarction	INC	
6.txt	NCT01255163	Condition	infection	INC	
6.txt	NCT01231971	Condition	of childbearing potential	INC	is_negated:not;
6.txt	NCT01231971	Measurement	cognitive functions	INC	
6.txt	NCT01231971	Condition	pregnant	INC	is_negated:not;
6.txt	NCT01255163	Condition	brain tumors	INC	
6.txt	NCT01231971	Condition	lactating	INC	is_negated:not;
6.txt	NCT01255163	Condition	benign lesions	INC	modified_by:other;
6.txt	NCT01255163	Condition	small meningiomas	INC	is_negated:other than;
6.txt	NCT01255163	Condition	focal lesions	INC	modified_by:other;
6.txt	NCT01231971	Measurement	Hachinski	INC	has_value:less than or equal to 4;
6.txt	NCT01231971	Condition	post-menopausal	INC	has_TempMea:two years;
6.txt	NCT01231971	Condition	surgically sterile	INC	
6.txt	NCT01255163	Condition	lacunes	INC	
6.txt	NCT01255163	Condition	multiple lacunes	INC	
6.txt	NCT01231971	Demographic	Age	INC	has_value:between *55 - 90 ( inclusive );
6.txt	NCT01255163	Condition	white matter changes	INC	modified_by:mild;is_negated:not;
6.txt	NCT01255163	Condition	confluent microvascular disease	INC	modified_by:severe;
6.txt	NCT01231971	Measurement	Geriatric Depression Scale	INC	has_value:less than 6;
6.txt	NCT01255163	Measurement	RPR	INC	modified_by:Positive;
6.txt	NCT01231971	Condition	general health	INC	modified_by:Good;
6.txt	NCT01231971	Measurement	Visual and auditory acuity	INC	modified_by:adequate;
6.txt	NCT01231971	Demographic	age	INC	has_value:between 65 - 90;
6.txt	NCT01255163	Condition	Coagulopathy	INC	
6.txt	NCT01255163	Condition	HIV	INC	modified_by:Positive;
6.txt	NCT01255163	Drug	coumadin	INC	
6.txt	NCT01255163	Drug	anti-coagulant therapy	INC	
6.txt	NCT01255163	Measurement	INR	INC	has_value:within 1.5 standard deviation over the upper normal limit;
6.txt	NCT01255163	Measurement	PT/PTT	INC	has_value:within 1.5 standard deviation over the upper normal limit;
6.txt	NCT01255163	Procedure	Lumbar Puncture	INC	
6.txt	NCT01255163	Procedure	CSF	INC	
6.txt	NCT01255163	Demographic	Age	INC	has_value:> 60;
6.txt	NCT01255163	Measurement	Clinical Dementia Rating ( global CDR )	INC	has_value:0.5 or 1;
6.txt	NCT01255163	Measurement	Memory box score	INC	has_value:at least 0.5;
6.txt	NCT01255163	Measurement	Mini Mental Status Exam ( MMSE )	INC	has_value:> 20;
6.txt	NCT01255163	Condition	psychiatric conditions	INC	
6.txt	NCT01255163	Condition	psychiatric disease	INC	modified_by:significant;
6.txt	NCT01255163	Condition	MCI	INC	
6.txt	NCT01255163	Condition	late-onset depression	INC	
6.txt	NCT01255163	Condition	depression	INC	
6.txt	NCT01255163	Condition	AD	INC	
6.txt	NCT01255163	Procedure	treatment	INC	
6.txt	NCT01255163	Condition	alcoholism	INC	
6.txt	NCT00951834	Condition	vascular CNS-disorders	EXC	has_TempMea:1 year before;
6.txt	NCT00951834	Condition	liver disorders	EXC	has_TempMea:1 year before;
6.txt	NCT00951834	Condition	TBC	EXC	
6.txt	NCT00951834	Condition	GI-disorders	EXC	
6.txt	NCT00951834	Condition	lung, infectious, heart or other CNS disorders	EXC	
6.txt	NCT00951834	Condition	functional disorders	EXC	
7.txt	NCT00401167	Condition	Dementia	EXC	
7.txt	NCT00401167	Condition	medical illness	EXC	has_TempMea:Current;modified_by:uncontrolled;
7.txt	NCT00448318	Condition	hearing impairment	EXC	modified_by:severe;
7.txt	NCT00401167	Condition	Alzheimer's Disease	EXC	is_negated:other than;
7.txt	NCT00448318	Condition	psychiatric conditions	EXC	modified_by:primary;
7.txt	NCT00448318	Condition	schizophrenia	EXC	
7.txt	NCT01689246	Condition	Alzheimer's disease	INC	modified_by:probable;
7.txt	NCT01689246	Measurement	Clinical Dementia Rating ( CDR ) total score	INC	has_value:1 ( mild ) to 2 ( moderate );
7.txt	NCT01689246	Condition	dementia	INC	
7.txt	NCT00355498	Condition	cerebrovascular disease	INC	is_negated:No;modified_by:significant;
7.txt	NCT00355498	Measurement	modified Ischemic Score	INC	has_value:<= 4;
7.txt	NCT00355498	Demographic	Age	INC	has_value:30 years or older;
7.txt	NCT01689246	Measurement	MMSE score	INC	has_value:14 - 26 ( inclusive );
7.txt	NCT00501111	Condition	Alzheimer's diseas	EXC	
7.txt	NCT01689246	Demographic	Age	INC	has_value:< 90 years;
7.txt	NCT01689246	Measurement	Modified Hachinski ischemic score	INC	has_value:<= 4;
7.txt	NCT00501111	Drug	memantine	EXC	has_TempMea:within 8 weeks;
7.txt	NCT01689246	Drug	memantine	INC	has_TempMea:currently;
7.txt	NCT01689246	Drug	acetylcholinesterase inhibitor	INC	has_TempMea:currently;
7.txt	NCT00448318	Condition	pneumonia	EXC	
7.txt	NCT00448318	Condition	cardiac failure	EXC	
7.txt	NCT00448318	Condition	medical conditions	EXC	modified_by:acute;
7.txt	NCT00448318	Condition	dementia	INC	
7.txt	NCT00448318	Condition	delirium	EXC	
7.txt	NCT01689246	Procedure	dosage	INC	modified_by:stable;
7.txt	NCT01689246	Condition	central nervous system ( CNS ) disorder	EXC	modified_by:Significant;
7.txt	NCT01689246	Condition	Alzheimer's disease	EXC	is_negated:other than;
7.txt	NCT01689246	Condition	focal or vascular intracranial pathology	EXC	modified_by:Significant;
7.txt	NCT01689246	Procedure	MRI scan	EXC	
7.txt	NCT00105547	Condition	Alzheimer's disease	INC	modified_by:probable;
7.txt	NCT00105547	Condition	surgically sterile	INC	
7.txt	NCT00105547	Condition	postmenopausal	INC	has_TempMea:> 1 year;
7.txt	NCT00105547	Drug	approved medication	INC	has_TempMea:currently;has_TempMea:at least six months;
7.txt	NCT00105547	Condition	Alzheimer's disease	INC	
7.txt	NCT01689246	Condition	Epilepsy	EXC	
7.txt	NCT01689246	Condition	stroke	EXC	
7.txt	NCT01689246	Condition	transient ischemic attack	EXC	
7.txt	NCT01689246	Condition	loss of consciousness	EXC	modified_by:unexplained or recurrent;has_value:>= 15 minutes;modified_by:other;
7.txt	NCT01689246	Condition	head injury	EXC	modified_by:significant;
7.txt	NCT00355498	Drug	clonidine	EXC	
7.txt	NCT00551772	Observation	smoke	EXC	has_value:more than 10 cigarettes or equivalent a day;
7.txt	NCT01689246	Drug	Treatment	EXC	has_TempMea:within 3 months;has_TempMea:currently;
7.txt	NCT00551772	Condition	condition	EXC	modified_by:other;
7.txt	NCT00355498	Measurement	Screening laboratory tests	INC	
7.txt	NCT00355498	Procedure	ECG	INC	
7.txt	NCT00355498	Condition	abnormalities	INC	is_negated:without;modified_by:significant;
7.txt	NCT00355498	Measurement	visual and auditory acuity	INC	modified_by:Adequate;
7.txt	NCT00355498	Condition	dementia	INC	
7.txt	NCT00355498	Condition	cognitive deterioration	EXC	
7.txt	NCT00355498	Condition	Parkinson's disease	EXC	
7.txt	NCT00355498	Condition	neurologic or other physical illness	EXC	
7.txt	NCT01689246	Drug	medication ( s )	INC	has_TempMea:>= 3 months;
7.txt	NCT00355498	Condition	MCI	INC	
7.txt	NCT01689246	Procedure	cochlear implants	EXC	
7.txt	NCT00355498	Condition	pulmonary disease	EXC	modified_by:clinically significant;
7.txt	NCT01689246	Procedure	pacemaker	EXC	
7.txt	NCT00355498	Condition	diabetes	EXC	
7.txt	NCT01689246	Condition	substance ( including alcohol ) related disorders	EXC	
7.txt	NCT00355498	Condition	liver disease	EXC	modified_by:significant;
7.txt	NCT01689246	Procedure	Metal implants	EXC	
7.txt	NCT01689246	Condition	psychotic disorders	EXC	modified_by:other;
7.txt	NCT01689246	Condition	bipolar disorder	EXC	
7.txt	NCT00355498	Condition	bipolar disorder	EXC	
7.txt	NCT01689246	Condition	freedom from disease	EXC	has_TempMea:at least 2 years;modified_by:complete;
7.txt	NCT01689246	Condition	swallowing difficulties	EXC	
7.txt	NCT00355498	Condition	schizophrenia	EXC	
7.txt	NCT01689246	Condition	contraindications	EXC	
7.txt	NCT01689246	Procedure	MRI	EXC	
7.txt	NCT00355498	Condition	psychiatric disorders	EXC	modified_by:Major;
7.txt	NCT00355498	Condition	cancer	EXC	
7.txt	NCT00355498	Condition	hypertension	EXC	modified_by:Uncontrolled;
7.txt	NCT00355498	Condition	cardiac disease	EXC	modified_by:unstable;
7.txt	NCT00355498	Condition	myocardial infarction	EXC	has_TempMea:within the previous year;
7.txt	NCT01689246	Condition	schizophrenia	EXC	
7.txt	NCT00355498	Measurement	systolic BP	EXC	has_value:> 170;
7.txt	NCT01689246	Condition	depressive disorder	EXC	modified_by:Major;
7.txt	NCT00355498	Measurement	diastolic BP	EXC	has_value:> 100;
7.txt	NCT01689246	Measurement	assessments	EXC	modified_by:abnormal;
7.txt	NCT01689246	Condition	cardiovascular disease	EXC	modified_by:Clinically significant;
7.txt	NCT00355498	Condition	depression	EXC	modified_by:untreated;
7.txt	NCT00355498	Measurement	HAM-D ( Hamilton, 1960 ) score	EXC	has_value:>= 12;
7.txt	NCT01689246	Measurement	serum chemistry laboratory value	EXC	modified_by:Abnormal;
7.txt	NCT00355498	Condition	drug dependence	EXC	
7.txt	NCT01689246	Condition	immunologic, hepatic or endocrine disease	EXC	modified_by:acute or chronic;modified_by:clinically significant;has_TempMea:Concurrent;
7.txt	NCT00355498	Drug	investigational drugs	EXC	has_TempMea:within the previous month or longer;
7.txt	NCT00355498	Measurement	Hamilton Anxiety Scale	EXC	has_value:>= 8;
7.txt	NCT01689246	Condition	respiratory failure	EXC	
7.txt	NCT00355498	Condition	anxiety	EXC	modified_by:untreated;
7.txt	NCT00355498	Drug	systemic corticosteroids	EXC	
7.txt	NCT01689246	Condition	hematological abnormality	EXC	modified_by:significant;
7.txt	NCT01689246	Condition	Glucose-6-phosphate dehydrogenase deficiency	EXC	
7.txt	NCT00355498	Drug	anti-Parkinsonian medications	EXC	
7.txt	NCT00355498	Drug	benzodiazepines	EXC	
7.txt	NCT00551772	Measurement	medical or lab evaluation	EXC	
7.txt	NCT01689246	Condition	Pregnant	EXC	
7.txt	NCT00355498	Drug	centrally active beta-blockers	EXC	
7.txt	NCT01689246	Condition	breastfeeding	EXC	
7.txt	NCT00355498	Drug	narcotics	EXC	
7.txt	NCT00105547	Condition	causes of dementia	EXC	modified_by:other;has_TempMea:Current;
7.txt	NCT00105547	Condition	basal cell carcinoma	EXC	is_negated:except;
7.txt	NCT01689246	Condition	abnormality	EXC	modified_by:acute or chronic;modified_by:clinically significant;has_TempMea:current;
7.txt	NCT00105547	Condition	malignancy	EXC	modified_by:active;has_TempMea:within the 24 months;
7.txt	NCT00355498	Condition	alcoholism	EXC	
7.txt	NCT00355498	Drug	warfarin	EXC	
7.txt	NCT00355498	Drug	medications with significant cholinergic or anticholinergic effects	EXC	
7.txt	NCT00105547	Condition	squamous cell carcinoma of the skin	EXC	is_negated:except;
7.txt	NCT00355498	Drug	anti-convulsants	EXC	
7.txt	NCT01689246	Drug	methylthioninium-containing drug	EXC	
7.txt	NCT01689246	Condition	intolerance	EXC	has_TempMea:Prior;
7.txt	NCT01689246	Condition	hypersensitivity	EXC	has_TempMea:Prior;
7.txt	NCT00551772	Measurement	pre-study urine screen	EXC	modified_by:positive;
7.txt	NCT00105547	Condition	prostate cancer	EXC	
7.txt	NCT00105547	Drug	investigational therapy	EXC	has_TempMea:within 30 days or 5 half-lives;
7.txt	NCT00105547	Condition	renal, hepatic or metabolic disorder	EXC	has_TempMea:Chronic or acute;
7.txt	NCT00105547	Drug	AD immunotherapy	EXC	
7.txt	NCT00105547	Procedure	Major surgery	EXC	has_TempMea:within 12 weeks;
7.txt	NCT01689246	Drug	Carbamazepine	EXC	
7.txt	NCT00551772	Procedure	donation of blood	EXC	has_TempMea:within a 56 day period;has_value:excess of 500ml;
7.txt	NCT01689246	Drug	primidone	EXC	
7.txt	NCT01689246	Drug	Clozapine	EXC	
7.txt	NCT00551772	Drug	dietary supplements	EXC	has_TempMea:within 7 days;
7.txt	NCT01689246	Drug	olanzapine	EXC	
7.txt	NCT00551772	Drug	prescription drugs	EXC	has_TempMea:within 7 days;
7.txt	NCT01689246	Drug	Tacrine	EXC	
7.txt	NCT00551772	Drug	herbal	EXC	has_TempMea:within 7 days;
7.txt	NCT01689246	Drug	similar organic dyes	EXC	
7.txt	NCT00551772	Condition	drugs of abuse	EXC	
7.txt	NCT01689246	Drug	excipients	EXC	
7.txt	NCT00551772	Condition	Abuse of alcohol	EXC	
7.txt	NCT00355498	Procedure	metal	EXC	
7.txt	NCT01689246	Condition	Alzheimer's disease	EXC	is_negated:other than;
7.txt	NCT00355498	Condition	Contraindication	EXC	
7.txt	NCT01689246	Condition	disease	EXC	modified_by:unstable or major;modified_by:other;
7.txt	NCT00355498	Procedure	MRI scan	EXC	
7.txt	NCT00105547	Condition	complications	EXC	modified_by:related;has_TempMea:within 12 weeks;
7.txt	NCT00401167	Demographic	age	INC	has_value:> 65 years;
7.txt	NCT00401167	Condition	Diagnosis and Statistical Manual of Mental Disorders ( DSM-IV-TR )	INC	
7.txt	NCT00401167	Condition	Dementia of the Alzheimer's type	INC	
7.txt	NCT00401167	Measurement	Mini Mental State Examination total score	INC	has_value:<= 15;
7.txt	NCT00401167	Condition	agitation/aggression subscale	INC	has_value:> 1;
7.txt	NCT00551772	Condition	abnormality	EXC	is_negated:No;modified_by:clinically significant;
7.txt	NCT00401167	Measurement	Neuropsychiatric Inventory-Nursing Home Version total score	INC	has_value:> 10;
7.txt	NCT00551772	Measurement	BMI	EXC	has_value:between 18.5 and 32.0 kg/m2;
7.txt	NCT01689246	Condition	basal cell or squamous cell skin cancer	EXC	is_negated:other than;
7.txt	NCT01689246	Condition	prostate cancer	EXC	modified_by:Stage 1;is_negated:other than;
7.txt	NCT00551772	Condition	post-menopausal	EXC	
7.txt	NCT00551772	Condition	Healthy	EXC	
7.txt	NCT00355498	Condition	claustrophobia	EXC	
7.txt	NCT01689246	Condition	cancer	EXC	has_TempMea:within the past 2 years;
7.txt	NCT00551772	Condition	surgically sterile	EXC	
7.txt	NCT00401167	Condition	behavioral and psychological symptoms	INC	
7.txt	NCT00501111	Condition	Alzheimer's disease	INC	modified_by:probable;
7.txt	NCT00551772	Condition	febrile seizures	EXC	
7.txt	NCT00551772	Condition	loss of consciousness	EXC	modified_by:recent;modified_by:unexplained;
7.txt	NCT00401167	Drug	benzodiazepine	INC	
7.txt	NCT00401167	Condition	dementia	INC	
7.txt	NCT00551772	Condition	seizures	EXC	
7.txt	NCT00401167	Drug	trazodone	INC	
7.txt	NCT00401167	Drug	antipsychotic	INC	
7.txt	NCT00401167	Drug	prescription medication	INC	has_TempMea:in the prior 3 months;has_value:at least 1 dose;has_TempMea:current;
7.txt	NCT00501111	Condition	major psychiatric disorder	EXC	modified_by:other;
7.txt	NCT00501111	Drug	acetylcholinesterase inhibitor	EXC	has_TempMea:within 8 weeks;
7.txt	NCT00501111	Condition	Major depressive disorder	EXC	
7.txt	NCT00551772	Condition	head trauma with loss of consciousness	EXC	modified_by:significant;
7.txt	NCT00501111	Condition	Alzheimer's disease	EXC	is_negated:other than;
7.txt	NCT00501111	Condition	neurologic disease	EXC	modified_by:Significant;
7.txt	NCT00501111	Condition	dementia	EXC	
7.txt	NCT01689246	Condition	methemoglobinemia	EXC	
7.txt	NCT01689246	Drug	Drugs	EXC	
7.txt	NCT00401167	Drug	psychotropic	INC	modified_by:regularly administered;has_TempMea:current;
7.txt	NCT00401167	Drug	serotonin-norepinephrine reuptake inhibitors	INC	
7.txt	NCT00401167	Drug	selective serotonin reuptake inhibitors	INC	
7.txt	NCT01689246	Drug	product	EXC	has_TempMea:within 3 months;
7.txt	NCT00401167	Drug	atypical antipsychotics	INC	
7.txt	NCT00401167	Drug	trazodone	INC	
7.txt	NCT00401167	Drug	cholinesterase inhibitors	INC	
7.txt	NCT00401167	Drug	typical antipsychotics	INC	
7.txt	NCT00401167	Procedure	dose	INC	modified_by:stable;
7.txt	NCT01689246	Procedure	biologic, therapeutic device	EXC	
7.txt	NCT01689246	Drug	medical food	EXC	
7.txt	NCT01689246	Procedure	dose/administration	EXC	modified_by:last;
7.txt	NCT00551772	Measurement	excretion	EXC	
7.txt	NCT01689246	Drug	drug	EXC	
7.txt	NCT00551772	Drug	investigational drug	EXC	has_TempMea:within 30 days or 5 half-lives or twice the duration of the biological effect;
7.txt	NCT00551772	Observation	distribution	EXC	
7.txt	NCT00551772	Observation	metabolism	EXC	
7.txt	NCT00551772	Condition	gastro-intestinal, hepatic or renal disease	EXC	
7.txt	NCT01689246	Condition	cognition	EXC	
7.txt	NCT00551772	Measurement	absorption	EXC	
8.txt	NCT01780974	Measurement	Screening laboratory values	INC	modified_by:within normal limits;modified_by:clinically insignificant;modified_by:abnormal;
8.txt	NCT01303744	Drug	sedatives	EXC	
8.txt	NCT01303744	Drug	hypnotics	EXC	
8.txt	NCT01780974	Condition	Alzheimer's	EXC	
8.txt	NCT01303744	Drug	psychoactive drugs	EXC	has_TempMea:Concomitant;
8.txt	NCT01780974	Condition	Dementia	EXC	
8.txt	NCT01780974	Condition	cancer	EXC	has_TempMea:< 5 years;
8.txt	NCT01780974	Condition	neurodegenerative disease	EXC	modified_by:other;
8.txt	NCT01258452	Measurement	standard laboratory tests	INC	
8.txt	NCT01258452	Measurement	vital signs	INC	
8.txt	NCT01258452	Procedure	12 -lead electrocardiogram ( ECG )	INC	
8.txt	NCT01258452	Observation	medical history	INC	
8.txt	NCT01258452	Measurement	complete physical examination	INC	
8.txt	NCT01780974	Measurement	gleason grade	EXC	has_value:< 3;
8.txt	NCT01780974	Condition	prostate cancer	EXC	
8.txt	NCT01780974	Condition	non metastatic skin cancers	EXC	
8.txt	NCT01303744	Drug	donepezil	EXC	has_TempMea:Concomitant;
8.txt	NCT01303744	Procedure	doses	EXC	has_value:> 5 mg/day;
8.txt	NCT01780974	Condition	liver disease	EXC	
8.txt	NCT01303744	Condition	chronic inflammatory bowel disease	EXC	
8.txt	NCT01780974	Condition	ventricular tachycardia	EXC	
8.txt	NCT01780974	Condition	ventricular fibrillation	EXC	
8.txt	NCT01780974	Condition	psychiatric disorder	EXC	modified_by:major;
8.txt	NCT01303744	Procedure	dose	EXC	has_value:> 20 mg/day;
8.txt	NCT01303744	Drug	galantamine	EXC	
8.txt	NCT01303744	Drug	memantine	EXC	has_TempMea:Concomitant;
8.txt	NCT01303744	Drug	cholinesterase inhibitors	EXC	modified_by:other;
8.txt	NCT01303744	Drug	rivastigmine	EXC	
8.txt	NCT01780974	Condition	brain tumor	EXC	
8.txt	NCT01780974	Condition	central nervous system diseases	EXC	
8.txt	NCT01780974	Condition	seizure disorder	EXC	
8.txt	NCT01780974	Condition	Insulin dependent diabetes	EXC	
8.txt	NCT01780974	Condition	diabetes	EXC	
8.txt	NCT01780974	Condition	diabetes	EXC	modified_by:uncontrolled;
8.txt	NCT01780974	Drug	insulin	EXC	
8.txt	NCT01780974	Drug	medications	EXC	
8.txt	NCT02103673	Condition	Alzheimer's disease	INC	modified_by:probable;
8.txt	NCT02103673	Condition	vascular dementia	INC	modified_by:probable;
8.txt	NCT02103673	Condition	vascular dementia	INC	
8.txt	NCT02103673	Condition	post-stroke period	INC	has_value:more than 3 months;
8.txt	NCT02103673	Measurement	Mini-Mental State scores	INC	has_value:between 5 - 26;
8.txt	NCT01780974	Drug	Fish intake	EXC	has_value:> once a week;has_value:6 ounce;has_TempMea:less than 4 months;
8.txt	NCT01780974	Drug	Omega- 3 fatty acid supplement	EXC	has_TempMea:less than 4 months;
8.txt	NCT01780974	Drug	cod liver oil	EXC	
8.txt	NCT01780974	Drug	fish oil capsules	EXC	
8.txt	NCT01780974	Drug	Lipoic Acid supplementation	EXC	has_TempMea:less than 1 month;
8.txt	NCT01258452	Measurement	liver function tests	EXC	modified_by:Abnormal;
8.txt	NCT01258452	Measurement	renal function tests	EXC	modified_by:Abnormal;
8.txt	NCT01258452	Condition	cardiovascular, hepatic or renal disease	EXC	has_TempMea:within the last 10 years;modified_by:major;
8.txt	NCT01258452	Condition	allergic conditions	EXC	modified_by:Significant;
8.txt	NCT01258452	Measurement	thyroid tests	EXC	modified_by:Abnormal;
8.txt	NCT01258452	Condition	good health	INC	
8.txt	NCT01258452	Measurement	body mass index	INC	has_value:between 18 and 30 kg/m^2, inclusive;
8.txt	NCT01780974	Condition	restless leg syndrome	EXC	
8.txt	NCT01780974	Drug	dopamine agonist	EXC	has_value:once a day;
8.txt	NCT01780974	Procedure	dose	EXC	modified_by:Low;
8.txt	NCT01780974	Drug	narcotic analgesics	EXC	
8.txt	NCT01780974	Drug	sinemet	EXC	has_value:once a day;
8.txt	NCT01780974	Procedure	stimulators	EXC	
8.txt	NCT01780974	Procedure	pacemakers	EXC	
8.txt	NCT01780974	Condition	Contraindications	EXC	
8.txt	NCT01780974	Procedure	MRI	EXC	
8.txt	NCT01258452	Drug	indomethacin	EXC	has_TempMea:within 2 weeks;
8.txt	NCT01258452	Drug	flurbiprofen	EXC	has_TempMea:within 2 weeks;
8.txt	NCT01258452	Drug	ibuprofen	EXC	has_TempMea:within 2 weeks;
8.txt	NCT01258452	Drug	sulindac sulfide	EXC	has_TempMea:within 2 weeks;
8.txt	NCT01258452	Drug	psychoactive, recreational or prescription drug	EXC	has_TempMea:within the 4 weeks;
8.txt	NCT01780974	Drug	neuroleptics	EXC	
8.txt	NCT01780974	Procedure	MRI-safe cardiac stents	EXC	is_negated:excluded;is_negated:not;
8.txt	NCT01780974	Drug	antiparkinsonian agents	EXC	
8.txt	NCT01780974	Drug	systemic corticosteroids	EXC	
8.txt	NCT01780974	Procedure	hip replacement	EXC	
8.txt	NCT02226835	Condition	contraindication	INC	
8.txt	NCT02226835	Condition	Huntington's disease	INC	
8.txt	NCT02226835	Condition	vascular dementia	INC	
8.txt	NCT02226835	Condition	Lewy body dementia	INC	
8.txt	NCT02226835	Condition	Parkinson s disease dementia	INC	
8.txt	NCT02226835	Procedure	procedures	INC	
8.txt	NCT02226835	Condition	medical or psychiatric illness	INC	has_TempMea:current;modified_by:severe;
8.txt	NCT02226835	Condition	Alzheimer s disease	INC	is_negated:other than;
8.txt	NCT01303744	Procedure	dose	EXC	modified_by:any;
8.txt	NCT01780974	Condition	claustrophobia	EXC	
8.txt	NCT01780974	Procedure	metal fragments	EXC	
8.txt	NCT01780974	Procedure	aneurysm clips	EXC	
8.txt	NCT01780974	Procedure	non-removable hearing aids	EXC	
8.txt	NCT02103673	Measurement	Clinical Dementia Rating score	INC	has_value:equal to or greater than 1;
8.txt	NCT02103673	Measurement	Behavioral Pathology in Alzheimer's Disease Rating Scale score	INC	has_value:equal to or greater than 2;
8.txt	NCT02226835	Condition	frontotemporal dementia	INC	
8.txt	NCT02103673	Condition	substance abuse	EXC	has_TempMea:Current;
8.txt	NCT02226835	Condition	normal pressure hydrocephalus	INC	
8.txt	NCT02103673	Condition	substance dependence	EXC	has_TempMea:in the past 6 months;
8.txt	NCT02226835	Condition	dementia	INC	modified_by:different type;
8.txt	NCT01780974	Procedure	intrathecal pumps	EXC	
8.txt	NCT01303744	Condition	cognitive deficits	EXC	
8.txt	NCT01303744	Condition	DSM-IV-TR	EXC	
8.txt	NCT01303744	Condition	NINCDS-ADRDA criteria	EXC	
8.txt	NCT02103673	Condition	psychiatric diagnoses	EXC	modified_by:major;modified_by:Other;
8.txt	NCT02103673	Condition	major depressive disorder	EXC	
8.txt	NCT02103673	Condition	schizophrenia	EXC	
8.txt	NCT02103673	Condition	mental retardation	EXC	
8.txt	NCT02103673	Condition	bipolar disorder	EXC	
8.txt	NCT02103673	Condition	medical or neurological illness	EXC	modified_by:Serious;
8.txt	NCT01303744	Condition	focal lesions	EXC	modified_by:clinical significance;
8.txt	NCT01303744	Procedure	MRI scan	EXC	
8.txt	NCT02103673	Condition	vascular dementia	EXC	is_negated:other than;
8.txt	NCT01303744	Condition	infection	EXC	modified_by:clinical significance;
8.txt	NCT02103673	Condition	Alzheimer's disease	EXC	is_negated:other than;
8.txt	NCT01303744	Condition	infarction	EXC	modified_by:clinical significance;
8.txt	NCT01303744	Procedure	MRI brain imaging	EXC	has_TempMea:within 12 months;
8.txt	NCT01303744	Condition	medical condition	EXC	
8.txt	NCT01303744	Procedure	CT	EXC	has_TempMea:within 12 months;
8.txt	NCT02226835	Procedure	procedures	INC	
8.txt	NCT02226835	Condition	brain disorder	INC	
8.txt	NCT02226835	Condition	contraindication	INC	
8.txt	NCT02103673	Condition	secondary dementia	EXC	modified_by:other;
8.txt	NCT01780974	Measurement	Montreal Cognitive Assessment	INC	has_value:> 26;
8.txt	NCT01780974	Measurement	Clinical Dementia Rating	INC	has_value:= 0;
8.txt	NCT01780974	Condition	Essential Hypertension	INC	
8.txt	NCT01303744	Procedure	MRI scan	INC	
8.txt	NCT01303744	Condition	Alzheimer's disease	EXC	
8.txt	NCT01303744	Measurement	Mini-Mental State Examination score	INC	has_value:higher than 24;
8.txt	NCT01780974	Measurement	systolic	INC	has_value:90 - 160 mm Hg;
8.txt	NCT02226835	Condition	medical or psychiatric illness	INC	has_TempMea:current;modified_by:severe;
8.txt	NCT01303744	Condition	amnestic or non-amnestic Mild Cognitive Impairment	INC	
8.txt	NCT01303744	Condition	childbearing potential	EXC	
8.txt	NCT01780974	Measurement	diastolic	INC	has_value:60 - 90 mm Hg;
8.txt	NCT01303744	Condition	Vitamin B12 or folate deficiency	EXC	
8.txt	NCT01303744	Condition	schizophrenia	EXC	has_TempMea:within 3 years;
8.txt	NCT01780974	Drug	antihypertensive medication	INC	
8.txt	NCT01780974	Procedure	dose	INC	modified_by:Stable;
8.txt	NCT01780974	Drug	lipid lowering medication	INC	
8.txt	NCT01303744	Condition	gastrointestinal bleeding	EXC	has_TempMea:within the last year;has_TempMea:Current;
8.txt	NCT01780974	Procedure	dose	INC	modified_by:Stable;
8.txt	NCT01303744	Condition	peptic ulcer	EXC	has_TempMea:within the last year;has_TempMea:Current;
8.txt	NCT01303744	Condition	unipolar and bipolar disorders	EXC	
8.txt	NCT01303744	Condition	mood disorder	EXC	modified_by:recurrent;has_TempMea:within 3 years;
8.txt	NCT01303744	Condition	cerebral microhemorrhages	EXC	has_value:more than 4;
8.txt	NCT01780974	Procedure	dose	INC	has_TempMea:4 months;modified_by:stable;
8.txt	NCT01303744	Condition	lesions	EXC	
8.txt	NCT01780974	Measurement	Omega- 3 fatty acid Status	INC	modified_by:Low;
8.txt	NCT01780974	Measurement	Omega- 3 index	INC	has_value:< 4% of total fatty acid;
8.txt	NCT01780974	Measurement	eicosapentanoic acid	INC	
8.txt	NCT01780974	Measurement	docsahexanoic acid	INC	
8.txt	NCT01303744	Measurement	Modified Hachinski ischemic scale score	EXC	has_value:> 4;
8.txt	NCT01780974	Measurement	Geriatric Depression Scale	INC	has_value:< 5;
8.txt	NCT01303744	Condition	stroke	EXC	
8.txt	NCT01303744	Measurement	Geriatric Depression Scale ( 30 -point scale ) score	EXC	has_value:> 9;
8.txt	NCT01303744	Measurement	diameter	EXC	has_value:<= 10 mm;
9.txt	NCT01163825	Condition	paranoid disorder	EXC	
9.txt	NCT01163825	Condition	Schizo-affective disorder	EXC	
9.txt	NCT01163825	Condition	cognitive decline	EXC	modified_by:suspicion;is_negated:without;
9.txt	NCT01047254	Condition	NINCDS/ADRDA criteria	INC	
9.txt	NCT01163825	Condition	DSM IV	EXC	
9.txt	NCT01047254	Condition	Marin/Starkstein criteria	INC	
9.txt	NCT02273895	Condition	drug, alcohol or medicine abuse	EXC	
9.txt	NCT01047254	Condition	Alzheimer's dementia	INC	modified_by:Mild to moderate;
9.txt	NCT00997425	Measurement	International Codes for Diagnosis ( ICD-9 ) codes	INC	
9.txt	NCT01163825	Condition	seizures	EXC	
9.txt	NCT01163825	Condition	meningeoma	EXC	
9.txt	NCT01163825	Condition	Brain tumor	EXC	
9.txt	NCT01047254	Measurement	MMSE	INC	has_value:10 - 25;
9.txt	NCT01047254	Measurement	Neuropsychiatric Inventory ( NPI ) apathy item	INC	has_value:>/= 4 points;
9.txt	NCT01047254	Condition	apathy	INC	modified_by:clinically relevant;
9.txt	NCT01163825	Condition	hepatic, renal, pulmonary, metabolic or endocrine disturbances	EXC	modified_by:Clinically significant;
9.txt	NCT01163825	Condition	Bleeding disorders	EXC	
9.txt	NCT02273895	Condition	Neurological-, cardiovascular-, gastrointestinal- or genitourinary disorders	EXC	
9.txt	NCT01163825	Condition	back pain	EXC	modified_by:Clinically significant;
9.txt	NCT02273895	Condition	Glaucoma	EXC	
9.txt	NCT00253123	Condition	mixed dementia	INC	
9.txt	NCT00253123	Condition	dementia of the Alzheimer's type	INC	
9.txt	NCT02273895	Drug	vesp	EXC	
9.txt	NCT00253123	Condition	Diagnostic and Statistical Manual of Mental Diseases, 4th edition ( DSM-IV )	INC	
9.txt	NCT00253123	Condition	vascular dementia	INC	
9.txt	NCT00253123	Measurement	Functional Assessment Staging ( FAST )	INC	has_value:4 or more;
9.txt	NCT02273895	Condition	Hypersensitivity	EXC	
9.txt	NCT02273895	Drug	Scopolamine	EXC	
9.txt	NCT02273895	Measurement	intraocular pressure	EXC	modified_by:raised;
9.txt	NCT02273895	Condition	Impaired liver or kidney function	EXC	
9.txt	NCT01047254	Drug	Cytochrom P450-Isoenzym 2D6	EXC	
9.txt	NCT00253123	Measurement	BEHAVE-AD total score	INC	has_value:least 8;
9.txt	NCT00253123	Measurement	Mini-Mental State Examination ( MMSE )	INC	has_value:23 or lower;
9.txt	NCT00253123	Measurement	BEHAVE-AD global rating	INC	has_value:at least 1;
9.txt	NCT02120664	Demographic	age	INC	has_value:>= 21 and <= 45 years;
9.txt	NCT02120664	Measurement	Mini-mental state examination ( MMSE )	INC	has_value:>= 29;
9.txt	NCT00253123	Condition	dementia	INC	
9.txt	NCT02120664	Demographic	age	INC	has_value:>= 50 years;
9.txt	NCT02120664	Condition	AD	INC	
9.txt	NCT02120664	Condition	dementia	INC	
9.txt	NCT00253123	Condition	reversible causes of dementia	EXC	modified_by:untreated;
9.txt	NCT00253123	Condition	medical or neurological conditions	EXC	
9.txt	NCT00253123	Condition	vitamin deficiency	EXC	modified_by:untreated;
9.txt	NCT00253123	Condition	liver or kidney malfunctions	EXC	modified_by:severe;
9.txt	NCT00253123	Condition	dementia	EXC	
9.txt	NCT00253123	Condition	brain tumor	EXC	
9.txt	NCT00253123	Condition	HIV infection ( human immunodeficiency virus )	EXC	
9.txt	NCT00997425	Condition	deaf	EXC	
9.txt	NCT00997425	Condition	blind	EXC	
9.txt	NCT01723553	Procedure	brain imaging studies	EXC	
9.txt	NCT00654563	Demographic	age	EXC	has_value:less than 18 years;
9.txt	NCT00654563	Condition	dementia with Lewy Bodies	INC	
9.txt	NCT00654563	Condition	frontotemporal dementia	INC	
9.txt	NCT00997425	Drug	anti-psychotic medications	EXC	has_TempMea:currently;
9.txt	NCT00654563	Condition	mixed dementia	INC	
9.txt	NCT01047254	Condition	fronto-temporal dementia	EXC	
9.txt	NCT01047254	Condition	vascular dementia	EXC	
9.txt	NCT01047254	Condition	Lewy-body dementia	EXC	
9.txt	NCT01047254	Condition	Dementia	EXC	modified_by:Other;
9.txt	NCT01047254	Drug	antidementia drugs	INC	is_negated:no;
9.txt	NCT01047254	Condition	depression	EXC	modified_by:clinically relevant;
9.txt	NCT01047254	Measurement	NPI depression item	EXC	has_value:>/= 4 points;
9.txt	NCT01047254	Drug	stimulants	EXC	
9.txt	NCT01047254	Condition	Suicidal tendency	EXC	
9.txt	NCT01047254	Drug	antidementia drugs	INC	modified_by:Stable;
9.txt	NCT01723553	Condition	chief complaint	INC	
9.txt	NCT01047254	Drug	MAO inhibitor	EXC	has_TempMea:Current;
9.txt	NCT01723553	Condition	atypical AD	INC	
9.txt	NCT01047254	Drug	Bupropion	EXC	
9.txt	NCT01723553	Demographic	age	INC	has_value:21;has_value:over;
9.txt	NCT01047254	Drug	benzodiazepines	EXC	has_TempMea:Current;
9.txt	NCT00253123	Condition	behavior disturbances	EXC	
9.txt	NCT01047254	Drug	Amantadin	EXC	has_TempMea:Current;
9.txt	NCT00253123	Condition	schizophrenia	EXC	
9.txt	NCT01723553	Condition	posterior cortical atrophy	INC	
9.txt	NCT01723553	Procedure	MRI	INC	
9.txt	NCT01047254	Condition	psychiatric disease	EXC	has_TempMea:in the last 6 months;modified_by:Severe;
9.txt	NCT01723553	Condition	primary progressive aphasia	INC	
9.txt	NCT01047254	Condition	sensibility	EXC	
9.txt	NCT01723553	Condition	visuospatial/perceptual deficits	INC	
9.txt	NCT01047254	Drug	Bupropion treatment	EXC	
9.txt	NCT01047254	Condition	contraindication	EXC	
9.txt	NCT01047254	Condition	Alcoholism	EXC	
9.txt	NCT01047254	Condition	Benzodiazepine addiction	EXC	
9.txt	NCT01047254	Condition	major depressive episode	EXC	
9.txt	NCT01047254	Drug	St. John's wart	EXC	
9.txt	NCT01047254	Condition	DSM-IV criteria	EXC	
9.txt	NCT00253123	Condition	substance-induced persisting dementia	EXC	
9.txt	NCT00253123	Condition	psychiatric disorders	EXC	
9.txt	NCT01047254	Drug	dopaminergic agents	EXC	has_TempMea:Current;
9.txt	NCT01047254	Drug	antipsychotics	EXC	has_TempMea:Current;
9.txt	NCT01047254	Drug	antidepressants	EXC	has_TempMea:Current;
9.txt	NCT01723553	Procedure	MRI	EXC	
9.txt	NCT01723553	Condition	post-partum	EXC	
9.txt	NCT01723553	Condition	breast-feeding	EXC	
9.txt	NCT01047254	Condition	cerebral substance defect	EXC	
9.txt	NCT01723553	Condition	Alzheimer's dementia	EXC	modified_by:typical;
9.txt	NCT01723553	Condition	pregnant	EXC	
9.txt	NCT01047254	Condition	craniocerebral injury	EXC	modified_by:Severe;
9.txt	NCT01047254	Drug	antimalarial agents	EXC	
9.txt	NCT01723553	Condition	claustrophobia	EXC	modified_by:severe;
9.txt	NCT01047254	Drug	Tramadol	EXC	
9.txt	NCT01047254	Drug	antipsychotics	EXC	
9.txt	NCT01723553	Procedure	cardiac pace maker	EXC	
9.txt	NCT01047254	Drug	antidepressants	EXC	
9.txt	NCT01723553	Condition	contraindicated	EXC	
9.txt	NCT01047254	Condition	renal disease	EXC	
9.txt	NCT01723553	Procedure	metal	EXC	
9.txt	NCT01047254	Condition	liver insufficiency	EXC	
9.txt	NCT01723553	Condition	illnesses	EXC	has_TempMea:concurrent;
9.txt	NCT01723553	Procedure	PET scans	INC	
9.txt	NCT01047254	Condition	psychotic symptoms	EXC	modified_by:acute;
9.txt	NCT01723553	Procedure	PET scanning	INC	
9.txt	NCT01723553	Measurement	pregnancy test	INC	has_TempMea:no more than 48 hours;
9.txt	NCT01047254	Condition	suicide attempt	EXC	
9.txt	NCT02120664	Condition	AD	INC	modified_by:probable;
9.txt	NCT02120664	Measurement	MMSE	INC	has_value:>= 16 and <= 26;
9.txt	NCT02120664	Demographic	age	INC	has_value:>= 50 years;
9.txt	NCT01723553	Condition	syndrome	EXC	
9.txt	NCT01047254	Condition	tumors	EXC	
9.txt	NCT02120664	Condition	AD	INC	modified_by:Possible;
9.txt	NCT01723553	Condition	neurodegenerative disease	EXC	modified_by:another;
9.txt	NCT02120664	Condition	dementia	INC	
9.txt	NCT01723553	Condition	strokes	EXC	
9.txt	NCT01047254	Condition	seizures	EXC	
9.txt	NCT01723553	Condition	developmental syndromes	EXC	
9.txt	NCT01047254	Condition	physical illness	EXC	modified_by:Severe;
9.txt	NCT01723553	Condition	traumatic brain injury	EXC	
9.txt	NCT01047254	Drug	Proanolol	EXC	
9.txt	NCT01047254	Drug	Timolol	EXC	
9.txt	NCT01047254	Drug	Carvediol	EXC	
9.txt	NCT02120664	Measurement	MMSE	INC	has_value:>= 16 and <= 26;
9.txt	NCT02120664	Condition	AD	INC	modified_by:possible;
9.txt	NCT02120664	Condition	MCI	INC	
9.txt	NCT02120664	Demographic	age	INC	has_value:>= 60 years;
9.txt	NCT02120664	Condition	dementia	INC	is_negated:not;
9.txt	NCT02273895	Demographic	age	INC	has_value:Between 60 - 80 years;
9.txt	NCT01047254	Drug	Flecinid	EXC	
9.txt	NCT02120664	Condition	cognitive impairment	INC	
9.txt	NCT01047254	Drug	treatment	EXC	has_TempMea:Simultaneous;
9.txt	NCT02120664	Measurement	MMSE	INC	has_value:> 24 and  < 29;
9.txt	NCT02273895	Condition	Healthy	INC	
9.txt	NCT02273895	Condition	MCI	INC	
9.txt	NCT01047254	Drug	Propafenon	EXC	
9.txt	NCT01047254	Drug	Donepezil	EXC	is_negated:except;
9.txt	NCT02273895	Condition	MCI	INC	
9.txt	NCT01047254	Drug	Galantamin	EXC	is_negated:except;
9.txt	NCT02273895	Condition	general health	INC	modified_by:good;
9.txt	NCT01047254	Drug	Nebivolol	EXC	
9.txt	NCT02273895	Procedure	Electrocardiograph ( ECG )	INC	modified_by:Normal;
9.txt	NCT01047254	Drug	Typ-1C-Antiarrhyhtmics	EXC	
9.txt	NCT01723553	Condition	subdural hematoma	EXC	
9.txt	NCT01723553	Condition	intracranial neoplasm	EXC	
9.txt	NCT01723553	Condition	conditions	EXC	
9.txt	NCT01047254	Drug	Theophyllin	EXC	
9.txt	NCT01723553	Condition	structural abnormalities	EXC	
9.txt	NCT01047254	Drug	systemic steroids	EXC	
9.txt	NCT02120664	Demographic	age	INC	has_value:>= 75 years;
9.txt	NCT02120664	Condition	Cognitively	INC	modified_by:Normal;
9.txt	NCT02120664	Condition	Cognitively normal	INC	
9.txt	NCT02120664	Measurement	MMSE	INC	has_value:>= 27;
9.txt	NCT02120664	Condition	AD	EXC	is_negated:other than;
9.txt	NCT01047254	Drug	beta blockers	EXC	
9.txt	NCT02120664	Condition	neurodegenerative disorders	EXC	has_TempMea:currently;
9.txt	NCT02273895	Demographic	age	INC	has_value:Between 60 - 80 years;
9.txt	NCT01047254	Drug	Metoprolol	EXC	
9.txt	NCT00997425	Measurement	Mini Mental State Examination ( MMSE )	INC	has_value:24 or less;
9.txt	NCT01047254	Drug	treatment	EXC	has_TempMea:Simultaneous;
9.txt	NCT01047254	Drug	sedative antihistamines	EXC	
9.txt	NCT00997425	Condition	Alzheimer's-like dementia	INC	
9.txt	NCT01047254	Drug	treatment	EXC	has_TempMea:Simultaneous;
9.txt	NCT01047254	Procedure	dose	EXC	modified_by:higher;
9.txt	NCT00997425	Demographic	age	INC	has_value:60 and over;
9.txt	NCT01047254	Drug	Chinolone	EXC	
9.txt	NCT02273895	Measurement	GDS	INC	has_value:between 3 - 5;
9.txt	NCT02120664	Condition	illness	EXC	modified_by:serious or unstable;has_TempMea:current;
9.txt	NCT00654563	Demographic	age	INC	has_value:older;has_value:18 years;
9.txt	NCT02120664	Condition	brain lesion	EXC	
9.txt	NCT02120664	Condition	pathology	EXC	
9.txt	NCT02120664	Drug	investigational medications	EXC	has_TempMea:in the past 30 days;
9.txt	NCT02120664	Condition	traumatic brain injury	EXC	
9.txt	NCT02120664	Procedure	radiopharmaceutical imaging or treatment	EXC	has_TempMea:within 7 days;
9.txt	NCT02273895	Drug	benzodiazepines	EXC	
9.txt	NCT00654563	Condition	vascular dementia	INC	
9.txt	NCT00253123	Condition	cognition	INC	
9.txt	NCT02273895	Drug	oxazepam	EXC	
9.txt	NCT02273895	Drug	tobacco	EXC	
9.txt	NCT00654563	Condition	Parkinson disease	INC	
9.txt	NCT02273895	Drug	neuroleptics	EXC	
9.txt	NCT00654563	Condition	Huntington disease	INC	
9.txt	NCT02273895	Condition	Alzheimer disease	INC	
9.txt	NCT00654563	Condition	Age Associated memory Impairment	INC	
9.txt	NCT02273895	Observation	Smoking	EXC	
9.txt	NCT00654563	Condition	Alzheimer's disease	INC	
9.txt	NCT02273895	Procedure	ECG	INC	modified_by:Normal;
9.txt	NCT02273895	Drug	Reminyl	INC	
9.txt	NCT00654563	Condition	memory disorder	INC	
9.txt	NCT02273895	Measurement	Global Deterioration Scale ( GDS )	INC	has_value:between 2 and 3;
9.txt	NCT01047254	Drug	Bupropion	EXC	
9.txt	NCT01163825	Demographic	Age	INC	has_value:50 - 80 years;
9.txt	NCT01047254	Drug	Carbamazepin	EXC	
9.txt	NCT01047254	Drug	Phenytoin	EXC	
9.txt	NCT00253123	Condition	cognition	EXC	modified_by:diminished;
9.txt	NCT01163825	Condition	Alzheimer's disease	INC	
9.txt	NCT01163825	Measurement	mini-mental state examination ( MMSE )	INC	has_value:between 15 - 24 inclusive;
9.txt	NCT01163825	Condition	NINDNDS-ARDRA criteria	INC	
9.txt	NCT01163825	Condition	Schizophrenia	EXC	
9.txt	NCT02273895	Demographic	age	INC	has_value:Between 60 - 80 years;
9.txt	NCT01047254	Condition	lactose intolerance	EXC	
9.txt	NCT02273895	Measurement	ICD - 10	INC	
9.txt	NCT01047254	Drug	appetite depressants	EXC	
9.txt	NCT02273895	Measurement	International Classification of Diseases ( ICD ) - 10	INC	
9.txt	NCT00654563	Measurement	Mini Mental State Exam score	INC	has_value:< 24;
9.txt	NCT02273895	Condition	Alzheimer's	INC	
9.txt	NCT01047254	Drug	Lopinavir	EXC	
9.txt	NCT02273895	Condition	AD	INC	
9.txt	NCT01047254	Condition	Diabetes mellitus	EXC	
9.txt	NCT01047254	Drug	Valproat	EXC	
9.txt	NCT02273895	Procedure	ECG	INC	modified_by:Normal;
9.txt	NCT01047254	Drug	Ritonavir	EXC	
Y_Alzheimers_11_20.txt	NCT00017940	Drug	Aricept	INC	
Y_Alzheimers_11_20.txt	NCT00017940	Drug	Cognex	INC	
Y_Alzheimers_11_20.txt	NCT00017940	Condition	Alzheimer's disease	INC	has_TempMea:within three years of onset;modified_by:Early stage;
Y_Alzheimers_11_20.txt	NCT00017940	Condition	Alzheimer's disease	INC	modified_by:probable;
Y_Alzheimers_11_20.txt	NCT02681172	Procedure	CSF examination	INC	
Y_Alzheimers_11_20.txt	NCT02147652	Condition	Alzheimer's disease	INC	
Y_Alzheimers_11_20.txt	NCT02147652	Condition	dementia	INC	
Y_Alzheimers_11_20.txt	NCT02681172	Procedure	FBB PET scan	INC	modified_by:able;has_value:20 -minute;
Y_Alzheimers_11_20.txt	NCT02147652	Condition	mixed dementia	INC	
Y_Alzheimers_11_20.txt	NCT02147652	Condition	Vascular disease	INC	
Y_Alzheimers_11_20.txt	NCT02147652	Condition	dementia	INC	modified_by:moderate stage;
Y_Alzheimers_11_20.txt	NCT02664584	Demographic	age	INC	has_value:> 60 years;
Y_Alzheimers_11_20.txt	NCT00017940	Drug	Exelon	INC	
Y_Alzheimers_11_20.txt	NCT02681172	Condition	dementias	INC	
Y_Alzheimers_11_20.txt	NCT00017940	Drug	Reminyl	INC	
Y_Alzheimers_11_20.txt	NCT02681172	Condition	contraindicated	INC	
Y_Alzheimers_11_20.txt	NCT02681172	Condition	atypical dementia	INC	
Y_Alzheimers_11_20.txt	NCT02681172	Condition	dementia	INC	modified_by:early onset;modified_by:rapid progressive;
Y_Alzheimers_11_20.txt	NCT02681172	Procedure	lumbar puncture	INC	
Y_Alzheimers_11_20.txt	NCT02681172	Condition	contraindicated	INC	
Y_Alzheimers_11_20.txt	NCT02147652	Measurement	MMSE	INC	has_value:< 20;
Y_Alzheimers_11_20.txt	NCT02147652	Demographic	Age	INC	has_value:60 to 90 inclusive;
Y_Alzheimers_11_20.txt	NCT02147652	Measurement	Pittsburgh agitation scale score	INC	has_value:>= 3;
Y_Alzheimers_11_20.txt	NCT02681172	Condition	medical condition	EXC	modified_by:unstable;
Y_Alzheimers_11_20.txt	NCT02147652	Condition	auditory deficits	EXC	
Y_Alzheimers_11_20.txt	NCT02147652	Condition	event	EXC	modified_by:recent acute;
Y_Alzheimers_11_20.txt	NCT02147652	Condition	MI	EXC	
Y_Alzheimers_11_20.txt	NCT02681172	Drug	radiopharmaceutical	EXC	has_TempMea:within 10 radioactive half-lives;
Y_Alzheimers_11_20.txt	NCT00099242	Condition	cardiovascular disease	EXC	modified_by:unstable;has_TempMea:Current;
Y_Alzheimers_11_20.txt	NCT00099242	Condition	seizure disorder	EXC	modified_by:uncontrolled;modified_by:active;has_TempMea:Current;
Y_Alzheimers_11_20.txt	NCT02681172	Drug	investigational pharmaceutical product	EXC	has_TempMea:within 30 days;
Y_Alzheimers_11_20.txt	NCT02681172	Drug	investigational pharmaceutical product	EXC	has_TempMea:currently;
Y_Alzheimers_11_20.txt	NCT01515982	Procedure	physical exercises	INC	is_negated:without;has_TempMea:At least six months;
Y_Alzheimers_11_20.txt	NCT01515982	Drug	anticholinesterase drugs	INC	has_TempMea:at least six months;
Y_Alzheimers_11_20.txt	NCT02147652	Condition	fractures	EXC	
Y_Alzheimers_11_20.txt	NCT02147652	Condition	UTI	EXC	is_negated:not;
Y_Alzheimers_11_20.txt	NCT02147652	Condition	infection	EXC	modified_by:major;
Y_Alzheimers_11_20.txt	NCT00099242	Condition	dementia of the Alzheimer's type	INC	
Y_Alzheimers_11_20.txt	NCT00099242	Condition	postmenopausal	INC	has_TempMea:one year;
Y_Alzheimers_11_20.txt	NCT00099242	Condition	surgically sterile	INC	
Y_Alzheimers_11_20.txt	NCT00099242	Condition	condition	EXC	
Y_Alzheimers_11_20.txt	NCT01515982	Condition	dementia	EXC	modified_by:Other;
Y_Alzheimers_11_20.txt	NCT01515982	Condition	Clinical depression	EXC	
Y_Alzheimers_11_20.txt	NCT01515982	Measurement	Cornell Scale	EXC	has_value:>= 7;
Y_Alzheimers_11_20.txt	NCT02273895	Demographic	age	INC	has_value:Between 60 - 80 years;
Y_Alzheimers_11_20.txt	NCT02273895	Procedure	Electrocardiograph ( ECG )	INC	modified_by:Normal;
Y_Alzheimers_11_20.txt	NCT02323334	Condition	AD	INC	modified_by:mild to moderate;
Y_Alzheimers_11_20.txt	NCT02273895	Condition	MCI	INC	
Y_Alzheimers_11_20.txt	NCT02664584	Condition	dementia	EXC	modified_by:Severe;
Y_Alzheimers_11_20.txt	NCT02273895	Observation	International Classification of Diseases ( ICD ) - 10	INC	
Y_Alzheimers_11_20.txt	NCT02273895	Demographic	age	INC	has_value:Between 60 - 80 years;
Y_Alzheimers_11_20.txt	NCT02664584	Demographic	age	EXC	has_value:< 60 years;
Y_Alzheimers_11_20.txt	NCT00099242	Condition	dementia	EXC	
Y_Alzheimers_11_20.txt	NCT00099242	Condition	Alzheimer's	EXC	is_negated:other than;
Y_Alzheimers_11_20.txt	NCT00099242	Condition	disease	EXC	modified_by:severe;modified_by:unstable;modified_by:advanced;
Y_Alzheimers_11_20.txt	NCT02273895	Measurement	Global Deterioration Scale ( GDS )	INC	has_value:between 2 and 3;
Y_Alzheimers_11_20.txt	NCT02273895	Procedure	ECG	INC	modified_by:Normal;
Y_Alzheimers_11_20.txt	NCT02273895	Condition	AD	INC	
Y_Alzheimers_11_20.txt	NCT02273895	Demographic	age	INC	has_value:Between 60 - 80 years;
Y_Alzheimers_11_20.txt	NCT01515982	Measurement	Clinical Dementia Rating ( CDR ) score	INC	has_value:1;
Y_Alzheimers_11_20.txt	NCT02273895	Observation	ICD - 10	INC	
Y_Alzheimers_11_20.txt	NCT02273895	Measurement	GDS	INC	has_value:between 3 - 5;
Y_Alzheimers_11_20.txt	NCT01515982	Measurement	Mini-Mental State Examination ( MMSE ) score	INC	has_value:>= 15;
Y_Alzheimers_11_20.txt	NCT02681172	Measurement	pregnancy test	EXC	modified_by:positive;
Y_Alzheimers_11_20.txt	NCT01515982	Condition	National Institute of Neurological Disorders and Stroke- Association Internationale pour la Recherche et l' Enseignement en Neurosciences ( NINDS-AIREN )	INC	
Y_Alzheimers_11_20.txt	NCT02273895	Procedure	ECG	INC	modified_by:Normal;
Y_Alzheimers_11_20.txt	NCT02273895	Drug	Reminyl	INC	
Y_Alzheimers_11_20.txt	NCT02273895	Condition	Alzheimer disease	INC	
Y_Alzheimers_11_20.txt	NCT02273895	Drug	tobacco	EXC	
Y_Alzheimers_11_20.txt	NCT02273895	Observation	Smoking	EXC	
Y_Alzheimers_11_20.txt	NCT02273895	Drug	benzodiazepines	EXC	
Y_Alzheimers_11_20.txt	NCT02273895	Drug	neuroleptics	EXC	
Y_Alzheimers_11_20.txt	NCT02551809	Condition	neurological disease	EXC	modified_by:Clinically significant;
Y_Alzheimers_11_20.txt	NCT02273895	Condition	Neurological-, cardiovascular-, gastrointestinal- or genitourinary disorders	EXC	
Y_Alzheimers_11_20.txt	NCT02551809	Measurement	Clinical dementia rating ( CDR ) scores	INC	has_value:0.5 or 1;
Y_Alzheimers_11_20.txt	NCT02273895	Drug	oxazepam	EXC	
Y_Alzheimers_11_20.txt	NCT02551809	Measurement	Mini-Mental State Examination ( MMSE ) scores	INC	has_value:between 20 and 26 ( inclusive );
Y_Alzheimers_11_20.txt	NCT02551809	Condition	Alzheimer's Disease	INC	modified_by:mild;
Y_Alzheimers_11_20.txt	NCT01515982	Condition	visual and/or auditory deficit	EXC	
Y_Alzheimers_11_20.txt	NCT01515982	Condition	arterial hypertension	EXC	modified_by:Severe;modified_by:uncontrolled;
Y_Alzheimers_11_20.txt	NCT02273895	Condition	Glaucoma	EXC	
Y_Alzheimers_11_20.txt	NCT00017940	Procedure	discontinue	INC	has_TempMea:the first 18 months;
Y_Alzheimers_11_20.txt	NCT02273895	Condition	Impaired liver- or kidney function	EXC	
Y_Alzheimers_11_20.txt	NCT02273895	Condition	raised intraocular pressure	EXC	modified_by:possibly;
Y_Alzheimers_11_20.txt	NCT02273895	Drug	Scopolamine	EXC	
Y_Alzheimers_11_20.txt	NCT02273895	Condition	Hypersensitivity	EXC	
Y_Alzheimers_11_20.txt	NCT01515982	Condition	Alzheimer Disease	INC	
Y_Alzheimers_11_20.txt	NCT02273895	Condition	drug, alcohol or medicine abuse	EXC	
Y_Alzheimers_11_20.txt	NCT01515982	Condition	National Institute of Neurological and Communicative Disorders and Stroke- Alzheimer's Disease and Related Disorders Association ( NINCDS-ADRDA )	INC	
Y_Alzheimers_11_20.txt	NCT02273895	Condition	general health	INC	modified_by:good;
Y_Alzheimers_11_20.txt	NCT01515982	Condition	neurological or neuromuscular impairments	EXC	
Y_Alzheimers_11_20.txt	NCT01515982	Procedure	physical exercise	EXC	modified_by:Incapacity;
Y_Alzheimers_11_20.txt	NCT02681172	Condition	Alzheimer disease	INC	
Y_Alzheimers_11_20.txt	NCT02273895	Condition	MCI	INC	
Y_Alzheimers_11_20.txt	NCT02681172	Condition	dementias	INC	
Y_Alzheimers_11_20.txt	NCT02273895	Condition	Healthy	INC	
Y_Alzheimers_11_20.txt	NCT02681172	Condition	AD	INC	
Y_Alzheimers_11_20.txt	NCT02273895	Procedure	investigational study	EXC	modified_by:another;
Y_Alzheimers_11_20.txt	NCT02323334	Condition	nonchildbearing potential	INC	
Y_Alzheimers_11_20.txt	NCT02323334	Condition	healthy	INC	
Y_Alzheimers_11_20.txt	NCT02323334	Measurement	body mass index ( BMI )	INC	has_value:18 to 32 kilograms per square meter ( kg/m^2 );
Y_Alzheimers_11_20.txt	NCT02323334	Condition	Mild Cognitive Impairment ( MCI )	INC	
Y_Alzheimers_11_20.txt	NCT02681172	Condition	systemic illness	EXC	modified_by:significant;
Y_Alzheimers_11_20.txt	NCT02681172	Condition	dementias	INC	
Y_Alzheimers_11_20.txt	NCT02681172	Procedure	beta amyloid imaging scan	EXC	has_TempMea:previous;
Y_Alzheimers_11_20.txt	NCT02681172	Procedure	lumbar puncture	INC	
Y_Alzheimers_11_20.txt	NCT02681172	Condition	AD	INC	
Y_Alzheimers_11_20.txt	NCT02681172	Procedure	CSF examination	INC	has_TempMea:in the last 12 months;
Y_Alzheimers_11_20.txt	NCT02551809	Condition	Alzheimer's disease	EXC	is_negated:other than;
Y_Alzheimers_11_20.txt	NCT01515982	Drug	treatment	EXC	has_TempMea:Less than six months;
Y_Alzheimers_11_20.txt	NCT02323334	Condition	Alzheimer's Disease ( AD )	INC	
Y_Alzheimers_11_20.txt	NCT02551809	Condition	psychiatric disorder	EXC	modified_by:Major;
Y_Alzheimers_11_20.txt	NCT02323334	Drug	over-the-counter or prescription medication	EXC	
Y_Alzheimers_11_20.txt	NCT02323334	Drug	minerals	EXC	is_negated:exception;
Y_Alzheimers_11_20.txt	NCT02323334	Drug	vitamins	EXC	is_negated:exception;
Y_Alzheimers_11_20.txt	NCT00291161	Condition	Dementia	INC	
Y_Alzheimers_11_20.txt	NCT02681172	Measurement	CSF results	INC	
Y_Alzheimers_11_20.txt	NCT02323334	Condition	Smoke	EXC	has_value:more than 10 cigarettes per day;
Y_Alzheimers_11_20.txt	NCT02551809	Condition	adverse reactions	EXC	modified_by:Serious;
Y_Alzheimers_11_20.txt	NCT02551809	Drug	vaccine	EXC	
Y_Alzheimers_11_20.txt	NCT02551809	Condition	systemic disease	EXC	modified_by:Severe;
Y_Alzheimers_1_10.txt	NCT02167256	Measurement	Alanine aminotransferase (ALT)	EXC	has_value:> 1.5 times ULN;
Y_Alzheimers_1_10.txt	NCT00153010	Drug	donepezil	INC	has_TempMea:within 6 weeks;
Y_Alzheimers_1_10.txt	NCT01677754	Condition	behavioral symptoms	EXC	modified_by:Uncontrolled;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	malignancy	INC	
Y_Alzheimers_1_10.txt	NCT02167256	Measurement	Total bilirubin	EXC	has_value:> 1.5 times ULN;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	DSM V criteria	EXC	
Y_Alzheimers_1_10.txt	NCT01677754	Condition	mental retardation	EXC	
Y_Alzheimers_1_10.txt	NCT01677754	Condition	Alzheimer's disease	EXC	is_negated:not;
Y_Alzheimers_1_10.txt	NCT01677754	Condition	neurological or psychiatric condition	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Procedure	procedure	INC	has_TempMea:within 30 days;modified_by:investigational;
Y_Alzheimers_1_10.txt	NCT01677754	Condition	DSM-IV-TR criteria	INC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	alcohol or substance abuse or dependence	EXC	has_TempMea:within the past 2 years;
Y_Alzheimers_1_10.txt	NCT01677754	Condition	Generally healthy	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	basal cell carcinoma	INC	is_negated:except;
Y_Alzheimers_1_10.txt	NCT00153010	Drug	rivastigmine	INC	has_TempMea:within 6 weeks;
Y_Alzheimers_1_10.txt	NCT00153010	Drug	galantamine	INC	has_TempMea:within 6 weeks;
Y_Alzheimers_1_10.txt	NCT01677754	Condition	Alcohol and/or substance abuse or dependence	EXC	has_TempMea:in the past 2 years;
Y_Alzheimers_1_10.txt	NCT00153010	Drug	tacrine	INC	has_TempMea:within 6 weeks;
Y_Alzheimers_1_10.txt	NCT01677754	Condition	DSM-IV-TR	EXC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	interstitial lung disease	EXC	
Y_Alzheimers_1_10.txt	NCT01677754	Procedure	formulation	INC	has_value:23 mg;
Y_Alzheimers_1_10.txt	NCT01677754	Procedure	dosages	INC	has_value:23 mg;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	medication	EXC	
Y_Alzheimers_1_10.txt	NCT02167256	Measurement	follow-up labs	EXC	modified_by:physiologically significant;
Y_Alzheimers_1_10.txt	NCT01677754	Drug	donepezil	INC	is_negated:except;
Y_Alzheimers_1_10.txt	NCT02167256	Measurement	MMA	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Drug	drug	INC	has_TempMea:within 30 days;modified_by:investigational;
Y_Alzheimers_1_10.txt	NCT02167256	Measurement	Serum creatinine	EXC	has_value:> 2.0 times ULN;
Y_Alzheimers_1_10.txt	NCT01677754	Measurement	pregnancy test	INC	modified_by:negative;
Y_Alzheimers_1_10.txt	NCT01677754	Observation	Alzheimer's Disease and Related Disorders Association (ADRDA)	INC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	neurologic disease	EXC	modified_by:significant;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	heart disease	INC	modified_by:other;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	blood clotting	EXC	has_TempMea:current;
Y_Alzheimers_1_10.txt	NCT01018875	Observation	medical history	INC	
Y_Alzheimers_1_10.txt	NCT01677754	Condition	diabetes	EXC	modified_by:Poorly controlled;
Y_Alzheimers_1_10.txt	NCT01018875	Condition	health	INC	modified_by:good;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	conduction defects	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	myocardial infarction	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	orthopnea	INC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	abnormalities	EXC	modified_by:Clinically significant;
Y_Alzheimers_1_10.txt	NCT01677754	Condition	hepatitis B, hepatitis C or HIV infection	EXC	modified_by:Positive;
Y_Alzheimers_1_10.txt	NCT01018875	Condition	medical conditions	INC	modified_by:stable;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	ischemic heart disease	INC	
Y_Alzheimers_1_10.txt	NCT01677754	Condition	cardiovascular disease	EXC	modified_by:Unstable;modified_by:clinically significant;
Y_Alzheimers_1_10.txt	NCT02167256	Measurement	Modified Hackinski	INC	has_value:less than or equal to 4;
Y_Alzheimers_1_10.txt	NCT01018875	Measurement	physical examination	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Procedure	ECG	INC	
Y_Alzheimers_1_10.txt	NCT01018875	Measurement	vital signs	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Drug	drugs	INC	
Y_Alzheimers_1_10.txt	NCT01018875	Measurement	clinical lab tests	INC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	malignant disease	EXC	modified_by:primary or recurrent;has_TempMea:within the last 5 years;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	bleeding disorder	EXC	has_TempMea:current;
Y_Alzheimers_1_10.txt	NCT01677754	Condition	AD	EXC	
Y_Alzheimers_1_10.txt	NCT01677754	Procedure	formulation	INC	modified_by:stabilized;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	cardiac, pulmonary, renal, hepatic, endocrine, or other systemic disease	EXC	modified_by:significant;
Y_Alzheimers_1_10.txt	NCT00153010	Drug	selective serotonin reuptake inhibitors	INC	has_TempMea:6 weeks;
Y_Alzheimers_1_10.txt	NCT01677754	Condition	hypertension	EXC	modified_by:Unstable;modified_by:poorly controlled;
Y_Alzheimers_1_10.txt	NCT01677754	Procedure	dose	INC	modified_by:stabilized;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	diabetes	EXC	modified_by:uncontrolled;
Y_Alzheimers_1_10.txt	NCT00153010	Drug	monoamine oxidase inhibitors	INC	has_TempMea:8 weeks;
Y_Alzheimers_1_10.txt	NCT01677754	Drug	nicotine replacement therapy	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Drug	antipsychotics/neuroleptics	INC	has_TempMea:8 weeks;
Y_Alzheimers_1_10.txt	NCT01677754	Drug	bupropion	EXC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	hypertension	EXC	modified_by:uncontrolled;
Y_Alzheimers_1_10.txt	NCT01677754	Drug	nicotine	EXC	is_negated:except;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	medical condition	EXC	modified_by:unstable;modified_by:Clinically significant;
Y_Alzheimers_1_10.txt	NCT01677754	Condition	childbearing potential	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	Cardiovascular illnesses	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	congestive heart failure	INC	modified_by:chronic;
Y_Alzheimers_1_10.txt	NCT00153010	Drug	Tricyclic antidepressants	INC	has_TempMea:4 weeks;
Y_Alzheimers_1_10.txt	NCT00153010	Drug	antihistamines	INC	has_TempMea:4 weeks;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	arrhythmias	INC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	NIA-Alzheimer's Association core clinical criteria	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	Gastrointestinal disorder	INC	
Y_Alzheimers_1_10.txt	NCT01018875	Condition	drug or alcohol abuse/dependence	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Drug	interferon	EXC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	progressive supranuclear palsy	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	hepatitis C	INC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	seizure disorder	EXC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	in situ prostate cancer	EXC	is_negated:exception;
Y_Alzheimers_1_10.txt	NCT01524887	Drug	anti-TNF	EXC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	normal pressure hydrocephalus	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	cirrhosis	INC	
Y_Alzheimers_1_10.txt	NCT00855868	Measurement	mini-mental state examination (MMSE)	INC	has_value:27-30;
Y_Alzheimers_1_10.txt	NCT01524887	Drug	anti-IL-1	EXC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	brain tumor	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	hepatitis B	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Drug	immunomodulatory therapies	EXC	has_TempMea:within 12 weeks;modified_by:other;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	multi-infarct dementia	EXC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	basal cell carcinoma	EXC	is_negated:exception;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	Huntington's disease	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	Liver disease	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Procedure	dose	INC	modified_by:stable;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	AD	INC	modified_by:probable;
Y_Alzheimers_1_10.txt	NCT01524887	Drug	non-systemic corticosteroids	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	malabsorption syndromes	INC	
Y_Alzheimers_1_10.txt	NCT02167256	Demographic	Age	INC	has_value:between 55-85 (inclusive);
Y_Alzheimers_1_10.txt	NCT02167256	Condition	multiple sclerosis	EXC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	cervical carcinoma in situ	EXC	is_negated:exception;
Y_Alzheimers_1_10.txt	NCT00855868	Condition	depression	INC	is_negated:no;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	GI bleeding	INC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	subdural hematoma	EXC	
Y_Alzheimers_1_10.txt	NCT00855868	Measurement	clinical dementia rating (CDR)	INC	has_value:0;
Y_Alzheimers_1_10.txt	NCT01018875	Drug	medication	EXC	
Y_Alzheimers_1_10.txt	NCT01018875	Condition	dementia	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	edema	INC	
Y_Alzheimers_1_10.txt	NCT01018875	Condition	AD	EXC	has_TempMea:with 60 days;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	residual angina	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Drug	drug	INC	has_TempMea:within 14 days;
Y_Alzheimers_1_10.txt	NCT01677754	Drug	Psychotropic medication	EXC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	cutaneous squamous cell carcinoma in situ	EXC	modified_by:resected;is_negated:exception;
Y_Alzheimers_1_10.txt	NCT02167256	Measurement	platelet count	EXC	has_value:> 100x103/microliter;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	labile hypertension	INC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	Thrombocytopenia	EXC	
Y_Alzheimers_1_10.txt	NCT01677754	Condition	smokers	EXC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	AD	EXC	is_negated:other than;
Y_Alzheimers_1_10.txt	NCT02167256	Measurement	PTT	EXC	modified_by:significantly abnormal;
Y_Alzheimers_1_10.txt	NCT01677754	Condition	Inadequate hepatic, renal or thyroid function	EXC	
Y_Alzheimers_1_10.txt	NCT01018875	Procedure	ECG	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Measurement	NYHA	INC	has_value:III or IV;
Y_Alzheimers_1_10.txt	NCT02167256	Measurement	PT	EXC	modified_by:significantly abnormal;
Y_Alzheimers_1_10.txt	NCT01018875	Condition	dementia	EXC	has_TempMea:with 60 days;
Y_Alzheimers_1_10.txt	NCT00153010	Drug	CYP 450 3A4	INC	
Y_Alzheimers_1_10.txt	NCT01677754	Procedure	AD immunization study	EXC	has_TempMea:less than 1 year;modified_by:passive;
Y_Alzheimers_1_10.txt	NCT01018875	Condition	AD	EXC	
Y_Alzheimers_1_10.txt	NCT01018875	Procedure	cognitive therapy	EXC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	Parkinson's disease	EXC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	non-melanoma skin cancers	EXC	is_negated:exception;
Y_Alzheimers_1_10.txt	NCT02167256	Measurement	absolute neutrophils count	EXC	has_value:< 1,500/microliter;
Y_Alzheimers_1_10.txt	NCT00438724	Condition	disease	INC	modified_by:mild stage;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	Neutropenia	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	stroke	EXC	modified_by:major;
Y_Alzheimers_1_10.txt	NCT02167256	Drug	antidepressants	INC	
Y_Alzheimers_1_10.txt	NCT02167256	Procedure	doses	INC	modified_by:Stable;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	Parkinson's disease	INC	
Y_Alzheimers_1_10.txt	NCT02167256	Drug	total radiation dose	EXC	has_value:exceed the limits of annual and total dose commitment;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	macrohemorrhage	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Procedure	MRI	EXC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	structural brain abnormalities	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	Dementia of the Alzheimer's Type	INC	is_negated:other than;Specified_by:multiple sclerosis;Specified_by:epilepsy;Specified_by:stroke;Specified_by:Parkinson's disease;Specified_by:encephalitis;Specified_by:Huntington's disease;
Y_Alzheimers_1_10.txt	NCT01524887	Drug	immunoglobulin treatment	EXC	has_TempMea:within the 2 years;
Y_Alzheimers_1_10.txt	NCT00153010	Demographic	age	INC	has_value:between 40 and 85 years;has_value:inclusive;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	Huntington's disease	INC	
Y_Alzheimers_1_10.txt	NCT02167256	Drug	radiation	EXC	has_TempMea:current, past, or anticipated;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	microhemorrhages	EXC	has_value:greater than 4;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	permitted medications	INC	modified_by:Stability;
Y_Alzheimers_1_10.txt	NCT01018875	Condition	neurologic disease	EXC	modified_by:significant;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	Neurological disease	INC	
Y_Alzheimers_1_10.txt	NCT00855868	Condition	alcohol abuse	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	white matter disease	EXC	modified_by:prominent;
Y_Alzheimers_1_10.txt	NCT01524887	Drug	immunization	EXC	modified_by:active;
Y_Alzheimers_1_10.txt	NCT00153010	Measurement	Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog) score	INC	has_value:geater than 12;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	dehydration	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	psychiatric disorders	INC	Specified_by:schizophrenia;Specified_by:major depression;Specified_by:mental retardation;
Y_Alzheimers_1_10.txt	NCT00153010	Measurement	Mini-Mental State Examination (MMSE) score	INC	has_value:10-24;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	stroke	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Drug	immunoglobulin	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	multiple sclerosis	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Procedure	Central nervous system imaging	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	encephalitis	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	postmenopausal	INC	has_value:less than 2 years;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	epilepsy	INC	
Y_Alzheimers_1_10.txt	NCT00855868	Condition	lab abnormalities	EXC	modified_by:clinically significant;
Y_Alzheimers_1_10.txt	NCT01018875	Drug	investigation product	EXC	has_TempMea:within 6 weeks;
Y_Alzheimers_1_10.txt	NCT02167256	Measurement	MMSE score	INC	has_value:between 18 and 26 (inclusive);
Y_Alzheimers_1_10.txt	NCT02167256	Condition	neurologic defaults	EXC	modified_by:persistent;
Y_Alzheimers_1_10.txt	NCT00153010	Measurement	CLCR	INC	has_value:30 mL/min;
Y_Alzheimers_1_10.txt	NCT01524887	Drug	systemic corticosteroids	EXC	
Y_Alzheimers_1_10.txt	NCT01018875	Condition	non-prescribed drugs of abuse	EXC	
Y_Alzheimers_1_10.txt	NCT00855868	Measurement	CDR	INC	has_value:>= 0.5;
Y_Alzheimers_1_10.txt	NCT01524887	Procedure	dose	EXC	modified_by:low;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	chronic renal failure	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Drug	topical, ophthalmic or inhaled glucocorticoids	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	post-gastrectomy	INC	
Y_Alzheimers_1_10.txt	NCT00855868	Measurement	MMSE	INC	has_value:18-26;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	head trauma	EXC	modified_by:significant;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	peptic ulcer disease	INC	modified_by:active;
Y_Alzheimers_1_10.txt	NCT02167256	Measurement	B12	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	intracerebral hemorrhage	EXC	has_TempMea:within the 5 years;
Y_Alzheimers_1_10.txt	NCT01524887	Drug	prednisone	EXC	has_value:10 mg/day or its equivalent;
Y_Alzheimers_1_10.txt	NCT01018875	Drug	donepezil	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	diabetes mellitus	INC	
Y_Alzheimers_1_10.txt	NCT00855868	Condition	psychiatric disorder	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	hypothyroidism	INC	
Y_Alzheimers_1_10.txt	NCT00855868	Condition	MRI abnormality	EXC	
Y_Alzheimers_1_10.txt	NCT01018875	Condition	adverse reaction	EXC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	abnormalities	EXC	modified_by:Clinically significant;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	Endocrine disease	INC	
Y_Alzheimers_1_10.txt	NCT00855868	Condition	neurological disease	EXC	modified_by:other;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	Renal disease	INC	modified_by:primary or secondary;
Y_Alzheimers_1_10.txt	NCT00855868	Procedure	MRI	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Procedure	MRI	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Drug	antiepileptic drug (AED)	EXC	modified_by:adequate;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	AD	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	symptomatic	INC	modified_by:unstable/uncontrolled;
Y_Alzheimers_1_10.txt	NCT01524887	Procedure	Neuroimaging	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	seizures	EXC	modified_by:breakthrough;has_value:per year;has_value:two or more;
Y_Alzheimers_1_10.txt	NCT02167256	Procedure	metal (ferromagnetic) implants	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	Hematological disease	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Procedure	computed tomography CT	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Drug	investigational product (IP)	EXC	has_TempMea:within 12 weeks;
Y_Alzheimers_1_10.txt	NCT02167256	Procedure	cardiac pacemaker	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	Mini-Mental State Examination MMSE	INC	has_value:16-26 inclusive;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	seizure disorder	EXC	modified_by:Uncontrolled;
Y_Alzheimers_1_10.txt	NCT01524887	Procedure	investigational device	EXC	has_TempMea:within 12 weeks;
Y_Alzheimers_1_10.txt	NCT02167256	Procedure	MRI studies	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	alleges	INC	modified_by:clinically significant;
Y_Alzheimers_1_10.txt	NCT01018875	Condition	intolerance	EXC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	claustrophobia	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Procedure	doses	INC	modified_by:stable;
Y_Alzheimers_1_10.txt	NCT01018875	Condition	AD	EXC	is_negated:other than;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	bipolar disorder	EXC	has_TempMea:within the past 1 year;
Y_Alzheimers_1_10.txt	NCT00153010	Measurement	Hepatitis C antibody	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Drug	acetylcholinesterase inhibitors	INC	has_value:two;is_negated:not;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	malignancy	EXC	modified_by:active;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	disorder	EXC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	DSM-IV	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Drug	AD medication(s)	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	Modified Hachinski score	EXC	has_value:4;
Y_Alzheimers_1_10.txt	NCT01524887	Drug	IP	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	HIV	INC	modified_by:positive;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	Major depression	EXC	has_TempMea:within the past 1 year;
Y_Alzheimers_1_10.txt	NCT01524887	Drug	biologic	EXC	has_TempMea:within 12 months;
Y_Alzheimers_1_10.txt	NCT00153010	Procedure	MRI scan	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Procedure	investigational device	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	Dementia of the Alzheimer's Type	INC	has_TempMea:within the past year;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	Organ system diseases	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	refractory anemia	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Procedure	CT	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	refractory myelosuppression	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	size	EXC	has_value:greater than 0.5 mm;
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	lacunae	EXC	has_value:more than 2;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	infarction	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Drug	passive immunotherapies	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	multiple lacunae	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	major depression	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Drug	drug	EXC	has_TempMea:within 12 months;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	infection	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	mental retardation	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	age-related white matter changes (ARWMC) scale	EXC	has_value:3;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	AD	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Measurement	Modified Hachinski Scale10 score	INC	has_value:no greater than 4;
Y_Alzheimers_1_10.txt	NCT02167256	Measurement	B12	EXC	modified_by:low;
Y_Alzheimers_1_10.txt	NCT00153010	Measurement	hematocrit	INC	has_value:> 48%;
Y_Alzheimers_1_10.txt	NCT02167256	Procedure	MRI scan	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	schizophrenia	INC	
Y_Alzheimers_1_10.txt	NCT02167256	Measurement	Aspartate aminotransferase (AST)	EXC	has_value:> 1.5 times ULN;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	Dementia	INC	modified_by:mild to moderate;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	open head injury	EXC	has_TempMea:within the 12 months;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	Lupus erythematosis	INC	
Y_Alzheimers_1_10.txt	NCT02167256	Drug	memantine	INC	modified_by:stable;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	contraindications	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	scleroderma	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	Head trauma with loss of consciousness	EXC	has_TempMea:within the 12 months;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	AD	EXC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	lacunes	EXC	modified_by:multiple;
Y_Alzheimers_1_10.txt	NCT02167256	Drug	prostate-specific antigen	EXC	modified_by:post-treatment;modified_by:normal;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	NINCDS-ADRDA* 1984 criteria	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	contusion	EXC	has_TempMea:within the 12 months;
Y_Alzheimers_1_10.txt	NCT02167256	Drug	Cholinesterase inhibitors	INC	modified_by:stable;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	lacunes	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	Immunological disorder	INC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	focal lesions	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	pulmonary disease	INC	modified_by:Significant;
Y_Alzheimers_1_10.txt	NCT01524887	Drug	monoclonal or polyclonal antibodies	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	hypoxia	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Drug	anticonvulsants	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	psychosis	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Drug	mood stabilizers	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	psychiatric disorder	EXC	modified_by:other;modified_by:major;
Y_Alzheimers_1_10.txt	NCT01524887	Drug	antipsychotics	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	autoimmune or neuro-immunologic disorder	EXC	modified_by:Active;
Y_Alzheimers_1_10.txt	NCT01524887	Drug	anti-coagulant agent	EXC	has_TempMea:Currently;
Y_Alzheimers_1_10.txt	NCT01524887	Drug	anxiolytics	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	major depression	EXC	modified_by:Uncontrolled;
Y_Alzheimers_1_10.txt	NCT01018875	Condition	AD (Alzheimer's Disease)	INC	modified_by:probable;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	dementia	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	neurosyphilis	INC	
Y_Alzheimers_1_10.txt	NCT01018875	Condition	postmenopausal	INC	has_TempMea:at least 2 years;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	hyperthyroidism	INC	
Y_Alzheimers_1_10.txt	NCT01677754	Procedure	treatment	EXC	has_TempMea:Current;
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	pregnancy test	INC	modified_by:negative;
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	glycosylated (or glycated) hemoglobin (HbA1c)	EXC	has_value:> 6.5%;
Y_Alzheimers_1_10.txt	NCT02167256	Measurement	Geriatric Depression Scale	INC	has_value:less than 6;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	childbearing potential	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	diabetes	EXC	modified_by:Poorly controlled;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	DSM V criteria	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Procedure	CT/MRI	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Procedure	doses	INC	modified_by:stable;
Y_Alzheimers_1_10.txt	NCT01524887	Drug	aspirin	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Drug	anti-platelet agent	EXC	has_TempMea:Currently;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	craniocerebral trauma	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Drug	acetylsalicylic acid	EXC	is_negated:other than;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	schizophrenia	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Procedure	infusion	INC	modified_by:repeated;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	basal cell or squamous cell carcinoma of the skin	EXC	is_negated:exception;modified_by:adequately treated;
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	clinical chemistry panel	EXC	modified_by:Abnormal;
Y_Alzheimers_1_10.txt	NCT01524887	Procedure	phlebotomy	INC	modified_by:repeated;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	malignancy	EXC	has_TempMea:within 5 years;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	anticholinergic side effects	INC	modified_by:significant;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	abnormality	EXC	modified_by:clinically significant;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	disease	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Measurement	pregnancy test	INC	modified_by:negative;
Y_Alzheimers_1_10.txt	NCT00153010	Procedure	general anesthesia	INC	
Y_Alzheimers_1_10.txt	NCT02500784	Condition	AD	INC	modified_by:Mild-to-moderate;
Y_Alzheimers_1_10.txt	NCT02500784	Measurement	MMSE	INC	has_value:16-26;
Y_Alzheimers_1_10.txt	NCT02500784	Condition	NINCDS/ADRDA criteria	INC	
Y_Alzheimers_1_10.txt	NCT02500784	Condition	Non-AD dementia	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Drug	monoamine oxidase inhibitors MAOIs	INC	is_negated:other than;
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	urine tests	EXC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	behavioral problems	EXC	has_TempMea:within 3 months;
Y_Alzheimers_1_10.txt	NCT02500784	Condition	AD	INC	modified_by:probable;
Y_Alzheimers_1_10.txt	NCT01524887	Drug	tricyclics	INC	modified_by:most;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	Secondary disorders	INC	
Y_Alzheimers_1_10.txt	NCT02500784	Condition	neurological disease	EXC	modified_by:significant;
Y_Alzheimers_1_10.txt	NCT01524887	Drug	antidepressants	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Procedure	electrocardiogram	EXC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	psychotic features	EXC	has_TempMea:within 3 months;
Y_Alzheimers_1_10.txt	NCT01524887	Procedure	chest x-ray	EXC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	agitation	EXC	has_TempMea:within 3 months;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	carcinoma in situ of the cervix	EXC	is_negated:exception;modified_by:adequately treated;
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	laboratory	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	Dementia of the Alzheimer's Type	INC	modified_by:mild to moderate;modified_by:probable;
Y_Alzheimers_1_10.txt	NCT02500784	Condition	Parkinson's disease	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Drug	psychoactive medications	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	prostate cancer	EXC	is_negated:exception;modified_by:stable;
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	clinical test(s)	EXC	modified_by:other;
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	blood tests	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	AD	EXC	modified_by:Possible;
Y_Alzheimers_1_10.txt	NCT01524887	Drug	immunoglobulin treatment	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	platelet counts	EXC	has_value:< 100,000 cells/L;
Y_Alzheimers_1_10.txt	NCT01018875	Procedure	CT	INC	has_TempMea:within 36 months;
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	Total serum protein	EXC	has_value:> 9 g/dL;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	lactating	INC	is_negated:not;
Y_Alzheimers_1_10.txt	NCT01018875	Procedure	MRI scan	INC	has_TempMea:within 36 months;
Y_Alzheimers_1_10.txt	NCT02500784	Condition	brain tumor	EXC	
Y_Alzheimers_1_10.txt	NCT02500784	Condition	stroke	EXC	
Y_Alzheimers_1_10.txt	NCT02500784	Condition	seizure disorder	EXC	
Y_Alzheimers_1_10.txt	NCT02500784	Condition	multiple sclerosis	EXC	
Y_Alzheimers_1_10.txt	NCT02500784	Condition	head injury with loss of consciousness	EXC	
Y_Alzheimers_1_10.txt	NCT02500784	Condition	focal brain lesion	EXC	
Y_Alzheimers_1_10.txt	NCT02500784	Condition	congestive heart failure	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	conditions	EXC	
Y_Alzheimers_1_10.txt	NCT02500784	Condition	Hypothyroidism	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	Parkinson's disease	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	vitamin B12 deficiency	EXC	has_TempMea:within 6 months;modified_by:untreated;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	surgically sterile	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	frontotemporal dementia	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	human immunodeficiency virus (HIV) type 1/2 antibody	EXC	
Y_Alzheimers_1_10.txt	NCT01018875	Condition	AD	INC	modified_by:mild-to-moderate;
Y_Alzheimers_1_10.txt	NCT02500784	Observation	New York Heart Association	EXC	has_value:Class III or IV;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	dementia arising from other diseases	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Drug	human albumin	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	vascular dementia	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	hepatitis C virus (HCV) antibody	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	dementia with Lewy bodies	EXC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	post-menopausal	INC	has_TempMea:two years;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	NINCDS-ADRDA criteria	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	hepatitis B surface antigen (HBsAg)	EXC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	of childbearing potential	INC	is_negated:not;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	non-Alzheimer dementia	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	risk	INC	modified_by:increased;is_negated:not;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	stent occlusion	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Procedure	coronary artery stent	INC	
Y_Alzheimers_1_10.txt	NCT02167256	Measurement	Visual and auditory acuity	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	folic acid deficiency	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	Creatinine clearance	EXC	has_value:50% of normal;
Y_Alzheimers_1_10.txt	NCT02500784	Procedure	neurological examination	EXC	
Y_Alzheimers_1_10.txt	NCT02500784	Condition	extrapyramidal symptoms	EXC	modified_by:significant;
Y_Alzheimers_1_10.txt	NCT02500784	Measurement	serum creatinine	EXC	has_value:>1.3 mg/dl;
Y_Alzheimers_1_10.txt	NCT02500784	Condition	arrhythmias	EXC	modified_by:significant;
Y_Alzheimers_1_10.txt	NCT02500784	Procedure	ECG	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	risk	INC	modified_by:increased;is_negated:not;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	disease	INC	is_negated:no;
Y_Alzheimers_1_10.txt	NCT02500784	Condition	conduction defect abnormalities	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	thromboembolic events	INC	
Y_Alzheimers_1_10.txt	NCT02167256	Condition	general health	INC	modified_by:Good;
Y_Alzheimers_1_10.txt	NCT02500784	Drug	beta2 adrenergic drug	EXC	modified_by:another;
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	Absolute neutrophil count (ANC)	EXC	has_value:< 1000 cells/L;
Y_Alzheimers_1_10.txt	NCT02167256	Condition	pregnant	INC	is_negated:not;
Y_Alzheimers_1_10.txt	NCT01524887	Procedure	endovascular stent	INC	
Y_Alzheimers_1_10.txt	NCT01677754	Procedure	AD vaccine study	EXC	modified_by:active;
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	Serum alanine aminotransferase (ALT)	EXC	has_value:> 2.5 x upper limit of normal (ULN);
Y_Alzheimers_1_10.txt	NCT01018875	Condition	surgically sterile	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Drug	immunoglobulin treatment	INC	
Y_Alzheimers_1_10.txt	NCT01018875	Condition	surgically sterile	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	congestive heart failure	EXC	modified_by:Clinically significant;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	New York Heart Association NYHA	EXC	has_value:Class III/IV;has_value:Class II;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	Immunoglobulin A (IgA) deficiency	EXC	has_value:8 mg/dL;
Y_Alzheimers_1_10.txt	NCT02500784	Condition	clinical disorder	EXC	modified_by:significant;
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	serology	EXC	modified_by:positive;
Y_Alzheimers_1_10.txt	NCT02500784	Drug	investigational new drug	EXC	is_negated:unsuitable;
Y_Alzheimers_1_10.txt	NCT02500784	Condition	hypersensitivity	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Drug	anti-CD20 therapy	EXC	has_TempMea:within 12 months;
Y_Alzheimers_1_10.txt	NCT02500784	Drug	formoterol	EXC	has_TempMea:prior;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	myocardial infarction	EXC	has_TempMea:within the 12 months;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	atrial fibrillation of unstable angina	EXC	has_TempMea:Current;
Y_Alzheimers_1_10.txt	NCT01524887	Drug	blood components	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	angina at rest	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Drug	human blood	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	hypersensitivity	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Drug	human immunoglobulins	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	vitamin B12 deficiency	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	thyroid abnormalities	EXC	
Y_Alzheimers_1_10.txt	NCT01231295	Measurement	clinical evaluation	INC	
Y_Alzheimers_1_10.txt	NCT02500784	Condition	asthma	EXC	modified_by:Active;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	Contraindication	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	vitamin B12	EXC	modified_by:clinically significant;modified_by:abnormally low;
Y_Alzheimers_1_10.txt	NCT01231295	Condition	memory problems	INC	
Y_Alzheimers_1_10.txt	NCT02500784	Condition	asthma	EXC	modified_by:family history;
Y_Alzheimers_1_10.txt	NCT01231295	Condition	memory problems	INC	
Y_Alzheimers_1_10.txt	NCT01231295	Condition	dementia	INC	is_negated:cannot;
Y_Alzheimers_1_10.txt	NCT01231295	Condition	memory complaint	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Procedure	ferromagnetic implants	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	anemia	EXC	modified_by:Clinically significant;
Y_Alzheimers_1_10.txt	NCT01231295	Condition	DSM-IV-R and NINCDS-ADRDA criteria	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Procedure	metal plate	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	coagulopathy	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	hemoglobin (Hgb)	EXC	has_value:< 10.0 g/dL;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	claustrophobia	EXC	modified_by:severe;
Y_Alzheimers_1_10.txt	NCT01524887	Procedure	MRI-compatible pacemaker	EXC	is_negated:exception;
Y_Alzheimers_1_10.txt	NCT01524887	Procedure	MRI	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Procedure	pacemaker	EXC	
Y_Alzheimers_1_10.txt	NCT01231295	Measurement	cognitive performance	INC	modified_by:well preserved;
Y_Alzheimers_1_10.txt	NCT01231295	Condition	memory problems	INC	
Y_Alzheimers_1_10.txt	NCT01231295	Measurement	Clinical Dementia Rating (CDR)	INC	has_value:> 0;
Y_Alzheimers_1_10.txt	NCT01231295	Condition	memory problem	INC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	siderosis	EXC	modified_by:superficial;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	edema	EXC	
Y_Alzheimers_1_10.txt	NCT01231295	Measurement	Instrumental Activities of Daily Living (IADL)	EXC	has_value:at least two items 1;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	AT III deficiency	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	antiphospholipid syndrome	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	protein S/protein C deficiency	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	procoagulant abnormalities	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	factor V Leiden	EXC	
Y_Alzheimers_1_10.txt	NCT01231295	Drug	memantine	EXC	
Y_Alzheimers_1_10.txt	NCT01231295	Drug	Anticholinesterasic treatments	EXC	
Y_Alzheimers_1_10.txt	NCT01231295	Condition	neurodegenerative disease	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Condition	hypertension	EXC	modified_by:Uncontrolled;
Y_Alzheimers_1_10.txt	NCT01231295	Condition	major depressive syndrome	EXC	
Y_Alzheimers_1_10.txt	NCT01231295	Condition	general disease	EXC	
Y_Alzheimers_1_10.txt	NCT01231295	Measurement	Global Depressive Scale	EXC	
Y_Alzheimers_1_10.txt	NCT01231295	Condition	physical problems	EXC	modified_by:major;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	thromboembolic disease	EXC	has_TempMea:within the 12 months;
Y_Alzheimers_1_10.txt	NCT01524887	Procedure	investigational device	EXC	has_TempMea:within 12 months;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	thrombosis	EXC	has_TempMea:within the 12 months;
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	diastolic	EXC	has_value:100 mm Hg;
Y_Alzheimers_1_10.txt	NCT01524887	Measurement	systolic blood pressure	EXC	has_value:160 mm Hg;
Y_Alzheimers_1_10.txt	NCT01231295	Condition	cancer	EXC	modified_by:evolving;
Y_Alzheimers_1_10.txt	NCT01231295	Condition	hepatic, renal or respiratory insufficiency	EXC	
Y_Alzheimers_1_10.txt	NCT01231295	Condition	cardiopathy	EXC	modified_by:non stable;
Y_Alzheimers_1_10.txt	NCT01231295	Procedure	MRI	EXC	
Y_Alzheimers_1_10.txt	NCT01231295	Condition	contra-indications	EXC	
Y_Alzheimers_1_10.txt	NCT01231295	Procedure	SPECT scans	EXC	
Y_Alzheimers_1_10.txt	NCT01231295	Procedure	PET	EXC	
Y_Alzheimers_1_10.txt	NCT01743534	Condition	insanities of type Alzheimer	INC	
Y_Alzheimers_1_10.txt	NCT00438724	Condition	AD	INC	
Y_Alzheimers_1_10.txt	NCT00438724	Demographic	Ages	INC	has_value:21 to 90;
Y_Alzheimers_1_10.txt	NCT00438724	Condition	psychological or physical illness	EXC	modified_by:Severe;
Y_Alzheimers_1_10.txt	NCT02500784	Demographic	ages	INC	has_value:50-85;
Y_Alzheimers_1_10.txt	NCT01743534	Measurement	EBS score	INC	has_value:< 16;
Y_Alzheimers_1_10.txt	NCT01743534	Condition	disease	INC	modified_by:Severe stage;
Y_Alzheimers_1_10.txt	NCT01743534	Condition	oral hurts	EXC	
Y_Alzheimers_1_10.txt	NCT01743534	Condition	Undernutrition	EXC	
Y_Alzheimers_1_10.txt	NCT01524887	Demographic	age	INC	has_value:50 to 89 years inclusive;
Y_Alzheimers_1_10.txt	NCT01524887	Condition	Alzheimers Disease (AD)	INC	modified_by:Probable;
Y_Alzheimers_1_10.txt	NCT00153010	Drug	cocaine	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Measurement	urine drug screen	INC	modified_by:positive;
Y_Alzheimers_1_10.txt	NCT00153010	Condition	DSM IV	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	hypothyroidism	INC	
Y_Alzheimers_1_10.txt	NCT02167256	Measurement	TFTs	EXC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	condition	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Drug	drug	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Drug	marijuana	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Drug	heroin	INC	
Y_Alzheimers_1_10.txt	NCT01677754	Drug	rivastigmine	INC	has_TempMea:at least 4 months;
Y_Alzheimers_1_10.txt	NCT02167256	Drug	radioactive agents	EXC	has_TempMea:Current or recent;
Y_Alzheimers_1_10.txt	NCT01677754	Drug	donepezil	INC	has_TempMea:at least 4 months;
Y_Alzheimers_1_10.txt	NCT00153010	Procedure	elective surgery	INC	
Y_Alzheimers_1_10.txt	NCT00153010	Condition	drug dependence or abuse	INC	has_TempMea:within two years;
Y_Alzheimers_1_10.txt	NCT01677754	Measurement	Cornell Scale for Depression in Dementia (CSDD) scores	INC	has_value:<= 13;
Y_Alzheimers_1_10.txt	NCT00153010	Procedure	hospitalization	INC	has_value:more than 1 day;
Y_Alzheimers_1_10.txt	NCT01677754	Measurement	Modified Hachinski Ischemia Score	INC	has_value:<= 4;
Y_Alzheimers_1_10.txt	NCT02167256	Measurement	HC	EXC	
Y_Alzheimers_1_10.txt	NCT02167256	Measurement	methylmalonic acid	EXC	
Y_Alzheimers_1_10.txt	NCT01677754	Drug	memantine	INC	
Y_Alzheimers_1_10.txt	NCT01677754	Drug	AChEIs	INC	
Y_Alzheimers_1_10.txt	NCT02167256	Measurement	homocysteine	EXC	
Y_Alzheimers_1_10.txt	NCT01677754	Drug	galantamine	INC	has_TempMea:at least 4 months;
Y_Alzheimers_1_10.txt	NCT01677754	Condition	National Institute of Neurological and Communicative Disorders and Stroke (NINCDS)	INC	
Y_Alzheimers_1_10.txt	NCT01677754	Condition	Alzheimer disease	INC	modified_by:Probable;
Y_Alzheimers_1_10.txt	NCT01677754	Demographic	age	INC	has_value:50-90 years;has_value:inclusive;
Y_Alzheimers_1_10.txt	NCT01677754	Measurement	Body mass index (BMI)	INC	has_value:between 18 and 36 kg/m2 (inclusive);
Y_Alzheimers_1_10.txt	NCT01677754	Measurement	MMSE score	INC	has_value:between 13 and 20, inclusive;
Y_Alzheimers_21_30.txt	NCT02380573	Condition	Contraindication	EXC	
Y_Alzheimers_21_30.txt	NCT02380573	Procedure	MRI	EXC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	Pregnancy	EXC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	breastfeeding	EXC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	AD	INC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	Alzheimer's Early-stage, sporadic-type	INC	
Y_Alzheimers_21_30.txt	NCT02380573	Observation	Texas Alzheimer's Research and Care Consortium	INC	
Y_Alzheimers_21_30.txt	NCT02380573	Measurement	TARCC	INC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	Claustrophobia	EXC	
Y_Alzheimers_21_30.txt	NCT02380573	Procedure	magnetic metal implants	EXC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	Glucose- 6 -phosphate deficiency	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	infectious disease	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	HIV	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	Syphilis	INC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	MCI	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	Hepatitis B, C	INC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	AD	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	cancer	INC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	neuropsychologic disturbances	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	Myocardial infarction	INC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	secondary dementia	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Observation	history	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Observation	Presence	INC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	new tumor	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	immunodeficiency	INC	
Y_Alzheimers_21_30.txt	NCT02380573	Procedure	neuroimaging	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Drug	medications	INC	
Y_Alzheimers_21_30.txt	NCT02380573	Procedure	endovascular neurosurgery	EXC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	stroke	EXC	
Y_Alzheimers_21_30.txt	NCT02380573	Procedure	Craniotomy	EXC	
Y_Alzheimers_21_30.txt	NCT02380573	Procedure	craniectomy	EXC	
Y_Alzheimers_21_30.txt	NCT02380573	Drug	MB	EXC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	Color-blindness	EXC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	methemoglobinemia	EXC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	Allergy	EXC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	transient ischemic attack	EXC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	TIA	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Observation	history	INC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	primary neurodegenerative disorder	EXC	
Y_Alzheimers_21_30.txt	NCT01926691	Condition	unconscious state	EXC	
Y_Alzheimers_21_30.txt	NCT01926691	Condition	TIA	EXC	
Y_Alzheimers_21_30.txt	NCT01926691	Observation	death	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	liver disease	INC	
Y_Alzheimers_21_30.txt	NCT01926691	Condition	cerebral vascular event	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Measurement	eGFR	INC	
Y_Alzheimers_21_30.txt	NCT01926691	Observation	history	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	renal insufficiency	INC	
Y_Alzheimers_21_30.txt	NCT01423396	Condition	cognitive disorders	INC	
Y_Alzheimers_21_30.txt	NCT01926691	Condition	chronic disease	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Measurement	ALT	INC	
Y_Alzheimers_21_30.txt	NCT01926691	Condition	malignant disease	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Measurement	alanine aminotransferase	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Measurement	BMI	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Measurement	NYHA	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	congestive heart failure	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	systemic illness	INC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	disease	EXC	
Y_Alzheimers_21_30.txt	NCT01926691	Condition	focal neurological deficit	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	diabetes	INC	
Y_Alzheimers_21_30.txt	NCT01926691	Condition	primary hemorrhagic stroke	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Measurement	HbA1c	INC	
Y_Alzheimers_21_30.txt	NCT01023685	Condition	autoimmune	EXC	
Y_Alzheimers_21_30.txt	NCT01423396	Condition	NINCDS/ADRDA diagnostic criteria	INC	
Y_Alzheimers_21_30.txt	NCT00056524	Condition	psychiatric disturbance	EXC	
Y_Alzheimers_21_30.txt	NCT01023685	Condition	cerebrovascular disease	EXC	
Y_Alzheimers_21_30.txt	NCT01423396	Condition	Alzheimer's disease	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Measurement	FT4 levels	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Measurement	thyroid-stimulating hormone	INC	
Y_Alzheimers_21_30.txt	NCT01023685	Condition	seizure disorder	EXC	
Y_Alzheimers_21_30.txt	NCT01423396	Demographic	aged	INC	
Y_Alzheimers_21_30.txt	NCT01600469	Condition	mild cognitive impairment	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Observation	History	INC	
Y_Alzheimers_21_30.txt	NCT01423396	Condition	arterial hypertension	INC	
Y_Alzheimers_21_30.txt	NCT01023685	Condition	inflammation	EXC	
Y_Alzheimers_21_30.txt	NCT01423396	Condition	VRF	INC	
Y_Alzheimers_21_30.txt	NCT01423396	Measurement	MMSE	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	hypothyroidism	INC	
Y_Alzheimers_21_30.txt	NCT01926691	Condition	trauma	EXC	
Y_Alzheimers_21_30.txt	NCT01926691	Condition	stroke	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Measurement	QTc interval prolongation	INC	
Y_Alzheimers_21_30.txt	NCT01926691	Observation	predicted survival	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Procedure	ECG	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Measurement	Fazekas	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Measurement	AST	INC	
Y_Alzheimers_21_30.txt	NCT01926691	Condition	prognosis	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Measurement	aspartate aminotransferase	INC	
Y_Alzheimers_21_30.txt	NCT01023685	Condition	psychiatric disorders	EXC	
Y_Alzheimers_21_30.txt	NCT01926691	Condition	dementia	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	Hypothyroidism	INC	
Y_Alzheimers_21_30.txt	NCT01926691	Condition	aphasia	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Measurement	TSH	INC	
Y_Alzheimers_21_30.txt	NCT01926691	Procedure	invasive procedure	EXC	
Y_Alzheimers_21_30.txt	NCT01023685	Condition	neurodegenerative disease	EXC	
Y_Alzheimers_21_30.txt	NCT01926691	Observation	prestroke history	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	systemic illness	INC	
Y_Alzheimers_21_30.txt	NCT01600469	Condition	visual or hearing impairment	EXC	
Y_Alzheimers_21_30.txt	NCT01423396	Condition	isolated vascular dementia	INC	
Y_Alzheimers_21_30.txt	NCT01423396	Condition	Lewy body dementia	INC	
Y_Alzheimers_21_30.txt	NCT01600469	Condition	dementia with psychotic features	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Observation	History	INC	
Y_Alzheimers_21_30.txt	NCT01600469	Condition	physical illnesses	EXC	
Y_Alzheimers_21_30.txt	NCT01423396	Condition	Non-Alzheimer's dementia	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	alcohol or drug abuse or dependence	INC	
Y_Alzheimers_21_30.txt	NCT00056524	Condition	pseudobulbar affect	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	AD	INC	is_negated:other than;
Y_Alzheimers_21_30.txt	NCT00056524	Condition	Sensitivity	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	National Institute on Aging-Alzheimer's Association ( NIA-AA ) criteria ( McKhann 2011 )	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	dementia	INC	
Y_Alzheimers_21_30.txt	NCT01423396	Condition	cardiovascular events	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	CNS disorder	INC	
Y_Alzheimers_21_30.txt	NCT00056524	Condition	PBA	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	Alzheimer's disease	INC	
Y_Alzheimers_21_30.txt	NCT00056524	Demographic	age	INC	
Y_Alzheimers_21_30.txt	NCT01423396	Drug	Psychotropic drugs	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Observation	evidence	INC	
Y_Alzheimers_21_30.txt	NCT01423396	Observation	history	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	Wernicke's encephalopathy	INC	
Y_Alzheimers_21_30.txt	NCT01423396	Condition	frontotemporal dementia	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Observation	History	INC	
Y_Alzheimers_21_30.txt	NCT01423396	Condition	type 2 diabetes	INC	
Y_Alzheimers_21_30.txt	NCT01600469	Measurement	Hachinski Ischemic Score	EXC	
Y_Alzheimers_21_30.txt	NCT01600469	Measurement	CDR	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	depressive episode	INC	
Y_Alzheimers_21_30.txt	NCT01600469	Condition	Alzheimer's	INC	
Y_Alzheimers_21_30.txt	NCT01423396	Measurement	SBP/DBP	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	psychiatric illness	INC	
Y_Alzheimers_21_30.txt	NCT01600469	Measurement	MMSE	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Observation	presence	INC	
Y_Alzheimers_21_30.txt	NCT00015548	Drug	anticonvulsants	INC	
Y_Alzheimers_21_30.txt	NCT00015548	Condition	schizoaffective disorder	INC	
Y_Alzheimers_21_30.txt	NCT00015548	Condition	schizophrenia	INC	
Y_Alzheimers_21_30.txt	NCT00015548	Condition	mood disorder with psychotic features	INC	
Y_Alzheimers_21_30.txt	NCT00015548	Condition	delusional disorder	INC	
Y_Alzheimers_21_30.txt	NCT01600469	Condition	epilepsy	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	Metabolic or toxic encephalopathy	INC	
Y_Alzheimers_21_30.txt	NCT00015548	Condition	medical illness	INC	modified_by:severe;modified_by:unstable;
Y_Alzheimers_21_30.txt	NCT01600469	Condition	major depressive disorder	EXC	
Y_Alzheimers_21_30.txt	NCT01423396	Condition	physical problems	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	dementia	INC	
Y_Alzheimers_21_30.txt	NCT00015548	Condition	hypersensitivity	INC	
Y_Alzheimers_21_30.txt	NCT01600469	Condition	substance abuse/dependence	EXC	
Y_Alzheimers_21_30.txt	NCT01423396	Condition	dyslipidaemia	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	major depressive episode	INC	
Y_Alzheimers_21_30.txt	NCT01600469	Condition	Parkinson disease	EXC	
Y_Alzheimers_21_30.txt	NCT01423396	Measurement	LDL cholesterol level	INC	
Y_Alzheimers_21_30.txt	NCT01423396	Measurement	glycaemia value	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Measurement	GDS	INC	
Y_Alzheimers_21_30.txt	NCT00015548	Condition	intolerance	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Measurement	Geriatric Depression Scale	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Measurement	Clinical Dementia Rating	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Measurement	Hachinski Ischemia Scale score	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Observation	dose	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Measurement	CDR	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	postmenopausal	INC	
Y_Alzheimers_21_30.txt	NCT00015548	Drug	study medications	INC	
Y_Alzheimers_21_30.txt	NCT02267057	Condition	aggression	EXC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	hypersensitivity	EXC	
Y_Alzheimers_21_30.txt	NCT02267057	Condition	dementia	INC	modified_by:probable or possible;
Y_Alzheimers_21_30.txt	NCT02380573	Drug	phenothiazines	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	Contraindication	INC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	MCI	INC	
Y_Alzheimers_21_30.txt	NCT02380573	Drug	thiazide diuretics	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	Infarction	INC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	non-amnestic MCI	INC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	cirrhosis	EXC	
Y_Alzheimers_21_30.txt	NCT01354444	Condition	AD	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Drug	components of the vaccine	INC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	Chronic kidney disease	EXC	
Y_Alzheimers_21_30.txt	NCT01354444	Measurement	CDR	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Procedure	MRI	INC	
Y_Alzheimers_21_30.txt	NCT02380573	Observation	old	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	breastfeeding	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Measurement	folic acid	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Condition	AD	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	allergy	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Condition	dementia	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Measurement	serum vitamin B12	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	Pregnant	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	Alzheimer's disease	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Drug	FDA-approved Alzheimer's treatments	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Condition	AD	INC	
Y_Alzheimers_21_30.txt	NCT00056524	Drug	quinidine	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Measurement	Mini Mental State Examination ( MMSE ) score	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	Cerebrovascular disease	INC	
Y_Alzheimers_21_30.txt	NCT00056524	Drug	opiate drugs	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	ischemic or haemorrhagic stroke	INC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	liver or renal transplants	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	vascular dementia	INC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	traumatic brain injury with loss of consciousness	EXC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	epilepsy	EXC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	psychosis	EXC	
Y_Alzheimers_21_30.txt	NCT02380573	Drug	psychiatric serotonergic antidepressant medication	EXC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	panic attacks	EXC	
Y_Alzheimers_21_30.txt	NCT01354444	Measurement	CDR	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Drug	acetylcholinesterase inhibitor	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	immunosuppressive drugs	INC	
Y_Alzheimers_21_30.txt	NCT02380573	Drug	psychotropic medication	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	Vitamin B12 or folic acid deficiency	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Demographic	Age	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	AD	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Condition	AD	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	AD	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Measurement	Mini-Mental State Exam	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Measurement	Scheltens score	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Drug	intravenous immunoglobulin	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Measurement	MMSE	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Procedure	MRI	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	Epilepsy	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Condition	NINCDS/ADRDA criteria	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	Medial temporal lobe atrophy	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Drug	experimental immunotherapeutics	INC	
Y_Alzheimers_21_30.txt	NCT02380573	Measurement	diastolic blood pressure	EXC	
Y_Alzheimers_21_30.txt	NCT01354444	Observation	dose	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Procedure	Surgery	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Drug	antidepressant	INC	
Y_Alzheimers_21_30.txt	NCT02380573	Measurement	systolic blood pressure	EXC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	Alzheimer's disease	INC	is_negated:other than;
Y_Alzheimers_21_30.txt	NCT02380573	Condition	Alcohol and/or drug abuse	EXC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	intercurrent illness	EXC	
Y_Alzheimers_21_30.txt	NCT02380573	Observation	death	EXC	
Y_Alzheimers_21_30.txt	NCT02380573	Condition	terminal cancer	EXC	
Y_Alzheimers_21_30.txt	NCT01354444	Condition	Parkinson's disease	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Condition	frontotemporal dementia	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Condition	non-AD dementias	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Drug	immunosuppressive	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Condition	Huntington's disease	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Drug	immunomodulatory treatment	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Observation	dose	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	autoimmune disease	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Drug	antipsychotics medications	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Observation	history	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Measurement	CDR	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Condition	AD	INC	
Y_Alzheimers_21_30.txt	NCT02267057	Condition	Diagnostic and Statistical Manual of Mental Disorders ( DSM-IV )	INC	
Y_Alzheimers_21_30.txt	NCT02267057	Measurement	FAST score	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	lacunar infarct	INC	
Y_Alzheimers_21_30.txt	NCT02267057	Condition	depression	INC	has_value:>= 4 week duration;
Y_Alzheimers_21_30.txt	NCT02267057	Measurement	CSDD	INC	has_value:>= 8;
Y_Alzheimers_21_30.txt	NCT02267057	Condition	suicide risk	EXC	
Y_Alzheimers_21_30.txt	NCT01354444	Drug	memantine	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Condition	mild cognitive impairment	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	focal lesions	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Drug	cholinesterase inhibitors	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	central nervous disease	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Condition	AD	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	Confluent hemispheric deep white matter lesions	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Condition	dementia	INC	
Y_Alzheimers_21_30.txt	NCT02579252	Condition	lacunar infarct	INC	
Y_Alzheimers_21_30.txt	NCT02267057	Condition	medical disease/disorder	EXC	
Y_Alzheimers_21_30.txt	NCT02267057	Condition	mental disorder	EXC	
Y_Alzheimers_21_30.txt	NCT01354444	Condition	hepatic or renal insufficiency	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Condition	Contraindications	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Drug	Beta-blocking agents	INC	
Y_Alzheimers_21_30.txt	NCT02267057	Condition	dementia	EXC	
Y_Alzheimers_21_30.txt	NCT02267057	Condition	Psychosis	EXC	
Y_Alzheimers_21_30.txt	NCT02267057	Condition	aggression	EXC	
Y_Alzheimers_21_30.txt	NCT01926691	Condition	stroke	INC	
Y_Alzheimers_21_30.txt	NCT01926691	Demographic	Age	INC	
Y_Alzheimers_21_30.txt	NCT02267057	Measurement	NPI subscale	EXC	
Y_Alzheimers_21_30.txt	NCT02267057	Condition	Schizophrenia	EXC	
Y_Alzheimers_21_30.txt	NCT02267057	Condition	bipolar disorder	EXC	
Y_Alzheimers_21_30.txt	NCT01354444	Condition	dementia	INC	is_negated:other than;
Y_Alzheimers_21_30.txt	NCT02267057	Condition	schizoaffective disorder	EXC	
Y_Alzheimers_21_30.txt	NCT01354444	Condition	major depression	INC	
Y_Alzheimers_21_30.txt	NCT02267057	Condition	epilepsy	EXC	
Y_Alzheimers_21_30.txt	NCT02267057	Condition	liver impairment	EXC	
Y_Alzheimers_21_30.txt	NCT02267057	Condition	Renal failure	EXC	
Y_Alzheimers_21_30.txt	NCT01354444	Drug	Beta-blocking agents	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Condition	substance abuse	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Condition	anxiety disorders	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Condition	alcohol abuse	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Condition	bipolar disorder	INC	
Y_Alzheimers_21_30.txt	NCT01354444	Condition	schizophrenia	INC	
Y_Alzheimers_21_30.txt	NCT02267057	Condition	injury	EXC	
Y_Alzheimers_21_30.txt	NCT02267057	Condition	comatose state	EXC	
Y_Alzheimers_21_30.txt	NCT02267057	Condition	anaemia	EXC	
Y_Alzheimers_21_30.txt	NCT02267057	Measurement	Hb	EXC	
Y_Alzheimers_21_30.txt	NCT02267057	Drug	paracetamol	EXC	
Y_Alzheimers_21_30.txt	NCT02267057	Condition	allergy or adverse reaction	EXC	
Y_Alzheimers_21_30.txt	NCT02267057	Drug	buprenorphine transdermal patch	EXC	
Y_Alzheimers_21_30.txt	NCT00015548	Condition	Dementia of the Alzheimer's Type	INC	
Y_Alzheimers_21_30.txt	NCT00015548	Condition	delusions	INC	
Y_Alzheimers_21_30.txt	NCT00015548	Condition	hallucinations	INC	
Y_Alzheimers_21_30.txt	NCT00015548	Condition	agitation	INC	
Y_Alzheimers_21_30.txt	NCT00015548	Condition	Agitation	INC	
Y_Alzheimers_21_30.txt	NCT00015548	Condition	psychotic symptoms	INC	
Y_Alzheimers_21_30.txt	NCT00015548	Condition	dementia	INC	
Y_Alzheimers_21_30.txt	NCT00015548	Drug	psychotropic medication	INC	
Y_Alzheimers_21_30.txt	NCT00015548	Drug	antidepressants	INC	
Y_Alzheimers_21_30.txt	NCT02267057	Observation	expected survival	EXC	
Y_Alzheimers_21_30.txt	NCT02267057	Condition	medical disease	EXC	
Y_Alzheimers_21_30.txt	NCT00056524	Observation	history	EXC	
Y_Alzheimers_21_30.txt	NCT02267057	Observation	survival	EXC	
Y_Alzheimers_21_30.txt	NCT02267057	Condition	psychiatric or neurological disorder	EXC	
Y_Alzheimers_31_40.txt	NCT00134953	Condition	post-menopausal	INC	
Y_Alzheimers_31_40.txt	NCT01780519	Drug	lorazepam	INC	
Y_Alzheimers_31_40.txt	NCT00134953	Condition	childbearing potential	INC	is_negated:without;
Y_Alzheimers_31_40.txt	NCT00267163	Condition	euthyroid	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	high cognitive performance	INC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	cognitive impairment	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Demographic	age	INC	
Y_Alzheimers_31_40.txt	NCT00267163	Drug	estrogen replacement therapy	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	marginally normal cognition	INC	
Y_Alzheimers_31_40.txt	NCT00267163	Drug	thyroid replacement therapy	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Observation	history	INC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	major depression	INC	is_negated:no;has_value:2 years;
Y_Alzheimers_31_40.txt	NCT01662882	Observation	problem solving	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Observation	functioning in personal care	INC	
Y_Alzheimers_31_40.txt	NCT00267163	Observation	history	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Observation	orientation	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Observation	judgment	INC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	incipient dementia	INC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	Buschke-Fuld	INC	has_value:34;
Y_Alzheimers_31_40.txt	NCT01662882	Condition	cognitive or neurological deficits	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	NINCDS-ADRDA criteria	INC	
Y_Alzheimers_31_40.txt	NCT01189084	Drug	UB 311	INC	
Y_Alzheimers_31_40.txt	NCT00380302	Procedure	Magnetic Resonance Imaging	INC	
Y_Alzheimers_31_40.txt	NCT00380302	Procedure	MRI	INC	
Y_Alzheimers_31_40.txt	NCT00380302	Procedure	Computerized Axial Tomographic Scan	INC	
Y_Alzheimers_31_40.txt	NCT00380302	Procedure	CAT scan	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	cognitive function	INC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	vascular	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	Lewy body	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	Human Immunodeficiency Virus ( HIV ) infection	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	hepatitis	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	Acquired Immune Deficiency Syndrome	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	surgically sterile	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	AIDS	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	dementia	EXC	Specified_by:vascular;modified_by:other;Specified_by:frontotemporal;Specified_by:Lewy body;
Y_Alzheimers_31_40.txt	NCT00267163	Condition	AD	EXC	modified_by:possible or probable;
Y_Alzheimers_31_40.txt	NCT01662882	Condition	infectious disease	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	childbearing potential	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	physical illness	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Measurement	serum beta-hCG	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	frontotemporal	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Measurement	laboratory tests	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Measurement	Multiple focal signs	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Procedure	ECG	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Procedure	neurologic examination	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Measurement	visual and auditory acuity	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Procedure	MRI scan	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	multiple ischemic episodes	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Measurement	Benton Visual Retention	INC	has_value:5;
Y_Alzheimers_31_40.txt	NCT01662882	Condition	NINCDS criteria	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Measurement	verbal fluency	INC	has_value:46 for letters, 7 for categories;
Y_Alzheimers_31_40.txt	NCT01662882	Observation	history	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	abnormalities	INC	modified_by:significant;is_negated:without;
Y_Alzheimers_31_40.txt	NCT01662882	Condition	Binswanger's disease	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	abuse	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Observation	history	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Drug	experimental medication	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Drug	investigational medication	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Observation	history	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	multi-infarct dementia	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Observation	History	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	hypertension	EXC	modified_by:Uncontrolled;
Y_Alzheimers_31_40.txt	NCT01662882	Condition	infarct	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	renal failure	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	drug allergy	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	Mental retardation	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	hypersensitivity	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Drug	amyloid targeting therapy	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	diabetes	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Drug	immunotherapy	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	cancer	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	cerebrovascular event	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Drug	experimental medication	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	pulmonary disease	EXC	modified_by:clinically significant;
Y_Alzheimers_31_40.txt	NCT00267163	Condition	liver disease	EXC	modified_by:significant;
Y_Alzheimers_31_40.txt	NCT00267163	Condition	lacunes	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	TIAs	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Drug	chloral hydrate	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	carotid bruits	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	breastfeeding	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	Parkinson's disease	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Observation	history	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Measurement	urine beta-hCG	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	cognitive deterioration	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	Cushing's syndrome	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	myocardial infarction	EXC	has_TempMea:within the previous year;
Y_Alzheimers_31_40.txt	NCT00267163	Condition	cardiac disease	EXC	modified_by:unstable;
Y_Alzheimers_31_40.txt	NCT00267163	Procedure	MRI	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Observation	History	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Drug	folate	EXC	is_negated:not;is_negated:excluded;
Y_Alzheimers_31_40.txt	NCT01189084	Condition	systemic disease	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Measurement	periventricular white matter	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Drug	alcohol	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Measurement	low attenuation	EXC	
Y_Alzheimers_31_40.txt	NCT01189084	Condition	Alzheimer's disease	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	Extensive periventricular white matter disease	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	AIDS	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Drug	clonidine	EXC	
Y_Alzheimers_31_40.txt	NCT01189084	Drug	prohibited medications	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	Leukoaraiosis	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	hypersensitivity	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Drug	anti-Parkinsonian medications	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	cancer	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Drug	centrally active beta-blockers	EXC	
Y_Alzheimers_31_40.txt	NCT01189084	Condition	Alzheimer's disease	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	HIV infection	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Drug	narcotics	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	White matter deterioration	EXC	is_negated:not;is_negated:exclusion;
Y_Alzheimers_31_40.txt	NCT01249196	Condition	Alzheimer's disease	INC	
Y_Alzheimers_31_40.txt	NCT00267163	Drug	warfarin	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	AD	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Procedure	MRI	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Drug	vitamins	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Demographic	age	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	Leukoaraiosis	EXC	
Y_Alzheimers_31_40.txt	NCT02059356	Condition	cognitive decline	INC	
Y_Alzheimers_31_40.txt	NCT00267163	Drug	medications with significant cholinergic or anticholinergic effects	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	AD	EXC	
Y_Alzheimers_31_40.txt	NCT02059356	Condition	liver disease/cirrhosis	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Drug	anti-convulsants	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Drug	benzodiazepines	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	multiple infarctions	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Procedure	radiopharmaceutical for imaging or therapy	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Drug	systemic corticosteroids	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Drug	antipsychotics	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	infarct	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Measurement	physical exam	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Procedure	ECG	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	medical comorbidities	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	mania	EXC	has_TempMea:within the previous two years;
Y_Alzheimers_31_40.txt	NCT01662882	Observation	history	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	DSMIV criteria	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	infarcts	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Drug	secretase inhibitor	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	psychiatric disorders	EXC	modified_by:major;
Y_Alzheimers_31_40.txt	NCT01662882	Measurement	white matter lacunes	EXC	
Y_Alzheimers_31_40.txt	NCT00380302	Condition	Alzheimer's disease	EXC	is_negated:other than;
Y_Alzheimers_31_40.txt	NCT00267163	Condition	depression	EXC	modified_by:untreated;
Y_Alzheimers_31_40.txt	NCT00380302	Drug	memantine	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	hepatic, renal, pulmonary, metabolic or endocrine disease	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Drug	drugs	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	infarct	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	drug dependence	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Measurement	laboratory evaluations	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Observation	history	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Measurement	QTc	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	alcoholism	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	memory or cognitive decline	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Demographic	age	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	AD	EXC	
Y_Alzheimers_31_40.txt	NCT01249196	Condition	central nervous disease	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Measurement	biomarker studies	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Procedure	MRI scan	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	mild cognitive impairment	INC	
Y_Alzheimers_31_40.txt	NCT00267163	Procedure	metal	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	claustrophobia	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	cognitive impairment	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	dementia	EXC	
Y_Alzheimers_31_40.txt	NCT01249196	Condition	T.I.A	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Drug	psychotropic medications	EXC	
Y_Alzheimers_31_40.txt	NCT01249196	Condition	infarction	EXC	
Y_Alzheimers_31_40.txt	NCT00546767	Drug	study-distributed multi-vitamins	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	major depression	EXC	
Y_Alzheimers_31_40.txt	NCT01249196	Condition	Neurosyphilis	EXC	
Y_Alzheimers_31_40.txt	NCT00006187	Condition	surgically sterilized	EXC	is_negated:not;
Y_Alzheimers_31_40.txt	NCT01662882	Condition	cognitive impairment	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	schizophrenia	EXC	
Y_Alzheimers_31_40.txt	NCT01249196	Condition	AIDS	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Measurement	Clinical Dementia Rating	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	Diagnostic and Statistical Manual of Mental Disorders, 4th Edition ( DSM-IV ) criteria	EXC	
Y_Alzheimers_31_40.txt	NCT01249196	Condition	Vitamin B12/ Folic acid deficiency	EXC	
Y_Alzheimers_31_40.txt	NCT00006187	Condition	good health	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Measurement	CDR	INC	
Y_Alzheimers_31_40.txt	NCT01249196	Condition	Hypercalcemia	EXC	
Y_Alzheimers_31_40.txt	NCT00006187	Condition	postmenopausal	EXC	is_negated:not;
Y_Alzheimers_31_40.txt	NCT01662882	Condition	psychiatric disease	EXC	
Y_Alzheimers_31_40.txt	NCT01249196	Condition	Hypothyroidism	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Observation	history	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	AD	EXC	modified_by:probable;is_negated:other than;
Y_Alzheimers_31_40.txt	NCT01662882	Condition	cognitive decline	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Measurement	MMSE score	INC	
Y_Alzheimers_31_40.txt	NCT01249196	Condition	AD	INC	
Y_Alzheimers_31_40.txt	NCT00267163	Drug	ginkgo biloba	EXC	is_negated:other than;
Y_Alzheimers_31_40.txt	NCT01662882	Measurement	biomarker studies	EXC	
Y_Alzheimers_31_40.txt	NCT01249196	Procedure	MRI	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Procedure	computed tomography	EXC	
Y_Alzheimers_31_40.txt	NCT01249196	Condition	NINCDS-ADRDA criteria	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	dementia	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Procedure	CT	EXC	
Y_Alzheimers_31_40.txt	NCT01249196	Condition	DSM-IV	INC	
Y_Alzheimers_31_40.txt	NCT00267163	Drug	standard multivitamin supplement	EXC	is_negated:other than;
Y_Alzheimers_31_40.txt	NCT00006187	Condition	cardiovascular disease	EXC	
Y_Alzheimers_31_40.txt	NCT00006187	Condition	thyroid disease	EXC	
Y_Alzheimers_31_40.txt	NCT00006187	Condition	neurological or psychiatric illness	EXC	
Y_Alzheimers_31_40.txt	NCT00006187	Condition	head trauma	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Procedure	MRI	EXC	
Y_Alzheimers_31_40.txt	NCT01249196	Drug	AChEI	INC	has_value:at least 3 months;
Y_Alzheimers_31_40.txt	NCT00546767	Demographic	Age	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	impairment	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Procedure	CT	EXC	
Y_Alzheimers_31_40.txt	NCT01249196	Drug	memantine	INC	has_value:at least 3 months;
Y_Alzheimers_31_40.txt	NCT00267163	Condition	Contraindication	EXC	
Y_Alzheimers_31_40.txt	NCT00546767	Measurement	MMSE	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	AD	EXC	
Y_Alzheimers_31_40.txt	NCT01249196	Measurement	CDR	INC	
Y_Alzheimers_31_40.txt	NCT00267163	Drug	investigational drugs	EXC	
Y_Alzheimers_31_40.txt	NCT00546767	Drug	multi-vitamins	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	memory deterioration	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	cognitive deficit	EXC	
Y_Alzheimers_31_40.txt	NCT01249196	Measurement	MMSE score	INC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	insomnia	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Drug	nutraceuticals	EXC	modified_by:any;is_negated:not;
Y_Alzheimers_31_40.txt	NCT00267163	Measurement	MMSE score	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Measurement	MMSE score	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	cardiovascular disease	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Procedure	cardiac surgery	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	cerebrovascular disease	INC	modified_by:significant;is_negated:No;
Y_Alzheimers_31_40.txt	NCT00546767	Drug	cognitive-enhancing drugs	EXC	
Y_Alzheimers_31_40.txt	NCT00546767	Condition	Dementia	EXC	
Y_Alzheimers_31_40.txt	NCT00546767	Drug	Razadyne	EXC	
Y_Alzheimers_31_40.txt	NCT00546767	Drug	Aricept	EXC	
Y_Alzheimers_31_40.txt	NCT00546767	Drug	Namenda	EXC	
Y_Alzheimers_31_40.txt	NCT00546767	Drug	Exelon	EXC	
Y_Alzheimers_31_40.txt	NCT00546767	Condition	psychiatric, neurological or neurodegenerative conditions	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	Pick's disease	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Drug	antidepressants	INC	
Y_Alzheimers_31_40.txt	NCT00546767	Drug	multi-vitamins	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	frontotemporal dementia	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	cardiac arrhythmia	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	depressed	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	AD	EXC	is_negated:other than;
Y_Alzheimers_31_40.txt	NCT01662882	Condition	Parkinson's disease	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	decompensated congestive heart failure	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	Neurodegenerative disorders	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	angina	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Measurement	modified Ischemic Score	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	coronary artery disease	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	MCI	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	myocardial infarction	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	AD	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Observation	History	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Measurement	ADL	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	head trauma	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	behavioral disturbances	EXC	
Y_Alzheimers_31_40.txt	NCT00546767	Drug	Central Nervous System ( CNS ) medications	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	stroke	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	behavioral dysfunction	EXC	
Y_Alzheimers_31_40.txt	NCT00546767	Condition	cognitive impairment	EXC	
Y_Alzheimers_31_40.txt	NCT00546767	Condition	stroke	EXC	
Y_Alzheimers_31_40.txt	NCT00546767	Condition	Multiple Sclerosis	EXC	
Y_Alzheimers_31_40.txt	NCT00546767	Condition	Parkinson's disease	EXC	
Y_Alzheimers_31_40.txt	NCT00546767	Condition	Transient Ischemic Attack	EXC	
Y_Alzheimers_31_40.txt	NCT00546767	Condition	Huntington's disease	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	cognitive impairment	INC	
Y_Alzheimers_31_40.txt	NCT00267163	Demographic	Age	INC	
Y_Alzheimers_31_40.txt	NCT00546767	Condition	TIA	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	cognitive impairment	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	cardiovascular disease	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Measurement	MMSE score	INC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	age-associated memory impairment	INC	
Y_Alzheimers_31_40.txt	NCT00546767	Condition	Medical conditions	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	hepatic, renal, pulmonary, metabolic or endocrine disturbances	EXC	
Y_Alzheimers_31_40.txt	NCT00267163	Condition	AAMI	INC	
Y_Alzheimers_31_40.txt	NCT01249196	Condition	asthma	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	demented	INC	is_negated:not;
Y_Alzheimers_31_40.txt	NCT01662882	Condition	febrile convulsions	EXC	is_negated:except;has_TempMea:during childhood;
Y_Alzheimers_31_40.txt	NCT00267163	Condition	NIMH diagnostic criteria	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	epilepsy	EXC	
Y_Alzheimers_31_40.txt	NCT01249196	Condition	disorder	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	convulsions	EXC	
Y_Alzheimers_31_40.txt	NCT01249196	Condition	COPD	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	mixed dementia	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	Cognitive impairment	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Procedure	ECG	EXC	
Y_Alzheimers_31_40.txt	NCT00546767	Observation	life expectancy	EXC	
Y_Alzheimers_31_40.txt	NCT01780519	Measurement	MMSE score	INC	
Y_Alzheimers_31_40.txt	NCT01780519	Measurement	Hamilton Depression Rating Scale score	INC	
Y_Alzheimers_31_40.txt	NCT01780519	Condition	allergy	INC	
Y_Alzheimers_31_40.txt	NCT01780519	Condition	Alzheimer's Disease	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Procedure	cardiac surgery	EXC	
Y_Alzheimers_31_40.txt	NCT01780519	Condition	Mild Cognitive Impairment	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Procedure	anesthesia	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	Hypoxic cerebral damage	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	cardiac arrest	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Observation	history	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	subdural hematoma	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Observation	History	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	injuries secondary to chronic trauma	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	drug or alcohol abuse	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	cerebral trauma	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Measurement	QTc	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	post-traumatic brain injury	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	Huntington's chorea	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	conduction disturbance	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	Down's syndrome	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Drug	B12	EXC	modified_by:regular;is_negated:not;is_negated:excluded;
Y_Alzheimers_31_40.txt	NCT01780519	Condition	impaired liver or kidney function	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	atrial or ventricular fibrillation	EXC	
Y_Alzheimers_31_40.txt	NCT01780519	Condition	medical, psychiatric and neurological illnesses	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	Creutzfeldt-Jacob disease	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	syncope	EXC	
Y_Alzheimers_31_40.txt	NCT01780519	Condition	traumatic brain injury	INC	
Y_Alzheimers_31_40.txt	NCT01780519	Condition	stroke	INC	
Y_Alzheimers_31_40.txt	NCT01780519	Condition	cognitive impairment	INC	
Y_Alzheimers_31_40.txt	NCT01780519	Condition	memory impairment	INC	
Y_Alzheimers_31_40.txt	NCT01780519	Observation	history	INC	
Y_Alzheimers_31_40.txt	NCT01780519	Condition	parkinsonism	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	dementing / neurodegenerative disease	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	high blood pressure	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	congenital heart disease	EXC	
Y_Alzheimers_31_40.txt	NCT01780519	Drug	benzodiazepines	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	dementia with Lewy bodies	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	mitral or aortic valvular disease	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	Lewy body variant AD	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	Parkinson's disease	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	normal pressure hydrocephalus	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	near syncope	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	supranuclear palsy	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	alterations in mental status	EXC	
Y_Alzheimers_31_40.txt	NCT01780519	Condition	bipolar disorder	INC	
Y_Alzheimers_31_40.txt	NCT01780519	Condition	schizophrenia	INC	
Y_Alzheimers_31_40.txt	NCT01780519	Condition	major depression	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	encephalitis	EXC	
Y_Alzheimers_31_40.txt	NCT01780519	Condition	psychoactive substance use disorder	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	AIDS	EXC	
Y_Alzheimers_31_40.txt	NCT01780519	Drug	benzodiazepines	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	syphilis	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	meningitis	EXC	
Y_Alzheimers_31_40.txt	NCT01780519	Drug	medications	INC	
Y_Alzheimers_31_40.txt	NCT01780519	Drug	stimulant medications	INC	
Y_Alzheimers_31_40.txt	NCT01780519	Drug	sedating antihistamines	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	endocrine or metabolic disease	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	thyroid, parathyroid or pituitary disease	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	cerebral neoplasia	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	cognitive impairment	EXC	
Y_Alzheimers_31_40.txt	NCT00134953	Demographic	ages	INC	
Y_Alzheimers_31_40.txt	NCT00134953	Measurement	Mini Mental State Examination ( MMSE ) score	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	orthostatic hypotension	EXC	
Y_Alzheimers_31_40.txt	NCT00134953	Condition	Mild cognitive impairment	INC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	hypovolemia	EXC	
Y_Alzheimers_31_40.txt	NCT00134953	Condition	cerebrovascular disease	EXC	
Y_Alzheimers_31_40.txt	NCT00134953	Condition	neurodegenerative disorder	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	abscess	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	Korsakoff's syndrome	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	Cerebral infection	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	folate, vitamin B 12 and other B complex deficiencies	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	thiamin deficiency	EXC	
Y_Alzheimers_31_40.txt	NCT01662882	Condition	Vitamin deficiency	EXC	
Y_Alzheimers_31_40.txt	NCT00134953	Condition	neuropsychologic disturbances	EXC	
Y_Alzheimers_31_40.txt	NCT00380302	Procedure	brain image	INC	
Y_Alzheimers_31_40.txt	NCT00134953	Condition	secondary dementia	EXC	
Y_Alzheimers_31_40.txt	NCT00134953	Condition	depression	EXC	
Y_Alzheimers_31_40.txt	NCT00134953	Condition	epilepsy	EXC	
Y_Alzheimers_31_40.txt	NCT00134953	Condition	disease	EXC	
Y_Alzheimers_31_40.txt	NCT00006187	Demographic	age	INC	
Y_Alzheimers_31_40.txt	NCT00006187	Condition	postmenopausal	INC	
Y_Alzheimers_31_40.txt	NCT00006187	Condition	surgically sterilized	INC	
Y_Alzheimers_31_40.txt	NCT00006187	Condition	AD	INC	
Y_Alzheimers_31_40.txt	NCT00006187	Condition	AD	INC	is_negated:except;
Y_Alzheimers_31_40.txt	NCT00006187	Condition	medical problems	EXC	
Y_Alzheimers_31_40.txt	NCT00006187	Condition	cancer	EXC	
Y_Alzheimers_31_40.txt	NCT00380302	Condition	Alzheimer's disease	INC	
Y_Alzheimers_31_40.txt	NCT00380302	Condition	disease	INC	
Y_Alzheimers_31_40.txt	NCT00380302	Condition	Depression	EXC	
Y_Alzheimers_31_40.txt	NCT00380302	Condition	medical diseases	EXC	
Y_Alzheimers_31_40.txt	NCT00380302	Condition	Neurological disorder	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	post-menopausal	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	child-bearing potential	EXC	
Y_Alzheimers_41_50.txt	NCT00898807	Drug	Monoamine oxidases (MAO) inhibitors	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Drug	citalopram	INC	
Y_Alzheimers_41_50.txt	NCT02360657	Measurement	QTc	EXC	
Y_Alzheimers_41_50.txt	NCT02360657	Procedure	ICD	EXC	
Y_Alzheimers_41_50.txt	NCT02360657	Measurement	CSF	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	surgically sterile	EXC	
Y_Alzheimers_41_50.txt	NCT02360657	Observation	evidence	INC	
Y_Alzheimers_41_50.txt	NCT02360657	Measurement	Cerebrospinal Fluid	INC	
Y_Alzheimers_41_50.txt	NCT02360657	Measurement	Clinical Dementia Rating Scale- Japanese version (CDR-J) score	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Drug	dilantin	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Drug	psychostimulants	INC	
Y_Alzheimers_41_50.txt	NCT02360657	Measurement	Amyloid (A)-beta	INC	
Y_Alzheimers_41_50.txt	NCT02360657	Condition	amyloid deposition	INC	
Y_Alzheimers_41_50.txt	NCT01565343	Measurement	biomarker	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Procedure	PET	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	Alzheimer's	INC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	multi-infarct dementia	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Procedure	oophorectomy	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Procedure	hysterectomy	INC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	infarct	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Procedure	contraception	INC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	endocrine disease	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Drug	HRT treatment	INC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	mental retardation	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	menopause	INC	
Y_Alzheimers_41_50.txt	NCT01565343	Procedure	MRI	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	cognitive deficit	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	physical examination	INC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	AD	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Observation	medical history	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	menopause	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Procedure	MRI	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	congestive heart failure	INC	modified_by:moderate;
Y_Alzheimers_41_50.txt	NCT00265148	Observation	History	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	FSH levels	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Demographic	oestradiol	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	AD	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Measurement	Mini-Mental score	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Drug	investigational agent	INC	has_TempMea:5 half-lives;has_TempMea:within 30 days;
Y_Alzheimers_41_50.txt	NCT00265148	Condition	ECG abnormalities	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Condition	Alzheimer's disease	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	ECG abnormalities	INC	modified_by:Significant;
Y_Alzheimers_41_50.txt	NCT00898807	Condition	agitation	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Condition	agitation	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Procedure	procedures	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Measurement	CSF	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Drug	study medication	INC	is_negated:unable;
Y_Alzheimers_41_50.txt	NCT01565343	Condition	hepatic, renal, pulmonary, metabolic or endocrine disturbances	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	cardiovascular disease	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Procedure	ECG	INC	
Y_Alzheimers_41_50.txt	NCT01565343	Observation	History	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	New York Heart Association criteria	INC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	convulsions	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Procedure	PET	INC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	psychiatric disease	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	arthritis	INC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	epilepsy	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	back pain	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Drug	medication	INC	
Y_Alzheimers_41_50.txt	NCT01565343	Drug	investigational medication	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	abnormalities	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	abnormalities	INC	modified_by:significant;
Y_Alzheimers_41_50.txt	NCT01574456	Measurement	MMSE	INC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	mild cognitive impairment	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Drug	citalopram	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Drug	citalopram	INC	
Y_Alzheimers_41_50.txt	NCT01574456	Procedure	scanning	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	dementia	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Condition	hallucinations	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Observation	dose	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	prodromal dementia	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Procedure	antipsychotic treatment	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	medications	EXC	
Y_Alzheimers_41_50.txt	NCT00898807	Condition	Psychosis	INC	
Y_Alzheimers_41_50.txt	NCT02360657	Condition	healthy	INC	
Y_Alzheimers_41_50.txt	NCT01574456	Measurement	levels of A42, t-tau or p-tau	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Condition	delusions	INC	
Y_Alzheimers_41_50.txt	NCT00469456	Procedure	imaging	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Observation	History	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Observation	history	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	substantial memory complaints	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	schizophrenia	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Measurement	QTc	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Observation	History	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Procedure	ECG	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	renal or hepatic impairment	EXC	
Y_Alzheimers_41_50.txt	NCT00898807	Condition	agitation	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Condition	dementia	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Condition	brain vascular disease	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Condition	AD	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Observation	dose	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Condition	brain disease	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Condition	Alzheimer's disease	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Condition	traumatic brain injury	INC	
Y_Alzheimers_41_50.txt	NCT01574456	Measurement	Medial temporal lobe atrophy scale MTA	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Condition	multiple sclerosis	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Drug	medication	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Condition	Parkinson's disease	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Condition	contraindicated	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Condition	dementia with Lewy bodies	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Condition	Major Depressive Episode	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Condition	agitation	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Condition	agitation	INC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	Psychiatric or neurological disorders	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	Major depression	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	stroke	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	osteoarthritis	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	heart disease	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	rheumatoid arthritis	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	vascular disorders	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	cromolyn	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	NSAID	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	bipolar disorder	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	cromolyn	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	psychotic disorder NOS	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	Allergy	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	schizophrenia	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Observation	history	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	aspirin	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Observation	dose	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	chronic inflammatory diseases	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Drug	contrast agent Gadovist	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	large body tattoos	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	acetylcholinesterase inhibitors	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	Contraindications	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Procedure	metal implants	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	claustrophobia	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	abuse	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Procedure	brain surgery	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	bipolar disorder	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Procedure	cardiac pacemaker	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	alcohol or substance abuse or dependence	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	trauma	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	Contraindications	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	renal failure	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	rifampicin	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Measurement	estimated Glomular Filtration Rate eGFR	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	cromolyn	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	CYP2C9 inducers	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	carbamazepine	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	Structural abnormalities	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	Cognitive impairment	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	Meniere's disease	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	brain infections	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	stroke	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Measurement	FEV1	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Measurement	Standardised Mini-Mental State Examination	INC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	AD	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Measurement	FEV1/FVC	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Demographic	Age	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Measurement	pulmonary function test	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	asthma	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	alcohol/drug abuse	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	epilepsy	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	cognitive impairment	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	Opticrom	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	alcohol abuse	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	treatment for a psychotic disorder	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	Intal	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	Nasalcrom	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Observation	history	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	stroke	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Observation	history	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	epilepsy	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	traumatic brain injury	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	Fasting plasma glucose level	INC	has_value:>126mg/dL (>7.0mmol/L);
Y_Alzheimers_41_50.txt	NCT01574456	Condition	electroshock therapy	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	Nuprin	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	space occupying lesions	INC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	kidney dialysis	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	respiratory disorders	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	HbA1c	INC	has_value:6.2%;
Y_Alzheimers_41_50.txt	NCT01574456	Condition	brain surgery	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	Advil	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	brain trauma	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	Motrin	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	Parkinson's disease	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	ibuprofen	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	MS	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	aspirin	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	Gastrocrom	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	Allergies	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Measurement	diastolic BP	INC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	dementia	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	Ejection fraction	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	ECG heart rate	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Procedure	echocardiography	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Procedure	echocardiogram	INC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	Creutzfeldt-Jakob disease	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	1st degree heart block	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	sustained or paroxysmal arrhythmia	INC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	normal pressure hydrocephalus	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	Huntington's disease	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	Ventricular bigemini or couplets, triplets	INC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	Pick's disease	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	trifascicular block	INC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	Parkinson's disease	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	vascular dementia	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	neurological disorders	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Drug	cholinesterase inhibitor	INC	
Y_Alzheimers_41_50.txt	NCT02017340	Measurement	SMMSE	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	respiratory obstruction	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Drug	anticoagulation	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Drug	anti-arrhythmic agent	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Procedure	cardioversion	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	PR interval	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Observation	History	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	2nd or 3rd degree heart block	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	Multifocal ventricular ectopy	INC	
Y_Alzheimers_41_50.txt	NCT02017340	Measurement	Systolic BP	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	symptomatic bifascicular block	INC	
Y_Alzheimers_41_50.txt	NCT02017340	Measurement	diastolic BP	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	cerebrovascular disease	INC	
Y_Alzheimers_41_50.txt	NCT02017340	Measurement	Systolic BP	INC	
Y_Alzheimers_41_50.txt	NCT02017340	Drug	memantine	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	transient ischaemic attack	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	stroke	INC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	structural brain abnormalities	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	vascular dementia	INC	modified_by:possible, probable or definite;
Y_Alzheimers_41_50.txt	NCT00265148	Condition	haemorrhage	INC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	neurological deficits	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	CNS disorder	INC	modified_by:other;
Y_Alzheimers_41_50.txt	NCT00265148	Observation	History	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Observation	evidence	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	structural abnormality	INC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	valvular heart disease	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	dementia	INC	Specified_by:Parkinson's disease;Specified_by:epilepsy;Specified_by:structural abnormality;Specified_by:infectious or inflammatory/demyelinating CNS conditions;
Y_Alzheimers_41_50.txt	NCT02017340	Condition	chronic heart failure	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	syncope	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Drug	calcium channel blocker	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Drug	Beta-blocker	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	condition	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	brain tumor	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	epilepsy	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	Parkinson's disease	INC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	progressive supranuclear palsy	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	infectious or inflammatory/demyelinating CNS conditions	INC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	seizure disorder	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	peripheral oedema	INC	modified_by:Significant;
Y_Alzheimers_41_50.txt	NCT00265148	Condition	Congestive Heart Failure	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Observation	History	INC	
Y_Alzheimers_41_50.txt	NCT02017340	Observation	history	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	psychiatric illness	INC	Specified_by:schizophrenia;modified_by:major;Specified_by:depression;Specified_by:bipolar affective disorder;
Y_Alzheimers_41_50.txt	NCT02017340	Condition	loss of consciousness	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	head trauma	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	HIV disease	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	neurosyphilis	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	subdural hematoma	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	multiple sclerosis	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	bipolar affective disorder	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	schizophrenia	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	depression	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	Systolic blood pressure	INC	has_value:>165 mmHg;
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	diastolic blood pressure	INC	has_value:>95 mmHG;
Y_Alzheimers_41_50.txt	NCT00265148	Drug	antihypertensive therapy	INC	modified_by:optimal;
Y_Alzheimers_41_50.txt	NCT00265148	Condition	anaemia	INC	modified_by:Clinically significant;
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	haemoglobin	INC	has_value:<10 g/dL for females;has_value:<11g/dL for males;
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	HbA1c	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	haemoglobinopathies	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	creatinine clearance	INC	has_value:<30 ml/min (;
Y_Alzheimers_41_50.txt	NCT00265148	Condition	Renal dysfunction	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	AST	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	ALT	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	alkaline phosphatase	INC	has_value:>2.5 times the upper limit of normal laboratory range;
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	total bilirubin	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Observation	history	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	hepatobiliary disease	INC	modified_by:severe;
Y_Alzheimers_41_50.txt	NCT00265148	Condition	hepatitis B or C or cirrhosis	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	enzyme	INC	is_negated:without;modified_by:elevation;
Y_Alzheimers_41_50.txt	NCT00265148	Condition	Post-menopausal	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Demographic	aged	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	Mini Mental State Examination	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	MMSE	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	Alzheimer's disease	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	claustrophobia	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	Childs-Pugh classes	INC	has_value:B/C;
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	Fasting triglycerides	INC	has_value:>12mmol/L;has_TempMea:within the past 12 months;modified_by:Abnormal/positive;
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	vitamin B12	INC	has_value:</=200pg/mL;
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	thyroid stimulating hormone	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	syphilis serology	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Observation	History	INC	
Y_Alzheimers_41_50.txt	NCT00369603	Condition	post-menopausal	INC	
Y_Alzheimers_41_50.txt	NCT02017340	Measurement	ABPM	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	NINCDS-ADRDA criteria	INC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	Dubois criteria	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	abnormality	INC	modified_by:other;
Y_Alzheimers_41_50.txt	NCT00265148	Condition	vasomotor symptoms	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Observation	history	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Demographic	age	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	new cardiovascular event	INC	has_TempMea:within the last 6 months;
Y_Alzheimers_41_50.txt	NCT00265148	Observation	History	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	Repolarisation abnormalities	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	MI	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	Q waves	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	Left ventricular hypertrophy	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	Asymptomatice bifascicular block	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Procedure	vascular surgery	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Procedure	percutaneous coronary intervention	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	PR	INC	has_value:<=0.3 s;
Y_Alzheimers_41_50.txt	NCT00265148	Drug	anti-platelet or anticoagulant therapy	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	heart rate	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	AF	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	bundle branch block	INC	modified_by:Left or right;
Y_Alzheimers_41_50.txt	NCT00265148	Condition	Unifocal ventricular ectopic beats	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	Atrial ectopic beats	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Observation	non-compliance	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	Pregnancy	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Observation	risk	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	medical condition	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Observation	evidence	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	inhaled protein products	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	NINDS-AIREN	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	systemic illness	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Procedure	angiography plus stenting	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Procedure	cardiac surgery	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	DSM-IV criteria	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	lactation	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	DSM-IV criteria	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	AD	INC	is_negated:not;
Y_Alzheimers_41_50.txt	NCT01238458	Measurement	psychometrictesting	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	arrhythmia	INC	modified_by:significant;
Y_Alzheimers_41_50.txt	NCT00265148	Condition	angina	INC	modified_by:unstable;
Y_Alzheimers_41_50.txt	NCT00265148	Condition	Q-wave myocardial infarction	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	non Q-wave myocardial infarction	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	coronary syndrome	INC	modified_by:acute;
Y_Alzheimers_41_50.txt	NCT00265148	Procedure	intervention	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Procedure	intervention	INC	modified_by:major;
Y_Alzheimers_41_50.txt	NCT02547818	Condition	neurological disease	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Drug	memantine	INC	
Y_Alzheimers_41_50.txt	NCT02017340	Drug	cholinesterase inhibitors	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	medications	INC	
Y_Alzheimers_41_50.txt	NCT02017340	Observation	dose	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Measurement	Clinical Dementia Rating	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Observation	Global	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Measurement	Memory Box score	INC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	Healthy	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	AD	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Measurement	Cerebrospinal fluid (CSF) biomarker	INC	
Y_Alzheimers_41_50.txt	NCT01238458	Measurement	laboratory values	EXC	modified_by:abnormal;
Y_Alzheimers_41_50.txt	NCT02547818	Condition	AD	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	demented	INC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	NINDS-AIREN criteria	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Measurement	general cognitive function	INC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	breast feeding	EXC	has_TempMea:current;
Y_Alzheimers_41_50.txt	NCT02547818	Observation	dose	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	NINCDS-ADRDA criteria	INC	
Y_Alzheimers_41_50.txt	NCT01238458	Observation	history	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Measurement	CSF A-42 levels	INC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	medical or psychiatric illness	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	hemodynamically significant coronary artery disease	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	medications	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Procedure	bone marrow transplant	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	acetylcholinesterase inhibitors	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	memantine	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Observation	Neuropsychiatric Inventory	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	structural brain abnormalities	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	multiple sclerosis	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	symptomatic orthostatic hypotension	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	significant head trauma	EXC	
Y_Alzheimers_41_50.txt	NCT00898807	Condition	National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association criteria	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Drug	tacrine	INC	has_TempMea:within 30 days;
Y_Alzheimers_41_50.txt	NCT00469456	Condition	systemic disease	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	neurological abnormality	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	memantine	EXC	
Y_Alzheimers_41_50.txt	NCT00898807	Observation	NPI	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	normal pressure hydrocephalus	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	brain tumor	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	multi-infarct dementia	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	AD	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	Huntington's disease	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Measurement	ABPM measurement	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	Major depressive episode	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Measurement	resting office based BP measurements	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	Parkinson's disease	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	Pregnant	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	Diagnostic and Statistical Manual of Mental Disorders	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	pregnant	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	DSM-IV	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	drug or alcohol abuse or dependence	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	seizure disorder	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	aortic and mitral stenosis	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	subdural hematoma	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	healthy	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	progressive supranuclear palsy	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	NINCDS-ADRDA	INC	
Y_Alzheimers_41_50.txt	NCT02017340	Drug	investigational or other unapproved drug	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Drug	Nivadil	EXC	
Y_Alzheimers_41_50.txt	NCT00469456	Condition	AD	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Observation	history	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	hypersensitivity	EXC	
Y_Alzheimers_41_50.txt	NCT00469456	Condition	AD	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Drug	nilvadipine	EXC	
Y_Alzheimers_41_50.txt	NCT00469456	Measurement	Mini Mental State Examination (MMSE) score	INC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	bipolar disorder	EXC	
Y_Alzheimers_41_50.txt	NCT00469456	Measurement	Modified Hachinski Ischemia Score	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	major depression	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Measurement	DBP	EXC	
Y_Alzheimers_41_50.txt	NCT02360657	Condition	familial autosomal dominant AD	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Measurement	BP measurements	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Measurement	SBP	EXC	
Y_Alzheimers_41_50.txt	NCT02547818	Condition	Objective memory impairment	INC	
Y_Alzheimers_41_50.txt	NCT02360657	Measurement	body mass index	INC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	cognitive impairment	INC	modified_by:significant;is_negated:no;
Y_Alzheimers_41_50.txt	NCT00469456	Drug	memantine	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	cognitively normal	INC	
Y_Alzheimers_41_50.txt	NCT00469456	Observation	history	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Drug	study medication	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	non-compliance	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Procedure	MRI	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Drug	Investigational agents	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Drug	prescribed medication	INC	
Y_Alzheimers_41_50.txt	NCT00469456	Condition	alcohol or drug abuse	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Condition	schizophrenia	EXC	
Y_Alzheimers_41_50.txt	NCT00469456	Observation	Evidence	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Drug	agent	EXC	
Y_Alzheimers_41_50.txt	NCT00469456	Condition	neurologic disorders	EXC	
Y_Alzheimers_41_50.txt	NCT00469456	Drug	medication	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	gastro-intestinal, hepatic or renal disease	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	HADS	INC	
Y_Alzheimers_41_50.txt	NCT00369603	Condition	life-threatening illness or injury	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	Type I or Type II diabetes mellitus	INC	
Y_Alzheimers_41_50.txt	NCT00369603	Condition	stroke	EXC	
Y_Alzheimers_41_50.txt	NCT02360657	Condition	cognitive deficit	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Measurement	Hospital Anxiety and Depression Scale	INC	has_value:>7;
Y_Alzheimers_41_50.txt	NCT00369603	Condition	AIDS	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Observation	presence	INC	
Y_Alzheimers_41_50.txt	NCT00369603	Condition	head injury	EXC	
Y_Alzheimers_41_50.txt	NCT02360657	Condition	AD	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Observation	History	INC	
Y_Alzheimers_41_50.txt	NCT02360657	Condition	dementia	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	abnormality	INC	Specified_by:clinically relevant;
Y_Alzheimers_41_50.txt	NCT00369603	Condition	Alzheimer's Disease	EXC	
Y_Alzheimers_41_50.txt	NCT02360657	Procedure	implantable cardioverter defibrillator	EXC	
Y_Alzheimers_41_50.txt	NCT00369603	Condition	alcoholism	EXC	
Y_Alzheimers_41_50.txt	NCT02360657	Condition	atrio-ventricular [AV] block second degree or higher	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	condition	INC	modified_by:other;
Y_Alzheimers_41_50.txt	NCT00369603	Condition	dementia	EXC	
Y_Alzheimers_41_50.txt	NCT02360657	Procedure	permanent pacemaker	EXC	
Y_Alzheimers_41_50.txt	NCT02360657	Condition	brain disease	EXC	
Y_Alzheimers_41_50.txt	NCT00369603	Condition	Vascular dementia	EXC	
Y_Alzheimers_41_50.txt	NCT00898807	Drug	medications	INC	
Y_Alzheimers_41_50.txt	NCT02360657	Condition	abnormality	EXC	
Y_Alzheimers_41_50.txt	NCT00369603	Condition	Alzheimer's disease	INC	
Y_Alzheimers_41_50.txt	NCT02360657	Procedure	prostheses	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Measurement	DBP	EXC	
Y_Alzheimers_41_50.txt	NCT02360657	Procedure	implants	EXC	
Y_Alzheimers_41_50.txt	NCT02360657	Procedure	Magnetic Resonance Imaging	EXC	
Y_Alzheimers_41_50.txt	NCT02017340	Measurement	SBP	EXC	
Y_Alzheimers_41_50.txt	NCT02360657	Procedure	MRI	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	neurological or other medical conditions	INC	
Y_Alzheimers_41_50.txt	NCT00369603	Procedure	MRI	EXC	
Y_Alzheimers_41_50.txt	NCT02360657	Condition	mixed dementia	EXC	
Y_Alzheimers_41_50.txt	NCT00369603	Observation	HIstory	EXC	
Y_Alzheimers_41_50.txt	NCT02360657	Condition	AD	EXC	
Y_Alzheimers_41_50.txt	NCT00369603	Procedure	Metal implants	EXC	
Y_Alzheimers_41_50.txt	NCT02360657	Condition	Alzheimer's disease	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Observation	presence	INC	
Y_Alzheimers_41_50.txt	NCT00369603	Procedure	medical devises	EXC	
Y_Alzheimers_41_50.txt	NCT02360657	Condition	AD	EXC	
Y_Alzheimers_41_50.txt	NCT02360657	Procedure	pacemakers	EXC	
Y_Alzheimers_41_50.txt	NCT02360657	Procedure	claustrophobia	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Measurement	pregnancy testing	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	thyroid disease	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Measurement	Mini-Mental State Examination	INC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	vascular dementia	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	hepatic, renal, pulmonary, metabolic or endocrine disturbances	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	dementia	INC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	cardiovascular disease	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Measurement	MMSE	INC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	AD	INC	
Y_Alzheimers_41_50.txt	NCT01238458	Measurement	MMSE	INC	has_value:> 24;
Y_Alzheimers_41_50.txt	NCT01565343	Demographic	age	INC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	pregnant	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	cognitive decline	INC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	MCI	INC	
Y_Alzheimers_41_50.txt	NCT01565343	Observation	History	INC	
Y_Alzheimers_41_50.txt	NCT01565343	Measurement	MMSE	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Observation	History	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	alcohol abuse	INC	has_TempMea:within the past 6 months;
Y_Alzheimers_41_50.txt	NCT00369603	Observation	History	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	drug abuse	INC	has_TempMea:within the past 6 months;
Y_Alzheimers_41_50.txt	NCT00369603	Observation	History	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	medical or psychiatric condition	INC	
Y_Alzheimers_41_50.txt	NCT00369603	Condition	drug abuse	EXC	
Y_Alzheimers_41_50.txt	NCT02360657	Condition	left bundle branch block	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Observation	History	INC	
Y_Alzheimers_41_50.txt	NCT01238458	Measurement	Modified Hachinski ischemic score	EXC	has_value:>4;
Y_Alzheimers_41_50.txt	NCT01565343	Condition	AD	INC	
Y_Alzheimers_41_50.txt	NCT01565343	Demographic	age	INC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	angina	EXC	
Y_Alzheimers_41_50.txt	NCT00369603	Condition	developmental delay	EXC	
Y_Alzheimers_41_50.txt	NCT00265148	Observation	History	INC	
Y_Alzheimers_41_50.txt	NCT00369603	Condition	major psychiatric illness	EXC	
Y_Alzheimers_41_50.txt	NCT00369603	Condition	seizure disorder	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	syncope	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	conduction disturbance	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	progressive supranuclear palsy	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	atrial or ventricular fibrillation	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	NINCDS criteria	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	dementing / neurodegenerative disease	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	brain infection	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	congenital heart disease	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	brain cancer	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	hypoxic damage	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	high blood pressure	EXC	Specified_by:uncontrolled;
Y_Alzheimers_41_50.txt	NCT01565343	Condition	vitamin deficiency	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	Cognitive impairment	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	mitral or aortic valvular disease	EXC	Specified_by:severe;
Y_Alzheimers_41_50.txt	NCT01565343	Condition	trauma	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	near syncope	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	alterations in mental status	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	mixed dementia	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	cardiovascular disease	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	Neurodegenerative disorders	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	AD	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	decompensated congestive heart failure	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	Creutzfeldt-Jacob disease	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	cardiac arrhythmia	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	normal pressure hydrocephalus	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	coronary artery disease	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	Huntington's chorea	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	Down syndrome	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	myocardial infarction	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	Pick's disease	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	fronto-temporal dementia	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Procedure	cardiac surgery	EXC	
Y_Alzheimers_41_50.txt	NCT01565343	Condition	Parkinson's disease	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	neurodegenerative disorders	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	AD	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	epilepsy	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	brain infarction	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	psychiatric disease	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	cognitive impairment	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	brain damage	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	infectious disease	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	AIDS or HIV infection	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Observation	History	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	drug or alcohol abuse	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	HIV-1	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	HIV-2	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	hepatitis C	EXC	
Y_Alzheimers_41_50.txt	NCT01238458	Condition	hepatitis B	EXC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	dementia	INC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	prodromal dementia	INC	
Y_Alzheimers_41_50.txt	NCT01574456	Measurement	CDR	INC	
Y_Alzheimers_41_50.txt	NCT01574456	Measurement	MMSE	INC	
Y_Alzheimers_41_50.txt	NCT01574456	Measurement	Delayed Recall on Verbal Learning Test	INC	
Y_Alzheimers_41_50.txt	NCT01574456	Measurement	15 WLT	INC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	Memory impairment	INC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	dementia of the Alzheimer's type	INC	
Y_Alzheimers_41_50.txt	NCT01574456	Measurement	Clinical dementia rating	INC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	AD	INC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	prodromal AD	INC	
Y_Alzheimers_41_50.txt	NCT01574456	Measurement	MMSE	INC	
Y_Alzheimers_41_50.txt	NCT01574456	Condition	dementia	INC	
Y_Alzheimers_41_50.txt	NCT01574456	Measurement	CDR	INC	
Y_Alzheimers_41_50.txt	NCT00469456	Condition	DSM-IV	EXC	
Y_Alzheimers_41_50.txt	NCT00469456	Condition	AD	INC	
Y_Alzheimers_41_50.txt	NCT00469456	Condition	NINCDS-ADRDA	INC	
Y_Alzheimers_41_50.txt	NCT02360657	Procedure	12-lead electrocardiogram	INC	
Y_Alzheimers_41_50.txt	NCT02360657	Measurement	vital signs	INC	
Y_Alzheimers_41_50.txt	NCT02360657	Observation	medical history	INC	
Y_Alzheimers_41_50.txt	NCT02360657	Measurement	physical examination	INC	
Y_Alzheimers_41_50.txt	NCT02547818	Measurement	Visual and auditory acuity	INC	
Y_Alzheimers_41_50.txt	NCT02360657	Condition	contra-indications	EXC	
Y_Alzheimers_41_50.txt	NCT02360657	Procedure	ECG	INC	
Y_Alzheimers_41_50.txt	NCT00265148	Condition	menstrual period	INC	is_negated:without;
Y_Alzheimers_41_50.txt	NCT02547818	Condition	general health	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Drug	antipsychotics	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Drug	anticonvulsants	INC	
Y_Alzheimers_41_50.txt	NCT02360657	Measurement	vital signs	EXC	
Y_Alzheimers_41_50.txt	NCT02360657	Measurement	12-lead ECG	EXC	
Y_Alzheimers_41_50.txt	NCT02360657	Measurement	physical- or neurological examination	EXC	
Y_Alzheimers_41_50.txt	NCT00898807	Drug	benzodiazepines	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Drug	lorazepam	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Drug	antidepressants	INC	
Y_Alzheimers_41_50.txt	NCT00898807	Drug	trazodone	INC	
Y_Alzheimers_51_60.txt	NCT02471196	Drug	duloxetine	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Drug	medications with known relevant alpha-2C AR affinity	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Drug	reboxetine	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Drug	venlafaxine	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Drug	guanfacine	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Drug	tizanidine	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Drug	mianserin	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Drug	clonidine	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	AD	INC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	NINCDS-ADRDA	INC	
Y_Alzheimers_51_60.txt	NCT02546310	Observation	medical history	INC	
Y_Alzheimers_51_60.txt	NCT02546310	Drug	caffeinated drinks	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	non-childbearing potential	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	post-menopausal	INC	
Y_Alzheimers_51_60.txt	NCT02546310	Measurement	urine drug screen	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	reproductive potential	INC	
Y_Alzheimers_51_60.txt	NCT02546310	Measurement	alcohol breath test	EXC	
Y_Alzheimers_51_60.txt	NCT01294540	Condition	child-bearing potential	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Demographic	age	INC	
Y_Alzheimers_51_60.txt	NCT02471196	Condition	cognitive function	EXC	
Y_Alzheimers_51_60.txt	NCT02546310	Drug	Recreational drug	EXC	
Y_Alzheimers_51_60.txt	NCT02546310	Observation	History	EXC	
Y_Alzheimers_51_60.txt	NCT02546310	Observation	Personal or family history	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Measurement	follicle stimulating hormone [FSH] level	INC	
Y_Alzheimers_51_60.txt	NCT02546310	Condition	congenital long QT syndrome	EXC	
Y_Alzheimers_51_60.txt	NCT02546310	Measurement	urinalysis	INC	
Y_Alzheimers_51_60.txt	NCT02546310	Procedure	pre-study psychological assessment	INC	
Y_Alzheimers_51_60.txt	NCT02546310	Measurement	haematology	INC	
Y_Alzheimers_51_60.txt	NCT02546310	Measurement	blood chemistry	INC	
Y_Alzheimers_51_60.txt	NCT02546310	Measurement	vital signs	INC	
Y_Alzheimers_51_60.txt	NCT02546310	Procedure	12-lead ECG	INC	
Y_Alzheimers_51_60.txt	NCT02546310	Condition	Healthy	INC	
Y_Alzheimers_51_60.txt	NCT02546310	Measurement	physical examination	INC	
Y_Alzheimers_51_60.txt	NCT02471196	Condition	risk of suicide	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Measurement	serum -human chorionic gonadotropin (-hCG) test	INC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	post-traumatic / post-surgery	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	non-pregnant	INC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	brain disorders	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	AD	INC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	subdural hematoma	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	NINCDS-ADRDA	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	cognitive and functional decline	INC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	large-artery stroke	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Observation	Nonsmoker	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Observation	history	INC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	thrombotic stroke	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	DSM-V	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Procedure	MRI	INC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	dementia	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	AD	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	healthy	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	cancer	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	Alzheimer's disease	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	HIV	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Demographic	aged	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	lost	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	Alzheimer's disease	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	AD	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Observation	History	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	cerebrovascular disease	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	human immunodeficiency virus	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	Vascular dementia	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Measurement	vital sign measurements	INC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	"Mixed" dementia	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Observation	medical history	INC	
Y_Alzheimers_51_60.txt	NCT02546310	Condition	claustrophobia	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Measurement	physical examination	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Procedure	oophorectomy	INC	
Y_Alzheimers_51_60.txt	NCT02546310	Observation	History	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Procedure	tubal ligation	INC	
Y_Alzheimers_51_60.txt	NCT02546310	Condition	sudden death	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Procedure	surgically sterile	INC	
Y_Alzheimers_51_60.txt	NCT02546310	Condition	neurological or psychiatric conditions	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Procedure	hysterectomy	INC	
Y_Alzheimers_51_60.txt	NCT02467413	Measurement	MMSE	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	health	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Procedure	magnetic resonance imaging	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Procedure	electrocardiogram	INC	
Y_Alzheimers_51_60.txt	NCT02467413	Measurement	Mini-Mental State Examination	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Procedure	ECG	INC	
Y_Alzheimers_51_60.txt	NCT01565291	Measurement	MMSE	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	psychiatric disorder	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	emotional problems	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	cardiac disease	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	vascular dementia	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Measurement	mini mental state exam (MMSE) score	INC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	Parkinson's disease	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Observation	dose	INC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	hypertension	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	dementia	INC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	diabetes mellitus	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	NIAAA criteria	INC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	Cognitive impairment	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	central nervous system infection	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	trauma	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Observation	History	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Measurement	platelet	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Measurement	creatinine	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	Neurodegenerative disorders	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	alcohol or drug abuse	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	hydrocephalus	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Drug	medication	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Measurement	hemoglobin	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	head injury	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	stroke	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Observation	history	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	tumor	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	demyelinated disease	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Drug	donepezil	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Drug	acetylcholinesterase inhibitors	INC	
Y_Alzheimers_51_60.txt	NCT02467413	Procedure	contraceptive method(s)	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Drug	AChEIs	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	AD	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	lactating	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Drug	galantamine	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	psychiatric disorders	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	premenopausal with childbearing potential	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Observation	History	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	endocrine, gastrointestinal, cardiovascular, hematological, hepatic, immunological, renal, respiratory, genitourinary or major neurological abnormalities or diseases	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	Pregnant	EXC	
Y_Alzheimers_51_60.txt	NCT00064870	Condition	dementia	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	AD	INC	
Y_Alzheimers_51_60.txt	NCT02467413	Observation	history	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	NINDS-AIREN International Workshop criteria	INC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	AD	INC	
Y_Alzheimers_51_60.txt	NCT02467413	Observation	history	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	NIAAA criteria iii	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Drug	rivastigmine	INC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	illness	EXC	
Y_Alzheimers_51_60.txt	NCT02546310	Observation	history	EXC	
Y_Alzheimers_51_60.txt	NCT00064870	Condition	AD	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Drug	tacrine	INC	
Y_Alzheimers_51_60.txt	NCT02546310	Procedure	surgery involving metal implants	EXC	
Y_Alzheimers_51_60.txt	NCT02546310	Procedure	MRI	EXC	
Y_Alzheimers_51_60.txt	NCT02546310	Condition	contraindications	EXC	
Y_Alzheimers_51_60.txt	NCT01294540	Observation	family history	INC	
Y_Alzheimers_51_60.txt	NCT01294540	Observation	history	INC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	pulmonary, hepatic, gastrointestinal, metabolic, endocrine or other life threatening diseases	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Procedure	donated	EXC	
Y_Alzheimers_51_60.txt	NCT01294540	Condition	cardiac abnormalities	INC	
Y_Alzheimers_51_60.txt	NCT01294540	Measurement	BMI	INC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	syphilis	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Procedure	major surgery	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	acquired immune deficiency syndrome	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Drug	drugs	EXC	
Y_Alzheimers_51_60.txt	NCT02546310	Drug	cranberry	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Measurement	Corrected QT (QTc) interval	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	psychiatric disease	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Procedure	radiological evidence	EXC	
Y_Alzheimers_51_60.txt	NCT01294540	Condition	neurological abnormalities	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Procedure	investigational trial	EXC	
Y_Alzheimers_51_60.txt	NCT01294540	Condition	Thyroid abnormalities	INC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	Alzheimer's disease	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	dementia	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	brain diseases	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	endocrine disease	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	intolerability	EXC	
Y_Alzheimers_51_60.txt	NCT01316562	Demographic	Age	INC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	brain infection	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	anaphylactic reaction	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Measurement	AST	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	brain cancer	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Drug	prescription or non-prescription drugs or food	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Measurement	alanine aminotransferase	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	hypoxic damage	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	multiple and/or severe allergies	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Measurement	ALT	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	vitamin deficiency	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Measurement	total bilirubin	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Measurement	aspartate aminotransferase	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Condition	Alzheimer's Disease	INC	
Y_Alzheimers_51_60.txt	NCT02471196	Condition	Alzheimer's Disease	INC	
Y_Alzheimers_51_60.txt	NCT02471196	Measurement	Modified Hachinski Ischemia Score	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Drug	ingredients	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Measurement	hepatitis C antibodies	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Measurement	MHIS	EXC	
Y_Alzheimers_51_60.txt	NCT01294540	Measurement	Body mass index	INC	
Y_Alzheimers_51_60.txt	NCT02471196	Drug	donepezil	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	allergy	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	hypersensitivity	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Drug	AChE inhibitor	EXC	
Y_Alzheimers_51_60.txt	NCT01294540	Demographic	aged	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Drug	lidocaine	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Drug	medications	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	depression	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Measurement	-glutamyl transferase	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Drug	rivastigmine	EXC	
Y_Alzheimers_51_60.txt	NCT01294540	Demographic	Aged	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Measurement	hepatitis B surface antigen	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Measurement	-GT	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Measurement	alkaline phosphates	EXC	
Y_Alzheimers_51_60.txt	NCT02467413	Measurement	ALP	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	cognitive deficit	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Procedure	extensive radiological examination	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Procedure	MRI	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Observation	Dose	INC	
Y_Alzheimers_51_60.txt	NCT02471196	Drug	galantamine	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Drug	memantine	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Measurement	Neuropsychiatric Inventory agitation/aggression item score	INC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	mental retardation	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Drug	AChEI	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Drug	benzodiazepines	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	AD	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Drug	AChEI	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Drug	mirtazapine	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	multi-infarct dementia	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Procedure	MRI	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Drug	antidepressant	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Drug	short-acting sleep medications	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Procedure	PET scanning	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	infarct	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Drug	ionizing radiation	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Observation	dosing	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	claustrophobia	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Condition	Cognitive Impairment	INC	
Y_Alzheimers_51_60.txt	NCT01294540	Condition	Healthy	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Drug	radioactive substance	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Condition	agitation symptoms	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Drug	alcohol	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Drug	investigational medication	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Drug	herbal remedies	EXC	
Y_Alzheimers_51_60.txt	NCT02546310	Drug	pomegranate	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	cardiovascular disease	EXC	
Y_Alzheimers_51_60.txt	NCT02546310	Drug	star fruit	EXC	
Y_Alzheimers_51_60.txt	NCT02546310	Drug	grapefruit	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Drug	anticholinergic medication	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Drug	psychotropic agents	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Observation	dosing	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Observation	dosing	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	drug (including alcohol) abuse	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	NINCDS criteria	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	AD	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Measurement	biomarker	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Drug	symptomatic treatment	INC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	epilepsy	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Drug	illicit drugs	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	convulsions	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Observation	history	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Condition	C-SSRS	EXC	
Y_Alzheimers_51_60.txt	NCT02546310	Drug	Seville oranges	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Observation	History	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Drug	cannabis	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Condition	agitation	INC	
Y_Alzheimers_51_60.txt	NCT02546310	Drug	pomelos	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	hepatic, renal, pulmonary, metabolic or endocrine disturbances	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Drug	caffeine	EXC	
Y_Alzheimers_51_60.txt	NCT02546310	Drug	exotic citrus fruits	EXC	
Y_Alzheimers_51_60.txt	NCT01316562	Condition	Subjective memory complaint	INC	
Y_Alzheimers_51_60.txt	NCT02546310	Measurement	Mini Mental State Examination (MMSE) Score	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	non-breast feeding	INC	
Y_Alzheimers_51_60.txt	NCT02471196	Observation	dosing	EXC	
Y_Alzheimers_51_60.txt	NCT01316562	Condition	dementia	EXC	
Y_Alzheimers_51_60.txt	NCT02546310	Observation	presents	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Drug	antipsychotics	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	risk	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Condition	arrhythmia tendency	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Condition	heart failure	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Condition	ischemic cardiac disease	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Observation	history	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Measurement	height	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Measurement	weight	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Measurement	BMI	INC	
Y_Alzheimers_51_60.txt	NCT02471196	Condition	International Psychogeriatric Association Provisional Criteria	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	major depressive disorder	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Measurement	Body Mass Index	INC	
Y_Alzheimers_51_60.txt	NCT02467413	Condition	stroke	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Demographic	age	INC	
Y_Alzheimers_51_60.txt	NCT01316562	Condition	Sensory deficit	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	psychotic disorder	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Observation	History	INC	
Y_Alzheimers_51_60.txt	NCT02471196	Condition	Myocardial infarction	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Drug	galantamine	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Condition	malignancy	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	cognitive decline	INC	
Y_Alzheimers_51_60.txt	NCT02471196	Condition	Suicidal ideation	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Condition	suicide risk	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Measurement	Colombia-Suicide Severity Rating Scale	EXC	
Y_Alzheimers_51_60.txt	NCT01294540	Condition	abnormality	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Procedure	metal objects or fragments	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Procedure	MRI	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Procedure	MRI	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	non-pregnant	INC	
Y_Alzheimers_51_60.txt	NCT01565291	Measurement	psychometric testing	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Observation	History	EXC	
Y_Alzheimers_51_60.txt	NCT01294540	Procedure	electrocardiogram (ECG)	INC	
Y_Alzheimers_51_60.txt	NCT01565291	Observation	history	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Observation	History	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	neurological or neurodegenerative disorder	EXC	
Y_Alzheimers_51_60.txt	NCT01565291	Condition	cognitive impairment	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	AD	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Condition	cortical infarct	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Procedure	CT	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Measurement	Supine heart rate	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Measurement	silent lacuna	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Measurement	Systolic blood pressure	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Observation	evidence	INC	
Y_Alzheimers_51_60.txt	NCT02471196	Measurement	SBP	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Measurement	DBP	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Measurement	diastolic blood pressure	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Measurement	Rosen-Modified Hachinski score	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Measurement	MMSE score	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	memory or cognitive impairment	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	AD	INC	
Y_Alzheimers_51_60.txt	NCT02471196	Measurement	QTc-Fridericia	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Condition	Symptomatic orthostatic hypotension	EXC	
Y_Alzheimers_51_60.txt	NCT02471196	Measurement	QTcF	EXC	
Y_Alzheimers_51_60.txt	NCT02621606	Drug	nicotine	INC	
Y_Alzheimers_51_60.txt	NCT00927108	Procedure	craniotomy	INC	
Y_Alzheimers_51_60.txt	NCT00927108	Procedure	muscle biopsy	INC	
Y_Alzheimers_51_60.txt	NCT00927108	Procedure	ventriculostomy surgery	INC	
Y_Alzheimers_51_60.txt	NCT00927108	Procedure	nerve biopsy	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Observation	history	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Condition	subjective memory or other cognitive complaints	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Measurement	Mini Mental Status Examination (MMSE) score	INC	
Y_Alzheimers_51_60.txt	NCT02621606	Drug	nicotine-containing products	INC	
Y_Alzheimers_51_60.txt	NCT02471196	Measurement	thyroid-stimulating hormone (TSH), vitamin B12 or folate serum levels	EXC	
Y_Alzheimers_51_60.txt	NCT00927108	Condition	craniectomy	INC	
Y_Alzheimers_51_60.txt	NCT00927108	Condition	medical and surgical conditions	INC	
Y_Alzheimers_51_60.txt	NCT02471196	Demographic	Age	INC	
Y_Alzheimers_51_60.txt	NCT02471196	Procedure	computed tomography	INC	
Y_Alzheimers_51_60.txt	NCT02471196	Procedure	CT	INC	
Y_Alzheimers_51_60.txt	NCT02471196	Procedure	magnetic resonance imaging	INC	
Y_Alzheimers_51_60.txt	NCT02471196	Procedure	MRI	INC	
Y_Alzheimers_51_60.txt	NCT02471196	Measurement	Mini-mental state examination (MMSE) score	INC	
Y_Alzheimers_51_60.txt	NCT02471196	Drug	antidepressant	EXC	
Y_Alzheimers_51_60.txt	NCT00927108	Condition	Brain herniation	INC	
Y_Alzheimers_51_60.txt	NCT00927108	Condition	Central nervous system infection	EXC	
Y_Alzheimers_51_60.txt	NCT00927108	Condition	head injury	INC	
Y_Alzheimers_51_60.txt	NCT00927108	Condition	Viral infection	EXC	
Y_Alzheimers_51_60.txt	NCT00927108	Condition	bacterial infection	EXC	
Y_Alzheimers_51_60.txt	NCT00927108	Condition	tuberculous	EXC	
Y_Alzheimers_51_60.txt	NCT00927108	Condition	fungal infection	EXC	
Y_Alzheimers_51_60.txt	NCT00927108	Condition	Malignancy	EXC	
Y_Alzheimers_51_60.txt	NCT00927108	Condition	Central nervous system Tumor	EXC	
Y_Alzheimers_51_60.txt	NCT00927108	Condition	metastasis	EXC	
